<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06489100-20021203-D00001.TIF SYSTEM "US06489100-20021203-D00001.TIF" NDATA TIF>
<!ENTITY US06489100-20021203-D00002.TIF SYSTEM "US06489100-20021203-D00002.TIF" NDATA TIF>
<!ENTITY US06489100-20021203-D00003.TIF SYSTEM "US06489100-20021203-D00003.TIF" NDATA TIF>
<!ENTITY US06489100-20021203-D00004.TIF SYSTEM "US06489100-20021203-D00004.TIF" NDATA TIF>
<!ENTITY US06489100-20021203-D00005.TIF SYSTEM "US06489100-20021203-D00005.TIF" NDATA TIF>
<!ENTITY US06489100-20021203-D00006.TIF SYSTEM "US06489100-20021203-D00006.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06489100</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021203</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09440503</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19991115</PDAT></DATE></B220>
</B200>
<B400>
<B472>
<B473US/>
</B472>
</B400>
<B500>
<B510>
<B511><PDAT>C12Q  168</PDAT></B511>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>435  6</PDAT></B521>
<B522><PDAT>435 72</PDAT></B522>
<B522><PDAT>435108</PDAT></B522>
<B522><PDAT>435105</PDAT></B522>
<B522><PDAT>435200</PDAT></B522>
<B522><PDAT>536 237</PDAT></B522>
<B522><PDAT>536 241</PDAT></B522>
<B522><PDAT>536 232</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Microorganisms and methods for overproduction of DAHP by cloned PPS gene</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5906925</PDAT></DNUM>
<DATE><PDAT>19990500</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Liao</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435 72</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5985617</PDAT></DNUM>
<DATE><PDAT>19991100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Liao</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435 72</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>6210937</PDAT></DNUM>
<DATE><PDAT>20010400</PDAT></DATE>
<KIND><PDAT>B1</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Ward et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</PCIT><CITED-BY-EXAMINER/>
</B561>
</B560>
<B570>
<B577><PDAT>10</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>435 72</PDAT></B582>
<B582><PDAT>435  6</PDAT></B582>
<B582><PDAT>435108</PDAT></B582>
<B582><PDAT>435105</PDAT></B582>
<B582><PDAT>435200</PDAT></B582>
<B582><PDAT>536 237</PDAT></B582>
<B582><PDAT>536 241</PDAT></B582>
<B582><PDAT>536 232</PDAT></B582>
</B580>
<B590><B595><PDAT>6</PDAT></B595><B596><PDAT>14</PDAT></B596></B590>
</B500>
<B600>
<B630><B631><PARENT-US><CDOC><DOC><DNUM><PDAT>09/440503</PDAT></DNUM></DOC></CDOC><PDOC><DOC><DNUM><PDAT>08/801454</PDAT></DNUM><DATE><PDAT>19970218</PDAT></DATE><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>00</PDAT></KIND></DOC></PDOC><PSTA><PDAT>01</PDAT></PSTA><PPUB><DOC><DNUM><PDAT>5906925</PDAT></DNUM><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>A </PDAT></KIND></DOC></PPUB></PARENT-US></B631></B630>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>James C.</PDAT></FNM><SNM><STEXT><PDAT>Liao</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Los Angeles</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Texas A &amp; M University System</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>College Station</PDAT></CITY><STATE><PDAT>TX</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Bracewell &amp; Patterson, L.L.P.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>W. Gary</PDAT></FNM><SNM><STEXT><PDAT>Jones</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Janell E.</PDAT></FNM><SNM><STEXT><PDAT>Taylor</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>1655</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>Genetic elements comprising expression vectors and a gene coding for phosphoenol pyruvate synthase is utilized to enhance diversion of carbon resources into the common aromatic pathway and pathways branching therefrom. The overexpression of phosphoenol pyruvate synthase increases DAHP production to near theoretical yields.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This is a request for filing a Continuation under 37 C.F.R. &sect;1.60 of prior Ser. No. 08/801,454 filed on Feb. 18, 1997, now U.S. Pat. No. 5,906,925, and of prior Ser. No. 09/277,183 filed on Mar. 26, 1999, to be issued as U.S. Pat. No. 5,985,617, both of JAMES C. LIAO for MICROORGANISMS AND METHODS FOR OVERPRODUCTION OF DAHP BY CLONED PPS GENE.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>GOVERNMENT RIGHTS</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This work was supported in part by the National Science Foundation (Grant BCS-9257351), the Welch Foundation (Grant A-1251), and the Texas Higher Education Coordinating Board (Grant 999903-084). The United States Government may own non-exclusive rights in and to the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>FIELD OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>The present invention relates to the biosynthetic production of organic chemical compounds. In particular, the present invention relates to methods for increasing the yield of 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) in microorganisms through genetic alterations. The present invention also relates to methods of enhancing the production of cyclic and aromatic metabolites derived from DAHP in microorganisms through genetic alterations. For example, the biosynthesis of DAHP is the first step in the common aromatic pathway from which tyrosine, tryptophan, phenylalanine, and other aromatic metabolites are formed. Also, pathways branching from the common aromatic pathway provide such useful chemical products as catechol and quinoid organics such as quinic acid, benzoquinone, and hydroquinone. In addition, aspartame and indigo can be produced from products derived from the common aromatic pathway.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>Production of chemicals from microorganisms has long been an important application of biotechnology. Typically, the steps involved in developing a microorganism production strain include (i) selection of a proper host microorganism, (ii) elimination of metabolic pathways leading to by-products, (iii) deregulation of such pathways at both the enzyme activity level and the transcriptional level, and (iv) overexpression of appropriate enzymes in the desired pathways.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>The last three steps can now be achieved by use of a variety of in vivo and in vitro methods. These methods are particularly user-friendly in well-studied microorganisms such as </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>(</PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>). Therefore, many examples of engineered microorganisms for physiological characterization and metabolite production have been published.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>In most cases, the first target for engineering is the terminal pathway leading to the desired product, and the results are usually successful. However, further improvements of productivity (product formation rate) and yield (percent conversion) of desired products call for the alteration of central metabolic pathways which supply necessary precursors and energy for the desired biosyntheses of those products.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>Cyclic and aromatic metabolites such as tryptophan, phenylalanine, tyrosine, quinones, and the like trace their biosynthesis to the condensation reaction of phosphoenolpyruvate (PEP) and D-erythrose 4-phosphate (E4P) to form DAHP. DAHP biosynthesis is the first committed step in the common aromatic pathway. DAHP biosynthesis is mediated by three DAHP synthases or isoenzymes. These isoenzymes are coded by genes aroF, aroG, and aroH, whose gene products are feed-back inhibited by tyrosine, phenylalanine and tryptophan, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>After DAHP biosynthesis, some DAHP is converted to chorismate. Chorismate is an intermediate in biosynthetic pathways that ultimately leads to the production of aromatic compounds such as phenylalanine, tryptophan, tyrosine, folate, melanin, ubiquinone, menaquinone, prephenic acid (used in the production of the antibiotic bacilysin) and enterochelin. Because of the large number of biosynthetic pathways that depend from chorismate, the biosynthetic pathway utilized by organisms to produce chorismate is often known as the &ldquo;common aromatic pathway&rdquo;.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Besides its use in chorismate production, DAHP can also be converted to quinic acid, hydroquinone, benzohydroquinone, or catechol as described by Draths et al. (Draths, K. M., Ward, T. L., Frost, J. W., &ldquo;Biocatalysis and Nineteenth Century Organic Chemistry: conversion of D-Glucose into Quinoid Organics,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>1992, 114, 1925-26). These biosynthetic pathways branch off from the common aromatic pathway before shikimate is formed.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>The efficient production of DAHP by a microorganism is important for the production of aromatic metabolites because DAHP is the precursor in major pathways that produce the aromatic metabolites. The three aromatic amino acids, besides being essential building blocks for proteins, are useful precursor chemicals for other compounds such as aspartame, which requires phenylalanine. Additionally, the tryptophan pathway can be genetically modified to produce indigo.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>The production of tryptophan and phenylalanine by </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>has been well documented. For example, Aiba et al. (Aiba, S., H. Tsunekawa, and T. Imanaka, &ldquo;New Approach to Tryptophan Production by </PDAT><HIL><ITALIC><PDAT>Escherichia coli</PDAT></ITALIC></HIL><PDAT>: Genetic Manipulation of Composite Plasmids In Vitro,&rdquo; </PDAT><HIL><ITALIC><PDAT>Appl. Env. Microbiol. </PDAT></ITALIC></HIL><PDAT>1982, 43:289-297) have reported a tryptophan overproducer that contains overexpressed genes in the tryptophan operon in a host strain that is trpR and tna (encoding tryptophanase) negative. Moreover, various enzymes, such as the trpE gene product, have been mutated to resist feedback inhibition. Similar work has been reported for phenylalanine production.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>In the past, the enhanced commitment of cellular carbon sources entering and flowing through the common aromatic pathway has been accomplished with only modest success (i.e., such attempts have fallen far below the theoretical yield). Typically, the enhancements were accomplished, by transferring into host cells, genetic elements encoding enzymes that direct carbon flow into and/or through the common aromatic pathway. Such genetic elements can be in the form of extrachromosomal plasmids, cosmids, phages, or other replicons capable of transforming genetic elements into the host cell.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>U.S. Pat. No. 5,168,056 to Frost described the use of a genetic element containing an expression vector and a. gene coding for transketolase (Tkt), the tkt gene. This genetic element can be integrated into the microorganisms chromosome to provide overexpression of the Tkt enzyme.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>Additional examples include: Miller et al. (Miller, J. E., K. C. Backman, J. M. O&apos;Connor, and T. R. Hatch, &ldquo;Production of phenylalanine and organic acids by PEP carboxylase-deficient mutants of </PDAT><HIL><ITALIC><PDAT>Escherichia coli,&rdquo;J. Ind. Microbiol., </PDAT></ITALIC></HIL><PDAT>1987, 2:143-149) who attempted to direct more carbon flux into the amino acid pathway by use of a phosphoenolpyruvate carboxylase (coded by ppc) deficient mutant; Draths et al. (Draths, K. M., D. L. Pompliano, D. L. Conley, J. W. Frost, A. Berry, G. L. Disbrow, R. J. Staversky, and J. C. Lievense, &ldquo;Biocatalytic synthesis of aromatics from D-glucose: The role of transketolase,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>1992, 114:3956-3962) who reported that overexpression of transketolase (coded by tktA) and a feed-back resistant DAHP synthase (coded by aroG</PDAT><HIL><SP><PDAT>fbr</PDAT></SP></HIL><PDAT>) resulted in improved production of DAHP from glucose.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>The overproduction of transketolase in tkt transformed cells has been found to provide an increased flow of carbon resources into the common aromatic pathway relative to carbon resource utilization in whole cells that do not harbor such genetic elements. However, the increased carbon flux may be further enhanced by additional manipulation of the host strain.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>Thus, it is desirable to develop genetically engineered strains of microorganisms that are capable of enhancing the production of DAHP to near theoretical yield. Such genetically engineered strains can then be used for selective production of DAHP or in combination with other incorporated genetic material for selective production of desired metabolites. Efficient and cost-effective biosynthetic production of chorismate, quinic acid, hydroquinone, benzohydroquinone, catechol, or derivatives of these chemicals requires that carbon sources such as glucose, lactose, galactose, xylose, ribose, or other sugars be converted to the desired product in high yields. Accordingly, it is valuable from the standpoint of industrial biosynthetic production of metabolites to increase the influx of carbon sources for cell biosynthesis of DAHP and its derivatives.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>The present invention provides genetically engineered strains of microorganisms that overexpress the pps gene for increasing the production of DAHP to near theoretical yields. The present invention also provides genetically engineered strains of microorganisms where at least one of the plasmids pPS341, pPSL706, pPS706, or derivatives thereof is transformed into a microorganism for increasing the production of DAHP to near theoretical yields.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>The present invention further provides a method for increasing carbon flow for the biosynthesis of DAHP in a host cell comprising the steps of transforming into the host cell recombinant DNA comprising a pps gene so that Pps is expressed at enhanced levels relative to wild type host cells, concentrating the transformed cells through centrifugation, resuspending the cells in a minimal, nutrient lean medium, fermenting the resuspended cells, and isolating DAHP from the medium.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>The present invention further provides methods of increasing carbon flow into the common aromatic pathway of a host cell comprising the step of transforming the host cell with recombinant DNA comprising a pps gene so that Pps is expressed at appropriate point in the metabolic pathways at enhanced levels relative to wild type host cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>The present invention further provides methods for enhancing a host cell&apos;s biosynthetic production of compounds derived from the common aromatic pathway relative to wild type host cell&apos;s biosynthetic production of such compound, said method comprising the step of increasing expression in a host cell of a protein catalyzing the conversion of pyruvate to PEP.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>The present invention also provides methods for overexpressing Pps in microorganism strains which utilize DAHP in the production DAHP of metabolites.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>The present invention further provides a culture containing a microorganism characterized by overexpressing Pps where the culture is capable of producing DAHP metabolites near theoretical yields upon fermentation in an aqueous resuspension, minimal, nutrient lean medium containing assimilable sources of carbon, nitrogen and inorganic substances.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>The present invention further provides a genetic element comprising a pps gene and one or more genes selected from the group consisting of an aroF gene, aroG gene, aroH gene, and an aroB gene.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>The present invention further provides a DNA molecule comprising a vector carrying a gene coding for Pps.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>. Overexpression of Pps increases the production of DAHP. The host strain used was AB2847 and the plasmids used are as labeled in the figure. Note that pPSX1 and pUHE denote pPS341X1 and pUHE23-2, respectively. These strains were cultured first in the YE medium (a rich medium) to late stationary phase, and then washed and re-suspended in a minimal medium. (A) DAHP concentrations measured at 10 and 27 hours after re-suspension. (B) The activities of DAHP synthase (aroG) and Pps measured at 27 hours after re-suspension.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>. DAHP production at 10 and 27 hours after re-suspension. (A) Strain AB2847 with plasmids labeled in the abscissa. pPSX1 and pUHE denote pPS341X1 and pUHE23-2, respectively. (B) Strains AB2847 (labeled as AB), JCL1283 ppc::Km (labeled as ppc), and JCL1362 pps::MudK (labeled as pps) with plasmids labeled in the abscissa.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>. The reaction pathways for maximal conversion of glucose to DAHP for (A) strains without Pps, (B) strains overexpressing Pps. The numbers are the relative fluxes needed for converting 7 moles of glucose to DAHP. The abbreviations are: G6P, glucose 6-P; F6P, fructose 6-P; 1,6FDP, 1,6-fructose diphosphate; DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-P, R5P, ribose 5-P; X5P, xylulose 5-P; S7P, sedoheptulose 7-P.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>. The common aromatic pathway is shown whereby E4P and PEP under go a condensation reaction to initiate the common aromatic pathway.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>. The construction of pPSL706. Plasmids pPS706 and pGS103 were restricted with EcoRI and ScaI. The fragments containing pps from pPS706 and the fragment containing luxl&prime; were purified and ligated to generate pPSL706. Plasmid pPS706 was constructed by inserting a pps PCR fragment into 9 the cloning vector pJF118EH.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>. Effects of Pps activity on DAHP production from glucose at different IPTG and autoinducer concentrations. The strains are AB2847/pPSL706/pAT1 and AB2847/pPSL706/pRW5. Plasmid pGS 104 was used to substitute pPSL706 as a control, and the data are the leftmost point in each graph.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>Many microorganisms synthesize aromatic precursors and aromatic compounds from the condensation reaction of PEP and E4P to produce DAHP. This condensation reaction to form DAHP is the first committed step in the biosynthetic pathway known as the common aromatic pathway. From this pathway, cells synthesize many cyclic metabolites, pre-aromatic metabolites, and aromatic metabolites, such as the aromatic amino acids, quinone biomolecules, and related aromatic and cyclic molecules.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>The inventor have found that cell lines can be developed that increase the carbon flux into DAHP production and achieve near theoretical yields of DAHP by overexpressing phosphoenolpyruvate synthase (Pps) in the cell lines. Overexpression of Pps can increase the final concentration and yield of DAHP by as much as two-fold, to a near theoretical maximum as compared to wild type cell lines. The overexpression of Pps is achieved by transforming a cell line with recombinant DNA comprising a pps gene so that Pps is expressed at enhanced level relative to the wild type cell line and so that the yield of DAHP approaches its theoretical value.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>Generally, the present invention enhances expression in a host cell of Pps relative to a wild type host cell either by the transfer and stable incorporation of an extrachromosomal genetic element into the host cell or by the transfer of the genetic element into the genome of the host cell. The expressed gene products are enzymes configured to provide appropriate catalytic sites for substrate conversion of common aromatic pathway compounds.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>Besides the use of the pps gene, the present invention also provides for transfer of genetic elements comprising the tkt gene, the gene coding for DAHP synthase (aroF in </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>), the gene coding for 3-dehydroquinate synthase (arob in </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>), or other genes encoding enzymes that catalyze reactions in the common aromatic pathway. Such a cell transformation can be achieved by transferring one or more plasmids that contain genes that code for enzymes that increase the carbon flux for DAHP synthesis and for subsequent synthesis of other desired cyclic, pre-aromatic, and aromatic metabolites. As a result of this transfer of genetic element(s), more carbon enters and moves through the common aromatic pathway relative to wild type host cells not containing the genetic elements of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>In one embodiment, the present invention comprises a method for increasing carbon flow into the common aromatic pathway of a host cell by increasing the production of DAHP through the overexpression of Pps at the appropriate point in the common aromatic pathway to provide additional PEP at the point where PEP condenses with E4P. Increasing carbon flow requires the step of transforming the host cell with recombinant DNA containing a pps gene so that Pps is overexpressed at enhanced levels relative to wild type host cells. DAHP is then produced by fermentation of the transformed cell in a nutrient medium where the DAHP can be extracted from the medium on a batch wise or continuous extraction procedure.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>In another embodiment, the present invention involves the co-overexpression of a pps gene and other genes coding for enzymes of the common aromatic pathway where additional genetic material is transformed into the host cell. The genes transferred can include the tkt gene, DAHP synthase gene and DHQ synthase gene (preferably the aroF or aroB genes, respectively). Although the work so far has centered around transforming certain host cell strains of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>such as AB2847 aroB, this particular host cell may not be the preferred host cells for the commercial production of DAHP or DAHP metabolites through the overexpression of Pps.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>Another embodiment of the present invention is a method for enhancing a host cell&apos;s biosynthetic production of compounds derived from the common aromatic pathway. This method involves the step of increasing expression of Pps in the host cell relative to a wild type host cell. The step of increasing expression of Pps can include transferring into the host cell a vector carrying the pps gene. The overexpression of Pps results in forcing increased carbon flow into the biosynthesis of DAHP.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>In another embodiment of the present invention, a method for enhancing a host cell&apos;s biosynthetic production of compounds derived from the common aromatic pathway relative to wild type host cell&apos;s biosynthetic production of such compound is provided. This method requires the step of increasing expression in a host cell of a protein catalyzing conversion of pyruvate to PEP. The expression of such a protein can involve transferring into the host cell recombinant DNA including a pps gene.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the present invention comprises a genetic element comprising the pps gene and a gene selected from the group consisting of a aroF gene, a aroB gene, and a tkt gene. Such a genetic element can comprise plasmid pPS341, a vector carrying a pps gene.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>To channel more carbon flux into the common aromatic pathway, the inventor has found that PEP production in a given cell line must be increased. This increase can be achieved by deactivating pathways competing for PEP or by recycling pyruvate back into PEP.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>Besides being used in the biosynthesis of DAHP, PEP is used as a phosphate donor in the phosphotransferase system (PTS) which is responsible for glucose uptake. Additionally, PEP can be converted to pyruvate by pyruvate kinases and to oxaloacetate by phosphoenolpyruvate carboxylase. All such competing pathways limit the availability of PEP for the biosynthesis of DAHP and all metabolites derived from the common aromatic pathway or pathways branching therefrom.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Once PEP is converted to pyruvate by either PTS or pyruvate kinases, pyruvate is not generally recycled back to PEP because of a high energy cost. As a result, a large amount of carbon flux is channeled from PEP through pyruvate and eventually to organic acids, carbon dioxide, or cell mass.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>PEP is critical for the biosynthesis of DAHP and DAHP metabolites including all metabolites from the common aromatic pathway. The first committed step of the common aromatic pathway involves the formation of DAHP from the condensation of E4P and PEP. This condensation involves an aldol condensation between an intermediate carbanion of C-3 of PEP and the carbonyl C-1 of E4P. The majority of the PEP molecules react stereospecifically with respect to the configuration on C-3.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>A key component of the methods of the present invention directed at increased carbon flux commitment to DAHP and DAHP metabolites is the recycling of pyruvate to PEP. Pyruvate is available in host cells as an end product of glycolysis.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>In glycolysis, the free energy of degradation of glucose to pyruvate is utilized to synthesize ATP. Broadly speaking, this process involves an investment of ATP to form a phosphoryl compound (FBP) from glucose, which is then cleaved to two C</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>units. The free energy of this reaction is used in the oxidation of GAP which is then utilized to synthesize an acyl phosphate, a &ldquo;high-energy&rdquo; intermediate (1,3-BPG). 1,3-BPG is used to phosphorylate ADP to ATP. The second &ldquo;high-energy&rdquo; compound of the pathway, PEP, which is produced from 2PG, also phosphorylates ADP to ATP. Thus, the degradation of glucose via the glycolytic pathway produces pyruvate. The overall reaction of glycolysis is therefore:</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><F><PTEXT><PDAT>Glucose&plus;2</PDAT><HIL><ITALIC><PDAT>ADP</PDAT></ITALIC></HIL><PDAT>&plus;2</PDAT><HIL><ITALIC><PDAT>P</PDAT></ITALIC></HIL><PDAT>&plus;2</PDAT><HIL><ITALIC><PDAT>NAD&plus;&gt;</PDAT></ITALIC></HIL><PDAT>2 pyruvate&plus;2</PDAT><HIL><ITALIC><PDAT>ATP</PDAT></ITALIC></HIL><PDAT>&plus;2</PDAT><HIL><ITALIC><PDAT>NADH</PDAT></ITALIC></HIL><PDAT>&plus;4</PDAT><HIL><ITALIC><PDAT>H</PDAT></ITALIC></HIL><PDAT>&plus;2</PDAT><HIL><ITALIC><PDAT>H</PDAT></ITALIC></HIL><PDAT>20</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>The first step of glycolysis is the transfer of a phosphoryl group from ATP to glucose to form glucose-6-phosphate (G6P) in a reaction catalyzed by hexokinase. Hexokinase is a relatively nonspecific enzyme contained in all cells that catalyzes the phosphorylation of hexoses such as D-glucose, D-mannose, and D-fructose. The second substrate for hexokinase, as with other kinases, is an Mg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>&mdash;ATP complex. In fact, uncomplexed ATP is a potent competitive inhibitor of hexokinase.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>Hexokinase has a Random Bi Bi mechanism in which the enzyme forms a ternary complex with glucose and Mg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>&mdash;ATP before the reaction occurs. By complexing with the phosphate oxygen atoms, the Mg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> is thought to shield their negative charges, making the phosphorus atom more accessible for the nucleophilic attack of the C(6)&mdash;OH group of glucose.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>Next G6P is converted to fructose 6-phosphate (F6P) by phosphoglucose isomerase (PGI). This reaction is an isomerization of an aldose to a ketose. Since G6P and F6P both exist predominantly in their cyclic forms, the reaction requires ring opening, followed by isomerization, and subsequent ring closure. The overall reaction is thought to occur by enzyme mediated general acid-base catalysis.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>Next, phosphofructokinase (PFK) phosphorylates F6P to yield fructose 1,6-bisphosphate (FBP or F1,6P). PFK catalyzes the nucleophilic attack by the C(1)&mdash;OH group of F6P on the electrophilic y-phosphorus atom of the Mg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>&mdash;ATP complex.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>PFK plays a central role in control of glycolysis because it catalyzes one of the pathway&apos;s rate-determining reactions. In many organisms the activity of PFK is enhanced allosterically by several substances, including AMP, and inhibited allosterically by several other substances, including ATP and citrate. The regulatory properties of PFK are exquisitely complex.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>Aldolase then catalyzes the cleavage of FBP to form the two trioses glyceraldehyde-3-phosphate (GAP) and dihydroxyacetone phosphate (DHAP). This reaction is an aldol cleavage (the reverse of an aldol condensation). The aldol cleavage between. C(3) and C(4) of FBP requires a carbonyl at C(2) and hydroxyl at C(4).</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>Only one of the products of the aldol cleavage reaction, GAP, continues along the glycolytic pathway. However, DHAP and GAP are ketose-aldose isomers just as are F6P and G6P. Interconversion of GAP and DHAP is therefore possible via an enediolate intermediate in analogous to the phosphoglucomutase reaction. Triose phosphate isomerase (TIM) catalyzes this process.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>At this point, the glucose which has been transformed into two GAPs, has completed the preparatory stage of glycolysis. This process has required the expenditure of two ATPs. However, this investment has resulted in the conversion of one glucose into two C</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>units, each of which has a phosphoryl group that, with a little chemical artistry, can be converted to a &ldquo;high-energy&rdquo; compound whose free energy of hydrolysis can be coupled to ATP synthesis. This energy investment will be doubly repaid in the final stage of glycolysis in which the two phosphorylated C</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>units are transformed to two pyruvates with the coupled synthesis of four ATPs per glucose.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>The next step in glycolysis involves the oxidation and phosphorylation of GAP by NAD</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> and P, as catalyzed by glyceraldehyde 3-phosphate dehydrogenase (GAPDH). In this reaction, aldehyde oxidation, an exergonic reaction, drives the synthesis of the acryl phosphate 1,3-diphosphyglycerate (1,3-BPG).</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>The next reaction of the glycolytic pathway results in the first formation of ATP together with 3-phosphoglycerate (3PG) in a reaction catalyzed by phosphoglycerate kinase (PGK):</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>3PG is then converted to 2-phosphoglycerate (2PG) by phosphoglycerate mutase (PGM). This reaction is necessary preparation for the next reaction in glycolysis, which generates a &ldquo;high-energy&rdquo; phosphoryl compound for use in ATP synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>Subsequently, 2PG is dehydrated to phosphoenolpyruvate (PEP) in a reaction catalyzed by enolase. The enzyme forms a complex with a divalent cation such as Mg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> before the substrate is bound. Fluoride ion inhibits glycolysis with the accumulation of 2PG and 3PG. It does so by strongly inhibiting enolase in the presence of P</PDAT><HIL><SB><PDAT>i</PDAT></SB></HIL><PDAT>. The inhibitory species is fluorophosphate ion (FPO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><HIL><SP><PDAT>3&minus;</PDAT></SP></HIL><PDAT>), which probably complexes the enzyme-bound Mg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> thereby inactivating the enzyme. Enolase&apos;s substrate 2PG, therefore builds up and as it does so, is equilibrated with 3PG by PGM.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>Finally, pyruvate kinase (PK) couples the free energy of PEP hydrolysis to the synthesis of ATP to form pyruvate. At this point, glycolysis has produced PEP, one of the precursors to DAHP production and the entry way to the common aromatic pathway.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>Besides PEP, DAHP biosynthesis, as well as that of other products derived from the common aromatic pathway and pathways branching therefrom, depends on the biosynthesis of E4P.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>With reference to </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT>, E4P is a biosynthetic intermediate of the pentose phosphate pathway. The pentose phosphate pathway is situated between glycolysis and a variety of different biosynthetic cascades. This pathway yields E4P via a nonoxidative branch of the pathway. The nonoxidative pentose phosphate pathway converts D-fructose 6-phosphate into varying equivalents of D-ribose 5-phosphate, D-sedoheptulose 7-phosphate, and E4P. The first two end products are associated with the biosynthesis of nucleotides and gram-negative bacterial lipopolysaccharides, respectively, while E4P is a precursor to the aromatic amino acids: phenylalanine, tyrosine, and tryptophan.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>The initial siphoning of intermediates from glycolysis by the pentose phosphate pathway involves transketolase catalyzed transfer of a ketol group from D-fructose 6-phosphate to D-glyceraldehyde 3-phosphate to form E4P and D-xylulose 5-phosphate. Pentose phosphate epimerase then converts the D-xylulose 5-phosphate into D-ribulose 5-phosphate followed by pentose phosphate isomerase mediated transformation of the D-ribulose 5-phosphate into D-ribose 5-phosphate.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>At this stage, the D-ribose 5-phosphate can be exploited by transketolase as an acceptor of a ketol group derived from another molecule of D-fructose 6-phosphate forming a second molecule of E4P and D-sedoheptulose 7-phosphate. Finally, the enzyme transaldolase catalyzes transfer of a dihydroxyacetone group from the D-sedoheptulose 7-phosphate to D-glyceraldehyde 3-phosphate yielding the third molecule of E4P and D-fructose 6-phosphate. Thus, the nonoxidative pentose phosphate pathway achieves net conversion of two molecules of D-fructose 6-phosphate into three molecules of E4P.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>The condensation of PEP and E4P is catalyzed by the enzyme DAHP synthase. Many microorganisms, including </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>, produce three DAHP synthase isoenzymes: phenylalanine-sensitive DAHP synthase (phe), tyrosine-sensitive DAHP synthase (tyr), and tryptophan-sensitive DAHP synthase (trp). The tetrameric DAHP synthase (phe) has a subunit molecular weight of 35,000. The dimeric DAHP synthase (tyr) and DAHP synthase (trp) have subunit molecular weights approaching 40,000. The native forms of the enzymes are probably protein-PEP adducts. In </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>the structural genes for DAHP synthase (tyr), DAHP synthase (phe), and DAHP synthase (trp) are aroF, aroG, and aroH, respectively. These genes are located at 56, 17, and 37 min, respectively, on the </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>linkage map.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>In wild-type </PDAT><HIL><ITALIC><PDAT>E. coli, </PDAT></ITALIC></HIL><PDAT>80% of the total DAHP synthase activity is contributed by the phenylalanine-sensitive isoenzyme, while 20% is contributed by the tyrosine-sensitive isoenzyme. There are only traces of the DAHP synthase (trp) in </PDAT><HIL><ITALIC><PDAT>E. coli. </PDAT></ITALIC></HIL></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>After the condensation of PEP and E4P, the next reaction of the common aromatic pathway is an intramolecular exchange of the DAHP ring oxygen with C-7, accompanied by an oxidation at C-6 and a reduction at C-2. Cleavage of the phosphoester provides the driving force to form 3-dehydroquinate (DAH). This reaction is catalyzed by dehydroquinate synthase (DAH synthase).</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>Pure DAH synthase is a single polypeptide chain having a molecular weight of 40,000-44,000. The enzyme requires Co and NAD for activity, the latter in catalytic amounts. The formation of 3-dehydroquinate from DAHP is stereospecific and proceeds with inversion at the C-7 of DAHP without exchange of hydrogen with the growth medium.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>Quinoid organics are formed from pathways which branch from the common aromatic and utilize DAH. A stereospecific syn-dehydration of 3-dehydroquinate introduces the first double bond of the aromatic ring system to yield 3-dehydroshikimate. The reaction is catalyzed by 3-dehydroquinate dehydratase. Schiff base formation between enzyme and substrate causes a conformational change in the substrate (twisted boat) that leads to the stereospecific course of the reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>Shikimate biosynthesis from 3-dehydroshikimate is catalyzed by shikimate dehydrogenase. This NADP-specific enzyme facilitates the hydrogen transfer from the A-side of NADPH.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>Shikimate is phosphorylated to shikimate 3-phosphate by shikimate kinase. Shikimate kinase is a polypeptide of 10,000 daltons that is complexed with the bifunctional DAHP synthase-chorismate mutase. The kinase, only active in the complex, has been purified to homogeneity. Since the enzyme is inhibited by chorismate, prephenate, ADP, and 5-enolpyruvoylshikimate 3-phosphate are derepressed by growth on limiting tyrosine, shikimate kinase is believed to represent a key allosteric control point of the pathway in some types of host cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>Shikimate-3-phosphate reacts with PEP to form 5-enolpyruvoyl shikimate 3-phosphate and inorganic phosphate. The reversible enzyme-catalyzed reaction is a transfer of an unchanged enolpyruvoyl moiety of PEP. Protonation of C-3 of PEP combined with a nucleophilic attack of the 5-hydroxyl of shikimate leads to a presumed intermediate from which 5-enolpyruvoylshikimate 3-phosphate is obtained in a 1,2-elimination of orthophosphate. The reaction is catalyzed by 5-enolpyruvoylshikimate 3-phosphate synthase.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>The second double bond in the aromatic ring system is introduced through a trans-1,4-elimination of orthophosphate from 5-enolpyruvoyl shikimate 3-phosphate to yield chorismate. The reaction is catalyzed by chorismate synthase.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>From chorismate, the endpoint of the common aromatic pathway, biosynthesis of a diverse number of aromatic compounds is possible. For example, as indicated in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT>, the aromatic amino acids tryptophan, tyrosine, and phenylalanine can be synthesized from chorismate along their respective biosynthetic pathways. As previously noted, other commercially important aromatic compounds also produced from chorismate include folates, aspartame, melanin, prephenic acid, and indigo.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>In addition to the common aromatic pathway, other pathways utilizing DAHP produce other aromatic metabolites. For example, catechol and quinoid organics, such as quinic acid, benzoquinone and hydroquinone, can be produced from pathways branching from the common aromatic pathway.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>According to theoretical analyses, the inventor believes that the maximum yield of DAHP and aromatic amino acids from glucose can be increased by two-fold if pyruvate is recycled back to PEP. The maximum yield may be calculated by assuming that the branched pathways are blocked and that the carbon flow is directed by the most efficient pathways with minimum loss to carbon dioxide and other metabolites. Under these conditions and under steady state conditions, the relative flux through each step can be calculated by balancing the input and output fluxes from each metabolite pool.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3A</PDAT></FGREF><PDAT>, for maximum yield of DAHP production by strains without Pps overproduction, 7 moles of glucose are needed to produce 3 moles of DAHP (43% molar yield) and 7 moles of pyruvate which is further metabolized. The relative flux through each intermediate step is also shown in FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>A. The formation of pyruvate is necessary because of the stoichiometry of the phosphotransferase system for glucose uptake.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>In the presence of glucose, pyruvate is not recycled back to PEP efficiently because the enzyme Pps is not induced. The inventor has found that pyruvate is effectively recycled to PEP via overexpressed Pps, even in the presence of glucose, resulting in a two-fold, increase in DAPH which approaches, if not achieves, the theoretical levels for DAHP synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 3B</PDAT></FGREF><PDAT>, at the theoretical maximum, 6 moles of DAHP can be produced from 7 moles of glucose (86% molar yield). The nonoxidative part of the pentose pathway provides E4P, while overexpression of Pps recycles pyruvate back to PEP.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>The data described above and shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 3A and 3B</PDAT></FGREF><PDAT> are in agreement with this flux distribution model. Controls with inactive Pps and with no Pps demonstrate that enhanced activity, through overexpression of Pps, is required to achieve high yields of DAHP and, of course, DAHP metabolites including metabolites of the common aromatic pathway.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>In previous work, the inventor demonstrated that overexpression of Pps in host cells cultured on nutrient rich, glucose containing medium led to growth inhibition, increased glucose consumption, and excretion of pyruvate and acetate. Their previous study also showed that the effects of Pps overexpression on DAHP production, in actively growing cultures, are not as significant, and that the adverse effects of Pps overexpression on cell growth negated any beneficial effects on DAHP production.</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>The stimulation of glucose consumption in the previous work was attributed to the altered PEP/pyruvate ratio. It was hypothesized that increased PEP/pyruvate ratio stimulates the phosphotransferase system for increased glucose consumption, which in turn results in the excretion of pyruvate.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>The inventor discovered that the problem of growth impairment could be overcome through the use of high density re-suspension cultures grown in nutrient lean, glucose media. Such re-suspension cultures attain high metabolic activity with low growth rates. This discovery led to DAHP yields approaching theoretical values.</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>In the present invention, PEP was redirected to the aromatic pathway, and thus the PEP/pyruvate ratio was decreased. This flux redirection explains the insensitivity of the specific glucose consumption rate to Pps overexpression in the experimental system of the present invention. The increased DAHP production from glucose caused by Pps overexpression also suggests that Pps actually functions in its physiological direction (from Pyruvate to PEP ) in vivo, even under glycolytic conditions.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>PEP is also a precursor to the pathways that utilize the Ppc enzyme coded by the ppc gene. It has been reported that the deletion of ppc increased the production of phenylalanine and acetate. Moreover, it has been shown that the overexpression of Ppc in a wild-type host reduces acetate production. Both results may indicate that the flux through Ppc (from PEP to OAA) is reasonably significant under those conditions, and thus, the modulation of Ppc expression level may affect the utilization of PEP. However, in the present invention, deleting the chromosomal ppc gene did not have a positive effect on DAHP production, suggesting that the flux through Ppc is not important in the methods of the present invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>One preferred embodiment of the present invention encompasses modification of a host cell to cause overexpression of an enzyme having the catalytic properties of naturally derived Pps, and, thereby maximizing the yield of DAHP to near theoretical yields. Enzymes having the catalytic activity of Pps include, but are not limited to, Pps produced by expression in whole cells of a naturally derived pps gene, enzymes produced by expression in whole cells of a naturally derived pps gene modified by sequence deletion or addition so that the expressed enzyme has an amino acid sequence that varies from unmodified Pps, abzymes produced to have catalytic sites with steric and electronic properties corresponding to catalytic sites of Pps, or other proteins produced to have the capability of catalyzing the conversion of pyruvate to PEP by any other art recognized means.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>In another preferred embodiment, the inventor has observed that the Pps effect on DAHP production is enhanced by the simultaneous overexpression of Tkt. Such simultaneous overexpression ensures that both precursors necessary for DAHP biosynthesis are overproduced. Although simultaneous overexpression of Pps and Tkt may be required to attain near theoretical yields of DAHP, the overexpression of Pps alone in the methods of the present invention significantly enhanced DAHP production over Tkt overexpression alone (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>A). This result may suggest that without pyruvate recycling mediated by Pps (FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>A), sufficient PEP flux to DAHP synthesis cannot be achieved.</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>Additionally, the transformation of DNA, including the pps gene, into microorganisms engineered for the overexpression of other substrates, and/or overexpression or derepression of enzymes in the pentose phosphate or common aromatic pathway can be used to tailor the microorganism to achieve near theoretical yields of such DAHP metabolites as tyrosine, tryptophan, phenylalanine, and other aromatic metabolites such as indigo, catechol and quinoid organics such as quinic acid, benzoquinone, and hydroquinone.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>Enzymes catalyzing reactions in the pentose phosphate or common aromatic pathway include those enzymes produced by expression in whole cells of naturally derived pentose phosphate or common aromatic pathway genes, enzymes produced by expression of naturally derived pentose phosphate or common aromatic pathway genes that have been modified by sequence deletion or addition so that the expressed enzyme has an amino acid sequence that. differs from the natural enzyme, or abzymes having catalytic sites with steric and electronic properties corresponding to catalytic sites of a natural enzyme in the common aromatic or pentose phosphate pathway.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>Pps or enzymes having Pps-like catalytic activity can be overexpressed relative to Pps production in wild type cells (as measured by standard PEP synthase activity assays known in the art and described in Example 1) in conjunction with any number of other enzymes in the common aromatic pathway or pathways branching therefrom. For example, overexpression of Pps, DAHP synthase, and transketolase; Pps, DHQ synthase, and transketolase; Pps, DAHP synthase, DHQ synthase, and transketolase; Pps, transketolase, and shikimate kinase; Pps, transketolase (Tkt), and chorismate mutase; or any other common aromatic pathway enzymes in conjunction with Pps overproduction can enhance carbon source input to and/or throughput of the common aromatic pathway.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>Enhanced expression of genes coding for proteins able to perform or control pentose phosphate or common aromatic pathway enzymatic functions is mediated by genetic elements transferable into a host cell. Genetic elements as herein defined include nucleic acids (generally DNA or RNA) having expressible coding sequences for products such as proteins, apoproteins, or antisense RNA, which can perform or control pentose phosphate or common aromatic pathway enzymatic functions. The expressed proteins can function as enzymes, as repressor or derepressor agents, or to control enzyme expression.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>The nucleic acids coding these expressible sequences can be either chromosomal (e.g., integrated into a host cell chromosome by homologous recombination) or extrachromosomal (e.g., carried by plasinids, cosmids, etc.). In addition, genetic elements are defined to include optional expression control sequences including promoters, repressors, and enhancers that act to control expression or derepression of coding sequences for proteins, apoproteins, or antisense RNA. For example, such control sequences can be inserted into wild type host cells to promote overexpression of selected enzymes already encoded in the host cell genome, or alternatively can be used to control synthesis of extrachromosomally encoded enzymes.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>The genetic elements of the present invention can be introduced into a host cell by a genetic agent including, but not limited to, plasmids, cosmids, phages, Yeast artificial chromosomes or other vectors that mediate transfer of the genetic elements into a host cell, or mixtures thereof. These vectors can include an origin of replication along with cis-acting control elements that control replication of the vector and the genetic elements carried by the vector. Selectable markers can be present on the vector to aid in the identification of host cells into which the genetic elements have been introduced. For example, selectable markers can be genes that confer resistance to particular antibiotics such as tetracycline, ampicillin, chloramphenicol, kanamycin, or neomycin.</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>A preferred means for introducing genetic elements into a host cell utilizes an extrachromosomal multi-copy plasmid vector into which genetic elements in accordance with the present invention have been inserted. Plasmid borne introduction of the genetic element into host cells involves an initial cleaving of a plasmid with a restriction enzyme, followed by ligation of the plasmid and genetic elements in accordance with the invention. Upon recircularization of the ligated recombinant plasmid, transformation or other mechanisms for plasmid transfer (e.g., electroporation, microinjection, etc.) is utilized to transfer the plasmid into the host cell.</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>Plasmids suitable for insertion of genetic elements into the host cell include, but are not limited to, pBR322 and its derivatives such as pAT153, pXf3, pBR325, and PBR327, pUC vectors, pACYC and its derivatives, pSC101 and its derivatives, and ColEI. U.S. Pat. No. 5,168,056, incorporated herein by reference, teaches the incorporation of the tkt gene which codes for the enzyme Tkt into host cell. Tkt catalyzes the conversion of the carbon source D-fructose-6-phosphate to E4P, one DAHP precursor.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>Suitable host cells for use in the present invention are members of those genera capable of being utilized for industrial biosynthetic production of desired aromatic compounds. Accordingly, host cells can include prokaryotes belonging to the genera Escherichia, Corynebacterium, Brevibacterium, Arthrobacter, Bacillus, Pseudoinonas, Streptomyces, Staphylococcus, or Serratia. Eukaryotic host cells can also be utilized, with yeasts of the genus Saccharoinyces or Schizosaccharoinyces being preferred.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>More specifically, prokaryotic host cells suitable for use in the present invention include, but are not limited to, </PDAT><HIL><ITALIC><PDAT>Escherichia coli, Corynebacterium glutamicuni, Corynebacterium herculis, Brevibacteriuni divaricatum, Brevibacterium lactofermeiztuimi, Brevibacterium flavum, Bacillus brevis, Bacillus cereus, Bacillus circulans, Bacillus coagulans, Bacillus lichenfonis, Bacillus megaterium, Bacillus mesenztericus, Bacillus pumilis, Bacillus subtilis, Pseudoliioizas aerugiizosa, Pseudomonas aiigulata, Pseudomnonas fluorescent, Pseudoiizoizas tabaci, Streptoomyces aureofaciens, Streptonzyces avernzitilis, Streptomyces coelicolor, Streptonzyces griseus, Streptolnyces kasugensis, Streptoiyces lavendulae, Streptomyces lipnianii, Streptornyces lividans, Staphylococcus epidermis, Staphylococcus saprophyticus</PDAT></ITALIC></HIL><PDAT>, or </PDAT><HIL><ITALIC><PDAT>Serratia marcescens </PDAT></ITALIC></HIL><PDAT>and their genetically engineered strains or mixtures thereof. Preferred eukaryotic host cells include </PDAT><HIL><ITALIC><PDAT>Saccharoniyces cerevisiae </PDAT></ITALIC></HIL><PDAT>or </PDAT><HIL><ITALIC><PDAT>Saccharomyces carlsbergensis </PDAT></ITALIC></HIL><PDAT>and their genetically engineered strains or mixtures thereof.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>For industrial production of primary metabolites derived from chorismate (such as aromatic amino acids), deregulated mutant strains of the above recited species that lack feedback inhibition of one or more enzymes in the metabolic biosynthetic pathway are preferred. Such strains can be created by random or directed mutagenesis, or are commercially available. Examples of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strains having DAHP synthase, prephenate dehydratase, or chorismate mutase feedback inhibition removed are described in U.S. Pat. No. 4,681,852 to Tribe and U.S. Pat. No. 4,753,883 to Backman et al., incorporated herein by reference.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>To overcome the stoichiometric limitations in the condensation of E4P and PEP, the present invention overexpresses Pps in the presence of glucose and directs more carbon flux into the production of DAHP.</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>The following list of abbreviations for compounds commonly noted in the specification and Examples is presented as follows:</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="offset" colwidth="14pt" align="left"/>
<colspec colname="1" colwidth="35pt" align="left"/>
<colspec colname="2" colwidth="168pt" align="left"/>
<thead>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry></entry>
<entry><PTEXT><PDAT>DHQ</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3-dehydroquinate</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>DAH</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3-deoxy-D-arabino-heptulosonic acid</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>DAHP</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3-deoxy-D-arabino-heptulosonic acid 7-phosphate</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>TSP</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>3-(trimethylsilyl)propionic-2, 2, 3, 3-d sub 4 acid,</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>sodium salt</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>PEP</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Phosphoenol pyruvate</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>NADH</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>beta-nicotinamide adenine dinucleotide phosphate,</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>reduced form</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Kan</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>kanamycin</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Ap</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>ampicillin</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Tc</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>tetracycline</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>Cm</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>chloramphenicol</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry namest="OFFSET" nameend="2" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00101" LVL="7"><PTEXT><PDAT>Strains and Plasmids</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>AB2847 aroB mal T6</PDAT><HIL><SP><PDAT>r</PDAT></SP></HIL><PDAT>, obtained from </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>Genetic Stock Center, Yale University, was used as the preferred host strain for DAHP production. BJ502 tkt-2 fhuA22 garB10 ompF627 fadL701 relA1 pit-10 spoT1 mcrB1 phoM510, also from </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>Genetic Stock Center, was used in the identification of the tkt clone. JCL1242 ppc::Km was constructed as described previously by inserting a kanamycin cassette into a cloned ppc gene, which is then integrated into the chromosome by homologous recombination.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>Plasmid pPS341 was constructed by cloning a fragment of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>chromosomal DNA containing pps gene into an IPTG-inducible expression vector pUHE23-2 (a pBR322 derivative) as taught by Patnaik et al., and the contents of which are herein incorporated by reference. Plasmid pPS341X1 containing the inactive gene product of pps was constructed by codon insertion mutagenesis, the details of wvlhich are fully described in Patnaik et al. The pps gene on pPS341 was inserted with a Mu dII1734 lac</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> Km</PDAT><HIL><SP><PDAT>r </PDAT></SP></HIL><PDAT>(MudK) according to published protocol of Castiho et al., the contents of which are herein incorporated by reference. Briefly, a Mu lysate was made from a donor strain POII1734/pPS341, which was lysogenized by the mini-Mu element and a Mu cts. The lysate was used to infect a Mu lysogen of HG4 pps pck, and colonies were selected for Ap</PDAT><HIL><SP><PDAT>r </PDAT></SP></HIL><PDAT>and Km</PDAT><HIL><SP><PDAT>r </PDAT></SP></HIL><PDAT>simultaneously to ensure that the mini-Mu element hopped to the plasmid. Colonies were further screened for Pps</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> phenotype (inability to grow on pyruvate). Restriction analysis of plasmid DNA further confirmed the insertion of the MudK element into the pps gene on plasmid pPS341. 20% of these selected colonies showed IPTG-dependent expression of &bgr;-galactosidase, indicating an in-frame insertion. Plasmid from one such colony was named pPS1734, which was then linearized at the Scal site, and then transformed into strain JC7623 recB21 recC22 sbcB15. Transformants were selected for Km</PDAT><HIL><SP><PDAT>r </PDAT></SP></HIL><PDAT>and scored for Ap sensitivity. Such colonies presumably contained pps::MudK on the chromosome. By use of P1 transduction, this locus was moved to AB2847 and Km</PDAT><HIL><SP><PDAT>r </PDAT></SP></HIL><PDAT>transductants were further screened for inability to grow on pyruvate. One such colony was designated JCL1362 and used for later studies. The MudK insertion into chromosomal pps was further confirmed by cotransduction frequency (89%) with Tet</PDAT><HIL><SP><PDAT>r </PDAT></SP></HIL><PDAT>marker from strain CAG12151 zdh-925::Tn10.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>Plasmid pRW5, Genencor International, South San Francisco, Calif., is a pACYC derivative and contains aroG</PDAT><HIL><SP><PDAT>fbr</PDAT></SP></HIL><PDAT>. This plasmid also contains a lad gene, and the aroGfbr is expressed from a lac promoter. To construct plasmid pAT1 containing both aroG</PDAT><HIL><SP><PDAT>fbr </PDAT></SP></HIL><PDAT>and tktA, a 5-Kb BamH1 fragment of </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>DNA was cut from page 473 of the Kohara miniset (National Institute of Genetics, Japan), and was inserted into the BamH1 site of pRW5. This fragment was reported to contain the tktA gene, and was confirmed by its ability to complement a tkt strain (BJ502) for growth on ribose, and also from the migration distance of the gene product as judged on a 12% SDS-PAGE (molecular weight ca. 72,500).</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="7"><PTEXT><PDAT>Construction of pPS706 and the Control</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>The plasmid pPS706 was constructed by inserting a 2.4 kb PCR fragment containing the promoter-less pps gene into the vector pJF118EH. The primers were designed from the published pps sequence and contained an EcoRI site and a &phgr;10 ribosome binding site upstream of the pps sequence and a BainzHl site downstream of the sequence. The PCR product was then cloned into the EcoRI and BaZizHI sites of pJF118EH. Positive clones were selected based on complementation of HG4 pps for growth on pyruvate. Expression of pps from this construct is controlled by the tac promoter inducible by IPTG.</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>The plasmid pPSL706 was then constructed from pPS706 as shown in FIG. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>. Briefly, a ScaI/EcoRI fragment containing the pps gene was cut from pPS706 and purified from the restriction buffer. This fragment was then cloned into a purified ScaI-EcoRI fragment containing the luxI&prime; promoter from pGS103, kindly given to the inventor by Tom Baldwin. Department of Biochemistry and Biophysics, Texas A&amp;M University. Expression using this system is controlled by the autoinducer (AI) in the culture media. pPSL706 is ampicillin resistant and compatible with other pACYC184 derivatives such as pRWS and pATI. The strains and plasmids used are summarized in Table I and Table II.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00002">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE I</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Bacterial Strains</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="42pt" align="left"/>
<colspec colname="2" colwidth="105pt" align="left"/>
<colspec colname="3" colwidth="70pt" align="left"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>Strain</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Relevant genotype</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Source</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>AB2847</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>aroB mal T6</PDAT><HIL><SP><PDAT>r</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>Genetic Stock Center</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>BJ502</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>tkt-2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Genetic Stock Center</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>JC7623</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>recB21 recC22 sbcB15</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(26)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>HG4</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>pck-2 pps-3</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Hughes Goldie</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>POII1734</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>araD139 ara::(Mu cts)3 &Dgr;(lac)X74</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(4)</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>gal U galK rpsL with Mu</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>dII1734 lac</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>(Km</PDAT><HIL><SP><PDAT>r</PDAT></SP></HIL><PDAT>)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>CAG12151</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>zdh-925::Tn10</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(22)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>JCL1242</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>VJS676 but ppc::Km</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(5)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>JCL1283</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>AB2847 but ppc::Km</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>This study</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>JCL1362</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>AB2847 but pps::Mu dII1734</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>This study</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<CWU>
<TABLE-US ID="TABLE-US-00003">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="217pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE II</PDAT></PTEXT></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Plasmids</PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="35pt" align="left"/>
<colspec colname="2" colwidth="105pt" align="left"/>
<colspec colname="3" colwidth="77pt" align="left"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>Plasmids</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Relevant genotype</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Source</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>pUHE23-2</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Ap</PDAT><HIL><SP><PDAT>r</PDAT></SP></HIL><PDAT>; IPTG-inducible T7(A1)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>H. Bujard</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>early promoter</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pPS341</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>same as pUHE23-2 but pps</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>(18)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pPS341X1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>same as pPS341 but pps-50</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>(18)</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>(2-codon insertion)</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pPS1734</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>pPS341::Mu dII1734 (Km</PDAT><HIL><SP><PDAT>r</PDAT></SP></HIL><PDAT>lac</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>)</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>This study</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pRW5</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>pACYC184 derivative Cm</PDAT><HIL><SP><PDAT>r</PDAT></SP></HIL><PDAT>, but</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>Genencor International</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry><PTEXT><PDAT>tandem lac promoters aroG</PDAT><HIL><SP><PDAT>fbr&plus;</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pAT1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>same as pRW5 but tktA</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>This study</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pPS706</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>as pJF118EH but pps</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>This study</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>pPSL706</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>as pGS104 but pps</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>This study</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00108" LVL="7"><PTEXT><PDAT>Media and Growth Conditions</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>All cloning procedures were carried out in Luria-Bertani medium. YE medium contained K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>HPO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(14 g/L), KH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(16 g/L), (NH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(5 g/L), MgSO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(1 g/L), yeast extract (15 g/L), and D-glucose (15 gIL). Minimal medium used for high-cell density re-suspension cultures contains per liter, K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>HPO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(14 g), KH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(16 g), (NH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(5 g), MgSO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(1 g), D-glucose (15 g) and was also supplemented with thiamine (1 mg), shikimic acid (50 mg), L-tyrosine (8 mg), L-phenylalanine (8 mg), and L-tryptophan (4 mg). The minimal medium was supplemented with succinate (0.1 g/L) when growing the ppc mutant and its control. For stable maintenance of plasmids, ampicillin (100 mg/ml), chloramphenicol (50 mg/ml) were added to the culture medium. Concentration of the antibiotics were reduced by half when minimal medium was used.</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>Overnight cultures in YE medium were grown at 37&deg; C. in a roller drum and then were subcultured in the same medium with appropriate enablement. Cultures were grown in 250 ml shake flasks at 37&deg; C. in a gyratory water bath shaken at 200 rpm. After four hours of incubation OD</PDAT><HIL><SB><PDAT>550</PDAT></SB></HIL><PDAT>: 2-3) cultures were induced with isopropyl-&bgr;-D-thiogalactopyranoside, IPTG (1 mM). Cells were harvested from late stationary phase by centrifugation at 6000 &times;G and were washed twice with minimal medium before re-suspending in the same minimal medium supplemented with appropriate enablement and IPTG (1 mM). Initial OD</PDAT><HIL><SB><PDAT>550 </PDAT></SB></HIL><PDAT>of all high-density re-suspension cultures were about 4.0. The optical density can be greater than 4.0. In other terms, the media may contain at least 5&times;10</PDAT><HIL><SP><PDAT>9 </PDAT></SP></HIL><PDAT>cells/mL. Samples from the re-suspension cultures were withdrawn periodically for assaying DAH(P) and glucose concentration in the medium.</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="7"><PTEXT><PDAT>Determination of Glucose and DAHP</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="0"><PTEXT><PDAT>Cells were removed from samples by centrifugation and the supernatants were stored at 4&deg; C. until all samples had been collected. Residual glucose in the culture supernatant was determined by the dinitrosalicylic acid assay for total reducing sugars. For additional information an this assay, see Miller (Miller, G. L. 1958. Use of dinitrosalicylic acid reagent for determination of reducing sugars. Anal. Chem. 31;426-428) and Patnaik et al. ( Patnaik, R., W. D. Roof, R. F. Young, and J. C. Liao. 1992. Stimulation of glucose catabolism in </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>by a potential futile cycle. J. Bacteriol. 174:7527-7532), the contents of which are herein incorporated by reference. The concentration of DAH(P) in the supernatant was determined by the thiobarbiturate assay. For additional information an thin assay, see Draths et al. and Gollub et al. (Gollub, E., H. Zalkin, and D. B. Sprinson. 1971. Assay for 3-Deoxy D-arabino-heptulosonic Acid 7-phosphate Synthase. Methods in Enzymology 17A:349-350), the contents of which are herein incorporated by reference. This assay does not distinguish between DAH and DAHP.</PDAT></PTEXT></PARA>
<PARA ID="P-00113" LVL="7"><PTEXT><PDAT>Enzyme Assays</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="0"><PTEXT><PDAT>Cells were harvested by centrifugation at 6000&times;G and were washed and re-suspended in potassium phosphate buffer (50 mM) pH 7 or 5 mM Tris-Cl-1 mM MgCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(pH 7.4), for DAHP, synthase or PEP synthase (Pps) assay, respectively. Cell extracts were prepared by rupturing cells through a French pressure cell (SLM Aminco, Urbana, Ill.) at 160,000 lb/in</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>DAHP synthase activity was assayed by the procedure of Schoner as described more fully in Schoner et al. (Schoner, R. and K. M. Herrmann. 1976. 3-Deoxy-D-arabino-heptulosonate 7-phosphate Synthase. J. Biol. Chem. 251:5440-5447), the contents of which are herein incorporated by reference. Pps activity was assayed as described previously. Total protein in the extracts was determined with the Bio-Rad dye reagent (Bradford assay) with bovine serum albumin as the standard.</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="7"><PTEXT><PDAT>Effects on Pps on DAHP Production from Glucose</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="0"><PTEXT><PDAT>The purpose of constructing pPS706 was to express Pps with an inducible promoter not affected by IPTG. This plasmid, together with pRW5, provided a means to vary the activities of the enzymes, Pps and AroG, independently Under the control of two different promoters. The third enzyme, TktA, was under the. control of its natural promoter and thus variable in only an on/off mode (presence or absence of the gene). This system then allowed the examination of Pps effect over a wider range of conditions. Moreover, it is possible that this system would show an optimal point where the enzyme activities were high enough to provide maximum production of DAHP but not so high as to exert a protein load on the system decreasing DAHP production as a result. The inventor therefore measured DAHP production by AB2847/pRW5/pPS706 and AB2847/pATI/pPS706 in a glucose medium at varying IPTG and autoinducer (N-(3-xox-hexanoyl)-hmoserine lactone) concentrations.</PDAT></PTEXT></PARA>
<PARA ID="P-00117" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT> shows the efffect of Pps at various AI and IPTG concentrations in glucose medium. At low IPTG concentrations (low AroG activities), Pps has little or no effect. When IPTG concentration exceeded 50 mM, Pps effect began to show. Plasmid pGS104, isogenic with pPS706 except for the pps locus, was used as a control, and it showed no effect with or without the addition of AI. The Pps effect was more significant in the strain overexpressing TktA, and it was not due to a variation in AroG or TktA activities, since AroG and TktA activities were shown to be constant with or without Pps overexpression. From the measurement of residual glucose (data not shown), the yields of DAHP from glucose reached 100%, which corresponds to 70-80% after adjusting for the overestimation of DAHP. The latter value is. consistent with that predicted by the stoichiometric analysis, which indicates a maximum theoretical yield of 86% from glucose when pyruvate is recycled to PEP by Pps. Although increases in DAHP levels and yields with Pps activity were observed, a drop with higher Pps activity which would have provided a peak was not evident. The levels of DAHP instead seem to reach saturation with further induction of Pps.</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="7"><PTEXT><PDAT>Formation of byproducts</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="0"><PTEXT><PDAT>To gain insight into the metabolic flux distribution, the culture broth was analyzed for fermentation byproducts by use of HPLC. Samples were taken from cultures in glucose media with varying activities of Pps, AroG, and TktA. Results indicate that the host strain AB2847 produced acetate, succinate, and formate as the major byproducts when neither AroG nor Pps was overexpressed. Production of these acids generally decreased with the increase in IPTG concentration, except formate. This decrease correlates with the increase in DAHP production. When AB2847/pAT1/pPS706 was cultured in glucose with IPTG concentration beyond 50 mM, the broth had undetectable levels of these acids (data not shown). While levels of formic and acetic acid decreased with increase in. Pps activity, succinic acid either remained constant (0 &mgr;M IPTG) or increased (10.50 &mgr;M IPTG) with an increase in Pps activity. This increase could be contributed to Pps induced increase in PEP level, which is spilled over through PEP carboxylase and eventually to succinate.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 1</PDAT></STEXT></H>
<PARA ID="P-00120" LVL="7"><PTEXT><PDAT>Production of DAHP</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>This example demonstrates that the </PDAT><HIL><ITALIC><PDAT>E. Coli </PDAT></ITALIC></HIL><PDAT>AB2847 is unable to utilize DAHP, and accumulates DAHP in the medium if DAHP synthase is overexpressed. This strain was used as a host for detecting the flux committed to the aromatic pathways. Since Draths et al. (Draths, K. M., D. L. Pompliano, D. L. Conley, J. W. Frost, A. Berry, G. L. Disbrow, R. J. Staversky, and J. C. Lievense, &ldquo;Biocatalytic synthesis of aromatics from D-glucose: The role of transketolase,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc., </PDAT></ITALIC></HIL><PDAT>1992, 114, 3956-3962) have shown a possible limitation in the production of DAHP by E4P, pATI (containing both aroG</PDAT><HIL><SP><PDAT>fbr </PDAT></SP></HIL><PDAT>and tktA) was transformed into AB2847 to eliminate the limitation of E4P. To test whether PEP supply limits DAHP production, PEP synthase (Pps) was overexpressed in AB2847/pAT1 by transforming plasmid pPS341 into this strain. 20-70 copies of the pps gene were expressed in the host cells. As a control, pPS341 was substituted by pPS341&times;1, which encodes an inactive, but stable pps gene product. The use of the inactive Pps control allowed discrimination between the effect of Pps activity and that of protein overexpression.</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>AB2847/pAT1/pUHE23-2 and AB2847/pAT1 were also used without any other plasmid as additional controls to identify the effect of the cloning vector, pUHE23-2, on DAHP production.</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>As described above, the strains were grown in a rich medium (YE) with IPTG and re-suspended in a minimal medium. Since the overexpression of Pps under glycolytic conditions may cause growth inhibition, re-suspension cultures were used to minimize the effect of cell growth on the biocatalytic conversion. After re-suspension, the excreted DAHP and residual glucose were measured periodically. At 27 hours after re-suspension, samples were taken for Pps and AroG assays. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1A</PDAT></FGREF><PDAT> shows that the strain overexpressing active Pps increased the DAHP production by almost two-fold. The strains containing pPS341&times;1 or pUHE23-2 produced the same amount of DAHP as the one containing only pAT1. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1B</PDAT></FGREF><PDAT> shows that, as expected, Pps activity was ten-fold overexpressed in the strain containing pPS341, while the aroG activity in all strains remain almost constant. These data strongly suggest that the activity of Pps is responsible for the increase in the DAHP production, whereas the inactive Pps or the cloning vector has no observable effect on DAHP production.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="0"><PTEXT><PDAT>The specific glucose consumption rates of these strains were not influenced by the presence of active or inactive Pps, nor by the cloning vector (data not shown). Therefore, the strain overexpressing Pps showed almost a two-fold increase in overall DAHP yield (c.a. 90% molar) as compared to the controls (ca. 52% molar), suggesting that Pps improves both the productivity and the yield of DAHP production. The maximum theoretical yield from glucose to DAHP is 86%, which is slightly lower than the measured yield from the strain overexpressing Pps. Because both glucose and DAHP measurements were reasonably reproducible, the discrepancy may be attributed to the inaccuracy of the extinction coefficient used to calculate DAHP concentration. However, the extinction coefficient has been calibrated by biosynthesized DAHP from cell extract and known amounts of E4P and PEP. Results show that the extinction coefficient is roughly within 30% accuracy. Therefore, the yield of DAHP is reasonably close. to the theoretical maximum, even though it may and probably; is lower than the theoretical value.</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>To determine whether the Pps effect requires overexpressed transketolase (Tkt) as well, plasmid pRW5, which contains only aroG</PDAT><HIL><SP><PDAT>fbr</PDAT></SP></HIL><PDAT>, was used in place of pAT1 in the above experiments. It was found that overproduction of Pps did not increase the DAHP production (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2A</PDAT></FGREF><PDAT>) without the elevated Tkt activity. Therefore, as limitation of small molecules in the biosynthesis of DAHP is concerned, the first limitation arises from the supply of E4P. This bottleneck shifts to the supply of PEP when Tkt is overexpressed, which is believed to increase the supply of E4P.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 2</PDAT></STEXT></H>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>As shown above, Pps overexpression improved DAHP production from glucose. We were interested to know whether the basal level of Pps expression in glucose medium contributed to the production of DAHP. Therefore, the chromosomal pps gene in strain AB2847 was knocked out. The resulting strain (JCL1362) was used as the host to repeat the above experiments. Results show that inactivation of chromosomal pps did not significantly affect the DAHP production in strains containing pRW5 or pAT1 (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>B). Therefore, the basal level of pps expression in glucose medium did not contribute to the DAHP production.</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="0"><PTEXT><PDAT>Since PEP is also converted to OAA by Ppc, the deletion of this enzyme may increase the supply of PEP. Therefore, the ppc gene on the chromosome of AB2847 was inactivated to determine whether DAHP production could be increased without Pps overexpression. This was done by transducing AB2847 with a PI lysate grown on JCL1242 ppc::Km. The resulting transductant, JCL1283 aroB ppc::Km was then transformed with pAT1 or pRW5 and tested for DAHP production in the re-suspension culture as described above. To avoid limitation of OAA in the ppc strain, the culture medium was supplemented with succinate, which was shown to have no effect on DAHP production, (data not shown). Contrary to the expectation, ppc mutation did not increase the production of DAHP (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>B), suggesting that the metabolic flux from PEP to OAA was not significant under the experimental conditions tested here. In fact, the ppc mutation actually decreased the DAHP production for unknown reasons.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 3</PDAT></STEXT></H>
<PARA ID="P-00128" LVL="7"><PTEXT><PDAT>Production of Tryptophan</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>Existing technologies for the production of tryptophan utilize either naturally occurring microorganisms, mutated microorganisms, or genetically engineered microorganisms. These microorganisms include, but are not limited to </PDAT><HIL><ITALIC><PDAT>Escherichia coli</PDAT></ITALIC></HIL><PDAT>, Brevibacteria, Corynebacieria, and yeast. The altered pathways may include: (1) deletion of pathways branching off to phenylalanine and tyrosine; (2) deletion of pyruvate kinases (pyk); (3) deletion of PEP carboxylase (ppc), (4) deletion of phosphoglucose isomerase (pgi); (5) desensitize feed-back inhibition of enzymes in the chorismate pathway and the trp operon; (6) deletion of the repressor, trpR, and the attenuation sequence in the trp operon, (7) deletion of tryptophan degradation enzymes; (8) overexpression of the trp operon enzymes; (9) overexpression of the wild-type or feedback resistant AroF, AroG, or AroH, or any enzyme in the chorismate pathway; (10) overexpression of SerA; and (11) overexpression of TktA or TktB.</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>To produce tryptophan, strain ATCC31743 which contains chromosomal markers such as trpR &Dgr;(trpAE) tna can be used as a host. This strain also contains a plasmid pSC102trp which harbors trpAE operon. Plasmids pAT1 and pPS341 (or pPS706 or pPSL706) can be transformed into this strain. The serA gene can be cloned into any of the plasmids. Alternatively, these cloned genes (trpAE, aroG, tktt, pps or serA) can be consolidated to one or two plasmids. The resulting strain was grown in MT medium which contains, per liter: KH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 3 g: K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>HPO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 3g; K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>HPO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 7 g; NH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>CL, 3 g; MgSO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 0.2 g; FeSO</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>7H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O), 10 mg, glucose, 0 to 30 g.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>The Pps technology is compatible with all of the above alterations in metabolism. Alterations that favor the supply of E4P, such as the deletion of phosphoglucose isomerase, may eliminate the need for overexpression Tkt associated with Pps in the preferred embodiment. Higher AroG levels may also eliminate the need for overexpressing Tkt. The Pps technology can be used in microorganisms such as Brevibacteria and Corynebacteria.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 4</PDAT></STEXT></H>
<PARA ID="P-00132" LVL="7"><PTEXT><PDAT>Production of Phenylalanine</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>Pathway alterations for the production of phenylalanine are simnilar to the above except at the terminal pathways leading to phenylalanine. These include (1) the overexpression of the enzymes from chorismate to phenylalanine; (2) deletion of trip operon; and (3) deletion of phenylalanine degrading enzymes, and (4) desensitize all the enzymes from DAHP to phenylalanine so that they are not inhibited by the latter.</PDAT></PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>To produce phenylalanine, an </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>mutant (W3110 &Dgr;trp &Dgr;tyr &Dgr;phe) (ref: Forberg, Eliaeson, and Haggstrom, 1988) can be used as a host. Plasmids pAT1 and pPS341 (or pPS706, pPSL706) can then be transformed into this strain. In addition, the pheAfbr gene from plasmid pJN6 (same ref) can be cut and ligated into either pPS341 or pAT1. The resulting stain can be cultured in the following medium containing, per liter; NH</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>CL, 5 g; K</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>SO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 0.8 g; KH</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>PO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 0.5 g; Na</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>HPO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, 1 g; Na-citrate, 2.5 g; FeCL</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>6H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 0.01 g; CaCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>2H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 0.20; MgCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>6H</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>O, 0.8 g; tryosine, 0.05 g; tryptophan, 0.025 g, glucose 10-30 g.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 5</PDAT></STEXT></H>
<PARA ID="P-00135" LVL="7"><PTEXT><PDAT>Production of Tyrosine</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>Pathway alterations for the production of tyrosine are similar to the above except at the terminal pathways leading to tyrosine. These include (1) the overexpression of the enzymes from chorismate to tyrosine; (2) deletion of trp operon and the phenylalanine branch; (3) deletion of tyrosine degrading enzymes; and (4) desensitize all the enzymes from DAHP to tyrosine so that they are not inhibited by the later.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 6</PDAT></STEXT></H>
<PARA ID="P-00137" LVL="7"><PTEXT><PDAT>Production of indigo</PDAT></PTEXT></PARA>
<PARA ID="P-00138" LVL="0"><PTEXT><PDAT>Production of indigo may be achieved by converting tryptophan or an intermediate from the trp pathway to indigo, either in vitro or in vivo. Since the Pps technology increases the production of DAHP, it will also increase the supply of any metabolite that serve as the precursor for indigo. To produce indigo, the tryptophan producing strain described above can be used as a host. However, the strain needs to be made tna&plus; and overexpressing naphthalene dioxygenase from Pseudomonas putida. In this strain, tryptophan produced will be degraded by tryptophanase to indole, which is then converted to cis-indole-2, 3-dihydrodiol by the cloned naphthalene dioxygenase. The cis-indole-2, 3-dihydrodiol produced is spontaneously converted to indigo in the presence of oxygen. ATCC 31743 is the strain used in conversion of DAHP to tryptophan.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 7</PDAT></STEXT></H>
<PARA ID="P-00139" LVL="7"><PTEXT><PDAT>Production of Quinoid Organics</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>Quinoid organics can be derived fromr dehydroquinate which is a down-stream metabolite of DAHP. To produce quinic acid, </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>AB2848 aroD harboring pTW8090A which contains the gene qad (quinic acid dehydrogenase from </PDAT><HIL><ITALIC><PDAT>Klebsiella pneuinoniae</PDAT></ITALIC></HIL><PDAT>) (ref: Draths, Ward, and Frost, 1992, JACS, 114, 9725-9726), and pKD136 (ref: same as above) which contains tkt, aroF, and aroB genes can be used as a host. The pps gene can be cloned into one of these plasmids and be simultaneously overexpressed. It has been reported that at least 80 mM of D-glucose can be converted into 25 mM of quinic acid. After cell removal, quinic acid in the supernatant can be converted into benzoquinone after addition of sulfuric acid and technical grade manganese (IV) dioxide and heating at 100&deg; C. for 1 h. In the absence of acidification, aqueous solutions of purified quinic acid were converted. to hydroquinone in 10% yield upon heating at 100&deg; C. for 18 h with technical grade manganese dioxide.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 8</PDAT></STEXT></H>
<PARA ID="P-00141" LVL="7"><PTEXT><PDAT>Production of Catechol</PDAT></PTEXT></PARA>
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>Production of catechol may be achieved by transforming pps into </PDAT><HIL><ITALIC><PDAT>E. Coli </PDAT></ITALIC></HIL><PDAT>expressing pKD136. Since the Pps technology increases the production of DAHP, it will also increase the supply of any metabolite that serves as the precursor for catechol.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 9</PDAT></STEXT></H>
<PARA ID="P-00143" LVL="7"><PTEXT><PDAT>Characterization of luxI&prime;-driven pps expression</PDAT></PTEXT></PARA>
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>To characterize the luxI&prime;-driven pps expression, pPS706 were transformed into AB2847/pRW5 and AB2847/pAT1, and the Pps activity was measured when the strains were cultured in either glucose or xylose medium. The Pps activity increased with the autoinducer (N-(3-xox-hexanoyl) -hmoserine lactone) concentration and reached saturation when 1 &mgr;M autoinducer was used. Pps activity in the same strain growing in xylose medium was the same as that in glucose. The Pps activity was independent of IPTG concentration (data not shown). Therefore, the inventor achieved the independent modulation of three key enzymes in the production of aromatics: AroG (IPTG-inducible), TktA (on/off or presence/absence) and Pps (autoinducer-inducible).</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>While in accordance with the patent statutes, the best mode and preferred embodiments of the invention have been described, it is to be understood that the invention is not limited thereto, but rather is to be measured by the scope and spirit of the appended claims.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>1. A method for increasing 3&prime; deoxy-D-arabino-heptulosonate (DAHB) production relative to wild type host cells, comprising the steps of:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) transforming a genetic agent into a microorganism to overexpress Pps to convert pyruvate to phosphoenolpyruvate (PEP); and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) cultivating the transformed organism in a medium. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>2. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> further comprising the step of isolating the DAHP.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00148" LVL="0"><PTEXT><PDAT>3. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> further comprising the step of overexpressing the tkt gene.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>4. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein the microorganism is </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>AB2847.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>5. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> further comprising the step of transforming a genetic agent into a microorganism to overexpress Tkt.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>6. A method for producing cyclic metabolites comprising the steps of:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) transforming a genetic agent into a microorganism to overexpress Pps wherein the microorganism is a genetically engineered strain adapted to produce a desired product; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) cultivating the transformed microorganism in a nutrient containing medium. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00152" LVL="0"><PTEXT><PDAT>7. A process for the production of DAHP which comprises cultivating a microorganism in a nutrient medium and overexpressing the Pps gene.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00153" LVL="0"><PTEXT><PDAT>8. The process of </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT> wherein the step of overexpressing the Pps gene comprises transforming a plasmid selected from the group consisting of pPS341, pPSL706, and pPS706 into the microorganism.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00154" LVL="0"><PTEXT><PDAT>9. The process of </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT> further comprising the step of overexpressing the tkt gene.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00155" LVL="0"><PTEXT><PDAT>10. The process of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> wherein the step of overexpressing the Tkt gene comprises transforming the plasmid pAT1 into the microorganism.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06489100-20021203-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06489100-20021203-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06489100-20021203-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06489100-20021203-D00004.TIF"/>
<EMI ID="EMI-D00005" ALT="embedded image" FILE="US06489100-20021203-D00005.TIF"/>
<EMI ID="EMI-D00006" ALT="embedded image" FILE="US06489100-20021203-D00006.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06489537-20021203-D00001.TIF SYSTEM "US06489537-20021203-D00001.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00002.TIF SYSTEM "US06489537-20021203-D00002.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00003.TIF SYSTEM "US06489537-20021203-D00003.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00004.TIF SYSTEM "US06489537-20021203-D00004.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00005.TIF SYSTEM "US06489537-20021203-D00005.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00006.TIF SYSTEM "US06489537-20021203-D00006.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00007.TIF SYSTEM "US06489537-20021203-D00007.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00008.TIF SYSTEM "US06489537-20021203-D00008.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00009.TIF SYSTEM "US06489537-20021203-D00009.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00010.TIF SYSTEM "US06489537-20021203-D00010.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00011.TIF SYSTEM "US06489537-20021203-D00011.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00012.TIF SYSTEM "US06489537-20021203-D00012.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00013.TIF SYSTEM "US06489537-20021203-D00013.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00014.TIF SYSTEM "US06489537-20021203-D00014.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00015.TIF SYSTEM "US06489537-20021203-D00015.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00016.TIF SYSTEM "US06489537-20021203-D00016.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00017.TIF SYSTEM "US06489537-20021203-D00017.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00018.TIF SYSTEM "US06489537-20021203-D00018.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00019.TIF SYSTEM "US06489537-20021203-D00019.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00020.TIF SYSTEM "US06489537-20021203-D00020.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00021.TIF SYSTEM "US06489537-20021203-D00021.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00022.TIF SYSTEM "US06489537-20021203-D00022.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00023.TIF SYSTEM "US06489537-20021203-D00023.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00024.TIF SYSTEM "US06489537-20021203-D00024.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00025.TIF SYSTEM "US06489537-20021203-D00025.TIF" NDATA TIF>
<!ENTITY US06489537-20021203-D00026.TIF SYSTEM "US06489537-20021203-D00026.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06489537</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021203</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09354123</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>19990715</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C12N 1509</PDAT></B511>
<B512><PDAT>C12N 1529</PDAT></B512>
<B512><PDAT>C12N 1531</PDAT></B512>
<B512><PDAT>C12N 1582</PDAT></B512>
<B512><PDAT>A01H  500</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>800278</PDAT></B521>
<B522><PDAT>800298</PDAT></B522>
<B522><PDAT>800295</PDAT></B522>
<B522><PDAT>800288</PDAT></B522>
<B522><PDAT>8003203</PDAT></B522>
<B522><PDAT>800306</PDAT></B522>
<B522><PDAT>435 691</PDAT></B522>
<B522><PDAT>4353201</PDAT></B522>
<B522><PDAT>435419</PDAT></B522>
<B522><PDAT>435468</PDAT></B522>
<B522><PDAT>536 231</PDAT></B522>
<B522><PDAT>536 232</PDAT></B522>
<B522><PDAT>536 236</PDAT></B522>
<B522><PDAT>536 237</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Phytochelatin synthases and uses therefor</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5023243</PDAT></DNUM>
<DATE><PDAT>19910600</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Tullis</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>514 44</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5168053</PDAT></DNUM>
<DATE><PDAT>19921200</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Altman et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435 91</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5190931</PDAT></DNUM>
<DATE><PDAT>19930300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Inouye</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>435 91</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5364451</PDAT></DNUM>
<DATE><PDAT>19941100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Raskin et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>210602</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5965796</PDAT></DNUM>
<DATE><PDAT>19991000</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Meagher et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>800298</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B562><NCIT><STEXT><PDAT>Vatamaniuk et al. The Journal of Biological Chemistry, vol. 275, No. 40, pp. 31451-31459, Jun. 2000.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Arisi et al. Planta, vol. 203, pp. 362-372, 1997.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Noctor et al. Journal of Experimental Botany, vol. 49, No. 321, pp. 623-647, Apr. 1998.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Newman et al. Accession No. W43439, Sequence Search Result, p. 3, Jan. 1998.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sambrooke et al. A Laboratory Manual, 2nd Edition, 1989.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Gietz et al., &ldquo;Transforming Yeast With DNA,&rdquo; </PDAT><HIL><ITALIC><PDAT>Methods in Molecular and Cellular Biology</PDAT></ITALIC></HIL><PDAT>, 5:255-269 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Stadtman, &ldquo;Metal Ion-Catalyzed Oxidation of Proteins: Biochemical Mechanism and Biological Consequences,&rdquo; </PDAT><HIL><ITALIC><PDAT>Free Radical Biology </PDAT></ITALIC></HIL><PDAT>&amp; </PDAT><HIL><ITALIC><PDAT>Medicine</PDAT></ITALIC></HIL><PDAT>, vol. 9, pp. 315-325, 1990. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Altschul et al., &ldquo;Basic Local Alignment Search Tool,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 215:403-410 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Anderson et al., &ldquo;Functional expression of a probable </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>potassium channel in</PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae</PDAT></ITALIC></HIL><PDAT>,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. U.S.A</PDAT></ITALIC></HIL><PDAT>. 89:3736-3740 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Baulcombe, &ldquo;Fast forward genetics based on virus-induced gene silencing,&rdquo; </PDAT><HIL><ITALIC><PDAT>Curr. Opinion Plant Biol</PDAT></ITALIC></HIL><PDAT>. 2:109-113 (1999). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bevan, &ldquo;Binary Agrobacterium vectors for plant transformation,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nucl. Acids Res</PDAT></ITALIC></HIL><PDAT>, 12:8711-8721 (1984). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Bradford, &ldquo;A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye-Binding,&rdquo; </PDAT><HIL><ITALIC><PDAT>Anal. Biochem</PDAT></ITALIC></HIL><PDAT>. 72:248-254 (1976). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cech, &ldquo;Ribozymes and Their Medical Implications,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Amer. Med. Assn</PDAT></ITALIC></HIL><PDAT>. 260:3030 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cech et al., &ldquo;RNA Catalysis by a Group I Ribozyme,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem.</PDAT></ITALIC></HIL><PDAT>, 267:17479-17482 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Chen et al., &ldquo;Characterization of phytochelatin synthase from tomato,&rdquo; </PDAT><HIL><ITALIC><PDAT>Physiol. Plant</PDAT></ITALIC></HIL><PDAT>. 101:165-172 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Clemens et al., &ldquo;The plant cDNA LCT1 mediates the uptake of calcium and cadmium in yeast,&rdquo; Proc. </PDAT><HIL><ITALIC><PDAT>Natl. Acad. Sci. U.S.A.</PDAT></ITALIC></HIL><PDAT>, 95:12043-12048 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cunningham et al., &ldquo;Phytoremediation of contaminated soils,&rdquo; </PDAT><HIL><ITALIC><PDAT>Trends Biotechnol</PDAT></ITALIC></HIL><PDAT>. 13:393-397 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Cunningham et al., &ldquo;Promises and Prospects of Phytoremediation,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 110:715-719 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Fahey and Newton, &ldquo;Determination of Low-Molecular-Weight Thiols Using Monobromobimane Fluorescent Labeling and High-Performance Liquid Chromatography,&rdquo; </PDAT><HIL><ITALIC><PDAT>Meth. Enzymol</PDAT></ITALIC></HIL><PDAT>. 143:85-97 (1987). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Freedman et al., &ldquo;The Role of Glutathione in Cooper Metabolism and Toxicity,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 44264:5598-5605 (1989). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Fuhr and Rabenstein, &ldquo;Nuclear Magnetic Resonance Studies of the Solution Chemistry of Metal Complexes,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Am. Chem. Soc</PDAT></ITALIC></HIL><PDAT>. 95:6944-6950 (1973). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Gietz and Schiestl, &ldquo;applications of High Efficiency Lithium Acetate Transformation of Intact Yeast Cells using Single-Stranded Nucleic Acids as Carrier,&rdquo; </PDAT><HIL><ITALIC><PDAT>Yeast </PDAT></ITALIC></HIL><PDAT>7:253-263 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Grill et al., &ldquo;Phytochelatins: The Principal Heavy-Metal Complexing Peptides of Higher Plants,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>230:674-676 (1985). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Grill et al., &ldquo;Phytochelatins, the heavy-metal-binding peptides of plants, are synthesized from glutathione by a specific &ggr;-glutamylcysteine dipeptidyl transpeptidase (phytochelatin synthase),&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>86:6838-6842 (1989). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Grill et al., &ldquo;Phytochelatins, a class of heavy-metal-binding peptides from plants, are functionally analogous to metallothioneins,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. U.S.A</PDAT></ITALIC></HIL><PDAT>. 84:439-443 (1987). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hamer, &ldquo;Metallothionein,&rdquo; </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Biochem</PDAT></ITALIC></HIL><PDAT>. 55:913-951 (1986). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hamer et al., &ldquo;Function and Autoregulation of Yeast Copperthionein,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>228:685-690 (1985). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hampel et al., &ldquo;RNA Catalytic Properties of the Minimum (&minus;)sTRSV Sequence,&rdquo; </PDAT><HIL><ITALIC><PDAT>Biochemistry </PDAT></ITALIC></HIL><PDAT>28:4929-4933 (1989). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Haselhoff and Gerlach, &ldquo;Simple RNA enzymes with new and highly specific endoribonuclease activities,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>334:585 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Higgins and Sharp, &ldquo;CLUSTAL: a package for performing multiple sequence alignment of a microcomputer,&rdquo; </PDAT><HIL><ITALIC><PDAT>Gene </PDAT></ITALIC></HIL><PDAT>73:237-240 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Ho et al., &ldquo;Isolation of Vacuolar Membrane H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>-ATPase-deficient Yeast Mutants; the VMA5 and VMA4 Genes Are Essential for Assembly and Activity of the Vacuolar H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>-ATPase,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 268:221-227 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hofmann and Stoffel, &ldquo;A Database of Membrane Spanning Protein Segments,&rdquo; </PDAT><HIL><ITALIC><PDAT>Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 347:166 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Horsch et al., &ldquo;Leaf Disc Transformation,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Molecular Biology Manual </PDAT></ITALIC></HIL><PDAT>A5:1-9 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Howden et al., &ldquo;Cadmium-Sensitive, cad1 Mutants of </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>Are Phytochelatin Deficient,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 107:1059-1066 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Inoue et al., &ldquo;Molecular identification of glutathione synthetase (GSH2) gene from </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae</PDAT></ITALIC></HIL><PDAT>,&rdquo; </PDAT><HIL><ITALIC><PDAT>Biochem. Biophys. Acta </PDAT></ITALIC></HIL><PDAT>1395:315-320 (1998). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Inz&eacute; and Van Montagu, &ldquo;Oxidative stress in plants,&rdquo; </PDAT><HIL><ITALIC><PDAT>Current Opinion in Biotech</PDAT></ITALIC></HIL><PDAT>. 6:153-158 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Jefferson et al. &ldquo;</PDAT><HIL><ITALIC><PDAT>GUS fusions: &bgr;-glucuronidase as a sensitive and versatile gene fusion market in higher plant</PDAT></ITALIC></HIL><PDAT>s,&rdquo; </PDAT><HIL><ITALIC><PDAT>EMBO J.</PDAT></ITALIC></HIL><PDAT>, 6:3901-3907 (1987). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kim et al., &ldquo;Heterologous expression of plant vacuolar pyrophosphatase in yeast demonstrates sufficiency of the substrate-binding subunit for proton transport,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>91:6128-6132 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kneer et al., &ldquo;</PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><ITALIC><PDAT>Neurosporoa crassa </PDAT></ITALIC></HIL><PDAT>contain heavy metal sequestering phytochelatin,&rdquo; </PDAT><HIL><ITALIC><PDAT>Arch. Microbiol</PDAT></ITALIC></HIL><PDAT>. 157:305-310 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Lagrimini et al., &ldquo;Peroxidase-Induced Wilting in Transgenic Tobacco Plants,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Cell </PDAT></ITALIC></HIL><PDAT>2:7-18 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Li et al., &ldquo;A new pathway for vacuolar cadmium sequestration in </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae</PDAT></ITALIC></HIL><PDAT>: YCF1-catalyzed transport of bis(glutathionateo)cadmium,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. U.S.A</PDAT></ITALIC></HIL><PDAT>. 94:42-47 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Li et al., &ldquo;The Yeast Cadmium Factor Protein (YCF1) is a Vacuolar Glutathione S-Conjugate Pump,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 271:6509-6517 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Lu et al., &ldquo;atMRP1 gene of Arabidopsis encodes a glutathione S-conjugage pump: Isolation and funcional definition of a plant ATP-binding cassette transporter gene,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. U.S.A</PDAT></ITALIC></HIL><PDAT>. 94:8243-8247 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Marcus-Sakura, &ldquo;Techniques for Using Antisense Oligodeoxyribonucleotides to Study Gene Expression,&rdquo; </PDAT><HIL><ITALIC><PDAT>Anal. Biochem</PDAT></ITALIC></HIL><PDAT>. 172:289 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Meuwly et al., &ldquo;Three families of thiol peptides are induced by cadmium in maize,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant J</PDAT></ITALIC></HIL><PDAT>. 7:391-400 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Mewes et al., &ldquo;Overview of the yeast genome,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>387:7-65 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Minet et al., &ldquo;Complementation of </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae </PDAT></ITALIC></HIL><PDAT>auxotrophic mutants by </PDAT><HIL><ITALIC><PDAT>Arabidopsis cDNAs</PDAT></ITALIC></HIL><PDAT>,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant J</PDAT></ITALIC></HIL><PDAT>. 2:417-422 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Murphy and Taiz, &ldquo;Comparison of Metallothionein Gene Expression and Nonprotein Thiols in Ten Arabidopsis Ecotypes,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 109:945-954 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Murphy et al., &ldquo;Purification and Immunological Identification of Metallothioneins 1 and 2 from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana</PDAT></ITALIC></HIL><PDAT>,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 113:1291-1301 (1997). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Mutoh and Hayashi, &ldquo;Isolation of Mutants of </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces Pombe </PDAT></ITALIC></HIL><PDAT>Unable To Synthesize Cadystin, Small Cadmium-Binding Peptides,&rdquo; </PDAT><HIL><ITALIC><PDAT>Biochem. Biophys. Res. Commun</PDAT></ITALIC></HIL><PDAT>. 151:32-39 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Napoli et al., &ldquo;Introduction of a Chimeric Chalcone Synthase Gene into Petunia Results in Reversible Co-Suppression of Homologous Genes in trans,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Cell</PDAT></ITALIC></HIL><PDAT>. 2:291-299 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Nriagu and Pacyna, &ldquo;Quantitative assessment of worldwide contamination of air, water and soils by trace metals,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>333:124-138 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Okazaki et al., &ldquo;High-frequency transformation method and library transducing vectors for cloning mammalian cDNAs by trans-complementation of </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces pombe</PDAT></ITALIC></HIL><PDAT>,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nucleic Acids Res</PDAT></ITALIC></HIL><PDAT>. 25:6485-6489 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Ortiz et al., &ldquo;Transport of Metal-binding Peptides by HMT1, A Fission Yeast ABC-type Vacuolar Membrane Protein,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 270:4721-4728 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Ortiz et al., &ldquo;Heavy metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter,&rdquo; </PDAT><HIL><ITALIC><PDAT>EMBO J</PDAT></ITALIC></HIL><PDAT>. 11:3491-3499 (1992). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Raskin, &ldquo;Plant genetic engineering may help with environmental cleanup,&rdquo; </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA</PDAT></ITALIC></HIL><PDAT>, 93:3164-3166 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Rauser, &ldquo;Phytochelatins,&rdquo; </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Biochem</PDAT></ITALIC></HIL><PDAT>. 59:61-86 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Rauser, &ldquo;Phytochelatins and Related Peptides,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 109:1141-1149 (1995). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Rea et al., &ldquo;From Vacuolar GS-X Pumps to Multispecific ABC Transporters,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 49:727-760 (1998). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Robinson et al., &ldquo;A Putative Zinc Finger Protein, </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae </PDAT></ITALIC></HIL><PDAT>Vps18p, Affects Late Golgi Functions Required for Vacuolar Protein Sorting and Efficient &agr;-Factor Prohormone Maturation,&rdquo; </PDAT><HIL><ITALIC><PDAT>Mol. Cell. Biol</PDAT></ITALIC></HIL><PDAT>. 11:5813-5824 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Rodriquez-Navarro and Ramos, &ldquo;Dual System for Potassium Transport in </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae</PDAT></ITALIC></HIL><PDAT>,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Bacterial</PDAT></ITALIC></HIL><PDAT>. 159:940-945 (1984). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Schachtman and Schroeder, &ldquo;Structure and transport mechanism of a high-affinity potassium uptake transporter from higher plants,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>370:655-658 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Silver and Phung, &ldquo;Bacterial Heavy Metal Resistance: New Surprises,&rdquo; </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Microbiol</PDAT></ITALIC></HIL><PDAT>. 50:753-789 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Steffans, The Heavy Metal-Binding Peptides of Plants, </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Plant Physiol. Plant Mol</PDAT></ITALIC></HIL><PDAT>. Biol. 41:553-575 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Strathern and Higgins, &ldquo;Recovery of Plasmids from Yeast into </PDAT><HIL><ITALIC><PDAT>Escherichia coli</PDAT></ITALIC></HIL><PDAT>: Shuttle Vectors,&rdquo; </PDAT><HIL><ITALIC><PDAT>Methods Enzymol</PDAT></ITALIC></HIL><PDAT>. 194:319-329 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Szczypka et al., &ldquo;A Yeast Metal Resistance Protein Similar to Human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Multidrug Resistance-associated Protein,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 269:22853-22857 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Thompson et al., &ldquo;Clustal W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,&rdquo; </PDAT><HIL><ITALIC><PDAT>Nuc. Acids Res</PDAT></ITALIC></HIL><PDAT>. 22:4673-4680 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Thumann et al., &ldquo;Reactivation of metal-requiring apoenzymes by phytochelatin-metal complexes,&rdquo; </PDAT><HIL><ITALIC><PDAT>FEBS Lett</PDAT></ITALIC></HIL><PDAT>. 284:66-69 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Udenfriend et al., &ldquo;Fluorescamine: A Reagent for Assay of Amino Acids, Peptides, Proteins, and Primary Amines in the Picomole Range,&rdquo; </PDAT><HIL><ITALIC><PDAT>Science </PDAT></ITALIC></HIL><PDAT>178:871-874 (1972). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Valvekens et al., </PDAT><HIL><ITALIC><PDAT>Agrobactgerium tumefaciens</PDAT></ITALIC></HIL><PDAT>-mediated transformation of </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>root explants by using kanamycin selection, Proc. </PDAT><HIL><ITALIC><PDAT>Natl. Acad. Sci. U.S.A</PDAT></ITALIC></HIL><PDAT>. 85:5536-5540 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>van der Krol et al., &ldquo;Antisense genes in plants: an overview,&rdquo; </PDAT><HIL><ITALIC><PDAT>Gene </PDAT></ITALIC></HIL><PDAT>72:45-50 (1988). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Vogeli-Lange and Wagner, &ldquo;Subcellular Localization of Cadmium and Cadmium-Binding Peptides in Tobacco Leaves,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol.</PDAT></ITALIC></HIL><PDAT>, 92:1086-1093 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Weintraub, &ldquo;Antisense RNA and DNA,&rdquo; </PDAT><HIL><ITALIC><PDAT>Scientific American </PDAT></ITALIC></HIL><PDAT>262:40 (1990). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Wemmie et al., &ldquo;Transcriptional Activation Mediated by the Yeast AP-1 Protein is Required for Normal Cadmium Tolerance,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem</PDAT></ITALIC></HIL><PDAT>. 269:14690-14697 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Zenk, &ldquo;Heavy metal detoxification in higher plants-a review,&rdquo; </PDAT><HIL><ITALIC><PDAT>Gene </PDAT></ITALIC></HIL><PDAT>179:21-30 (1996). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Zhou and Goldsbrough, &ldquo;Functional Homologs of Fungal Metallothionein Genes from Arabidopsis,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Cell </PDAT></ITALIC></HIL><PDAT>6:875-884 (1994). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Hayashi et al., &ldquo;Two pathways in the biosynthesis of cadystins (&ggr;EC)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>G in the cell-free system of the fission yeast,&rdquo; </PDAT><HIL><ITALIC><PDAT>Biochem. Cell. Biol.</PDAT></ITALIC></HIL><PDAT>, vol. 69, 115-121 (1991). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kondo et al., &ldquo;Synthesis of Metallothionein-like Peptides Cadystin A and B Occurring in a Fission Yeast, and Their Isomers,&rdquo; </PDAT><HIL><ITALIC><PDAT>Agric. Biol. Chem.</PDAT></ITALIC></HIL><PDAT>, vol. 49(1), 71-83 (1985). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Salt et al., &ldquo;Cadmium Transport across Tonoplast of Vesicles from Oat Roots,&rdquo; </PDAT><HIL><ITALIC><PDAT>J. Biol. Chem.</PDAT></ITALIC></HIL><PDAT>, 268:17, 12297-12302 (1993). </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>van der Krol et al., &ldquo;Flavenoid Genes in Petunia: Addition of a Limited Number of Gene Copies May Lead to a Suppression of Gene Expression,&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Cell</PDAT></ITALIC></HIL><PDAT>, vol. 2, 291-299 (1990).</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>18</PDAT></B577>
<B578US><PDAT>10</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>800298</PDAT></B582>
<B582><PDAT>800278</PDAT></B582>
<B582><PDAT>800295</PDAT></B582>
<B582><PDAT>8003203</PDAT></B582>
<B582><PDAT>800288</PDAT></B582>
<B582><PDAT>800306</PDAT></B582>
<B582><PDAT>536 231</PDAT></B582>
<B582><PDAT>536 232</PDAT></B582>
<B582><PDAT>536 236</PDAT></B582>
<B582><PDAT>536 237</PDAT></B582>
<B582><PDAT>435 691</PDAT></B582>
<B582><PDAT>4353201</PDAT></B582>
<B582><PDAT>435419</PDAT></B582>
<B582><PDAT>435468</PDAT></B582>
</B580>
<B590><B595><PDAT>26</PDAT></B595><B596><PDAT>38</PDAT></B596></B590>
</B500>
<B600>
<B630><B632><PARENT-US><CDOC><DOC><DNUM><PDAT>09/354123</PDAT></DNUM></DOC></CDOC><PDOC><DOC><DNUM><PDAT>09/315449</PDAT></DNUM><DATE><PDAT>19990520</PDAT></DATE><CTRY><PDAT>US</PDAT></CTRY><KIND><PDAT>00</PDAT></KIND></DOC></PDOC><PSTA><PDAT>03</PDAT></PSTA></PARENT-US></B632></B630>
<B680US><DOC><DNUM><PDAT>60/095624</PDAT></DNUM><DATE><PDAT>19980807</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Philip A.</PDAT></FNM><SNM><STEXT><PDAT>Rea</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Ardmore</PDAT></CITY>
<STATE><PDAT>PA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Olena K.</PDAT></FNM><SNM><STEXT><PDAT>Vatamaniuk</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Philadelphia</PDAT></CITY>
<STATE><PDAT>PA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Stephane</PDAT></FNM><SNM><STEXT><PDAT>Mari</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Jenkintown</PDAT></CITY>
<STATE><PDAT>PA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Yu-Ping</PDAT></FNM><SNM><STEXT><PDAT>Lu</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Oak Park</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Julian I.</PDAT></FNM><SNM><STEXT><PDAT>Schroeder</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>La Jolla</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Eugene J.</PDAT></FNM><SNM><STEXT><PDAT>Kim</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>San Diego</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Stephan</PDAT></FNM><SNM><STEXT><PDAT>Clemens</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Halle</PDAT></CITY>
<CTRY><PDAT>DE</PDAT></CTRY>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>The Trustees of the University of Pennsylvania</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Philadelphia</PDAT></CITY><STATE><PDAT>PA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>University of California</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>La Jolla</PDAT></CITY><STATE><PDAT>CA</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Dilworth Paxson LLP</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>David T.</PDAT></FNM><SNM><STEXT><PDAT>Fox</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Medina A.</PDAT></FNM><SNM><STEXT><PDAT>Ibrahim</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>1638</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>The present invention relates to novel phytochelatin synthases and uses thereof.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>CROSS REFERENCE TO RELATED APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application is a continuation in part of U.S. application Ser. No. 09/315,449 now abandoned, filed May 20, 1999, and is thereby entitled to priority, pursuant to 35 U.S.C. &sect;119(e), to U.S. Provisional Application No. 60/095,624, filed on Aug. 7, 1998, both of which are incorporated herein by reference.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention was supported in part by finds from the U.S. Government (National Science Foundation Grant No. MCB-9604246, Department of Agriculture NRICGP Grant No. 9337304, Department of Agriculture Grant No. 98-35304-6684, and Department of Energy Grant Nos. DE-FG02-91ER20055, DE-FG02-94ER20162, and DE-FG07-96ER20253) and the U.S. Government may therefore have certain rights in the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>Essential heavy metals, such as copper and zinc, are required as cofactors in redox reactions and ligand interactions and they also participate in charge stabilization, water ionization, and charge shielding during biocatalysis (Voet and Voet, 1995, In: Biochemistry, 2nd ed., John Wiley &amp; Sons, Inc., New York). In addition to the essential heavy metals, non-essential heavy metals, such as arsenic, cadmium, mercury and lead,.are found in natural mineral deposits or as a result of human activity and they are frequently encountered by living organisms (Nriagu and Pacyna, 1988, Nature 333:134-138). Both essential and non-essential heavy metals can pose an acute problem for all living organisms in that the organisms often encounter supraoptimal concentrations of essential heavy metals and excess micromolar concentrations of non-essential heavy metals such as As, Cd, Hg and Pb. High concentrations of these non-essential heavy metals exert toxic effects through the displacement of endogenous metal cofactors, heavy or otherwise, from their cellular binding sites, aberrant reactions with the thiol groups of proteins and coenzymes, and the promotion of the formation of active oxygen species (AOS; Stadtman, 1990, Free Radic. Biol. Med. 9:315-325).</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>Massive global expansion in industrial and mining activities during the last two decades combined with changes in agricultural practices, have markedly increased contamination of groundwaters and soils with heavy metals. Indeed, it is estimated that the annual toxicity of metal emissions exceeds that of organics and radionuclides combined (Nriagu and Pacyna, 1988, Nature 333:134-138). Since soil and water contamination results in the uptake of heavy metals and toxins by crop plants, and eventually by humans, there is a pressing need for environmental cleanup to prevent entry of non-essential heavy metals into the food chain.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>As sessile photosynthetic organisms, the mechanisms deployed by vascular plants for abrogating or alleviating heavy metal toxicity are of general interest. Not only does their lack of specialized excretory organs subject plants to large fluctuations in the levels of these substances and necessitate stringent intracellular homeostatic mechanisms, but the special status of plants as the principal points of entry of these substances into the food chain means that the mechanisms by which plants dispose of or sequester heavy metals have repercussions for all heterotrophic organisms.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>In addition, bioremediation, the use of plants or microbes for the extraction and/or degradation of xenobiotics for environmental cleanup, is attracting increasing interest because of its potentially low cost by comparison with conventional physical and chemical methods. In the case of pollutants, such as heavy metals that cannot be degraded, phytoremediation is particularly appealing because of the ease with which plants can be harvested. Therefore, there is currently a great interest in the identification of native plant species or in the identification of genes from model systems useful for engineering crop species for increased resistance to and/or increased accumulation of heavy metals. In the latter category is the search for new heavy metal-binding peptides for the purpose of better understanding the mechanisms underlying the alleviation of heavy metal stress by plants and of obtaining genes encoding such peptides or the enzymes responsible for their synthesis. The identification and characterization of these genes will facilitate the development of a &ldquo;mix-and-match&rdquo; approach to the manipulation of plant heavy metal responses according to the specific requirements of the type of environmental site that is to be phytoremediated.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>To date, three classes of peptides have been shown to contribute to heavy metal resistance in plants: glutathione (GSH), metallothioneins (MTs), and phytochelatins (PCs). The thiol peptide, GSH (&ggr;-Glu-Cys-Gly), and in some species its variant homoglutathione (h-GSH, &ggr;-Glu-Cys-&bgr;-Ala), is considered to influence the form and toxicity of heavy metals, such as As, Cd, Cu, Hg, and Zn, in several ways. These include the following mechanisms: direct metal binding (Fuhr and Rabenstein, 1973, J. Am. Chem. Soc. 95:6944-6950), promotion of the transfer of metals to other ligands (e.g, PCs and MTs; Freedman et al., 1989, J. Biol. Chem. 264:5598-5605), provision of reducing equivalents for the generation of metal oxidation states more amenable to binding by MTs and possibly PCs (Freedman et al., supra), removal of the active oxygen species formed as a result of exposure of cells to heavy metals (Inze and Van Montagu, 1995, Current Opinion in Biotech. 6:153-158), the formation of transport-active metal complexes with GSH (Li et al., 1997, Proc. Natl. Acad. Sci. U.S.A. 94:42-47), and by serving as a precursor for the biosynthesis of PCs and other cysteinyl peptides (Grill et al., 1987, Proc. Natl. Acad. Sci. U.S.A. 84:439-443; Meuwly et al., 1995, Plant J. 7:391-400).</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>The MTs, another class of peptides previously implicated in heavy metal metabolism in plants, are small (4-8 kDa), cysteine-rich metal-binding polypeptides which are induced in cells by the presence of heavy metals. MTs, which contain multiple Cys-Xaa-Cys motifs, confer tolerance to a broad range of metals in mammals (Hamer, 1986, Annu. Rev. Biochem. 55:913-951) but appear to be involved primarily in Cu homeostasis in plants (Zhou and Goldsbrough, 1994, Plant Cell 6:875-884). Arabidopsis MT1 and MT2 confer tolerance to high levels of Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> but only to low levels of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> when heterologously expressed in MT-deficient cup1 &Dgr; mutants of </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>(Zhou and Goldsbrough, 1994, Plant Cell 6:875-884). Further, MT expression in Arabidopsis seedlings is strongly induced by Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> but not by Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (Zhou and Goldsbrough, 1994, Plant Cell 6:875-884; Murphy et al., 1997, Plant Physiol. 113:1291-1301), and comparisons between Arabidopsis ecotypes (i.e., subspecific forms in a true species, resulting from selection within a particular habitat, which can interbreed with other members of the species) demonstrate MT2 expression to be more closely correlated with Cu-tolerance than tolerance to other metals (Murphy and Taiz, 1995, Plant Physiol. 109:945-954).</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Exposure of plants to heavy metals elicits the elaboration of PCs, a class peptides that play a pivotal role in heavy metal tolerance, primarily tolerance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, in plants and fungi by chelating these substances and decreasing their free concentrations. PCs consist of repeating units of &ggr;-glutamylcysteine followed by a C-terminal glycine &lcub;poly-(&ggr;-Glu-Cys)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>-Gly polymer&rcub; (Rauser, 1990, Annu. Rev. Biochem. 59:61-86; Steffens, 1990, Annu. Rev. Plant Physiol. Plant Mol. Biol. 41: 553-575). Unlike MTs, PCs are synthesized posttranslationally from GSH (&ggr;-Glu-Cys-Gly) by PC synthases (i.e., &ggr;-glutamylcysteine dipeptidyl transpeptidases, EC 2.3.2.15), which transfer a &ggr;-glutamylcysteine moiety from GSH to a second molecule or a previously synthesized PC molecule (Rauser, 1990, Annu. Rev. Biochem. 59:61-86; Zenk, 1996, Gene 179:21-30). Found in some fungi and in all plant species investigated to date (Rauser, 1990, Annu. Rev. Biochem. 59:61-86; Zenk, 1996, Gene 179:21-30), PCs bind heavy metals, such as Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, with high affinity, and localize together with Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> to the vacuole of intact cells (Vogeli-Lange and Wagner, 1990, Plant Physiol. 92:1086-1093). As indicated by the hypersensitivity of PC-deficient Arabidopsis cadl mutants to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> but not to Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (Howden et al., 1995, Plant Physiol. 107:1059-1066), PCs contribute most markedly to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> detoxification in planta. PC-dependent vacuolar Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sequestration is best understood in the fission yeast </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces pombe, </PDAT></ITALIC></HIL><PDAT>in which the hmt1</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> gene product, a PC-selective ATP-binding cassette (ABC) transporter, pumps Cd.PCs and apo-PCs from the cytosol into the vacuole at the expense of ATP (Ortiz et al., 1992, EMBO J. 11:3491-3499; Ortiz et al., 1995, J. Biol. Chem. 270:47214728).</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>In addition to heavy metal tolerance mechanisms involving GSH, MTs, and PCs, the results of recent studies are consistent with the transport of free Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> into the plant vacuole via a Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>/H</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> antiport (Salt and Wagner, 1993,.J. Biol. Chem. 268:12297-12302). However, the physiological significance of such a process remains to be determined.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>Although PCs play an important role in heavy metal tolerance in plants, the molecular identity of the enzyme(s) responsible for the elaboration of these peptides remained elusive. The prior art teaches the partial purification of heavy metal-, primarily Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, activated enzymes (i.e., &ggr;-glutamylcysteine dipeptidyl transpeptidases, EC 2.3.2.15, more commonly referred to as PC synthases) which are competent in the synthesis of PCs from GSH, homo-GSH or related thiol peptides by transfer of a &ggr;-glutamylcysteine unit from one thiol tripeptide to another or to a previously synthesized PC molecule (Grill et al., 1989, Proc. Natl. Acad. Sci. U.S.A. 89:6838-6842; Zenk, 1996, Gene 179:21-30). However, the prior art does not disclose the isolation or identification of the moiety or moieties involved in PC synthesis at either the protein or nucleic acid level.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>Thus, despite the need for efficient and cost-effective methods for the bioremediation of contaminated soils and groundwaters, and the established importance of PCs for heavy metal accumulation and detoxification in plants, the identification and isolation of the enzyme(s) responsible for PC biosynthesis and for the phytoremediation of heavy metals has until now not been achieved. The present invention meets these need.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BRIEF SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>The invention includes an isolated nucleic acid encoding a phytochelatin synthase. In one aspect, the nucleic acid shares at least about 15% homology with at least one of AtPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>In another aspect, the isolated nucleic acid is selected from the group consisting of (SEQ ID NO: 1), (SEQ ID NO: 3), (SEQ ID NO: 5), (SEQ ID NO: 7), (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>The invention further includes an isolated nucleic acid encoding a plant phytochelatin synthase, wherein the phytochelatin synthase shares at least about 15% homology with at least one of AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10).</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>The invention also includes an isolated polypeptide comprising a phytochelatin synthase. In one aspect, the isolated polypeptide shares at least about 15% homology with at least one of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, and SEQ ID NO: 10.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>In another aspect, the isolated polypeptide comprising a phytochelatin synthase is at least one of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, and SEQ ID NO: 10.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>In another aspect, the isolated nucleic acid encoding a phytochelatin synthase further comprises a reporter nucleic acid covalently linked thereto.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>In yet another aspect, the reporter nucleic acid encodes a reporter polypeptide selected from the group consisting of a FLAG octapeptide, a human influenza virus hemagglutinin epitope, a &bgr;-glucuronidase epitope, a green fluorescent protein epitope, and a luciferase epitope.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>The invention includes a recombinant cell comprising an isolated nucleic acid wherein the nucleic acid shares at least about 15% homology with at least one of AtPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>In one aspect, the cell is selected from the group consisting of a prokaryotic cell and a eukaryotic cell.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>The invention also includes a vector comprising an isolated nucleic acid, wherein the nucleic acid shares at least about 15% homology with at least one of ATPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TAPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>The invention includes a transgenic plant, the cells, seeds and progeny of which comprise an isolated nucleic acid encoding a phytochelatin synthase, wherein the nucleic acid comprises at least one of AtPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7) and CePCS (SEQ ID NO: 9), or a fragment thereof, and wherein the nucleic acid shares at least about 15% homology with at least one of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, and SEQ ID NO: 9.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>The invention further includes a transgenic plant, the cells, seeds and progeny of which comprise an isolated nucleic acid encoding a phytochelatin synthase, or a fragment thereof, wherein the phytochelatin synthase shares at least about 15% homology with at least one of AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10).</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>The invention includes a method of preventing removal of a heavy metal from soil. The method comprises growing in the soil a transgenic plant comprising an isolated nucleic acid encoding a phytochelatin synthase in an antisense orientation and harvesting the plant from the soil, thereby preventing removal of the heavy metal from the soil.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>The invention also includes a method of removing a heavy metal from soil. The method comprises growing in the soil a transgenic plant comprising an isolated nucleic acid encoding a phytochelatin synthase and harvesting the plant from the soil, thereby removing the heavy metal from the soil. In one aspect, the heavy metal is selected from the group consisting of cadmium, arsenate, arsenite, mercury, lead, zinc, nickel, bismuth, selenium, silver, gold, and copper.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>The invention includes a method of generating a transgenic heavy metal resistant plant. The method comprises introducing to the cells of the plant an isolated nucleic acid encoding a phytochelatin synthase, thereby generating a transgenic heavy metal resistant plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>The invention further includes a method of biosynthesizing a phytochelatin. The method comprises contacting an isolated phytochelatin synthase with a sufficient amount of glutathione, or a glutathione-related thiol peptide, under conditions which permit biosynthesis of a phytochelatin from the glutathione or related thiol peptide, thereby biosynthesizing a phytochelatin.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>In one aspect, the biosynthesis is biosynthesis selected from the group consisting of a biosynthesis performed in vitro, and a biosynthesis performed in vivo, In another aspect, the glutathione-related thiol peptide is selected from the group consisting of a homoglutathione, a PC2, a PC3, a PC4, a homo-glutathione, a hydroxymethyl-glutathione, and a &ggr;-glutamylcysteinylglutamic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>In yet another aspect, the phytochelatin is selected from the group consisting of a PC2, a PC3, a PC4, a homo-PC2, a hydroxymethyl-PC2, an iso-PC2(Glu), and a desGly-PC2.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>In-even another aspect, the phytochelatin synthase is selected from the group consisting of a AtPCS1, a AtPCS2, a TaPCS1, a SpPCS, and a CePCS.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>The invention includes a method of transferring a &ggr;-glutamylcysteine unit from one thiol peptide to another. The method comprises contacting an isolated phytochelatin synthase with a glutathione, or a related thiol peptide, under conditions which permit transfer of the &ggr;-glutamylcysteine unit from one thiol peptide to another, thereby transferring a &ggr;-glutamylcysteine unit from one thiol peptide to another.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>The invention also includes a method of decreasing the level of a heavy metal in a harvestable portion of a plant. The method comprises expressing a nucleic acid encoding a phytochelatin synthase in a non-harvestable portion of a plant, thereby decreasing the level of a heavy metal in the harvestable portion of the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>In one aspect, the method further comprises inhibiting expression of a phytochelatin synthase in the harvestable portion of the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>The invention includes a method of removing a heavy metal from groundwater. The method comprises growing in the groundwater a transgenic plant comprising an isolated nucleic acid encoding a phytochelatin synthase and harvesting the plant from the groundwater, thereby removing the heavy metal from the groundwater.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>The foregoing summary, as well as the following detailed description of the invention, will be better understood when read in conjunction with the appended drawings. For the purpose of illustrating the invention, there are shown in the drawings embodiment(s) which are presently preferred. It should be understood, however, that the invention is not limited to the precise arrangements and instrumentalities shown. In the drawings:</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> is a diagram depicting the alignment of the deduced amino acid sequence of the polypeptide encoded by AtPCS1(SEQ ID NO:2) and its 46.7 and 40.8 kDa homologs from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>(SEQ ID NO:8)(GenBank accession number Q10075) and </PDAT><HIL><ITALIC><PDAT>C. elegans (SEQ ID NO:</PDAT></ITALIC></HIL><PDAT>10) (GenBank Accession number Z665 13), respectively. Sequences were aligned by the CLUSTAL W method (Higgins and Sharp, 1988, Gene 73:237-240). Identical residues are shown in white on a black background. Similar residues are shown in black on a gray background. Gaps introduced to maximize the alignments are denoted by hyphens. Abbreviations for the amino acid residues are: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is an image of a Northern blot depicting the expression of AtPCS1 transcript in roots and shoots of Arabidopsis. Total RNA was extracted from 21-day-old Arabidopsis seedlings and the RNA was hybridized with </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-labeled, random primed AtPCS1 cDNA. Ten &mgr;g of RNA was loaded on each gel lane. The 1.7 kb bands shown were the only </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-labeled bands detected after probing the blots with ATPCS1. Also shown are the results of hybridizing the same blots with a probe directed against 18S rRNA (2.0 kb) to verify that similar amounts of RNA were loaded onto each gel lane.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is a graph depicting the suppression of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-hypersensitivity of </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>ycf1 &Dgr; mutant strain DTY167 by plasmid-borne AtPCS1. Yeast ycf1 &Dgr; strain DTY167 was transformed with pYES3-AtPCS1::FLAG(&compfn;) (encoding functional FLAG-tagged AtPCS1) or empty vector pYES3 lacking an AtPCS1::FLAG insert (&Circlesolid;). Transformed yeast cells were grown at 30&deg; C. to an OD</PDAT><HIL><SB><PDAT>600 nm </PDAT></SB></HIL><PDAT>of approximately 1.8 in AHC medium supplemented with glucose and tryptophan before inoculation of aliquots into 2 ml volumes of the same medium containing different concentrations of heavy metal salts. OD</PDAT><HIL><SB><PDAT>600 nm </PDAT></SB></HIL><PDAT>was measured after growth for 36 hours. Similar growth assays in liquid media containing AsO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>3&minus;</PDAT></SP></HIL><PDAT>, AsO</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> or Hg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, demonstrated that plasmid-borne ATPCS1::FLAG increased the concentrations of these heavy metal ions or their oxides required for 50% attenuation of cell density from 300, 200, 250, and 4 &mgr;M to 550, 325, 600, and 6.3 &mgr;M, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> is an image depicting a SDS-PAGE and Western analysis of AtPCS1 -FLAG in the total soluble and membrane fractions from whole cell extracts prepared from DTY167/pYES3-AtPCS1::FLAG (FLAG) and DTY167/pYES3 (Control) cells. The membrane fraction is comprised of material sedimented by centrifugation of the 4,000&times;g supernatant from whole cell extracts at 10,000&times;g. The soluble fraction comprised material retained in the supernatant of whole cell extracts after successive centrifugations at 4,000&times;g and 10,000&times;g. Proteins (25 &mgr;g) were subjected to SDS-PAGE on 10% gels, and were then electrotransferred to nitrocellulose membrane filters and probed with anti-FLAG M2 monoclonal antibody to detect the fusion protein. The immunoreactive bands were visualized using enhanced chemiluminescence (ECL) detection with an ECL kit (Amersham Pharmacia Life Sciences, St. Petersburg, Fla.), according to the manufacturer&apos;s instructions.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> is an image (comprising an insert) depicting the gel-filtration chromatography of soluble fractions extracted from DTY167/pYES3-AtPCS1::FLAG (&compfn;) cells and DTy167/pYES3 cells (&Circlesolid;) after growth in media containing </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(main graph). The data illustrate a direct comparison of the </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity profile of peak 1 from the soluble fraction extracted from DTY167/pYES3-AtPCS1::FLAG (&compfn;) cells with the </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity profile obtained after Superose-6 chromatography of immunoaffinity-purified AtPCS1-FLAG after equilibrium dialysis against 5 &mgr;M </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(peak 1 of histogram of insert depicting fractions 25-38). AtPCS1-FLAG was detected by SDS-PAGE and Western blot analysis of 20 &mgr;l aliquots of pooled pairs of fractions (i.e., 27-28, 29-30, 31-32, 33-34, 35-36) from chromatography of the DTY167/pYES3-AtPCS1::FLAG cell extracts as depicted under the histogram insert.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT> is an image (comprising two panels) of a gel depicting the purification of AtPCS1-FLAG by immunoaffinity chromatography of the soluble fraction from DTY167/pYES3-AtPCS1::FLAG cells on an anti-FLAG M2 immunoaffinity column. Left panel (Protein): Silver-stained SDS-gel visualizing the proteins of the soluble fraction (5 &mgr;g protein) before (Before) and after (1 &mgr;g protein) (After) purification of AtPCS1-FLAG. Right panel (FLAG): Western blot analysis of FLAG epitope before (25 &mgr;g of the total soluble fraction protein) (Before) and after (1 &mgr;g protein) (After) purification of AtPCS1-FLAG. The positions of the molecular weight markers (M</PDAT><HIL><SB><PDAT>r</PDAT></SB></HIL><PDAT>&times;10</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>) are indicated.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 7A</PDAT></FGREF><PDAT> is a graph depicting AtPCS1-FLAG-dependent PC synthesis in vivo and in vitro. The data disclosed herein depict reverse-phase FPLC analysis of non-protein thiols present in the soluble fractions extracted from DTY167/pYES3-AtPCS1::FLAG cells after growth in liquid medium containing CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(50 &mgr;M). Peaks 1 and 2 were found to comigrate with PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>standards, respectively, purified from </PDAT><HIL><ITALIC><PDAT>S. pombe. </PDAT></ITALIC></HIL><PDAT>The equivalent fractions extracted from DTY167/pYES3-AtPCS1::FLAG cells after growth in medium lacking CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and from DTY167/pYES3 cells after growth in medium containing CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(50 &mgr;M) were devoid of PC-like, non-protein thiols.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 7B</PDAT></FGREF><PDAT> is a graph depicting the reverse-phase FPLC analysis of the non-protein thiols formed after incubation of GSH (3.3 mM) with immunoaffinity-purified AtPCS1-FLAG in the presence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (200 &mgr;M). The peaks designated &ldquo;PC</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>&rdquo; and &ldquo;PC</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>&rdquo; were identified on the basis of their Glu/Gly ratios (2.1&plusmn;0.1 and 2.9&plusmn;0.2, respectively) and their comigration with </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>PC standards. The major thiol peaks eluting 4-10 minutes after sample injection are-cellular GSH, and GSH and 2-mercaptoethanol (2-ME) present in the PC synthase assay media, respectively. No peaks other than those corresponding to GSH and 2-ME were detected when AtPCS1-FLAG or Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> were omitted from the incubation medium.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 8A</PDAT></FGREF><PDAT> is a graph depicting that TaPCS1 expression renders yeast cells more Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerant. Control INVSc1 cells (Invitrogen, Carlsbad, Calif.) carrying the empty pYES2 plasmid (squares) and cells expressing TaPCS1 (circles) were grown in YNB (1% sucrose/1% galactose) containing-either no Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (open symbols) or 200 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (filled symbols).</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 8B</PDAT></FGREF><PDAT> is a graph depicting the growth of yeast cells in YNB (1% sucrose/1% galactose) of control cells (open circles) and TaPCS1 expressing cells (filled circles) at different Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations. Cell growth, measured as the optical density of the cultures at 600 nm (OD</PDAT><HIL><SB><PDAT>600 nm</PDAT></SB></HIL><PDAT>) after 24 hours growth, is shown.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 8C</PDAT></FGREF><PDAT> is a graph depicting the growth in YNB (2% raffinose) of control cells (open circles) and TaPCS1 expressing cells (filled circles) at different Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations. OD</PDAT><HIL><SB><PDAT>600 nm </PDAT></SB></HIL><PDAT>of cultures after 40 hours is shown.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 9A</PDAT></FGREF><PDAT> is a diagram depicting the CLUSTAL W alignment (Thompson et al., 1994, Nucleic Acids Res. 22:4673-4680) of the amino acid sequences of wheat (TaPCS1; SEQ ID NO: 6), </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>(AtPCS1; SEQ ID NO: 2), </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>(SpPCS; SEQ ID NO: 8), and </PDAT><HIL><ITALIC><PDAT>C. elegans </PDAT></ITALIC></HIL><PDAT>(CePCS; SEQ ID NO: 10). Amino acids which are identical are shown in black boxes, similar amino acid residues are indicated within light gray-boxes.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 9B</PDAT></FGREF><PDAT> is an image of a photograph depicting the growth of control cells (carrying the empty pYES2 plasmid) and of cells expressing either TaPCS1, AtPCS1 or SpPCS on YNB medium without (left) and with 100 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (middle). The drawing at the far right of the figure depicts the position on each plate at which the respective yeast transformants were streaked.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT> is a graph depicting the greater accumulation of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> by cells expressing TaPCS1 compared to the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulation by control cells. Yeast cells carrying the empty pYES2 plasmid (white bars) and TaPCS1-expressing cells (black bars) were grown in arginine-phosphate medium containing different non-inhibitory Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations. After 24 hours, the cells were harvested and washed and the amount of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulated inside the cells was determined using </PDAT><HIL><SP><PDAT>109 </PDAT></SP></HIL><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (Error bars&equals;S.E., n&equals;3).</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT> is a graph depicting that the expression of TaPCS1 in &Dgr;vps18, a </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>strain lacking morphologically visible vacuoles (Robinson et al., 1991, Mol. Cell. Biol. 11:5813-5824), still confers a Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance phenotype. Cells carrying the empty pYES2 plasmid (open circles) and cells expressing TaPCS1 (closed circles) were grown in YNB medium in the presence of different Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 12A</PDAT></FGREF><PDAT> is an image depicting a Southern blot demonstrating a </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>strain with a disruption of SpPCS exhibits increased metal sensitivity. The low-stringency Southern blot of </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>genomic DNA was probed with SpPCS. The lanes were loaded with DNA digested with: BamHI (lane 1), HindIII (lane 2), and EcoRI (lane 3).</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 12B</PDAT></FGREF><PDAT> is an image of a photograph depicting the growth of a SpPCS knockout strain (&Dgr;SpPCS) and, as controls, a strain transformed with the empty plasmid pTZura4 and a transformant with a non-homologous integration of the knockout construct (Sp3). The transformants were grown on EMM-ura containing either 0 or 10 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 12C</PDAT></FGREF><PDAT> is a graph depicting the growth of the marker-transformed control strain (open circles) and the &Dgr;SpPCS strain (filled circles). The strains were grown in liquid EMM-ura in the presence of different Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations, and the OD was measured after 24 hours of growth.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 13A</PDAT></FGREF><PDAT> is a graph depicting phytochelatin synthesis in cells expressing PCS. The growth of </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells expressing either TaPCS1 (circles) or an Arabidopsis metallothionein (squares) in the presence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (200 &mgr;M for TAPCS1 and 60 &mgr;M for metallothionein) following a 6 hour preincubation using different concentrations of BSO (L-Buthionine-sulfoxime), a glutathione synthesis inhibitor. The OD was measured 18 hours after the addition of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 13B</PDAT></FGREF><PDAT> is a graph (comprising two panels) depicting the HPLC analysis of extracts of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-treated </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>wildtype cells (control, top panel) and </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>knockout cells (&Dgr;SpPCS, bottom panel) labeled with monobromobimane and analyzed by HPLC using a reversed-phase column and fluorescence detection. The peaks labeled 1 and 2 are identical to those depicted in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13C</PDAT></FGREF><PDAT> based on co-injection experiments. These peaks represent PC2 and PC3 as demonstrated by comparison of retention times with standards synthesized on an Abimed peptide synthesizer (as described elsewhere herein).</PDAT></PTEXT></PARA>
<PARA ID="P-00058" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 13C</PDAT></FGREF><PDAT> is a graph (comprising two panels) depicting the HPLC analysis of extracts of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-treated </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells expressing TaPCS1 (top panel) and </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>wildtype (bottom panel) labeled with monobromobimane and analyzed by HPLC using a reversed-phase column and fluorescence detection. The peaks labeled 1 and 2 are identical to the peaks labeled 1 and 2 in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13B</PDAT></FGREF><PDAT>, supra, based on co-injection experiments. They represent PC2 and PC3 as shown by comparison of retention times with standards synthesized on an Abimed peptide synthesizer (as described elsewhere herein).</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 14A</PDAT></FGREF><PDAT> is a diagram (comprising two panels) depicting that PCS mediates phytochelatin synthesis. Crude extracts of </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>control wildtype cells (top panel) or </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>&Dgr;SpPCS cells (bottom panel) were incubated in 200 mM Tris-Cl (pH 8.0), 1 mM dithiothreitol (DTT), 1 mM GSH and 0.1 mM CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>at 30&deg; C. for 30-120 minutes and the reaction products were monobromobimane-labeled and analyzed by HPLC. Peak 1 corresponds to free GSH, and peak 2 represents PC2.</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 14B</PDAT></FGREF><PDAT> is an image depicting a Western blot analysis of extracts from &Dgr;SpPCS cells harboring SpPCS-HA(left lane) or empty vector (right lane) using anti-HA monoclonal antibody (BAbCo, Berkeley, Calif.). The sizes of the molecular mass standards run in parallel with the sample lanes are indicated along the left side of the figure.</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 14C</PDAT></FGREF><PDAT> is an image of a western blot depicting that SpPCS-HA was purified from crude extracts of cells expressing SpPCS-HA using anti-HA antibody affinity column. Protein was eluted from the affinity column using 5 mg HA peptide (YPYDVPDYA) and the eluted fraction was analyzed by SDS-PAGE (left lane) and Western blotting (right lane). A second band, possibly a proteolytic fragment of the 46 kDa SpPCS-HA, was detected at about 30 kDa.</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 14D</PDAT></FGREF><PDAT> is a graph depicting the PC synthesis by purified SpPCS-HA. Affinity-purified SpPCS-HA was assayed for PC synthase activity and the resulting products were labeled and analyzed by HPLC as described previously elsewhere herein. Peaks 1 and 2 represent free GSH and PC2, respectively.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 15</PDAT></FGREF><PDAT> is an image (comprising three panels) of a gel depicting that TaPCS1 expression in roots is induced by Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> as demonstrated using competitive PCR. RNA was isolated from 4 day old wheat roots that were either untreated or treated with 100 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> for 6 hours. First-strand cDNA was synthesized and 10 ng were used as template in PCR reactions. The competitor DNA used in this study was a PCR fragment amplified from genomic DNA that was approximately 100 bp longer than the cDNA-amplified fragment because of the presence of an intron. The indicated amounts of competitor DNA were added. The aliquots were analyzed by agarose gel electrophoresis. The experiment was repeated twice with similar results.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 16</PDAT></FGREF><PDAT>, comprising </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 16A and 16B</PDAT></FGREF><PDAT>, lists the nucleotide sequence (SEQ ID NO: 1) of a DNA encoding AtPCS1.</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 17</PDAT></FGREF><PDAT>, comprising </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 17A</PDAT></FGREF><PDAT>, </PDAT><HIL><BOLD><PDAT>17</PDAT></BOLD></HIL><PDAT>B, and </PDAT><HIL><BOLD><PDAT>17</PDAT></BOLD></HIL><PDAT>C, lists the nucleotide sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 17A and 17B</PDAT></FGREF><PDAT>; SEQ ID NO: 3) of the gene encoding AtPCS2 and the amino acid sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 17C</PDAT></FGREF><PDAT>; SEQ ID NO: 4) of AtPCS2.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 18</PDAT></FGREF><PDAT>, comprising </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 18A</PDAT></FGREF><PDAT>, </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>B, and </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>C, lists the nucleotide sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 18A and 18B</PDAT></FGREF><PDAT>; SEQ ID NO: 5) of the gene encoding TaPCS1 and the amino acid sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 18C</PDAT></FGREF><PDAT>; SEQ ID NO: 6) of TaPCS1.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 19</PDAT></FGREF><PDAT>, comprising </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 19A and 19B</PDAT></FGREF><PDAT>, lists the nucleotide sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 19A</PDAT></FGREF><PDAT>; SEQ ID NO: 7) of the gene encoding SpPCS and the amino acid sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 19B</PDAT></FGREF><PDAT>, SEQ ID NO: 8) of SpPCS.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 20</PDAT></FGREF><PDAT>, comprising </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 20A and 20B</PDAT></FGREF><PDAT>, lists the nucleotide sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 20A</PDAT></FGREF><PDAT>; SEQ ID NO: 9) of the gene encoding CePCS and the amino acid sequence (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 20B</PDAT></FGREF><PDAT>, SEQ ID NO: 10) of CePCS.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>The invention is based on the discovery of novel phytochelatin synthases from plants, yeast and nematodes. Prior to the instant disclosure, no phytochelatin synthase had been identified or isolated from any source such that no amino acid or nucleic acid sequence information was available for these proteins. These enzymes are important in that phytochelatins are useful molecules which bind to and sequester, inter alia, heavy metals. As a result of the present invention, new insights into the phenomena associated with heavy metal tolerance and/or resistance and phytoremediation are possible. The molecular identification of PC synthases provides a means, as is evident from the description of the present invention, for the manipulation of plants and the cells thereof, to affect heavy metal tolerance, resistance and accumulation associated with PC synthase-catalyzed PC biosynthesis for the bioremediation of contaminated soils and groundwaters. Therefore, isolation and purification of phytochelatin synthase and the nucleic acids encoding the same makes possible the large-scale production of these useful compounds and the development of recombinant plants and cells producing such compounds all of which will be useful in bioremediation to assist environmental cleanup efforts.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>The process of &ldquo;storage excretion&rdquo; is a necessity for plants. Whereas mammals have the option of excreting biotoxins to the extracellular medium for elimination by the kidneys, plants are nearly totally reliant on the sequestration of noxious compounds in the central vacuole, which frequently accounts for 40-90% of the total intracellular volume. Due to the virtual absence of specialized excretory organs and the presence of massive vacuoles in plants, a process termed intracellular compartmentation that is probably only an intermediate step in the elimination of xenobiotics from the cytosol of mammalian cells, is believed to constitute a terminal phase of detoxification in plants.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>The data disclosed herein establish that two plant nucleic acids, AtPCS1 and AtPCS2, isolated from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana, </PDAT></ITALIC></HIL><PDAT>a nucleic acid from wheat, TaPCS1, a nucleic acid from </PDAT><HIL><ITALIC><PDAT>C. elegans, </PDAT></ITALIC></HIL><PDAT>CePCS, and one from </PDAT><HIL><ITALIC><PDAT>S. pombe, </PDAT></ITALIC></HIL><PDAT>SpPCSe, each encode a phytochelatin synthase. The data further establish that the novel phytochelatin synthases participate in phytochelatin biosynthesis and, more importantly, heavy metal sequestration as exemplified by binding and transport of cadmium, arsenate, arsenite, lead, mercury and copper.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>The discovery of these genes in the present invention is important on several levels. The identification of these genes and the elucidation of the catalytic activity of their translation products represents the first combined molecular identification and biochemical definition of phytochelatin synthases from any organism. In the present invention, nucleic acids encoding PC synthases have been identified and isolated from plants, yeast and worms and the biochemical function of the proteins encoded thereby has been defined. Further, the identification and isolation of these genes and their encoded products permits a plant element, critical for removal of compounds from the cytosol that can form GSH conjugates, to be studied and manipulated.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>Two novel plant genes isolated from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana, </PDAT></ITALIC></HIL><PDAT>AtPCS1 and AtPCS2, which encode plant phytochelatin synthases involved in the biosynthesis of PCs, have been disclosed in the present invention. The genes are exemplified herein as SEQ ID NO: 1 and SEQ ID NO: 3, being AtPCS1 and AtPCS2, respectively. Proteins encoded by plant AtPCS1 and AtPCS2 (SEQ ID NO: 2 and SEQ ID NO: 4, respectively) thus represent novel enzymes never before characterized or isolated from any source.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>Additionally, a novel gene isolated from wheat, </PDAT><HIL><ITALIC><PDAT>Triticum aestivum, </PDAT></ITALIC></HIL><PDAT>TaPCS1 (SEQ ID NO: 5; GenBank Accession No. AF093752; </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 18</PDAT></FGREF><PDAT>) encoding a protein having the amino acid sequence SEQ ID NO: 6 is also disclosed, as is a nucleic acid isolated from the yeast </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces pombe, </PDAT></ITALIC></HIL><PDAT>SpPCS (SEQ ID NO: 7; GenBank Accession No. Q10075; FIG. </PDAT><HIL><BOLD><PDAT>19</PDAT></BOLD></HIL><PDAT>), encoding a novel yeast PCS polypeptide, SpPCS (SEQ ID NO: 8). Further, the invention also includes a </PDAT><HIL><ITALIC><PDAT>Caenorhabditis elegans </PDAT></ITALIC></HIL><PDAT>gene, CePCS (SEQ ID NO: 9; GenBank Accession No. Z66513; FIG. </PDAT><HIL><BOLD><PDAT>20</PDAT></BOLD></HIL><PDAT>), encoding a novel animal PCS, CePCS (SEQ ID NO: 10). The predicted amino acid sequences of AtPCS1, TaPCS1, CePCS, and SpPCS are disclosed in FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>A.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>It has been further discovered in the present invention that when nucleic acid encoding AtPCS1 is introduced into a mutant yeast strain which is hypersensitive to cadmium toxicity, the nucleic acid suppresses the cadmium-sensitive phenotype and, indeed, confers resistance to cadmium levels in excess of those tolerated by the wild type yeast strain from which the mutant is derived. Similarly, introduction of the wheat, yeast, and </PDAT><HIL><ITALIC><PDAT>C. elegans </PDAT></ITALIC></HIL><PDAT>gene into yeast also conferred resistance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> thereby demonstrating that these genes encode functional phytochelatin synthases. Further, expression of the wheat TaPCS1 nucleic acid or the SPPCS nucleic in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>caused Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance. Also, expression of TaPCS1 in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>caused an increase in the accumulation of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> in the cells even at low Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> levels. In addition, the data disclosed herein demonstrate that purified recombinant SpPCS protein synthesizes phytochelatins from glutathione in vitro and that expression of TaPCS1 or SpPCS in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>induced phytochelatin biosynthesis in vivo. Further, deletion of SpPCS in </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>caused increased sensitivity to cadmium and copper and this deletion mutant (&Dgr;SpPCS) did not synthesize phytochelatins.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>&ldquo;Encoding&rdquo; refers to the inherent property of specific sequences of nucleotides in a polynucleotide, such as a gene, a cDNA, or an mRNA, to serve as templates for synthesis of other polymers and macromolecules in biological processes having either a defined sequence of nucleotides (i.e., rRNA, tRNA and mRNA) or a defined sequence of amino acids and the biological properties resulting therefrom. Thus, a gene encodes a protein if transcription and translation of mRNA corresponding to that gene produces the protein in a cell or other biological system. Both the coding strand, the nucleotide sequence of which is identical to the mRNA sequence and is usually provided in sequence listings, and the non-coding strand, used as the template for transcription of a gene or cDNA, can be referred to as encoding the protein or other product of that gene or cDNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>Unless otherwise specified, a &ldquo;nucleotide sequence encoding an amino acid sequence&rdquo; includes all nucleotide sequences that are degenerate versions of each other and that encode the same amino acid sequence. Nucleotide sequences that encode proteins and RNA may include introns.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>An &ldquo;isolated nucleic acid,&rdquo; as used herein, refers to a nucleic acid sequence which has been separated from the sequences which flank it in a naturally occurring state, e.g., a nucleic acid fragment which has been removed from the sequences which are normally adjacent to the fragment, e.g., the sequences adjacent to the fragment in a genome in which it naturally occurs. The term also applies to nucleic acids which have been substantially purified from other components which naturally accompany the nucleic acid (e.g., RNA, DNA or protein) in its natural state. The term therefore includes, for example, a recombinant nucleic acid which is incorporated into a vector; into an autonomously replicating plasmid or virus; or into the genomic DNA of a prokaryote or eukaryote; or which exists as a separate molecule (e.g., as a cDNA or a genomic or cDNA fragment produced by PCR or restriction enzyme digestion) independent of other sequences. It also includes a recombinant nucleic acid which is part of a hybrid gene encoding additional polypeptide sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>Further discovered in the present invention is the fact that the plant phytochelatin synthases of the invention bind cadmium directly in a stoichiometric ratio of approximately 6 cadmium molecules for each AtPCS1. In addition, the data disclosed herein demonstrate that expression of AtPCS1 mediates the synthesis of PCs including PC</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, PC</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>, thereby facilitating the vacuolar transport and storage of heavy metals by PCs.</PDAT></PTEXT></PARA>
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>The identification of two plant phytochelatin synthases, AtPCS1 and AtPCS2 (SEQ ID NO: 2 and SEQ ID NO: 4, respectively; see </PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 16 and 17</PDAT></FGREF><PDAT>, respectively), is described in detail in the experimental details section. Further, the identification of a PC synthase from: wheat (TaPCS1 &lcub;SEQ ID NO: 5&rcub; and TaPCS1 &lcub;SEQ ID NO: 6&rcub;), yeast (SpPCS &lcub;SEQ ID NO: 7&rcub;) and SpPCS &lcub;SEQ ID NO: 8&rcub;), and nematodes (CePCS &lcub;SEQ ID NO: 9&rcub; and CePCS &lcub;SEQ ID NO: 10&rcub;) are also described in the detail elsewhere herein. Once armed with the present invention, the skilled artisan will know how to identify and isolate additional genes encoding other phytochelatin synthases from plants and other organisms, involved in sequestration of a variety of compounds by following the procedures described herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>A gene encoding a PC synthase is isolated using any one of several known molecular procedures. For example, primers comprising conserved regions of the sequences of any of ATPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9) may be used as probes to isolate, by polymerase chain reaction (PCR) or -by direct hybridization, as yet unknown AtPCS1, AtPCS2, TaPCS1 , SpPCS, and CePCS homologs in a DNA library comprising specific DNAs. Alternatively, antibodies directed against AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), or CePCS (SEQ ID NO: 10) may be used to isolate clones encoding a PC synthase from an expression library comprising specific DNAs. The isolation of primers, probes, molecular cloning and the generation of antibodies are procedures that are well known in the art and are described, for example, in Sambrook et al. (1989, In: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, N.Y.), Ausubel et al. (1997, In: Current Protocols in Molecular Biology, Green &amp; Wiley, New York), and in Harlow et al. (1988, In: Antibodies, A Laboratory Manual, Cold Spring Harbor, N.Y).</PDAT></PTEXT></PARA>
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>The invention includes isolated nucleic acids encoding phytochelatin synthases, which phytochelatin synthases are capable of synthesizing PCs which will, in turn, bind heavy metals including cadmium. Preferably, the nucleic acid encoding a phytochelatin synthase is at least about 15% homologous to at least one of AtPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9). More preferably, the isolated nucleic acid encoding a phytochelatin synthase is at least about 25%, preferably, at least about 35%, more preferably, at least about 45%, even more preferably, at least about 55%, more preferably, at least about 65%, even more preferably, at least about 75%, yet more preferably, at least about 85% homologous, more preferably, at least about 95% and even more preferably, at least about 99% homologous to at least one of AtPCSJ (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9). More preferably, the isolated nucleic acid encoding a phytochelatin synthase is Arabidopsis AtPCS1, or AtPCS2, or wheat TaPCS1 , or yeast SpPCS, or worm CePCS. Most preferably, the isolated nucleic acid encoding a phytochelatin synthase is SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, or SEQ ID NO: 9.</PDAT></PTEXT></PARA>
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>Thus, the invention should be construed to include nucleic acids which encode Arabidopsis AtPCS1 (SEQ ID NO: 2) and AtPCS2 (SEQ ID NO: 4), wheat TaPCS1 (SEQ ID NO: 6), yeast SpPCS (SEQ ID NO: 8), and worm CePCS (SEQ ID NO: 10), as well as nucleic acids homologous to Arabidopsis AtPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), wheat TaPCS1 (SEQ ID NO: 5), yeast SpPCS (SEQ ID NO: 7), and worm CePCS (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>In addition, when the term &ldquo;homology&rdquo; is used herein to refer to the nucleic acids and proteins, it should be construed to be applied to homology at both the nucleic acid and the amino acid levels.</PDAT></PTEXT></PARA>
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>Thus, the invention also includes an isolated nucleic acid encoding a phytochelatin synthase where the nucleic acid encodes a protein which is preferably, at least about 15% homologous to at least one of AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10). More preferably, the isolated nucleic acid encodes a phytochelatin synthase which is at least about 25%, more preferably, at least about 35%, even more preferably, at least about 45%, more preferably, at least about 55%, yet more preferably, at least about 65%, even more preferably, at least about 75%, yet more preferably, at least about 85% homologous, and more preferably, at least about 95%, and even more preferably, at least about 99% homologous to at least one of AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10). More preferably, the isolated nucleic acid encodes a plant phytochelatin synthase that is Arabidopsis AtPCS1 or AtPCS2, or wheat TaPCS1, or yeast SpPCS, or nematode CePCS. Most preferably, the isolated nucleic acid encodes a phytochelatin synthase having the amino acid sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 10.</PDAT></PTEXT></PARA>
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>Therefore, the invention should be construed to include nucleic acids which encode Arabidopsis AtPCS1 (SEQ ID NO: 2) and AtPCS2 (SEQ ID NO: 4), Triticum TaPCS1 (SEQ ID NO: 6), yeast SpPCS (SEQ ID NO: 8), and Caenorhabditis CePCS (SEQ ID NO: 10), as well as nucleic acids which encode a protein homologous to AtPCS1, AtPCS2, TaPCSl, SpPCS, and CePCS.</PDAT></PTEXT></PARA>
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>By &ldquo;phytochelatin synthase&rdquo; as used herein, is meant a protein which is involved in the biosynthesis of phytochelatins. These proteins (also referred to as &ggr;-glutamylcysteine dipeptidyl transpeptidases) synthesize PCs from GSH, homo-GSH, and related thiol peptides by transfer of a &ggr;-glutamylcysteine unit from a thiol peptide to another or to a previously synthesized PC molecule (Rauser, 1996, Annu. Rev. Biochem. 59:61-86; Zenk, 1990, Gene 179:21-30).</PDAT></PTEXT></PARA>
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>&ldquo;Phytochelatins,&rdquo; in turn, are poly-(&ggr;-Glu-Cys)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>-Xaa polymers that bind heavy metals with high affinity.</PDAT></PTEXT></PARA>
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>By the term &ldquo;nucleic acid encoding a phytochelatin synthase&rdquo; as used herein is meant a nucleic acid encoding a polypeptide capable of producing, or which is associated with the accumulation of, phytochelatins.</PDAT></PTEXT></PARA>
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>The present invention includes an isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase. Preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is at least about 15% homologous to a nucleic acid encoding a fragment of at least one of AtPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9). More preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is at least about 25%, more preferably, at least about 35%, even more preferably, at least about 45%, more preferably, at least about 55%, yet more preferably, at least about 65%, even more preferably, at least about 75%, yet more preferably, at least about 85%, and even more preferably, at least about 95%, and even more preferably, at least about 99% homologous to a fragment of at least one of tPCS1 (SEQ ID NO: 1), AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9). More preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is a nucleic acid encoding a fragment of AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS. Most preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is a nucleic acid encoding a fragment of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, or SEQ ID NO: 9.</PDAT></PTEXT></PARA>
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>As used herein, by the term &ldquo;biologically active&rdquo; as it refers to phytochelatin synthase activity as used herein, is meant a polypeptide, or a fragment thereof, which is capable of transferring a &ggr;-glutamylcysteine unit from a thiol peptide to another or to a previously synthesized phytochelatin molecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>Also included in the invention is an isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase. Preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is at least about 15% homologous to a nucleic acid encoding a biologically active polypeptide fragment of at least one of AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10). More preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is at least about 25%, more preferably, at least about.35%, even more preferably, at least about 45%, more preferably, at least about 55%, yet more preferably, at least about 65%, even more preferably, at least about 75%, yet more preferably, at least about 85%, yet more preferably, at least about 90%, and even more preferably, at least about 99% homologous to a nucleic acid encoding a biologically active polypeptide fragment of at least one of AtPCS l (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10). More preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is a nucleic acid encoding a biologically active polypeptide fragment of AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS. Most preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a phytochelatin synthase is a nucleic acid encoding a biologically active polypeptide fragment of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 10.</PDAT></PTEXT></PARA>
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>Preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a PC synthase is about 200 nucleotides in length. More preferably, the isolated nucleic acid encoding a biologically active polypeptide fragment of a PC synthase is about 400 nucleotides, even more preferably, at least about 600, yet more preferably, at least about 800, even more preferably, at least about 1000, more preferably, at least about 1200, even more preferably 1300, and yet more preferably 1400 nucleotides in length.</PDAT></PTEXT></PARA>
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>The invention further includes a vector comprising an isolated nucleic acid encoding a PC synthase and a vector comprising nucleic acid sequence encoding a biologically active fragment thereof. The procedures for the generation of a vector encoding a PC synthase, or fragment thereof, are well known in the art once the sequence of the gene is known, and are described, for example, in Sambrook et al., supra, Ausubel et al., supra. Suitable vectors include, but are not limited to, yeast-</PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>shuttle vectors as described elsewhere herein, and disarmed Agrobacterium tumor-inducing (Ti) plasmids (e.g., pBIN19) containing the target gene under the control of the cauliflower mosaic virus (CaMV) 35S promoter (Lagrimini et al., 1990, Plant Cell 2:7-18), its endogenous promoter or an inducible promoter (Bevan, 1984, Nucl. Acids Res. 12:8711-8721).</PDAT></PTEXT></PARA>
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>Further, the invention includes plant tissue-specific promoters such as are well-known in the art. These promoters direct expression of the nucleic acid operably linked thereto in certain tissue but not in others. One skilled in the art would appreciate, based upon the disclosure provided herein, that tissue-specific promoters would be useful for directing the expression of a nucleic acid encoding a PCS in a certain portion of the plant thereby localize heavy metals to, for example, the non-harvested portion of the plant, and away from the harvested portion of the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>The present invention includes a method of expressing a nucleic acid encoding a PC synthase in one tissue of a plant but not in another using a tissue-specific promoter as discussed previously. By doing so, the present invention provides a means for accumulating toxic metals in a part of the plant which is not, for instance, harvested for human or non-human animal consumption. Thus, the invention includes a method for accumulating heavy metals in a portion of the plant, such as the leaves or roots, which is not subject to animal consumption while minimizing the level of toxic heavy metals in an edible part of the same plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00097" LVL="0"><PTEXT><PDAT>By &ldquo;harvestable portion,&rdquo; as the term is used herein, is meant any portion of a plant which is cultivated and gathered for human use including consumption. Such harvestable portions include, but are not limited to, the fruits, seeds, leaves, stems, and roots of various plants. One skilled in the art would appreciate, based on the disclosure provided herein, that the harvested portion of one plant may be the non-harvested of another. For example, the harvested portion of a tobacco plant may be the leaves but not the roots whereas the harvested portion of a potato plant would be the root, or tuberous portion, but not the leaves of the plant. Further, the invention includes plants which have multiple portions which are harvested such as grape vines where both the fruits and leaves may be used for human consumption.</PDAT></PTEXT></PARA>
<PARA ID="P-00098" LVL="0"><PTEXT><PDAT>The &ldquo;non-harvested portion&rdquo; includes the portion(s) of a plant which are not used for human consumption. These parts may be used for purposes other than human or non-human animal consumption such as, but not limited to, portions of plants used for building materials. Therefore,.the non-harvested portion of a plant may encompass portions which are useful and/or commercially important, but which are not used for human or non-human animal consumption, i.e., the portion is not ingested or used in food preparation.</PDAT></PTEXT></PARA>
<PARA ID="P-00099" LVL="0"><PTEXT><PDAT>Also included in the invention is a cell comprising an isolated nucleic acid encoding a PC synthase and a cell comprising an isolated nucleic acid encoding a biologically active fragment thereof</PDAT></PTEXT></PARA>
<PARA ID="P-00100" LVL="0"><PTEXT><PDAT>The procedures for the generation of a cell encoding a PC synthase, or fragment thereof, are well know in the art once the sequence of the gene is known, and are described, for example, in Sambrook et al., supra, or Ausubel et al., 1997, supra. Suitable cells include, but are not limited to, yeast cells, bacterial cells, mammalian cells, and baculovirus-infected insect cells transformed with the gene for the express purpose of generating PC synthase polypeptide. In addition, plant cells transformed with the gene for the purpose of producing cells and regenerated plants having increased resistance to and increased capacity for heavy metal accumulation are included in the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00101" LVL="0"><PTEXT><PDAT>The invention also includes an isolated polypeptide comprising a PC synthase capable of producing PCs from GSH or another suitable substrate. Preferably, the isolated polypeptide comprising a PC synthase is at least about 15% homologous to at least one of AtPCSl (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10). More preferably, the isolated preparation of a polypeptide comprising a PC synthase is at least about 25%, more preferably, at least about 35%, even more preferably, at least about 45%, more preferably, at least about 55%, yet more preferably, at least about 65%, even more preferably, at least about 75%, more preferably, at least about 85%, even more preferably, at least about 95% and more preferably, at least about 99% homologous to at least one of AtPCS1, AtPCS2, TaPCS1, SpPCS, and CePCS. More preferably, the isolated preparation of a polypeptide comprising a PC synthase is AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS. Most preferably, the isolated preparation of a polypeptide comprising a PC synthase is at least one of SEQ ID NOS: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, and SEQ ID NO: 10.</PDAT></PTEXT></PARA>
<PARA ID="P-00102" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;isolated polypeptide&rdquo; describes a polypeptide which has been separated from components which naturally accompany it. Typically, a polypeptide is isolated when at least 10%, more preferably at least 20%, more preferably at least 50%, more preferably at least 60%, even more preferably at least 75%, more preferably at least 90%, and most preferably at least 99% of the total material (by volume, by wet or dry weight, or by mole per cent or mole fraction) of a sample is the polypeptide of interest. The degree of isolation of the polypeptide can be measured by any appropriate method, e.g., by column chromatography, polyacrylamide gel electrophoresis, or by HPLC analysis. For example, a polypeptide is isolated when it is essentially free of naturally associated components or when it is separated from the native compounds which accompany it in its natural state.</PDAT></PTEXT></PARA>
<PARA ID="P-00103" LVL="0"><PTEXT><PDAT>Also included in the invention is an isolated biologically active polypeptide fragment of a PC synthase. Preferably, the isolated biologically active polypeptide fragment of a PC synthase is at least about 15% homologous to a biologically active polypeptide fragment of at least one of AtPCS1, AtPCS2, TaPCS1, SpPCS, and CePCS. More preferably, the isolated biologically active polypeptide fragment of a PC synthase is at least about 25%, more preferably, at least about 35%, even more preferably, at least about 45%, more preferably, at least about 55%, yet more preferably, at least about 65%, even more preferably, at least about 75% and yet more preferably, at least about 85%, even more preferably, at least about 95%, and more preferably, at least about 99% homologous to a biologically active polypeptide fragment of at least one of AtPCS1 (SEQ ID NO: 2), AtPCS2 (SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 6), SpPCS (SEQ ID NO: 8), and CePCS (SEQ ID NO: 10). More preferably, the isolated biologically active polypeptide fragment of a PC synthase is a biologically active polypeptide fragment of AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS. Most preferably, the isolated biologically active polypeptide fragment of a PC synthase is a biologically active polypeptide fragment of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 10.</PDAT></PTEXT></PARA>
<PARA ID="P-00104" LVL="0"><PTEXT><PDAT>Preferably, the isolated biologically active polypeptide fragment of a PC synthase is about 60 amino acids in length. More preferably, the isolated biologically active polypeptide fragment of a PC synthase is about 130 amino acids, even more preferably, at least about 200, yet more preferably, at least about 300, even more preferably, at least about 350, and more preferably, at least about 400 amino acids in length.</PDAT></PTEXT></PARA>
<PARA ID="P-00105" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;homologous&rdquo; refers to the subunit sequence similarity between two polymeric molecules e.g., between two nucleic acid molecules, or two polypeptide molecules. When a subunit position in both of the two molecules is occupied by the same monomeric subunit, e.g., if a position in each of two polypeptide molecules is occupied by phenylalanine, then they are homologous at that position. The homology between two sequences is a direct function of the number of matching or homologous positions, e.g., if half (e.g., 5 positions in a polymer 10 subunits in length) of the positions in two polypeptide sequences are homologous then the two sequences are 50% homologous; if 70% of the positions, e.g., 7 out of 10, are matched or homologous, the two sequences share 70% homology. By way of example, the polypeptide sequences 5&prime;-ACDEFG-3&prime; and 5&prime;-ACDHIK-3&prime; (SEQ ID NOS:9 and 10, respectively) share 50% homology and the nucleotide sequences 5&prime;-CAATCG-3&prime; and 5&prime;-CAAGAC-3&prime; share 50% homology.</PDAT></PTEXT></PARA>
<PARA ID="P-00106" LVL="0"><PTEXT><PDAT>In summary, the invention should be construed to include nucleic acids comprising AtPCS1 or AtPCS2, or sharing at least 15% homology with SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, or SEQ ID NO: 9, and any fragments thereof, which encode phytochelatin synthase biological activity, and polypeptides comprising AtPCS1, AtPCS2, TaPCS1, SpPCS, and CePCS, or sharing at least 15% homology with SEQ ID NO: 2, SEQ ID NO; 4, SEQ ID NO: 6, SEQ ID NO: 8, or SEQ ID NO: 10, and any fragments thereof, which comprise phytochelatin synthase biological activity.</PDAT></PTEXT></PARA>
<PARA ID="P-00107" LVL="0"><PTEXT><PDAT>The invention further features an isolated a nucleic acid which is antisense in orientation to a portion or all of a nucleic acid encoding a phytochelatin synthase comprising AtPCS1, AtPCS2, TaPCS1, SpPCS, CePCS, or sharing at least 15% homology with at least one of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, or SEQ ID NO: 9, and any fragments thereof, wherein the antisense nucleic acid, or fragment thereof, is capable of inhibiting expression of the nucleic acid encoding a phytochelatin synthase when introduced into cells comprising the nucleic acid encoding a phytochelatin synthase.</PDAT></PTEXT></PARA>
<PARA ID="P-00108" LVL="0"><PTEXT><PDAT>&ldquo;Antisense&rdquo; refers particularly to the nucleic acid sequence of the non-coding strand of a double stranded DNA molecule encoding a protein, or to a sequence which is substantially homologous to the non-coding strand. As defined herein, an antisense sequence is complementary to the sequence of a double stranded DNA molecule encoding a protein. It is not necessary that the antisense sequence be complementary solely to the coding portion of the coding strand of the DNA molecule. The antisense sequence may be complementary to regulatory sequences specified on the coding strand of a DNA molecule encoding a protein, which regulatory sequences control expression of the coding sequences.</PDAT></PTEXT></PARA>
<PARA ID="P-00109" LVL="0"><PTEXT><PDAT>&ldquo;Complementary,&rdquo; as used herein, refers to the subunit sequence complementarity between two nucleic acids, e.g., two nucleic acid molecules. When a nucleotide position in both of the molecules is occupied by nucleotides normally capable of base pairing with each other, then the nucleic acids are considered to be complementary to each other at this position. Thus, two nucleic acids are complementary to each other when a substantial number (at least 50%) of corresponding positions in each of the molecules are occupied by nucleotides which normally base pair with each other (e.g., A:T and G:C nucleotide pairs).</PDAT></PTEXT></PARA>
<PARA ID="P-00110" LVL="0"><PTEXT><PDAT>The present invention also provides for analogs of proteins or peptides encoded by AtPCS1, AtPCS2, TaPCS1, SPPCS, or CePCS. Analogs can differ from naturally occurring proteins or peptides by conservative amino acid sequence differences or by modifications which do not affect sequence, or by both.</PDAT></PTEXT></PARA>
<PARA ID="P-00111" LVL="0"><PTEXT><PDAT>For example, conservative amino acid changes may be made, which although they alter the primary sequence of the protein or peptide, do not normally alter its function. Conservative amino acid substitutions typically include substitutions within the following groups:</PDAT></PTEXT></PARA>
<PARA ID="P-00112" LVL="2"><PTEXT><PDAT>glycine, alanine;</PDAT></PTEXT></PARA>
<PARA ID="P-00113" LVL="2"><PTEXT><PDAT>valine, isoleucine, leucine;</PDAT></PTEXT></PARA>
<PARA ID="P-00114" LVL="2"><PTEXT><PDAT>aspartic acid, glutamic acid;</PDAT></PTEXT></PARA>
<PARA ID="P-00115" LVL="2"><PTEXT><PDAT>asparagine, glutamine;</PDAT></PTEXT></PARA>
<PARA ID="P-00116" LVL="2"><PTEXT><PDAT>serine, threonine;</PDAT></PTEXT></PARA>
<PARA ID="P-00117" LVL="2"><PTEXT><PDAT>lysine, arginine;</PDAT></PTEXT></PARA>
<PARA ID="P-00118" LVL="2"><PTEXT><PDAT>phenylalanine, tyrosine.</PDAT></PTEXT></PARA>
<PARA ID="P-00119" LVL="7"><PTEXT><PDAT>Modifications (which do not normally alter primary sequence) include in vivo, or in vitro chemical derivatization of polypeptides, e.g, acetylation, or carboxylation. Also included are modifications of glycosylation, e.g., those made by modifying the glycosylation patterns of a polypeptide during its synthesis and processing or in further processing steps; e.g., by exposing the polypeptide to enzymes which affect glycosylation, e.g., mammalian glycosylating or deglycosylating enzymes. Also embraced are sequences which have phosphorylated amino acid residues, e.g., phosphotyrosine, phosphoserine, or phosphothreonine.</PDAT></PTEXT></PARA>
<PARA ID="P-00120" LVL="0"><PTEXT><PDAT>Also included are polypeptides which have been modified using ordinary molecular biological techniques so as to improve their resistance to proteolytic degradation or to optimize solubility properties or to render them more suitable as a therapeutic agent. Analogs of such polypeptides include those containing residues other than naturally occurring L-amino acids, e.g., D-amino acids or non-naturally occurring synthetic amino acids. The peptides of the invention are not limited to products of any of the specific exemplary processes listed herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00121" LVL="0"><PTEXT><PDAT>The invention further includes a transgenic plant comprising an isolated nucleic acid encoding a plant phytochelatin synthase, or a fragment thereof, capable of producing PCs. The transgenic plant of the invention may comprise a transgene encoding a plant phytochelatin synthase polypeptide, or a fragment thereof, or it may comprise a transgene encoding a phytochelatin synthase from a non-plant species which shares at least &Dgr;SpPCS homology with the plant nucleic acid and/or protein, which heterologous transgene is expressed in the plant to yield a biologically active phytochelatin synthase protein product. By way of example, there is provided herein in the experimental examples section a yeast transformant comprising an Arabidopsis phytochelatin synthase AtPCS1 transgene, which when the transgene is expressed in the yeast cell, confers upon the cell the ability to grow on media containing concentrations of heavy metal (cadmium) that would otherwise prevent growth of nontransgenic yeast. Similarly, the experimental examples disclose a yeast transformant expressing the phytochelatin synthase transgene, (i)TaPCS1, isolated from wheat which yeast demonstrated increased tolerance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, increased accumulation of this heavy metal even in low levels of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, and induced the increased biosynthesis of PCs in the yeast transformant. Therefore, the present invention teaches that expression of a nucleic acid encoding a PC synthase from another species confers PC synthase biological activity upon another organism.</PDAT></PTEXT></PARA>
<PARA ID="P-00122" LVL="0"><PTEXT><PDAT>By &ldquo;transgenic plant&rdquo; as used herein, is meant a plant, the cells, the seeds and the progeny of which comprise an isolated nucleic acid inserted therein, which isolated nucleic acid has been manipulated to be inserted into the cells of the plant by recombinant DNA technology. The manipulated isolated nucleic acid is designated as a &ldquo;transgene.&rdquo;</PDAT></PTEXT></PARA>
<PARA ID="P-00123" LVL="0"><PTEXT><PDAT>If heavy metal detoxification is limited by the rate of PC biosynthesis, transgenic plants with increased AtPCS1, AtPCS2, TaPCS1, SpPCS, and/or CePCS expression would be expected to be more resistant to the toxic effects of heavy metals. By the same token, if vacuolar heavy metal sequestration is limited by the rate of PC biosynthesis, transgenic plants with increased AtPCS1, AtPCS2, TaPCS1, SpPCS, and/or CePCS expression would be expected to be capable of accumulating higher vacuolar heavy metal levels than otherwise identical, non-transgenic plants. The former property permits the sustained growth of transgenic plants in the presence of heavy metal concentrations that would retard the growth of plants exhibiting normal levels of PC synthase expression. The latter property confers on transgenic plants the capacity for vacuolar heavy metal hyperaccumulation.</PDAT></PTEXT></PARA>
<PARA ID="P-00124" LVL="0"><PTEXT><PDAT>&ldquo;Heavy metal resistance,&rdquo; as the term is used herein, means that the organism is able to tolerate a higher intracellular level of a heavy metal than an otherwise identical organism which is not heavy metal resistant. Such ability to tolerate may be demonstrated by the ability of the organism to survive and even grow and/or divide in the presence of heavy metal which would kill and or cause an otherwise identical but non-resistant organism to not grow or divide.</PDAT></PTEXT></PARA>
<PARA ID="P-00125" LVL="0"><PTEXT><PDAT>In one embodiment, yeast transformants were heavy metal resistant to higher concentrations of arsenate, arsenite, copper, or mercury compared with otherwise identical non-transformant yeast of the same strain. However, the present invention should not be limited to these heavy metals or to yeast transformants. Rather, the invention should be construed to encompass any living organism and includes resistance to any heavy metal which may be encountered by the organism.</PDAT></PTEXT></PARA>
<PARA ID="P-00126" LVL="0"><PTEXT><PDAT>Further, yeast heavy metal transformants were able to grow and divide in culture in the presence of heavy metal salts as measured by the amount of heavy metal required to cause a 50% attenuation of growth as measured by increased optical density of the liquid growth culture. However, the present invention is not limited to measuring the toxic effect(s) of heavy metal exposure on cell growth and division in any particular manner. Rather, the invention should be interpreted to include any method to measure the growth and/or survival of a living organism before, during or after heavy metal exposure, compared with an otherwise identical organism that is not resistant to heavy metal. Other heavy metal assays include, but are not limited to, measurements of LD</PDAT><HIL><SB><PDAT>50</PDAT></SB></HIL><PDAT>, dry or fresh weight, tissue chlorosis/necrosis, CO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>fixation, O</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>consumption, CO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>evolution, the formation of activated oxygen species, cell or tissue turgidity, and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00127" LVL="0"><PTEXT><PDAT>Increased resistance to heavy metals has application in plant technology and plant growth in habitats polluted with xenobiotics. Since the plant vacuole frequently constitutes 40-90% of the total intracellular volume and since PCs mediate the uptake of heavy metals into this compartment, the potential for hyperaccumulation on a tissue weight basis as a result of increased production of PCs by phytochelatin synthase is great. Hyperaccumulators may then be used for the fixation/sequestration of heavy metals and their removal from soils.</PDAT></PTEXT></PARA>
<PARA ID="P-00128" LVL="0"><PTEXT><PDAT>The generation of transgenic plants comprising an isolated nucleic acid comprising the nucleic or amino acid sequence of a plant phytochelatin synthase, or a fragment thereof, may be accomplished by transformation of the plant with a plasmid encoding the desired nucleic acid sequence. Suitable vectors include, but are not limited to, disarmed Agrobacterium tumor-inducing (Ti) plasmids containing a sense or antisense strand placed under the control of the strong constitutive CaMV 35S promoter or under the control of an inducible promoter (Lagrimini et al., 1990, supra; van der Krol et al., 1988, Gene 72:45-50). Methods for the generation of such constructs, plant transformation and plant regeneration are well known in the art once the sequence of the desired gene is known and are described, for example, in Ausubel et al. (1993, Current Protocols in Molecular Biology, Greene and Wiley, New York).</PDAT></PTEXT></PARA>
<PARA ID="P-00129" LVL="0"><PTEXT><PDAT>Suitable vector and plant combinations will be readily apparent to those of skill in the art and can be found, for example, in Maliga et al. (1994, Methods in Plant Molecular Biology: A Laboratory Manual, Cold Spring Harbor, N.Y.).</PDAT></PTEXT></PARA>
<PARA ID="P-00130" LVL="0"><PTEXT><PDAT>A &ldquo;vector&rdquo; is a composition of matter which comprises an isolated nucleic acid and which can be used to deliver the isolated nucleic acid to the interior of a cell. Numerous vectors are known in the art including, but not limited to, linear polynucleotides, polynucleotides associated with ionic or amphiphilic compounds, plasmids, and viruses. Thus, the term &ldquo;vector&rdquo; includes an autonomously replicating plasmid or a virus. The term should also be construed to include non-plasmid and non-viral compounds which facilitate transfer of nucleic acid into cells, such as, for example, polylysine compounds, liposomes, and the like.</PDAT></PTEXT></PARA>
<PARA ID="P-00131" LVL="0"><PTEXT><PDAT>&ldquo;Expression vector&rdquo; refers to a vector comprising a recombinant polynucleotide comprising expression control sequences operatively linked to a nucleotide sequence to be expressed. An expression vector comprises-sufficient cis-acting elements for expression; other elements for expression can be supplied by the host cell or in an in vitro expression system. Expression vectors include all those known in the art, such as cosmids, plasmids (e.g., naked or contained in liposomes) and viruses that incorporate the recombinant polynucleotide.</PDAT></PTEXT></PARA>
<PARA ID="P-00132" LVL="0"><PTEXT><PDAT>Transformation of plants may be accomplished using the Agrobacterium-mediated leaf disc transformation method described by Horsch et al. (1988, Leaf Disc Transformation, Plant Molecular Biology Manual A5: 1).</PDAT></PTEXT></PARA>
<PARA ID="P-00133" LVL="0"><PTEXT><PDAT>A number of procedures may be used to assess whether the transgenic plant comprises the desired nucleic acid. For example, genomic DNA obtained from the cells of the transgenic plant may be analyzed by Southern blot hybridization or by PCR to determine the length and orientation of any inserted, transgenic nucleic acid present therein. Northern blot hybridization analysis or PCR may be used to characterize mRNA transcribed in cells of the transgenic plant. In situations where it is expected that the cells of the transgenic plant express phytochelatin synthase polypeptide, or a fragment thereof, Western blot analysis may be used to identify and characterize polypeptides so expressed using antibody raised against the phytochelatin synthase, or fragments thereof. In situations where phytochelatin synthase polypeptide is expressed in a catalytically active form, PC biosynthesis assays may be used to identify and characterize the enzyme molecules so expressed. The procedures for performing such analyses are well known in the art and are described, for example, in Sambrook et al. (supra).</PDAT></PTEXT></PARA>
<PARA ID="P-00134" LVL="0"><PTEXT><PDAT>The transgenic plants of the invention are useful for the manipulation of heavy metal detoxification. For example, a transgenic plant encoding an AtPCS1 or an AtPCS2 is useful for heavy metal detoxification when grown on soil containing heavy metals. Such plants are capable of removing heavy metals from the soil thereby generating soil which has reduced levels of compounds that are detrimental to the overall health of the environment.</PDAT></PTEXT></PARA>
<PARA ID="P-00135" LVL="0"><PTEXT><PDAT>Accordingly, the invention includes a method of removing heavy metals from soil comprising generating a transgenic plant having a transgene encoding a phytochelatin synthase and planting the plant or the seeds of the plant in the soil wherein heavy metals in the soil are hyperaccumulated/sequestered within the plant during growth of the plant in the soil. The plants are then harvested from the soil by standard agricultural methods well-known in the art or by methods to be developed in the future for harvesting of plants and/or methods developed specifically for phytoremediation.</PDAT></PTEXT></PARA>
<PARA ID="P-00136" LVL="0"><PTEXT><PDAT>When the levels of heavy metals in the soil have been sufficiently reduced, the transgenic plant may be removed from the soil and destroyed or discarded in an environmentally safe manner. For example, the harvested plants can be reduced in volume and/or weight by thermal, microbial, physical or chemical means to decrease handling, processing and potential subsequent land filling costs (Cunningham et al., 1996, Plant Physiol. 110:715-719). In the case of valuable metals, subsequent smelting and recovery of the metal may be cost-effective (Raskin, 1996, Proc. Natl. Acad. Sci. USA 93:3164-3166).</PDAT></PTEXT></PARA>
<PARA ID="P-00137" LVL="0"><PTEXT><PDAT>This technique of remediating soil is more efficient, less expensive and easier than most chemical or physical methods. The estimated costs of remediation are as follows: U.S. $10-100 per cubic meter of soil for removal of volatile or water soluble pollutants by in situ remediation using plants; U.S. $60-300 per cubic meter of soil for landfill or low temperature thermal treatment remediation of soil contaminated with the same compounds; and, U.S. $200-700 per cubic meter of soil for remediation of soil contaminated with materials requiring special landfilling arrangements or high temperature thermal treatment (Cunningham et al., 1995, Trends Biotechnol. 13:393-397).</PDAT></PTEXT></PARA>
<PARA ID="P-00138" LVL="0"><PTEXT><PDAT>Preferably, the transgene in the transgenic plant of the invention is AtPCS1, AtPCS2, or genes encoding fragments or analogs of AtPCS1, AtPCS2, or the transgene is a nucleic acid which is at least about 15% homologous to AtPCS1 , (SEQ ID NO: 1) AtPCS2 (SEQ ID NO: 3), TaPCS1 (SEQ ID NO: 5), SpPCS (SEQ ID NO: 7), and CePCS (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
<PARA ID="P-00139" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;transgene&rdquo; means an exogenous nucleic acid sequence comprising a nucleic acid which encodes a promoter/regulatory sequence operably linked to nucleic acid which encodes an amino acid sequence, which exogenous nucleic acid is-encoded by a transgenic organism.</PDAT></PTEXT></PARA>
<PARA ID="P-00140" LVL="0"><PTEXT><PDAT>By describing two polynucleotides as &ldquo;operably linked&rdquo; is meant that a single-stranded or double-stranded nucleic acid moiety comprises the two polynucleotides arranged within the nucleic acid moiety in such a manner that at least one of the two polynucleotides is able to exert a physiological effect by which it is characterized upon the other. By way of example, a promoter operably linked to the coding region of a gene is able to promote transcription of the coding region.</PDAT></PTEXT></PARA>
<PARA ID="P-00141" LVL="0"><PTEXT><PDAT>As used herein, the term &ldquo;promoter/regulatory sequence&rdquo; means a nucleic acid sequence which is required for expression of a gene product operably linked to the promoter/regulator sequence. In some instances, this sequence may be the core promoter sequence and in other instances, this sequence may also include an enhancer sequence and other regulatory elements which are required for expression of the gene product. The promoter/regulatory sequence may, for example, be one which expresses the gene product in a tissue-specific manner.</PDAT></PTEXT></PARA>
<PARA ID="P-00142" LVL="0"><PTEXT><PDAT>One skilled in the art, based upon the disclosure provided herein, would appreciate that expression of PC synthase in certain tissues, such as roots, may minimize the level of heavy metals present in harvestable tissues of the plant (e.g., leaves and fruits). Further, for purposes of bioremediation of contaminated groundwaters, expression of PC synthases in aerial tissues would increase the accumulation of heavy metals in those tissues. Additionally, the selective expression of PC synthase in plant roots would enhance the ability to the plants to remove toxic heavy metals from contaminated groundwaters in a process termed &ldquo;rhizofiltration.&rdquo; The plants containing the heavy metals could then be easily harvested from such waters thereby removing the heavy metal contaminants from groundwaters.</PDAT></PTEXT></PARA>
<PARA ID="P-00143" LVL="0"><PTEXT><PDAT>By &ldquo;groundwater,&rdquo; as the term is used herein, is meant any water source, either natural or man-made.</PDAT></PTEXT></PARA>
<PARA ID="P-00144" LVL="0"><PTEXT><PDAT>The types of plants which are suitable for use in this method of the invention include, but are not limited to, high yield crop species for which cultivation practices have already been perfected, or engineered endemic species that thrive in the area to be remediated.</PDAT></PTEXT></PARA>
<PARA ID="P-00145" LVL="0"><PTEXT><PDAT>In certain situations, it may be necessary to prevent the removal of substances such as xenobiotic toxins and heavy metals from the soil or groundwater. In such situations, transgenic plants are generated comprising a transgene comprising an AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS sequence, or a sequence having at least 15% homology with at least one of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, and SEQ ID NO: 9, or a fragment thereof, which is in the antisense orientation with respect to transcription. Such transgenes therefore serve to inhibit the function of AtPCS1 , AtPCS2, TaPCS1, SpPCS, or CePCS expressed in the plants thereby preventing removal of heavy metals from the soil and/or groundwater.</PDAT></PTEXT></PARA>
<PARA ID="P-00146" LVL="0"><PTEXT><PDAT>One skilled in the art will appreciate that one way to decrease the levels of a PCS protein in a cell is to inhibit expression of the PCS nucleic acid encoding such protein. Expression of PC synthase protein may be inhibited using, for example, antisense molecules, ribozymes, virus-induced genetic suppression, and co-suppression.</PDAT></PTEXT></PARA>
<PARA ID="P-00147" LVL="0"><PTEXT><PDAT>Antisense molecules and their use for inhibiting gene expression are well known in the art (see, e.g., Cohen, 1989, In: Oligodeoxyribonucleotides, Antisense Inhibitors of Gene Expression, CRC Press). Antisense nucleic acids are DNA or RNA molecules that are complementary, as that term is defined elsewhere herein, to at least a portion of a specific mRNA molecule (Weintraub, 1990, Scientific American 262:40). In the cell, antisense nucleic acids hybridize to the corresponding mRNA, forming a double-stranded molecule thereby inhibiting the translation of genes.</PDAT></PTEXT></PARA>
<PARA ID="P-00148" LVL="0"><PTEXT><PDAT>The use of antisense methods to inhibit the translation of genes is known in the art, and is described, for example, in Marcus-Sakura, 1988, Anal. Biochem. 172:289. Such antisense molecules may be provided to the cell via genetic expression using DNA encoding the antisense molecule as taught by Inoue, 1993, U.S. Pat. No. 5,190,931 (incorporated by reference herein in its entirety).</PDAT></PTEXT></PARA>
<PARA ID="P-00149" LVL="0"><PTEXT><PDAT>Alternatively, antisense molecules of the invention may be made synthetically and then provided to the cell. Antisense oligomers of about 15 nucleotides are preferred, since they are easily synthesized and introduced into a target PC synthase-producing cell. Synthetic antisense molecules contemplated by the invention include oligonucleotide derivatives known in the art which have improved biological activity compared to unmodified oligonucleotides (see Cohen, supra; Tullis, 1991, U.S. Pat. No. 5,023,243, incorporated by reference herein in its entirety).</PDAT></PTEXT></PARA>
<PARA ID="P-00150" LVL="0"><PTEXT><PDAT>Ribozymes and their use for inhibiting gene expression are also well known in the art (see, e.g:, Cech et al., 1992, J. Biol. Chem. 267:17479-17482; Hampel et al., 1989, Biochemistry 28:4929-4933; Eckstein et al., International Publication No. WO 92/07065; Altman et al., U.S. Pat. No. 5,168,053, incorporated by reference herein in its entirety). Ribozymes are RNA molecules possessing the ability to specifically cleave other single-stranded RNA in a manner analogous to DNA restriction endonucleases. Through the modification of nucleotide sequences encoding these RNAs, molecules can be engineered to recognize specific nucleotide sequences in an RNA molecule and cleave it (Cech, 1988, J. Amer. Med. Assn. 260:3030). A major advantage of this approach is that, because they are sequence-specific, only mRNAs with particular sequences are inactivated.</PDAT></PTEXT></PARA>
<PARA ID="P-00151" LVL="0"><PTEXT><PDAT>There are two basic types of ribozymes, namely, tetrahymena-type (Hasselhoff, 1988,.Nature 334:585) and hammerhead-type. Tetrahymena-type ribozymes recognize sequences which are four bases in length, while hammerhead-type ribozymes recognize base sequences 11-18 bases in length. The longer the sequence, the greater the likelihood that the sequence will occur exclusively in the target mRNA species. Consequently, hammerhead-type ribozymes are preferable to tetrahymena-type ribozymes for inactivating specific mRNA species, and 18-base recognition sequences are preferable to shorter recognition sequences which may occur randomly within various unrelated mRNA molecules.</PDAT></PTEXT></PARA>
<PARA ID="P-00152" LVL="0"><PTEXT><PDAT>Ribozymes useful for inhibiting the expression of phytochelatin synthases may be designed by incorporating target sequences into the basic ribozyme structure which are complementary to the mRNA sequence of the phytochelatin synthase encoded by AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS, or having at least about 15% homology to SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, or SEQ ID NO: 9. Ribozymes targeting phytochelatin synthase may be synthesized using commercially available reagents (Applied Biosystems, Inc., Foster City, Calif.) or they may be genetically expressed from DNA encoding them.</PDAT></PTEXT></PARA>
<PARA ID="P-00153" LVL="0"><PTEXT><PDAT>Another approach for inhibiting expression of the PC synthase of interest may be accomplished using virus-induced gene silencing (VIGS) as described by Baulcombe (1999, Curr. Opinion Plant Biol. 2:109-113). That is, portion(s) of an exon is cloned into an appropriate virus vector which, when expressed in the plant tissue, cause the decreased expression of the nucleic acid homologous to the cloned exon. Further, gene expression may be inhibited in plants using co-suppression methods (Kral et al., 1990, Plant Cell 2:279-289; Napoli et al., 1990, Plant Cell. 2:291-299). One skilled in the art would appreciate, based on the disclosure provided herein, that the particular method used to inhibit expression of the PCS of interest may vary depending on the tissue and/or plant and/or the particular PCS gene whose expression is the target of regulation.</PDAT></PTEXT></PARA>
<PARA ID="P-00154" LVL="0"><PTEXT><PDAT>AtPCS1, AtPCS2, TAPCS1, SpPCS, and CePCS antisense sequences and/or ribozymes homologous to these PCS sequences, and/or VIGS using sequences homologous to these sequences, has application in the manipulation of plant/food diminution of heavy metal accumulation by crop species. For example, ingestion by animals or humans of low heavy metal crops will likely contribute to an improvement in the overall health of animals and humans.</PDAT></PTEXT></PARA>
<PARA ID="P-00155" LVL="0"><PTEXT><PDAT>Accordingly, the invention includes a method of preventing the removal of heavy metals from soil comprising generating a transgenic plant having a transgene comprising a PCS sequence which is in the antisense orientation with respect to transcription or a ribozyme or a VIGS construct and/or a co-suppression construct and planting the plant or the seeds of the plant in the soil, wherein removal of heavy metals from the soil is prevented during growth of the plant in the soil.</PDAT></PTEXT></PARA>
<PARA ID="P-00156" LVL="0"><PTEXT><PDAT>The antisense, ribozyme, VIGS, and/or co-suppression sequences which are useful for the generation of transgenic plants having antisense, ribozyme, VIGS, or co-suppression PCS sequences are those which will inhibit expression of a resident PCS gene in the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00157" LVL="0"><PTEXT><PDAT>The types of plants which are suitable for use in this method of the invention using antisense, ribozyme, VIGS or co-suppression sequences include, but are not limited to, crops for which decreased heavy metal accumulation is desirable.</PDAT></PTEXT></PARA>
<PARA ID="P-00158" LVL="0"><PTEXT><PDAT>The invention further includes an isolated nucleic acid encoding a phytochelatin synthase covalently linked to a reporter nucleic acid. The procedures for the generation of a isolated nucleic acid encoding a phytochelatin synthase and a reporter nucleic acid are well know in the art once the sequence of the nucleic acid encoding phytochelatin synthase is known, and such techniques are described, for example, in Sambrook et al. (supra). Suitable vectors include, but are not limited to, yeast-</PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>shuttle vectors, disarmed Agrobacterium tumor-inducing (Ti) plasmids (e.g., pBIN19) (Lagrimini et al., 1990, Plant Cell 2:7-18; Bevan, 1984, Nuci. Acids Res. 12:8711-8721).</PDAT></PTEXT></PARA>
<PARA ID="P-00159" LVL="0"><PTEXT><PDAT>A &ldquo;reporter nucleic acid&rdquo; as used herein, is one which when transcribed or translated in a cell, results in the production of a detectable product in the cell. Typically, the level of expression of the product in the cell is proportional to the activity of the promoter sequence which drives expression of the reporter nucleic acid and the nucleic acid encoding the plant phytochelatin synthase linked to the reporter nucleic acid. Therefore, expression of the reporter nucleic acid indicates the level of expression of the plant phytochelatin synthase and may also be used to determine the cellular location of the phytochelatin synthase nucleic acid and/or polypeptide expressed therefrom and linked to the reporter sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00160" LVL="0"><PTEXT><PDAT>By describing two nucleic acid sequences as &ldquo;covalently linked&rdquo; as used herein, is meant that a single-stranded or double-stranded nucleic acid moiety comprises each of the two nucleic acid sequences and that the two sequences are arranged within the nucleic acid moiety in such a manner that the two sequences are transcribed and/or translated to produce a chimeric nucleic acid and/or polypeptide.</PDAT></PTEXT></PARA>
<PARA ID="P-00161" LVL="0"><PTEXT><PDAT>Suitable reporter nucleic acids encode, for example, human influenza virus hemagglutinin (HA) epitope, the octapeptide FLAG epitope, &bgr;-glucuronidase (GUS) and green fluorescent protein (QFP), or luciferase (LUC), although any reporter nucleic acid capable of expression and detection in plant cells which are either known or heretofore unknown, may be linked to the plant phytochelatin synthase nucleic acids of the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00162" LVL="0"><PTEXT><PDAT>The invention further includes a transgenic plant comprising an isolated nucleic acid comprising a phytochelatin synthase comprising AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS, or a nucleic acid sharing at least 15% homology with SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, and/or SEQ ID NO: 9, linked to a reporter nucleic acid.</PDAT></PTEXT></PARA>
<PARA ID="P-00163" LVL="0"><PTEXT><PDAT>The basic principle of reporter gene analysis is illustrated by, but not limited to, the GUS method. Briefly, to assess PCS expression in a plant cell, whether the cell is contained within a plant or is separated from a plant, a plasmid may be generated which comprises the GUS reporter gene fused to a PCS promoter sequence, or to a tissue-specific promoter sequence. For example, the appropriate restriction fragment is subcloned into the GUS expression vector pBI101.3 (Jefferson et al., 1987, EMBO J., 6:3901-3907). After confirming the correct reading frame by sequencing, Agrobacterium or any other suitable vector, is transformed with the expression construct and is then used to used to transform the plant, or the cells thereof (Valvekens et al., 1988, Proc. Natl. Acad. Sci. U.S.A. 85:5536-5540).</PDAT></PTEXT></PARA>
<PARA ID="P-00164" LVL="0"><PTEXT><PDAT>Expression of GUS may be localized histochemically by staining with 5-bromo-4-chloro-3-indoyl &bgr;-D-glucuronide (X-Gluc; Jefferson et al., supra). Sections are obtained from the plant, they are incubated in X-Gluc, cleared by boiling in ethanol and are examined under the microscope. To eliminate or enumerate complications arising from the transfer of GUS reaction product between cells, the distribution of GUS expression is then further examined both immunologically and biochemically. &bgr;-glucuronidase protein is assessed using standard dot-blotting and immunolocalization techniques (Harlow et. al., 1988, Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory, NY) using rabbit anti-&bgr;-glucuronidase serum (ClonTech, Inc., Palo Alto, Calif.). Direct estimates of GUS activity are be made fluorimetrically using 4-methyl-umbelliferyl glucuronide as substrate (Jefferson et al., supra) after dissection and extraction of explants.</PDAT></PTEXT></PARA>
<PARA ID="P-00165" LVL="0"><PTEXT><PDAT>The present invention also includes a method of biosynthesizing a phytochelatin. The method comprises contacting an isolated phytochelatin synthase with a sufficient amount of glutathione, or a glutathione-related thiol peptide, under conditions which permit biosynthesis of phytochelatins from glutathione or other related thiol peptide.</PDAT></PTEXT></PARA>
<PARA ID="P-00166" LVL="0"><PTEXT><PDAT>By the term &ldquo;sufficient amount,&rdquo; as that term is used herein, is meant an amount of glutathione, or glutathione-related thiol peptide, which allows a detectable amount of PC biosynthesis to occur under conditions which typically permit such biosynthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00167" LVL="0"><PTEXT><PDAT>Conditions which permit biosynthesis of phytochelatins from glutathione or other related thiol peptide are the chemical and biological parameters required for the transfer of a &ggr;-glutamylcysteine unit from or onto a peptide. Such parameters, for example, are set forth in Grill et al. (1989, Proc. Natl. Acad. Sci. U.S.A. 89:6838-6842), and they include, but are not limited to, the presence of about 3.3 mM GSH, 10 mM 2-ME, and 200 mM Tris-HCl buffer (pH 8.0), in the absence or presence of CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. However, the present invention should not be construed to be limited to these or any other specific conditions for PC biosynthesis. Rather, the present invention should be construed to encompass any conditions under which a detectable level of enzymatic transfer of a &ggr;-glutamylcysteine unit from a substrate onto another -I molecule may take place in the presence of any required ions, substrates and/or cofactors.</PDAT></PTEXT></PARA>
<PARA ID="P-00168" LVL="0"><PTEXT><PDAT>By &ldquo;glutathione-related thiol peptide,&rdquo; as the term is used herein, is meant any peptide which may be used by a phytochelatin synthase to transfer a &ggr;-glutamylcysteine unit from that peptide onto another moiety or onto which a phytochelatin synthase may transfer a &ggr;-glutamylcysteine unit from another source. Such GSH-related thiol peptides include, but are not limited to, homoglutathione, PC</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, PC</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, and PC</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00169" LVL="0"><PTEXT><PDAT>&ldquo;Biosynthesis,&rdquo; as the term is used herein, means any bona fide catalytic reaction mediated by an enzyme to produce a compound. In one embodiment, the biosynthesis is the enzymatic reaction whereby an isolated phytochelatin synthase produces a phytochelatin by transfer of a &ggr;-glutamylcysteine unit from GSH to another related thiol peptide. However, the present invention encompasses PC biosynthesis performed in vitro in an appropriate buffer system in the presence of purified PC synthase, GSH, or any other related thiol peptide source of &ggr;-glutamylcysteine units, and a concentration of heavy metal ion sufficient to activate PC synthase-mediated PC biosynthesis as disclosed elsewhere herein. Purified PC synthase may be employed at a concentration ranging from about 0.1 &mgr;g to about 0.1 mg/ml, GSH &lcub;or, for example, &ggr;-glutamylcysteine, PC2, PC3, or PC4, or homo-GSH, hydroxymethyl-GSH (&ggr;-Glu-Cys-Ser), or &ggr;-glutamylcysteinylglutamic acid (Zenk et al., supra)&rcub; at a concentration ranging from about 0.1 &mgr;M to about 50 mM, and heavy metal (e.g., Cd2&plus;, Hg2&plus;, Pb2&plus;, As3&plus;, Cu2&plus;, Ni2&plus;, or Zn2&plus;) at a concentration ranging from about 0.1 to about 500 &mgr;M. Thus, PC biosynthesis requires at least a PC synthase (e.g., AtPCS1, AtPCS2, TaPCS1, SpPCS, or CePCS), GSH (as &ggr;-glutamylcysteine donor or acceptor), and a heavy metal activator. The invention should not be construed to be limited to biosynthesis of any particular phytochelatin or to reactions where the &ggr;-glutamylcysteine unit is derived from GSH; rather, the present invention should be construed to encompass the synthesis of any (&ggr;-Glu-Cys)</PDAT><HIL><SB><PDAT>n </PDAT></SB></HIL><PDAT>polymer mediated by a PC synthase molecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00170" LVL="0"><PTEXT><PDAT>Further, the present invention is intended to encompass biosynthesis of PCs whether in vitro using PC synthase from biological extracts as well as biosynthesis performed in vivo. In one embodiment, the biosynthesis is performed by heterologous expression of </PDAT><HIL><ITALIC><PDAT>A. thaliana </PDAT></ITALIC></HIL><PDAT>PC synthase 1 in yeast cells. In another embodiment, the biosynthesis is performed by heterologous expression of either a wheat PC synthase (TaPCS1) or a yeast PC synthase (SpPCS) in a </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>yeast cell. In yet another embodiment, the biosynthesis is performed in vitro using a purified recombinant SpPCS protein. The present invention encompasses PC biosynthesis performed in vitro in an appropriate buffer system in the presence of a purified PC synthase, GSH, or any other related thiol peptide source of &ggr;-glutamylcysteine units, and an amount of CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>sufficient to elicit PC synthase catalyzed biosynthesis of PCs as disclosed herein.</PDAT></PTEXT></PARA>
<PARA ID="P-00171" LVL="0"><PTEXT><PDAT>In one embodiment, the isolated phytochelatin synthase protein is AtPCS1. However, the present invention should not be construed to be limited to solely AtPCS1. Rather, the invention should be construed to include other phytochelatin synthases wherein the PC synthases share at least about 15% sequence homology at either the nucleic or amino acid sequence level with AtPCS1 (i.e., SEQ ID NO: 1 or SEQ ID NO: 2, respectively), including, but not limited to, AtPCS2 (SEQ ID NO: 3 and SEQ ID NO: 4), TaPCS1 (SEQ ID NO: 5 and SEQ ID NO: 6), SpPCS (SEQ ID NO: 7 and SEQ ID NO: 8), and CePCS (SEQ ID NO: 9 and SEQ ID NO: 10).</PDAT></PTEXT></PARA>
<PARA ID="P-00172" LVL="0"><PTEXT><PDAT>The invention also includes a method of transferring a &ggr;-glutamylcysteine unit from one thiol peptide to another, said method comprising contacting an isolated phytochelatin synthase with a glutathione, or a related thiol peptide, under conditions which permit transfer of said &ggr;-glutamylcysteine unit from one thiol peptide to another, thereby transferring a &ggr;-glutamylcysteine unit from one thiol peptide to another.</PDAT></PTEXT></PARA>
<PARA ID="P-00173" LVL="0"><PTEXT><PDAT>The invention includes a method of decreasing the level of a heavy metal in a harvestable portion of a plant. The method comprises expressing a nucleic acid encoding a phytochelatin synthase in a non-harvestable portion of a plant. As discussed previously elsewhere herein, tissue-specific expression of a nucleic acid encoding PCS may be performed using a tissue-specific promoter sequence covalently linked to the nucleic acid encoding PCS. Such tissue-specific promoters are well-known in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00174" LVL="0"><PTEXT><PDAT>Expression of a phytochelatin synthase in the non-harvestable portion of the plant causes the heavy metal to be accumulated therein, thereby reducing the amount of heavy metal in the harvestable portion of the plant. Expression of a phytochelatin synthase in the non-harvestable portion of the plant may be accomplished by operably linking nucleic acid encoding PCS to a promoter, either a constitutive or a tissue-specific promoter, and introducing the nucleic acid so operably linked, into the non-harvestable portion of the plant. As described previously elsewhere herein, transgenic plants may be produced comprising a nucleic acid encoding a phytochelatin synthase under the control of an appropriate promoter thereby causing the PC synthase to be selectively expressed in the non-harvestable portion of the transgenic plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00175" LVL="0"><PTEXT><PDAT>Thus, one skilled in the art, based upon the disclosure provided herein, would appreciate that expression of PCS in a non-harvestable portion of the plant results in hyperaccumulation of heavy metal in that portion of the plant thereby decreasing the level of a heavy metal elsewhere in the plant including a decrease in the level of heavy metal in the harvestable portion of the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00176" LVL="0"><PTEXT><PDAT>In one aspect, the level of heavy metal in the harvestable portion of the plant would be decreased further by inhibiting the expression of any endogenous phytochelatin synthase in the harvestable portion of the plant. As discussed previously elsewhere herein, methods for specifically inhibiting the expression of PCS in a plant are well-known in the art and include, but are not limited to, the use of antisense molecules, ribozymes, VIGS, and co-suppression techniques. These methods allow the tissue-specific inhibition of PCS in a harvestable portion of a plant. Thus, the level of expression of a nucleic acid encoding a phytochelatin synthase is increased in a non-harvestable portion of a plant causing hyperaccumulation of heavy metal in such portion while, at the same time, the expression of phytochelatin synthase in a harvestable portion of the same plant is inhibited causing an even. further reduction in the level of heavy metal present in the harvestable portion of the plant.</PDAT></PTEXT></PARA>
<PARA ID="P-00177" LVL="0"><PTEXT><PDAT>The invention also includes a method of removing a heavy metal from groundwater. The method comprises growing in the groundwater a transgenic plant comprising an isolated nucleic acid encoding a phytochelatin synthase. The transgenic plant therefore accumulates heavy metals obtained from the groundwater such that when the plant is harvested from the groundwater the heavy metals are removed with the plant thereby removing heavy metal from the groundwater.</PDAT></PTEXT></PARA>
<PARA ID="P-00178" LVL="0"><PTEXT><PDAT>The invention is further described in detail by reference to the following experimental examples. These examples. are provided for purposes of illustration only, and are not intended to be limiting unless otherwise specified. Thus, the invention should in no way be construed as being limited to the following examples, but rather, should be construed to encompass any and all variations which become evident as a result of the teaching provided herein.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 1</PDAT></STEXT></H>
<PARA ID="P-00179" LVL="7"><PTEXT><PDAT>Phytochelatin Synthases from Arabidopsis</PDAT></PTEXT></PARA>
<PARA ID="P-00180" LVL="0"><PTEXT><PDAT>The experiments presented in this example may be summarized as follows.</PDAT></PTEXT></PARA>
<PARA ID="P-00181" LVL="0"><PTEXT><PDAT>Phytochelatins, a class of posttranslationally synthesized proteins, play a pivotal role in heavy metal, primarily Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, tolerance in plants and fungi. PCs chelate heavy metals thereby decreasing their free concentrations in samples. Derived from glutathione and related thiols by the action of &ggr;-glutamylcysteine dipeptidyl transpeptidases (i.e., phytochelatin syntheses; EC 2.3.2.15), phytochelatins consist of repeating units of &ggr;-glutamylcysteine followed by a C-terminal Gly, Ser or &bgr;-Ala &lcub;poly-(&ggr;-Glu-Cys)</PDAT><HIL><SB><PDAT>n</PDAT></SB></HIL><PDAT>-Xaa&rcub;. The data disclosed herein demonstrate, for the first time, the suppression cloning of a novel cDNA (AtPCS1) from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>encoding a 55 kDa soluble protein that enhances heavy metal tolerance and promotes Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-elicited phytochelatin accumulation when expressed in </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae. </PDAT></ITALIC></HIL><PDAT>Based on these properties, the data disclosed herein demonstrate that AtPCS1 encodes the enzyme phytochelatin synthase. In addition, the data disclosed herein demonstrated the sufficiency of immunoaffinity-purified epitope-tagged AtPCS1 polypeptide for high rates of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-activated phytochelatin synthesis from glutathione in vitro, further supporting that AtPCS1 encodes the enzyme phytochelatin synthase.</PDAT></PTEXT></PARA>
<PARA ID="P-00182" LVL="0"><PTEXT><PDAT>The Materials and Methods used in the experiments presented in this example are now described.</PDAT></PTEXT></PARA>
<PARA ID="P-00183" LVL="0"><PTEXT><PDAT>Yeast strains and plant materials</PDAT></PTEXT></PARA>
<PARA ID="P-00184" LVL="0"><PTEXT><PDAT>The yeast strains used in the experiments disclosed herein were as follows: yap1&Dgr; mutant SM12 (MAT&agr;leu2-3,-112 ura3-52 his3-&Dgr;200 trp1-&Dgr;901 lys2-801 suc2-&Dgr;9 Mel</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> yap1-&Dgr;1::HIS3; Wemmie et al., 1994, J. Biol. Chem. 269:14690-14697); the ycf1&Dgr; mutants DTY167 (MAT&agr;ura3-52 leu2-3,-112 his-&Dgr;200 trp1-&Dgr;901 lys2-801 suc2-&Dgr;9 ycf1::hisG; Li et al., 1996, J. Biol. Chem. 271:6509-6517) and DTY168 (MAT&agr;ura3-52 leu2-3,-112 his6ycf1::hisG; Szczypka et al., 1994, J. Biol. Chem. 269:22853-22857); the pep5 &Dgr; mutant DTY214 (MAT&agr;ura3-52 leu2-3,-112 his3-&Dgr;200 trp1-&Dgr;901 lys2-801 suc-&Dgr;9pep5::LEU2); and the cup1&Dgr; mutant DTY4 (MAT&agr;ura3-52 leu2-3,-112 trp1-1 gal1 his-cup1&Dgr;::URA3; Hamer et al., 1985, Science 228:685-690). </PDAT><HIL><ITALIC><PDAT>A. thaliana, </PDAT></ITALIC></HIL><PDAT>cultivar Columbia, was the source of the RNA used for construction of the pFL61 cDNA library as described by Minet et al. (1992, Plant J. 2:417-422) and Northern blot analyses, and the genomic DNA used for the Southern blot analyses.</PDAT></PTEXT></PARA>
<PARA ID="P-00185" LVL="0"><PTEXT><PDAT>Isolation of AtPCS1</PDAT></PTEXT></PARA>
<PARA ID="P-00186" LVL="0"><PTEXT><PDAT>To identify plant genes which are capable of suppressing Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-hypersensitivity, </PDAT><HIL><ITALIC><PDAT>S. cerevisiae yap</PDAT></ITALIC></HIL><PDAT>1&Dgr; strain SM12 was transformed with an Arabidopsis cDNA library constructed in the yeast-</PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>shuttle vector pFL61 (Minet et al., 1992, Plant J. 2:417-422). Stable Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-tolerant, Ura</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> transformants were selected by first plating the SM12 transformants on synthetic complete-Ura medium containing 100 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>followed by replication to medium containing 200 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. The pFL61 plasmids from all 105 Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-tolerant SM12 transformants identified in this step were rescued (Strathern and Higgins, 1991 Methods Enzymol. 194:319-329), used to transform </PDAT><HIL><ITALIC><PDAT>S cerevisiae </PDAT></ITALIC></HIL><PDAT>ycf1&Dgr; strain DTY168, and Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-tolerant transformants were selected by plating on AHC medium (Kim et al., 1994, Proc. Natl. Acad. Sci. U.S.A. 91:6128-6132) containing 200 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. Of the 104 pFL61 clones found to suppress the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-hypersensitivity of strains SM12 and DTY168, only two, whose 1.7 kb inserts were determined to be identical, conferred a particularly high level of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance. One of these, termed pFL61-AtPCS1, was analyzed functionally.</PDAT></PTEXT></PARA>
<PARA ID="P-00187" LVL="0"><PTEXT><PDAT>Heterologous expression of FLAG-tagged AtPCS1</PDAT></PTEXT></PARA>
<PARA ID="P-00188" LVL="0"><PTEXT><PDAT>In order to constitutively express immunoreactive protein in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae, </PDAT></ITALIC></HIL><PDAT>the AtPCS1 cDNA insert of pFL61-AtPCS1 was first subcloned into the pYES3 vector, a derivative of pYES2 (Invitrogen, Carlsbad, Calif.), in which the galactose-inducible yeast GAL1 gene promoter was replaced by the constitutive 3-phosphoglycerate kinase (PGK) promoter (GTTACATGCGTACACGCGTCTG; SEQ ID NO: 11; Lu et al., 1997, Proc. Natl. Acad. Sci. U.S.A. 94:8243-8247), and engineered to encode AtPCS1 fused to a C-terminal FLAG (DYKDDDDK; SEQ ID NO: 12) epitope tag as described by the manufacturer&apos;s instructions (International Biotechnologies, Inc., New Haven, Conn.), which yielded a stable translation product. More specifically, the construct was engineered to contain the 24 bp DNA sequence encoding the FLAG epitope and a SmaI restriction site for directional cloning (i.e. ,AAACAGCTGCTTGTCATCGTCGTCCTTGTAGTCCCCGGGATAGGCAGG AGC; the FLAG coding sequence underlined; SEQ ID NO: 13). The FLAG octapeptide sequence on the AtPCS1-FLAG fusion protein was detected using known immunohistochemical methods which involve use of an Anti-FLAG antibody such as, for example, monoclonal antibodies M2 or M5, as described by the manufacturer&apos;s instructions (International Biotechnologies, Inc., New Haven, Conn.).</PDAT></PTEXT></PARA>
<PARA ID="P-00189" LVL="0"><PTEXT><PDAT>After the fidelity of the resulting construct, pYES3-AtPCS1::FLAG, was confirmed by sequencing, </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>ycf1&Dgr; strain DTY167 was transformed with this construct or an empty vector lacking the AtPCS1::FLAG insert using the LiOAc/PEG method described by Giest and Schiestl (1991,Yeast 7:253-263) and the transformants were selected for uracil prototrophy by plating on ammonia/hydrolyzed casein (AHC) medium (0.17% (w/v) yeast nitrogen base without amino acids, 0.5% (w/v) ammonium sulfate, 1% (w/v) acid-hydrolyzed casein, 0.02% (w/v) adenine hemisulfate and 2% (w/v) glucose, buffered to pH 5.5 using 50 mM Mes-Tris) with or without tryptophan supplementation (Kim et al., 1994, Proc. Natl. Acad. Sci. USA 91:6128-6132).</PDAT></PTEXT></PARA>
<PARA ID="P-00190" LVL="0"><PTEXT><PDAT>Cell fractionation</PDAT></PTEXT></PARA>
<PARA ID="P-00191" LVL="0"><PTEXT><PDAT>In order to examine the localization of AtPCS1-FLAG, DTY167/pYES3-AtPCS1::FLAG or control DTY167/pYES3 cells were subjected to cell wall digestion, disruption and fractionation by differential centrifugation. Two-hundred ml volumes of stationary phase cultures were diluted into 1 1 of AHC medium containing tryptophan and the cells were grown for 16-18 hours at 30&deg; C. to an A</PDAT><HIL><SB><PDAT>600 nm </PDAT></SB></HIL><PDAT>of approximately 1.0. The cells were collected by centrifugation and were converted to spheroplasts as described by Lu et al. (1997, Proc. Natl. Acad. Sci. U.S.A. 94:8243-8247). After disruption of the spheroplasts by homogenization in homogenization medium (10 mM Tris-HCl, pH 7.6) containing 1 mM phenylmethylsulfonylfluoride and 1 &mgr;g/ml each of leupeptin, pepstatin and aprotinin in a Dounce homogenizer, the crude lysate was cleared by centrifugation at 4,000&times;g for 10 minutes. After two final centrifugations at 100,000&times;g for 1 hour, the supernatant (soluble fraction) was frozen and reduced in volume by lyophilization and the pellet (membrane fraction) was resuspended in 1-2 ml of homogenization buffer containing protease inhibitors before freezing in liquid nitrogen and storage at &minus;85&deg; C. For investigations of the PC contents and PC synthesis capacities of the soluble fractions and for purification of AtPCS1-FLAG, the cells were fractionated in an identical manner except that the homogenization medium contained 10 mM 2-ME, 10% (v/v) glycerol, and 50 mM Tris-HCl, pH 8.0, in addition to protease inhibitors.</PDAT></PTEXT></PARA>
<PARA ID="P-00192" LVL="0"><PTEXT><PDAT>Purification of AtPCS1-FLAG</PDAT></PTEXT></PARA>
<PARA ID="P-00193" LVL="0"><PTEXT><PDAT>AtPCS1-FLAG was purified from the soluble fraction of DTY167/pYES3-AtPCS1-FLAG cells on an anti-FLAG M2 monoclonal antibody affinity gel colunm (Sigma Chemical Co., St. Louis, Mo.) according to the manufacturer&apos;s recommendations, except that the wash buffer (Tris-buffered saline, TBS, 150 mM NaCl, 50 mM Tris-HCl, pH 7.4) and the elution buffer (0.1 M glycine-HCl, pH 3.5) both contained 10% (v/v) glycerol.</PDAT></PTEXT></PARA>
<PARA ID="P-00194" LVL="0"><PTEXT><PDAT>Equilibrium dialysis of AtPCS1-FLAG</PDAT></PTEXT></PARA>
<PARA ID="P-00195" LVL="0"><PTEXT><PDAT>The binding of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> was determined by equilibrium dialysis of a 400-800 &mgr;l (160 &mgr;g) sample of purified AtPCS1-FLAG against 80 ml volumes of 10 mM Tris-HCl buffer, pH 7.8, containing 0.05 to 20 &mgr;M </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(specific activity 22 Ci/mol, Amersham Pharmacia Biotech, Piscataway, N.J.) for 12 hours at 4&deg; C. in 2 ml mini-collodion membrane tubes (molecular weight cut-off of 25,000; Schleicher and Schuell, Inc., Keene, N.H.). Protein-bound </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd was estimated by measuring the radioactivity of the bulk medium outside the dialysis tube and that of the solution within the dialysis tube and determining the increase in </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity consequent on AtPCS1-FLAG. Binding constants and stoichiometries of binding were estimated by nonlinear least squares analysis (Marquardt, 1963, J. Soc. Ind. Appl. Math. 11:431-441) using the Ultrafit nonlinear curve fitting package from BioSoft (Ferguson, Mo.).</PDAT></PTEXT></PARA>
<PARA ID="P-00196" LVL="0"><PTEXT><PDAT>Gel filtration FPLC of soluble fractions and purified AtPCS1-FLAG</PDAT></PTEXT></PARA>
<PARA ID="P-00197" LVL="0"><PTEXT><PDAT>Analysis of the distribution of </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd in the soluble fractions extracted from DTY167/pYES3-AtPCS1::FLAG and DTY167/pYES3 cells after growth in media containing </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>was by FPLC of the extracts on a Superose&trade;6 HR10/30 column (Pharmacia LKB Biotechnology Inc., Piscataway, N.J.). One hundred ml aliquots of stationary phase cultures grown on AHC medium supplemented with glucose and tryptophan were diluted into 500 ml volumes of fresh medium containing 50 &mgr;M </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(specific activity 2.3 Ci/mol) and the cells were grown at 30&deg; C. for a further 18 hours. Samples of the soluble fractions (1 ml, 1.2-1.8 mg protein) were prepared as described previously elsewhere herein, and the samples were incubated for 30 minutes on ice with 10 mM dithiothreitol (DTT) and the samples were then applied to the Superose-6 column. The column was developed with 50 mM Tris-HCl, pH 7.8, at a flowrate of 0.3 ml/min. Fractions of 0.5 ml were collected and the level of </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd present in the column fraction was determined by counting aliquots (60 &mgr;l) of each fraction in BCS liquid scintillation cocktail (Amersham, Arlington Heights, Ill.). To determine the distribution of AtPCS1-FLAG, aliquots of the column fractions were analyzed by SDS-PAGE and Western blot analysis as described elsewhere herein. Immunoaffinity-purified AtPCS1-FLAG (1 ml, 140-180 &mgr;g protein), either before or after equilibrium dialysis against 5 &mgr;M </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>(specific activity 2.3 Ci/mol), was chromatographed under identical conditions.</PDAT></PTEXT></PARA>
<PARA ID="P-00198" LVL="0"><PTEXT><PDAT>Measurement of PCs and PC synthase activity</PDAT></PTEXT></PARA>
<PARA ID="P-00199" LVL="0"><PTEXT><PDAT>Cellular PC content was estimated by reverse-phase FPLC of the soluble fractions prepared from DTY167/pYES3-AtPCS1::FLAG or DTY167/pYES3 cells after growth in liquid media containing or lacking 50 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. For reverse-phase FPLC, 1-2 ml volumes of the extracts (2.3-4.6 mg protein) were made 5% (w/v) with 5-sulfosalicylic acid and the samples were centrifuged before loading aliquots (500 &mgr;l) of the supernatant onto a PepRPC HR5/5 HPLC column (Pharmacia LKB Biotechnology Inc., Piscataway, N.J.). The column was developed with a water/0.1% (v/v) phosphoric acid (solvent A)-acetonitrile/0.1% (v/v) phosphoric acid (solvent B) gradient at a flowrate of 0.4 ml/minute. The program parameters were: 0-2 minutes, 0-2% solvent B; 2-5 minutes, 2% solvent B; 5-33 minutes, 2-30% solvent B. Thiols were estimated spectrophotometrically at 412 nm by reacting aliquots (100 &mgr;l) of the column fractions with 0.4 mM 5,5&prime;-dithio-bis(2-nitrobenzoic acid) (900 &mgr;l) dissolved in 50 mM phosphate buffer, pH 7.6 (DTNB) as described in Ellman (1959, Arch. Biochem. Biophys. 82:70-72). PC standards were extracted from Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-grown </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>(ATCC 38390) as described by Ortiz et al. (1995, J. Biol. Chem. 270:4721-4728).</PDAT></PTEXT></PARA>
<PARA ID="P-00200" LVL="0"><PTEXT><PDAT>PC synthase activity was assayed according to Grill et al. (1989, Proc. Natl. Acad. Sci. U.S.A. 86:6838-6842) in reaction media containing crude soluble fraction (50 &mgr;g protein), purified AtPCS1-FLAG (0.5 &mgr;g) or no protein, 3.3 mM GSH, 10 mM 2-mercaptoethanol and 200 mM Tris-HCl buffer (pH 8.0) plus or minus 200 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>at 37&deg; C. for 40 minutes. After terminating the reactions with 5% (w/v) 5-sulfosalicylic acid, PCs were estimated in the supernatant by reverse-phase FPLC and reaction with DTNB.</PDAT></PTEXT></PARA>
<PARA ID="P-00201" LVL="0"><PTEXT><PDAT>Amino acid analysis</PDAT></PTEXT></PARA>
<PARA ID="P-00202" LVL="0"><PTEXT><PDAT>The chain lengths of the PCs synthesized from GSH by AtPCS1-FLAG in vitro were determined by estimating their Glu/Gly ratios (ratio&equals;n&equals;number of Glu-Cys repeats per Gly) after acid hydrolysis of the appropriate fractions from reverse-phase FPLC. Aliquots of the fractions were taken to dryness in pyrolyzed glass tubes, hydrolyzed in gas-phase 6 N HCl for 20 hours at 110&deg; C. before ion-exchange chromatography, post-column derivatization with O-phthalaldehyde and fluorescence detection (Udenfriend et al., 1972, Science 178:871-874).</PDAT></PTEXT></PARA>
<PARA ID="P-00203" LVL="0"><PTEXT><PDAT>Northern and Southern blot analyses</PDAT></PTEXT></PARA>
<PARA ID="P-00204" LVL="0"><PTEXT><PDAT>Arabidopsis seedlings were grown for 21 days in Gamborg&apos;s B-5 medium and total RNA and genomic DNA were extracted from roots and shoots in TRIzol R Reagent (Gibco BRL Life Technologies, Gaithersburg, Md.) according to the manufacturer&apos;s recommendations. The RNA samples and restricted DNA samples were electrophoresed, blotted and hybridized with </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-labeled, random-primed 1.5 kb NotI/SmaI restriction fragment corresponding to the coding sequence of AtPCS1 by standard procedures (Lu et al., 1997, Proc. Natl. Acad. Sci. U.S.A. 94:8243-8247).</PDAT></PTEXT></PARA>
<PARA ID="P-00205" LVL="0"><PTEXT><PDAT>SDS-PAGE and Western blot analyses</PDAT></PTEXT></PARA>
<PARA ID="P-00206" LVL="0"><PTEXT><PDAT>Protein samples were dissolved in denaturation buffer and subjected to one-dimensional SDS-polyacrylamide gel electrophoresis on 10% (w/v) slab gels in a Bio-Rad mini-gel apparatus (Kim et al., 1994, Proc. Natl. Acad. Sci. U.S.A. 91:6128-6132). For direct protein detection, the gels were stained with Silver Stain-Plus (Bio-Rad Laboratories, Richmond, Calif.)., For immunodetection of AtPCS1-FLAG, the separated samples were electrotransferred and probed with anti-FLAG M2 antibody (Sigma. Chemical Co., St. Louis, Mo.) by standard procedures. Immunoreactive bands were visualized by enhanced chemiluminescence (ECL) detection with an ECL kit (Amersham Corp., Arlington Heights, Ill.) per the manufacturer&apos;s instructions.</PDAT></PTEXT></PARA>
<PARA ID="P-00207" LVL="0"><PTEXT><PDAT>Protein estimations</PDAT></PTEXT></PARA>
<PARA ID="P-00208" LVL="0"><PTEXT><PDAT>Protein was estimated by the dye-binding method (Bradford, 1976, Anal. Biochem. 72:248-254).</PDAT></PTEXT></PARA>
<PARA ID="P-00209" LVL="0"><PTEXT><PDAT>Chemicals</PDAT></PTEXT></PARA>
<PARA ID="P-00210" LVL="0"><PTEXT><PDAT>All of the general reagents were obtained from Fisher Scientific (Pittsburgh, Pa.), Research Organics Inc. (Cleveland, Ohio), or Sigma Chemical Co. (St. Louis, Mo.).</PDAT></PTEXT></PARA>
<PARA ID="P-00211" LVL="0"><PTEXT><PDAT>The Results of the experiments presented in this example are now described.</PDAT></PTEXT></PARA>
<PARA ID="P-00212" LVL="0"><PTEXT><PDAT>Suppression cloning</PDAT></PTEXT></PARA>
<PARA ID="P-00213" LVL="0"><PTEXT><PDAT>The isolation of a plant cDNA encoding a PC synthase was based on yeast suppression screens for Arabidopsis yeast activation protein 1 (YAP1)-like transcription factors. Briefly, since expression of the yeast (</PDAT><HIL><ITALIC><PDAT>S. cerevisiae</PDAT></ITALIC></HIL><PDAT>) cadmium (resistance) factor gene YCF1 (ScYCF1), which encodes an ATP-binding cassette (ABC) transporter responsible for the vacuolar sequestration of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> as Cd.GSH complexes (Li et al., 1997, Proc. Natl. Acad. Sci. U.S.A. 94:42-47), is transcriptionally activated by the bZIP DNA-binding protein YAP1 (Wemmie et al., 1994, J. Biol. Chem. 269:14690-14697), a two-step screening procedure described previously elsewhere herein (see Materials and Methods) was performed to isolate AtPCS1. That is, first, the </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>yap1&Dgr; disruptant strain SM12 was transformed with an Arabidopsis CDNA library constructed in the yeast-</PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>shuttle vector pFL61 (Minet et al., 1992, Plant J. 2:417-422) and transformants were selected that were capable of growth on YPD medium containing 200 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. Then, rescue of pFL61 plasmids from the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-resistant transformants was performed and the plasmids were used to transform </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>ycf1&Dgr; disruptant strain DTY 168. Ura&plus; transfornants capable of growth on AHC medium containing 200 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>were selected.</PDAT></PTEXT></PARA>
<PARA ID="P-00214" LVL="0"><PTEXT><PDAT>It was reasoned that pFL61-borne Arabidopsis cDNAs encoding YAP1-like factors would suppress yap1&Dgr; but not ycf1&Dgr; mutants whereas cDNAs encoding Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> resistance factors acting through a pathway distinct from that of YAP1 would not only suppress yap1&Dgr; but would also suppress ycf1&Dgr; mutants.</PDAT></PTEXT></PARA>
<PARA ID="P-00215" LVL="0"><PTEXT><PDAT>Of a total of 105 Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-resistant SM12 transformants identified which suppressed yap1&Dgr;, only one harbored a pFL61-borne cDNA satisfying the minimum requirement of a YAP1 equivalent, i.e., the cDNA did not suppress the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-hypersensitivity of strain DTY168. All of the remaining 104 SM12 transformants harbored pFL61 plasmids and were able to suppress the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> hypersensitivity of strain DTY168 in the second step. Of these, two identical clones were isolated and characterized further because of their ability to confer tolerance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations well in excess of those tolerated by DTY168 cells transformed with any one of the other clones.</PDAT></PTEXT></PARA>
<PARA ID="P-00216" LVL="0"><PTEXT><PDAT>After determining that the cDNA inserts of these clones were identical by sequencing their ends, one, pFL61-AtPCS1, was investigated further.</PDAT></PTEXT></PARA>
<PARA ID="P-00217" LVL="0"><PTEXT><PDAT>Sequence characteristics of AtPCS1</PDAT></PTEXT></PARA>
<PARA ID="P-00218" LVL="0"><PTEXT><PDAT>Sequence analysis established that the open reading frame of the 1.7 kb cDNA insert (SEQ ID NO: 1) of pFL61-AtPCS1 encoded a 55 kDa polypeptide (SEQ ID NO: 2) sharing about 33% identity (about 48% similarity) to a hypothetical gene product in the GenBank database from </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces pombe </PDAT></ITALIC></HIL><PDAT>(accession number Q10075) and about 32% identity (about 45% similarity) to a hypothetical gene product from </PDAT><HIL><ITALIC><PDAT>Caenorhabditis elegans </PDAT></ITALIC></HIL><PDAT>(GenBank accession number Z66513). AtPCS1 shares these regions of homology with the GenBank sequences from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><ITALIC><PDAT>C. elegans </PDAT></ITALIC></HIL><PDAT>in overlaps of 379 and 366 amino acid residues, respectively (FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT> and FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>). Whichever pair of polypeptides was compared, sequence conservation was greater in the N-terminal halves than the C-terminal halves of the predicted amino acid sequences. AtPCS1 was 44% and 45% identical (62% and 63% similar) to the 46.7 kDa </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>and 40.8 kDa </PDAT><HIL><ITALIC><PDAT>C. elegans </PDAT></ITALIC></HIL><PDAT>gene products, respectively, in the sequences encompassed by AtPCS1 residues 1-241 but only 20% and 12% identical (40% and 37% similar) in the sequences encompassed by AtPCS1 residues 266-241. Without wishing to be bound by theory, although AtPCS1 was distinguishable from the other two polypeptides by its possession of a 73-74 amino acid residue C-terminal extension, AtPCS1 has conserved sequences corresponding to positions 49-68, 70-91, 152-165 and 176-190 which are family-specific inasmuch as BLAST searches of the GenBank database using these sequences identified these three gene products but did not identify other gene products.</PDAT></PTEXT></PARA>
<PARA ID="P-00219" LVL="0"><PTEXT><PDAT>Searches of the Arabidopsis Genomic Database indicated that this organism contains at least two AtPCS genes: AtPCS1 (SEQ ID NO: 1) which is located within P1 clone MRH10 and which maps adjacent to marker mi83 on chromosome 5 and another gene, nominally AtPCS2 (SEQ ID NO: 3; GenBank Accession No. AC003027, FIG. </PDAT><HIL><BOLD><PDAT>17</PDAT></BOLD></HIL><PDAT>), located within BAC clone F21M11 which maps to chromosome 1 and which encodes a deduced polypeptide (SEQ ID NO: 4) sharing greater than approximately 70% sequence identity (approximately 85% similarity) with AtPCS1. Since Southern blot analyses of restricted Arabidopsis genomic DNA yielded hybridization patterns necessitating two, but not more, AtPCS-like genes when probed with the coding sequence of AtPCS1, AtPCS1 and AtPCS2 are inferred to be the sole representatives of this gene family in Arabidopsis.</PDAT></PTEXT></PARA>
<PARA ID="P-00220" LVL="0"><PTEXT><PDAT>Further, high stringency Northern blot analysis detected a single 1.7 kb band after hybridization of random-primed, </PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P-labeled AtPCS1 cDNA with total RNA extracted from roots and shoots of 21-day-old Arabidopsis seedlings (FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>), indicating that the cDNA insert of pFL61-AtPCS1 was full-length and was derived from Arabidopsis rather than being derived from a nonplant contaminant of the cDNA library.</PDAT></PTEXT></PARA>
<PARA ID="P-00221" LVL="0"><PTEXT><PDAT>Heavy metal tolerance</PDAT></PTEXT></PARA>
<PARA ID="P-00222" LVL="0"><PTEXT><PDAT>To probe the functional capabilities of AtPCS1 and to render its translation product immunodetectable, AtPCS1::FLAG fusions were engineered in the yeast-</PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>shuttle vector pYES3. Since BLAST searches did not disclose any AtPCS1-like sequences in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae, </PDAT></ITALIC></HIL><PDAT>this organism was considered suitable for examining the mode of action of AtPCS1 without interference from endogenous orthologs.</PDAT></PTEXT></PARA>
<PARA ID="P-00223" LVL="0"><PTEXT><PDAT>After establishing that the resulting pYES3-AtPCS1::FLAG construct (and its C-terminally FLAG epitope-tagged translation product) was as efficacious as pFL61-AtPCS1 and pYES3-AtPCS1 in suppressing the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-hypersensitivity of </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>ycf1&Dgr; disruptant strain DTY167, pYES3-AtPCS1::FLAG-dependent suppression of sensitivity to a broader range of metals or their oxides was screened in this strain and in the metallothionein-deficient, Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-hypersensitive, cup1&Dgr; strain DTY4.</PDAT></PTEXT></PARA>
<PARA ID="P-00224" LVL="0"><PTEXT><PDAT>The data disclosed herein demonstrate that AtPCS1-FLAG is a multispecific heavy metal resistance factor. That is, plasmid-borne AtPCS1-FLAG not only conferred strong resistance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> but also conferred moderate resistance to AsO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>3&minus;</PDAT></SP></HIL><PDAT>, AsO</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> and Hg</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> with an overall rank order, based on the fold increases in the concentrations at which the metals exerted 50% inhibition of growth in liquid culture compared with pYES3 empty-vector controls, of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (24-fold)&gt;&gt;Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (2.4)&gt;AsO</PDAT><HIL><SB><PDAT>4</PDAT></SB></HIL><HIL><SP><PDAT>3&minus;</PDAT></SP></HIL><PDAT> (1.8)&gt;AsO</PDAT><HIL><SP><PDAT>2&minus;</PDAT></SP></HIL><PDAT> (1.6)&equals;Hg</PDAT><HIL><SP><PDAT>2&minus;</PDAT></SP></HIL><PDAT> (1.6) (FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>). Thus, AtPCS1-FLAG (and AtPCS1) confers resistance not only to cadmium, but also to arsenate, arsenite, mercury, and copper concentrations well in excess of those tolerated by the untransformed ycf1&Dgr; DTY167 or cup1&Dgr; DTY4 strains.</PDAT></PTEXT></PARA>
<PARA ID="P-00225" LVL="0"><PTEXT><PDAT>Cellular localization of AtPCS1</PDAT></PTEXT></PARA>
<PARA ID="P-00226" LVL="0"><PTEXT><PDAT>Heterologously expressed AtPCS1-FLAG did not appear to confer tolerance by promoting the exclusion or extrusion of heavy metals from the cytosol through an association with the plasma or vacuolar membrane. Cells expressing AtPCS1-FLAG demonstrated an enhanced, not diminished, heavy metal content. Further, the vacuole-deficient pep5&Dgr; strain DTY214, which is Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> hypersensitive due to the absence of a sizable vacuolar compartment for metal sequestration (Li et al., 1997, Proc. Natl. Acad. Sci. U.S.A. 94:42-47), was nearly as susceptible to suppression by pYES3AtPCS1::FLAG as strain DTY167. AtPCS1-FLAG localized almost exclusively to the soluble fraction of DTY167/pYES3-AtPCS1::FLAG transformants.</PDAT></PTEXT></PARA>
<PARA ID="P-00227" LVL="0"><PTEXT><PDAT>Differential centrifugation of mechanically disrupted DTY167/pYES3-AtPCS1::FLAG spheroplasts resolved the total extracts into soluble (supernatant) and membrane-enriched (pelletable) fractions. Of the two fractions, only the supernatant fraction yielded appreciable M</PDAT><HIL><SB><PDAT>r </PDAT></SB></HIL><PDAT>58,000, anti-FLAG antibody-reactive polypeptide after SDS-PAGE and Western blot analysis (FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>). The migration properties of the sole anti-FLAG antibody-reactive polypeptide recovered were precisely those expected from the coding sequence of AtPCS1::FLAG, and fractionation of DTY167/pYES3 negative control cells in an identical manner did not yield an immunoreactive protein in either the soluble or membrane fraction (FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>). Therefore, the FLAG-bearing band in the soluble fraction from DTY167/pYES3-AtPCS1::FLAG cells was inferred to be derived solely from the cDNA insert of pYES3-AtPCS1::FLAG.</PDAT></PTEXT></PARA>
<PARA ID="P-00228" LVL="0"><PTEXT><PDAT>In vivo Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> binding</PDAT></PTEXT></PARA>
<PARA ID="P-00229" LVL="0"><PTEXT><PDAT>Having determined that AtPCS1-FLAG heterologously expressed in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>was a soluble protein, the effects, if any, of AtPCS1 on the amount and distribution of bound heavy metal were assessed by comparing the chromatographic profiles of soluble extracts from DTY167/pYES3-AtPCS1::FLAG cells to the profiles of soluble extracts from DTY167/pYES3 control cells after growth in liquid medium containing </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. The results of these analyses not only provided the first indication that AtPCS1-FLAG, itself, binds </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> but also implicated AtPCS1-FLAG in increasing in the amount of, and/or increasing the degree of binding of </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> to, another heavy metal-binding factor.</PDAT></PTEXT></PARA>
<PARA ID="P-00230" LVL="0"><PTEXT><PDAT>FPLC of the soluble fraction from </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-grown DTY167/pYBS3-AtPCS1::FLAG cells on a Superose-6 HR 10/30 column resolved-two major peaks and one minor peak of </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity with maxima corresponding to fractions 34 (peak 1), 39 (peak 2) and 43 (peak 3) (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT>, main graph). Equivalent </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity profiles were obtained for the soluble fraction from </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-grown DTY167/pYES3-AtPCS1 cells demonstrating that the FLAG epitope-tag did not contribute to </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> binding. By contrast, the soluble fraction from DTY167/pYES3 cells grown under identical conditions lacked most of the </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity under peak 1 although peaks 2 and 3 had the same profiles and eluted at the same positions as the corresponding peaks in the DTY167/pYES3-AtPCS1::FLAG extracts (FIG. </PDAT><HIL><BOLD><PDAT>5</PDAT></BOLD></HIL><PDAT>). While superficially consistent with the notion that the peak unique to the DTY167/pYES3-AtPCS1::FLAG extracts (peak 1) might be wholly explicable by direct binding of </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd to AtPCS1-FLAG, closer inspection of the column fractions and experiments on purified AtPCS1-FLAG demonstrated this not to be the case. AtPCS1-FLAG bound Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> at high affinity and high capacity but this, alone, did not account for the peak profiles of the DTY I 67/pYES3-AtPCS1::FLAG cell extracts.</PDAT></PTEXT></PARA>
<PARA ID="P-00231" LVL="0"><PTEXT><PDAT>Immunoaffinity purification of AtPCS1-FLAG</PDAT></PTEXT></PARA>
<PARA ID="P-00232" LVL="0"><PTEXT><PDAT>In order to define its chromatographic and metal-binding properties directly (and, eventually, to assay for its enzymatic activity) AtPCS1-FLAG was purified from the soluble fraction of DTY I 67/pYES3-AtPCS1::FLAG cells by immunoaffinity chromatography on an anti-FLAG M2 affinity column. SDS-PAGE (Protein) and Western blot (FLAG) analyses of the soluble fraction before and after chromatography demonstrated that this immunopurification procedure yielded a single, anti-FLAG antibody-reactive, M</PDAT><HIL><SB><PDAT>r </PDAT></SB></HIL><PDAT>58,000 protein species retaining the electrophoretic and immunological properties of the polypeptide in the starting material (FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00233" LVL="0"><PTEXT><PDAT>Intrinsic and extrinsic binding</PDAT></PTEXT></PARA>
<PARA ID="P-00234" LVL="0"><PTEXT><PDAT>Equilibrium dialysis of the immunoaffinity-purified protein against a range of </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>concentrations verified that AtPCS1-FLAG bound </PDAT><HIL><SP><PDAT>109Cd2&plus;</PDAT></SP></HIL><PDAT> at a high affinity (K</PDAT><HIL><SB><PDAT>d </PDAT></SB></HIL><PDAT>of 0.54&plusmn;0.20 &mgr;M) and at a high capacity (stoichiometric ratio of 7.09&plusmn;0.94). However, though consistent with a contribution by AtPCS1-FLAG to the overall </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> radioactivity profile, the intrinsic Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-binding activity of AtPCS1-FLAG, whether in whole extracts or in purified state, was not sufficient to account fully for the </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd-radioactivity profile of peak 1 in the DTY167/pYES3-AtPCS1::FLAG cell extracts. Whereas SDS-PAGE and Western analysis of the fractions from chromatography of the DTY167/pYES3-AtPCS1::FLAG cell extracts demonstrated a consistent displacement of the maximum for AtPCS1-FLAG polypeptide (fraction 29-32) from the maximum for </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity (fractions 33-35), this could not be simulated with pure </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd-complexed AtPCS1-FLAG. Chromatography of purified AtPCS1-FLAG after equilibrium dialysis against </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>yielded strictly superimposable profiles for both AtPCS1-FLAG polypeptide and </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity whose maxima (fractions 29-32) coincided with that of AtPCS1-FLAG in the DTY167/pYES3-AtPCS1::FLAG extracts (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT>, insert graph). On this basis, AtPCS1-FLAG was concluded to not only bind Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> itself but also to elicit the formation or activation of a lower molecular weight metal-binding factor or factors. This interpretation was reinforced by two factors. First, the finding that Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-complexed and free AtPCS1-FLAG coeluted during Superose-6 chromatography, so excluding a change in the elution properties of AtPCS1-FLAG consequent on Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> binding as a factor contributing to peak profile. Second, by experiments demonstrating the inapplicability of a scheme in which chromatographic displacement of the AtPCS1-FLAG and </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd radioactivity maxima was the result of partial dissociation of bound </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd from AtPCS1-FLAG and its transfer to a smaller pre-existent factor common to both DTY167/pYES-AtPCS1::FLAG and DTY167/pYES3 cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00235" LVL="0"><PTEXT><PDAT>PC biosynthesis</PDAT></PTEXT></PARA>
<PARA ID="P-00236" LVL="0"><PTEXT><PDAT>The capacity of AtPCS1to bind Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> and stimulate the formation of lower weight metal ligands was indicative of a PC synthase in that such an enzyme ostensibly has the same property, i.e., the facility to catalyze PC synthesis when activated by Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>. Other similarities between AtPCS1 and PC synthase that prompted investigation of whether AtPCS1 is a PC synthase or, at least, contributes to PC synthesis, were as follows. AtPCS1 has a computed mass of 55 kDa (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>) and an elecfrophoretic mobility of 58,000 (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIGS. 4 and 6</PDAT></FGREF><PDAT>) which is commensurate with an apparent subunit size of 50,000 for the activity of partially purified PC synthase preparations from plants (Grill et al., 1989, Proc. Natl. Acad. Sci. U.S.A. 89:6838-6842). Further, AtPCS1and its homologs (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT>) are found in both plants and </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>as is PC synthase (Rauser, 1990, Annu. Rev. Biochem. 59:61-86; Zenk, 1996, Gene 179:21-30). In addition, AtPCS1, like the products of PC synthase activity, though capable of conferring greatest tolerance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, also confers tolerance to other heavy metals such as Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (Rauser, supra; Zenk, supra). Moreover, transformation of OGSH-deficient </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>gsh2&Dgr; mutants, in which the coding sequence for GSH synthetase is disrupted (Inoue et al., 1998, Biochem. Biophys. Acta 1395:315-320), with pYES3-AtPCS1::FLAG does not confer Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-tolerance, suggesting that AtPCS1, like PC synthase, is ineffective unless GSH is available.</PDAT></PTEXT></PARA>
<PARA ID="P-00237" LVL="0"><PTEXT><PDAT>The involvement of AtPCS1 in PC biosynthesis was examined at three levels. First, it was determined whether. CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-grown DTY167/pYES3-AtPCS1::FLAG cells contained elevated PC levels when compared with CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-grown DTY167/pYES3 cells, and, if so, whether PC accumulation required growth in media containing Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>. Second, it was determined whether the soluble fraction from DTY167/pYES3-AtPCS1::FLAG cells had an increased capacity for Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-dependent PC synthesis in vitro when compared with the soluble fraction from DTY167/pYES3 cells. Third, it was examined whether purified AtPCS1-FLAG catalyzed Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-dependent PC synthesis from GSH. At all levels investigated, AtPCS1 exhibited all of the characteristics of a PC synthase.</PDAT></PTEXT></PARA>
<PARA ID="P-00238" LVL="0"><PTEXT><PDAT>DTY167/pYES3-AtPCS1::FLAG cells accumulated PCs in a Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-dependent manner. Reverse-phase FPLC analysis of nonprotein thiol compounds in the soluble fraction from DTY167/pYES3-AtPCS1::FLAG cells after growth in medium containing CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>revealed multiple peaks eluting after the GSH/2-ME injection peak, whose total thiol content represented 51 nmol/mg extracted protein (FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>A). The two most prominent of these peaks, peaks 1 and 2, contributed 4 nmol thiol/mg protein and eluted at the same positions as PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>standards prepared from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>(FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>A). The corresponding fractions from CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>-grown DTY167/pYES3 cells and DTY167/pYES3-AtPCS1::FLAG cells after growth in medium lacking Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> were devoid of nonprotein thiols, other than those associated with the GSH/2-mercaptoethanol injection peak.</PDAT></PTEXT></PARA>
<PARA ID="P-00239" LVL="0"><PTEXT><PDAT>Expression of plasmid-borne AtPCS1::FLAG was necessary for the generation of extractable PC synthase activity but, unlike intracellular PC accumulation, did not require exposure of the cells to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> before extraction. In vitro assays of the capacity of the soluble fractions from DTY167/pYES3-AtPCS1::FLAG cells grown in the presence and absence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> for the incorporation of GSH into PCs demonstrated exclusive synthesis of PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>at aggregate rates of 0.50 and 0.34 nmol/mg/minute when assayed in media containing 3.3 mM GSH and 200 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00240" LVL="0"><PTEXT><PDAT>The corresponding fractions from DTY167/pYES3 cells yielded rates below the limits of detection (&lt;0.01 nmol/mg/minute) irrespective of whether the cells had been grown in the presence or absence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>. In no case was PC synthase activity detectable when Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> was omitted from the assay medium, implying an obligate requirement for heavy metal ions for PC synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00241" LVL="0"><PTEXT><PDAT>AtPCS1-FLAG was sufficient for the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-dependent synthesis of PCs from GSH in vitro. The single M</PDAT><HIL><SB><PDAT>r </PDAT></SB></HIL><PDAT>58,000 polypeptide species purified by immunoaffinity chromatography of the soluble fraction from DTY167/pYES3-AtPCS1::FLAG cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT>) catalyzed the incorporation of GSH into PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>at an aggregate rate of 30-35 &mgr;mol/mg/min and &lt;0.01 nmol/mg/min in the presence and absence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, respectively (FIG. </PDAT><HIL><BOLD><PDAT>7</PDAT></BOLD></HIL><PDAT>B). Control reaction mixtures lacking AtPCS1-FLAG did not yield any PCs. Given that AtPCS1-FLAG was the sole protein species in the reaction medium and that the products of its reaction with GSH, PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>, were determined by quantitative amino acid analysis to have Glu/Gly ratios of 2.1&plusmn;0.1 and 2.9&plusmn;0.2, respectively, AtPCS1 was evidently capable of catalyzing the transfer of a &ggr;-glutamylcysteine unit from one GSH molecule to another to form PC</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>, or from one GSH molecule to PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>to form PC</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>. As would be expected for a bona fide enzyme-catalyzed reaction, the amounts of PC</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and PC</PDAT><HIL><SB><PDAT>3 </PDAT></SB></HIL><PDAT>synthesized increased linearly with time to yield strict proportionality between the rates of synthesis and the amounts of AtPCS1-FLAG added to the reaction medium.</PDAT></PTEXT></PARA>
<PARA ID="P-00242" LVL="0"><PTEXT><PDAT>The data disclosed herein establish that AtPCS1, a novel cDNA from Arabidopsis, and, as more fully set forth below, its homologs from </PDAT><HIL><ITALIC><PDAT>T. aestivum, S. pombe </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><ITALIC><PDAT>C. elegans, </PDAT></ITALIC></HIL><PDAT>as well as AtPCS2, encode PC synthases: Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-binding enzymes capable of high rates of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-activated PC synthesis from GSH. As such, the cloning and in vitro reconstitution of AtPCS1 is of considerable value. Enzymologically, the ease with which AtPCS1-FLAG can be purified to apparent homogeneity in a single step from pYES3-AtPCS1::FLAG-transformed yeast to yield PC synthase preparations with a catalytic activity exceeding that of previous preparations from plants (Grill et al., 1989, Proc. Natl. Acad. Sci. U.S.A. 86:6838-6842) by more than 10</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>-fold will enable detailed mechanistic and crystallographic studies of this enzyme and the facile production of PCs in vitro on a milligram to gram scale. Molecularly, the amenability of AtPCS1 to be expressed in yeast in an active state and to confer a selectable phenotype provides a basis for probing the structural requirements of AtPCS1-catalyzed PC synthesis by the application of both site-directed and random mutagenic approaches. Evolutionarily, the existence of a PC synthase in </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>was suggested by the prior art extensively researching PC-based metal tolerance in that organism (Rauser, 1990, supra; Zenk, 1996, supra). Nonetheless, prior to the present invention, all previous attempts to identify and isolate a PC synthase from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>had failed. Further, the discovery of an AtPCS1 homolog in the genome of </PDAT><HIL><ITALIC><PDAT>C. elegans </PDAT></ITALIC></HIL><PDAT>was completely surprising in that it invokes a role for not only GSH and MTs but also PCs in metal homeostasis in at least some animals. Genetically, the now ready availability of isolated genes encoding PC synthases and the demonstrated sufficiency of a single gene product for reconstitution of core catalysis will expedite investigations into the mechanisms by which plants and other organisms detoxify heavy metals.</PDAT></PTEXT></PARA>
<PARA ID="P-00243" LVL="0"><PTEXT><PDAT>In addition, as stated previously elsewhere herein, bioremediation (i.e., the use of organisms, usually plants or microbes, for the extraction and/or degradation of xenobiotics for environmental cleanup) has attracted considerable interest because of its potentially low cost and unobtrusive nature by comparison with conventional physical and chemical methods (Cunningham et al., 1995, Trends Biotechnol. 13:393-397). Of the different options for bioremediation, phytoremediation is particularly appealing for pollutants such as heavy metals that cannot be biodegraded because of the ease with which plants can be harvested using traditional technology. Therefore, the capacity of heterologously expressed AtPCS1 to confer resistance to the first, third and seventh ranked substances on the ASTDR/EPA priority list for the top 20 hazardous substances on U.S. Superfund sites, i.e., arsenic, mercury and cadmium, respectively, is particularly striking (URL http://www.atsdr.cdc.gov:8080/97list.html, 1997 CERCLA Priority List of Hazardous Substances, n&equals;275, accessed on Mar. 25, 1999). The ability of AtPCS1 to confer resistance to these hazardous substances and the fact that in many Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerant plant cell lines at least 90% of this metal is accumulated as Cd.PC complexes (Rauser, 1990, Annu. Rev. Biochem. 59:61-86; Zenk, 1996, Gene 179:21-30), indicate that AtPCS1 and similar genes may find application in the development of phytoremediation technologies through genetic manipulation of the capacity of plants for heavy metal hyperaccumulation.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLE 2</PDAT></STEXT></H>
<PARA ID="P-00244" LVL="7"><PTEXT><PDAT>Phytochelatin Synthases from Wheat and Yeast</PDAT></PTEXT></PARA>
<PARA ID="P-00245" LVL="0"><PTEXT><PDAT>The experiments presented in this example may be summarized as follows.</PDAT></PTEXT></PARA>
<PARA ID="P-00246" LVL="0"><PTEXT><PDAT>Phytochelatins play major roles in metal detoxification in plants and fungi. However, prior to the present invention, no gene encoding phytochelatin synthase had been identified. By screening for plant genes mediating metal tolerance, a wheat (</PDAT><HIL><ITALIC><PDAT>Triticum aestivum</PDAT></ITALIC></HIL><PDAT>) cDNA, TaPCS1, was identified whose expression in </PDAT><HIL><ITALIC><PDAT>Saccharomyces cerevisiae </PDAT></ITALIC></HIL><PDAT>(</PDAT><HIL><ITALIC><PDAT>S. cerevisiae</PDAT></ITALIC></HIL><PDAT>) results in a dramatic increase in cadmium tolerance. TaPCS1 encodes a protein (SEQ ID NO: 6; </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9</PDAT></FGREF><PDAT>) of about 55 kDa with no similarity to proteins of known function. Homologs of this new gene family were identified from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>(</PDAT><HIL><ITALIC><PDAT>A. thaliana</PDAT></ITALIC></HIL><PDAT>), </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces pombe </PDAT></ITALIC></HIL><PDAT>(</PDAT><HIL><ITALIC><PDAT>S. pombe</PDAT></ITALIC></HIL><PDAT>), and interestingly also from the nematode </PDAT><HIL><ITALIC><PDAT>Caenorhabditis elegans </PDAT></ITALIC></HIL><PDAT>(</PDAT><HIL><ITALIC><PDAT>C. elegans</PDAT></ITALIC></HIL><PDAT>). The Arabidopsis and </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>genes were also demonstrated to confer substantial increases in metal tolerance in yeast. PCS-expressing yeast cells accumulate more Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> than control cells. Further, PCS expression mediates Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance even in yeast mutants that are either deficient in vacuolar acidification or impaired in vacuolar biogenesis. PCS-induced metal resistance is lost upon exposure to an inhibitor of glutathione biosynthesis, a process necessary for phytochelatin formation. </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>cells disrupted in the PCS gene exhibit hypersensitivity to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> and Cu and are unable to synthesize phytochelatins upon Cd</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>&plus; exposure as determined by HPLC analysis. </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells expressing PCS produce phytochelatins. Moreover, the recombinant purified </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>PCS protein displays phytochelatin synthase activity. These data demonstrate that PCS genes encode phytochelatin synthases and mediate metal detoxification in eukaryotes.</PDAT></PTEXT></PARA>
<PARA ID="P-00247" LVL="0"><PTEXT><PDAT>The Materials and Methods used in the experiments presented in this example are now described.</PDAT></PTEXT></PARA>
<PARA ID="P-00248" LVL="0"><PTEXT><PDAT>Yeast cultures, transformation and growth assays</PDAT></PTEXT></PARA>
<PARA ID="P-00249" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>strains CY162 (MAT&agr;ura3-52 trk1&Dgr; his3&Dgr;200 his4-15 trk2&Dgr;1::pCK64; Anderson et al., 1992, Proc. Natl. Acad. Sci. U.S.A. 89:3736-3740), INVSc1 (MAT&agr;his3&Dgr;1 leu2 trp1-289 ura3-62), SEY6210 (MAT&agr;leu2-3, 112 Ura3-52 his3-&Dgr;200 trp1-&Dgr;901 lys2-801 suc2-&Dgr;9), &Dgr;vps-18 (Robinson et al, 1991 Mol. Cell. Biol. 11:5813-5824) and &Dgr;vma4 (Ho et al, 1993, J. Biol. Chem. 268:221-227), and the </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>strains FY254 (h</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>ade6-M210 leu1-32 ura4-&Dgr;18 can1-1) and FY261 (h</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> ade6-M216 leu1-32 ura4-&Dgr;18 can1-1), were used. </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells were grown in yeast nitrogen base (YNB) or arginine-phosphate medium (Rodriguez-Navarro and Ramos, 1984, J. Bacteriol. 159:940-945) supplemented with the appropriate amino acids. </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>cells were grown in yeast extract medium (YE) or Edinburgh&apos;s Minimal Medium (EMM; Mitchison, 1970, In: Methods in Cell Physiology, Vol. 4, p. 131, Prescott, ed., Academic Press, New York; Nurse, 1975, Nature 256:457-451), supplemented appropriately. Growth assays using </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>were performed as described previously (Clemens et al., 1998, Proc. Natl. Acad. Sci. U.S.A. 95:12043-12048). Growth of </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>in the presence of different Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations was assayed on EMM plates and in EMM liquid medium.</PDAT></PTEXT></PARA>
<PARA ID="P-00250" LVL="0"><PTEXT><PDAT>Library screening</PDAT></PTEXT></PARA>
<PARA ID="P-00251" LVL="0"><PTEXT><PDAT>CY162 cells (Anderson et al., 1992, Proc. Natl. Acad. Sci. U.S.A. 89:3736-3740) were transformed with a size-selected (greater than about 1.5 kb) fraction of a yeast expression library constructed using mRNA from root tips of wheat seedlings (Schachtman and Schroeder, 1994, Nature 370:655-658) following the lithium acetate method described by Gietz and Schiestl (1995, Meth. Mol. Cell. Biol. 5:255-269). Transformants were first selected for uracil prototrophy on YNB-ura, then the cells were transferred to arginine-phosphate liquid medium containing either 20 or 50 &mgr;M CdCl</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>. After 2-4 days, DNA was extracted from the saturated cultures and </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>cells were transformed. Several colonies per flask were analyzed further using restriction digests and nucleic acid sequencing.</PDAT></PTEXT></PARA>
<PARA ID="P-00252" LVL="0"><PTEXT><PDAT>DNA manipulations</PDAT></PTEXT></PARA>
<PARA ID="P-00253" LVL="0"><PTEXT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>strain DH5&agr; was used for all DNA manipulations. Nucleic acids were expressed in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>using the inducible expression vector pYES2 (Invitrogen, La Jolla, Calif.) or the constitutive expression vector pYX132 (R &amp; D Systems, Abingdon, UK).</PDAT></PTEXT></PARA>
<PARA ID="P-00254" LVL="0"><PTEXT><PDAT>DNA sequencing was performed on an ABI 370 automatic sequencer or using Sequenase (U.S. Biochemical Corp., Cleveland, Ohio).</PDAT></PTEXT></PARA>
<PARA ID="P-00255" LVL="0"><PTEXT><PDAT>PCR and Southern analysis were performed following established procedures (Ausubel et al., 1997, In: Current Protocols in Molecular Biology, Greene Pub. Associates and Wiley-Interscience, New York). Homologous sequences were identified by searching within the GenBank database using BLAST (Altschul et al., 1990, J. Mol. Biol. 215:403-410).</PDAT></PTEXT></PARA>
<PARA ID="P-00256" LVL="0"><PTEXT><PDAT>Amino acid sequences were analyzed with TMPred (Hofmann and Stoffel, 1993, Biol. Chem. 347:166) for the presence of putative transmembrane spans. Alignments were performed using the CLUSTAL W multiple sequence alignment program (Thompson et al., 1994, Nuc. Acids Res. 22:4673-4680).</PDAT></PTEXT></PARA>
<PARA ID="P-00257" LVL="0"><PTEXT><PDAT>Expression analysis</PDAT></PTEXT></PARA>
<PARA ID="P-00258" LVL="0"><PTEXT><PDAT>Northern analysis of RNA from wheat and Arabidopsis plants cells grown in the presence and absence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> was performed according to established procedures (Ausubel et al., 1987, In: Current protocols in molecular biology. Greene Pub. Associates and Wiley-Interscience, New York). For RT-PCR, RNA was isolated from 4 day old wheat plants that were either untreated or treated with 100 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> for 6 hours. RNA was isolated from roots and shoots separately. First strand cDNA was synthesized from these RNA samples using the cDNA Cycle Kit (Invitrogen, La Jolla, Calif.). Ten ng of cDNA were used per PCR reaction. For competitive PCR, a PCR fragment amplified from wheat genomic DNA was cloned using the same primer pair as for the RT-PCR assay. Due to the presence of an intron, this fragment is about 100 bp longer than the fragment amplified from cDNA and this longer fragment was used as a competitor in PCR reactions. Competitor DNA was added to the PCR reaction in varying amounts between 0.1 and 5 fg. The PCR reaction was performed using 32 cycles of 30 seconds at 94 &deg; C., 2 minutes at 55&deg; C., and 1 minute at 72&deg; C. The PCR products were analyzed using agarose gel electrophoresis.</PDAT></PTEXT></PARA>
<PARA ID="P-00259" LVL="0"><PTEXT><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulation</PDAT></PTEXT></PARA>
<PARA ID="P-00260" LVL="0"><PTEXT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells were grown in arginine-phosphate medium for 24 hours in the presence of various amounts of CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>containing 0.5 &mgr;Ci </PDAT><HIL><SP><PDAT>109</PDAT></SP></HIL><PDAT>Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>. The cells were harvested and washed. The radioactivity was determined as described previously (Clemens et al., 1998, Proc. Natl. Acad. Sci. U.S.A. 95:12043-12048).</PDAT></PTEXT></PARA>
<PARA ID="P-00261" LVL="0"><PTEXT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>knockout</PDAT></PTEXT></PARA>
<PARA ID="P-00262" LVL="0"><PTEXT><PDAT>The internal XbaI/HindIII fragment of SpPCS was subcloned into pYES2. Using site-directed mutagenesis, a BamHI site and a Sacd site were introduced into this construct. A BamHI/SacI fragment of the ura4 marker in pTZura was cloned into the mutated SpPCS construct. </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>strain FY254 was transformed with 0.5 &mgr;g of the linearized knockout construct using the LiAc procedure (Okazaki et al., 1990, Nucleic Acids Res. 25:6485-6489). Transformants were selected on EMM with all the required supplements omitting ura. Twenty-five transformants were selected and analyzed by Southern blotting for a disruption of SpPCS. Transformants with a disruption of the SpPCS gene were identified by the appearance of a second band due to the EcoRV site in the ura4 gene. Non-homologous insertion of the knockout construct led to a third band hybridizing with the SpPCS probe.</PDAT></PTEXT></PARA>
<PARA ID="P-00263" LVL="0"><PTEXT><PDAT>Phytochelatin assay</PDAT></PTEXT></PARA>
<PARA ID="P-00264" LVL="0"><PTEXT><PDAT>Phytochelatins were assayed essentially as described (Fahey and Newton, 1987, Meth. Enzymol. 143:85-97). Briefly, </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells were grown to mid-log phase (in EMM-ura, YNB-ura, respectively) and treated with 100 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>. Six hours after Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> addition, the cells were harvested and they were lyophilized. One to five mg of the lyophilized material were extracted in 0.1% TFA, the sample was centrifuged and the supernatant was derivatized with monobromobimane at 45&deg; C. in the dark. The extracts were separated by HPLC on a C18 column (3 &mgr;M, 150 mm) using an acetonitrile gradient. SH-containing compounds were detected fluorimetrically. For the identification of phytochelatins, (&ggr;-EC)</PDAT><HIL><SB><PDAT>2</PDAT></SB></HIL><PDAT>G (&equals;PC2), (&ggr;-EC)</PDAT><HIL><SB><PDAT>3</PDAT></SB></HIL><PDAT>G (&equals;PC3) and (&ggr;-EC)</PDAT><HIL><SB><PDAT>4 </PDAT></SB></HIL><PDAT>(&equals;PC4), standards were synthesized on an Abimed (Langenfeld, Germany) Economy Peptide Synthesizer EPS 211 using N-&agr;-Fmoc-L-glutamic acid &agr;-butyl ester (Novabiochem, L&auml;ufelfingen, Switzerland).</PDAT></PTEXT></PARA>
<PARA ID="P-00265" LVL="0"><PTEXT><PDAT>Protein extraction from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL></PTEXT></PARA>
<PARA ID="P-00266" LVL="0"><PTEXT><PDAT>Protein was extracted from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>cultures grown to mid-log phase in EMM essentially as described (Hayashi et al., 1991, Biochem. Cell Biol. 69:115-121). In brief, cells were harvested by centrifugation. The cell pellet was frozen in liquid N</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>and ground in a chilled mortar using three volumes of quartz sand. Following extraction with 50 mM Tris-Cl, pH 8.0, 10% glycerol, 150 mM,NaCl, 1 mM DTT, 1 mM PMSF, 10 &mgr;M leupeptin and centrifugation at 10,000&times;g for 15 minutes, ammonium sulphate was added to the supernatant to 75% saturation. After 30 minutes, the precipitate was collected by centrifugation at 18,000&times;g for 15 minutes and was dissolved in 25 mM Tris-Cl (pH 8.0), 10% glycerol, and 1 mM DTT.</PDAT></PTEXT></PARA>
<PARA ID="P-00267" LVL="0"><PTEXT><PDAT>Phytochelatin synthase assay</PDAT></PTEXT></PARA>
<PARA ID="P-00268" LVL="0"><PTEXT><PDAT>Aliquots of crude extracts or column fractions were incubated in 200 mM Tris-Cl (pH 8.0), 1 mM DTT, 1 mM GSH (total volume 100 &mgr;l). The assay mixtures were kept on ice for 5 minutes. CdCl</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>was added to a final concentration of 0.1 mM and the samples were incubated at 35&deg; C. for 30-120 minutes. At the end of the incubation period, 50 &mgr;l aliquots were taken and TFA was added to a concentration of 5%. Following a 10 minute incubation on ice and 10 minutes of centrifugation at 13,000&times;g, aliquots of the supernatant were derivatized with monobromobimane and were analyzed by HPLC as described above.</PDAT></PTEXT></PARA>
<PARA ID="P-00269" LVL="0"><PTEXT><PDAT>Purification of HA-tagged SpPCS</PDAT></PTEXT></PARA>
<PARA ID="P-00270" LVL="0"><PTEXT><PDAT>SpPCS was subcloned into pSGP73 to express SpPCS protein with an N-terminal HA tag using the knock-out strain. The crude extract from a 200 ml culture of SpPCS-HA-expressing cells grown to mid-log phase in EMM without leucine and uracil was incubated with 600 &mgr;l of HA-monoclonal antibody affinity matrix slurry (BAbCo, Berkeley, Calif.) at 4&deg; C. under gentle shaking. After 3 hours, the mixture was transferred to a column and the matrix was allowed to settle. Subsequently, the column was washed with 20 ml 50 mM Tris-Cl, pH 8.0, 10% glycerol, 150 mM NaCl, 1 mM DTT. HA-tagged protein was eluted at 30&deg; C. with 5 mg HA peptide dissolved in 5 ml wash buffer. The protein fractions were analyzed by SDS-PAGE followed by silver staining and Western blotting using established procedures (Ausubel et al., 1997, supra).</PDAT></PTEXT></PARA>
<PARA ID="P-00271" LVL="0"><PTEXT><PDAT>The Results of the experiments presented in this example are now described.</PDAT></PTEXT></PARA>
<PARA ID="P-00272" LVL="0"><PTEXT><PDAT>Cloning of TaPCS1</PDAT></PTEXT></PARA>
<PARA ID="P-00273" LVL="0"><PTEXT><PDAT>A screening assay was used to identify plant genes that confer cellular Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance. Yeast cells were transformed with a size-selected (about greater than 1.5 kb) wheat root library (Schachtman and Schroeder, 1994, Nature 370:655-658) and 2&times;10</PDAT><HIL><SP><PDAT>7 </PDAT></SP></HIL><PDAT>cells representing approximately 1&times;10</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>independent transformants were added to 50 ml of arginine-phosphate liquid medium containing either 20 or 50 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>. These Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations are growth-inhibiting for yeast cells in arginine-phosphate medium. However, the liquid cultures were growth-saturated within 2-4 days. Following saturation, surviving yeast cell aliquots were taken, DNA was extracted from these survivors and, after </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>transformation, the pYES2 inserts of the survivors were analyzed.</PDAT></PTEXT></PARA>
<PARA ID="P-00274" LVL="0"><PTEXT><PDAT>All inserts from the same culture exhibited identical restriction patterns indicating that the liquid cultures grew to saturation starting from one or a small number of yeast cells containing the same wheat cDNA. In six liquid cultures of this screen (which included two repetitions with newly transformed cells), a single cDNA, differing only in the length of the 5&prime; untranslated regions (UTRs), was cloned. The cDNA was initially named CdR (for Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> Resistance) but after further characterization, the nucleic acid was named TaPCS1 for its function in Triticum aestivum phytochelatin synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00275" LVL="0"><PTEXT><PDAT>TaPCS1 expression makes </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>more Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerant</PDAT></PTEXT></PARA>
<PARA ID="P-00276" LVL="0"><PTEXT><PDAT>TaPCS1 expression mediated a dramatic increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance of </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells. TaPCS1-expressing cells grew to saturation in the presence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations that completely inhibited growth of control cells harboring the empty pYES2 plasmid (FIG. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT>A). Dose-response analyses demonstrated that TaPCS1-expressing cells tolerate 15-fold higher Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations than control cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 8B</PDAT></FGREF><PDAT>) &lcub;K</PDAT><HIL><SB><PDAT>0.5</PDAT></SB></HIL><PDAT>(TaPCS1)&equals;90 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>; K</PDAT><HIL><SB><PDAT>0.5</PDAT></SB></HIL><PDAT>(control)&equals;6 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>&rcub;. TaPCS1-expressing cells grown in the absence of the inducer galactose also displayed a strong degree of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance, suggesting that low levels of TaPCS1 are sufficient for Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> resistance and indicating a catalytic role of TaPCS1 in mediating Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance (FIG. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT>C), rather than tolerance by direct binding of metals to TaPCS1. Even with glucose as the carbon source, which represses the GAL1 promoter, a slight enhancement of growth was seen in TaPCS1 containing cells, further suggesting a catalytic activity of TaPCS1.</PDAT></PTEXT></PARA>
<PARA ID="P-00277" LVL="0"><PTEXT><PDAT>Sequence analysis and TaPCS1 homologs</PDAT></PTEXT></PARA>
<PARA ID="P-00278" LVL="0"><PTEXT><PDAT>The TaPCS1 open reading frame (ORF; GenBank Accession AF093752) encodes a polypeptide of a predicted mass of 55 kDa (FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>A). The deduced amino acid sequence (SEQ ID NO: 6; </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 9A</PDAT></FGREF><PDAT>) shows no homology to any protein of known function. However, homology was found for the </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>EST G11G3T7 (GenBank W43439), a </PDAT><HIL><ITALIC><PDAT>Schizosaccharomyces pombe </PDAT></ITALIC></HIL><PDAT>hypothetical 46.7 kDa protein C3H1.10 (GenBank Z68144), and the </PDAT><HIL><ITALIC><PDAT>Caenorhabditis elegans </PDAT></ITALIC></HIL><PDAT>ORF F54D5.1 (GenBank Z66513). These sequences are 55%, 28%, and 32% identical at the amino acid level, respectively (FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>A). TaPCS1 and its homologs thus constitute a new gene family. The homologs from Arabidopsis (AtPCS1) and </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>(SpPCS) also confer strong Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance when expressed in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>(FIG. </PDAT><HIL><BOLD><PDAT>9</PDAT></BOLD></HIL><PDAT>B). Low-stringency DNA gel blot analysis in Arabidopsis suggests the presence of more than one AtPCS homolog (see Example 1, supra). Meanwhile, a second Arabidopsis gene (AtPCS2, GenBank AC003027, see Example 1) and a second </PDAT><HIL><ITALIC><PDAT>C. elegans </PDAT></ITALIC></HIL><PDAT>gene (GenBank AL023633) with homology to the PCS genes have been identified through genome sequencing efforts.</PDAT></PTEXT></PARA>
<PARA ID="P-00279" LVL="0"><PTEXT><PDAT>TaPCS1 mediates an increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulation</PDAT></PTEXT></PARA>
<PARA ID="P-00280" LVL="0"><PTEXT><PDAT>One possible mechanism underlying Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance is an efflux of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> ions as observed in many bacteria (Silver and Phung, 1996, Annu. Rev. Microbiol. 50:753-789). This possibility was investigated by measuring the accumulation of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> by control and TaPCS1-expressing cells grown at Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations that do not significantly affect the growth even of control cells. As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>, TaPCS1 expression led to an increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulation by about 30-50% during a 24 hour culture period (n&equals;3). Similar results were obtained for the Arabidopsis homolog (n&equals;2). These data are evidence in support of PCS-dependent Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> chelation or sequestration.</PDAT></PTEXT></PARA>
<PARA ID="P-00281" LVL="0"><PTEXT><PDAT>TaPCS1 confers Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance even in vacuolar mutants</PDAT></PTEXT></PARA>
<PARA ID="P-00282" LVL="0"><PTEXT><PDAT>Sequestration of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> and other heavy metal ions into vacuoles is a well-characterized mechanism of detoxification (Rea et al., 1998, Plant Mol. Biol. 49:727-760). One postulated pathway for plants that would function parallel to the transport of Cd-phytochelatin complexes into vacuoles is a Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>/H&plus; exchanger (Salt and Wagner, 1993, J. Biol. Chem. 268:12297-12302). To determine whether TaPCS1 is involved in this process TAPCS1 was expressed in a &Dgr;vma4 strain, which lacks a functional vacuolar ATPase and therefore cannot establish a pH gradient (Ho et al., 1993, J. Biol. Chem. 268:221-227) required for Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> uptake via the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>/H&plus; exchanger. Growth assays with the &Dgr;vma4 and the parental strain showed that TaPCS1 still confers Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance (n&equals;3). Furthermore, TaPCS1 was expressed in the yeast strain &Dgr;vps18, which fails to form any structures morphologically resembling normal vacuoles (Robinson et al, 1991, Mol. Cell. Biol. 11:5813-5824). This strain is significantly more sensitive to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> than the parental strain (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, open circles). Interestingly, TaPCS1 expression again led to a strong increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>, filled circles).</PDAT></PTEXT></PARA>
<PARA ID="P-00283" LVL="0"><PTEXT><PDAT>SpPCS deletion results in metal sensitivity</PDAT></PTEXT></PARA>
<PARA ID="P-00284" LVL="0"><PTEXT><PDAT>To investigate the physiological role of the PCS genes more directly, a deletion mutant of SpPCS, dSpPCS, was generated in </PDAT><HIL><ITALIC><PDAT>S. pombe. </PDAT></ITALIC></HIL><PDAT>First, Southern analysis of </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>genomic DNA was performed to search for additional PCS homologs. Under low-stringency conditions, no indication of sequences homologous to SpPCS could be detected (FIG. </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>A), demonstrating that SpPCS is a single-copy gene in this organism. Subsequently, the SpPCS gene was deleted by a one-step gene disruption using the ura4 marker. The Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sensitivity of </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>with a disruption of the SpPCS gene (&Dgr;SpPCS) was tested in media containing various Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations. For controls, a.strain transformed with the empty plasmid pTZura4 and a transformant with a non-homologous integration of the knockout construct (Sp3) were analyzed. In the absence of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, the knockout strain grew normally (FIG. </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>B). Growth of the knockout strain was more strongly inhibited by Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> than that of the two different control strains that were indistinguishable (FIG. </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>B). Growth of the knockout strain was also more sensitive than control strains to copper (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 12C</PDAT></FGREF><PDAT>) demonstrating a role for SpPCS in resistance to Cu2&plus;.</PDAT></PTEXT></PARA>
<PARA ID="P-00285" LVL="0"><PTEXT><PDAT>PCS genes are involved in phytochelatin synthesis</PDAT></PTEXT></PARA>
<PARA ID="P-00286" LVL="0"><PTEXT><PDAT>The findings indicating a catalytic role of the PCS genes in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sequestration (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 8C</PDAT></FGREF><PDAT>) suggested a possible role for the PCS gene family in phytochelatin synthesis. Glutathione is a precursor required for phytochelatin synthesis (Grill et al., 1989, Proc. Natl. Acad. Sci. USA 86:6838-6842). Pre-treatment of TaPCS1-expressing </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>with the glutathione biosynthesis inhibitor BSO (L-Buthionine-sulfoxime) reduced the TaPCS1-mediated Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance in a dose-dependent manner (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13A</PDAT></FGREF><PDAT>, filled circles). In controls, expression of an Arabidopsis metallothionein exhibited no effect of BSO on metallothionein-dependent Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13A</PDAT></FGREF><PDAT>, filled squares). TaPCS1 expressing cells exhibited a significantly higher.growth rate at 200 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> than that of metallothionein-expressing cells at only 60 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (FIG. </PDAT><HIL><BOLD><PDAT>13</PDAT></BOLD></HIL><PDAT>A).</PDAT></PTEXT></PARA>
<PARA ID="P-00287" LVL="0"><PTEXT><PDAT>Wildtype </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>cells (control) and the &Dgr;SpPCS strain were analyzed for phytochelatin synthesis upon Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> exposure by fluorescence HPLC. Peaks demonstrating retention times identical to the synthesized phytochelatin standards, PC2 and PC3, were detected in extracts from wildtype cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13B</PDAT></FGREF><PDAT>, top panel, peaks 1 and 2) but were absent in extracts from &Dgr;SpPCS cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13B</PDAT></FGREF><PDAT>, bottom panel). Thus, the increased Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sensitivity of the </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>knockout is correlated with a deficiency in phytochelatin synthesis. Furthermore, TaPCS1-expressing </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells synthesized compounds following Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> treatment (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13C</PDAT></FGREF><PDAT>, top panel) that were not formed in wildtype cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13C</PDAT></FGREF><PDAT>, bottom panel). Those compounds demonstrated retention times identical to PC2 and PC3 which were not observed in the </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>controls, demonstrating that TaPCS1 expression is sufficient to elicit the synthesis of PCs in an organism proposed not to normally form PCs (Rauser, 1995, Plant Physiol. 109:1141-1149). PC synthesis in TaPCS1-expressing cells can also be elicited by treatment with Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> or Zn</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00288" LVL="0"><PTEXT><PDAT>PCS proteins catalyze phytochelatin synthesis</PDAT></PTEXT></PARA>
<PARA ID="P-00289" LVL="0"><PTEXT><PDAT>PCS enzyme assays with crude extracts from </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>marker-transformed cells and &Dgr;SpPCS cells demonstrated that the knock-out strain lacks PCS activity (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14A</PDAT></FGREF><PDAT>, bottom panel). In extracts from control cells, PC2 formation from glutathione was clearly detectable (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14A</PDAT></FGREF><PDAT>, top panel), similar to previous reports using purified enzyme preparations (Grill et al., 1989, Proc. Natl. Acad. Sci. USA 86:6838-6842; Hayashi et al., 1991, Biochem. Cell Biol. 69:115-121). Thus, the ASpPCS strain provided a suitable background for the expression of a tagged SpPCS protein in order to demonstrate directly that the PCS proteins catalyze phytochelatin synthesis. SpPCS was expressed comprising an N-terminal hemagglutinin (HA)-tag (SpPCS-HA) in the knock-out strain and this construct restores metal tolerance, PCS enzyme activity, and the ability to form PC2 and PC3. Western blots of extracts from cells expressing- the HA-tagged SpPCS protein demonstrate a band at about 46 kDa, corresponding to the predicted molecular weight of SpPCS, which is recognized by a monoclonal anti-HA antibody (BAbCo, Berkeley, Calif.; </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14B</PDAT></FGREF><PDAT>, left lane). No signal was detected in extracts from control cells containing the empty pSGP73 plasmid (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14B</PDAT></FGREF><PDAT>, right lane).</PDAT></PTEXT></PARA>
<PARA ID="P-00290" LVL="0"><PTEXT><PDAT>SpPCS-HA was purified using the monoclonal HA-antibody coupled to sepharose (BAbCo, Berkeley, Calif.). The fraction eluted with synthesized HA peptide (YPYDVPDYA) was analyzed by SDS polyacrylamide gel electrophoresis. Silver staining of the gel demonstrated two bands, one at about 46 kDa, the same as found for the anti-HA-immunoreactive band detected from extracts of SpPCS-HA expressing cells, and a lower molecular weight band of approximately 30 kDa (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14C</PDAT></FGREF><PDAT>, left panel). Western blot analysis of the eluate fraction demonstrated cross-reactivity of both polypeptides to anti-HA antibodies (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14C</PDAT></FGREF><PDAT>, right panel). Recognition of the 30 kDa protein by anti-HA antibodies, combined with the fact that this band was not detected from lysates of SpPCS-HA expressing and control cells (FIG. </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>B), suggest, without wishing to be bound by theory, that the polypeptide might represent a proteolytic degradation product of the 46 kDa protein which may have arisen during purification.</PDAT></PTEXT></PARA>
<PARA ID="P-00291" LVL="0"><PTEXT><PDAT>Aliquots of the peptide eluate were further analyzed for PCS enzyme activity. As shown in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14D</PDAT></FGREF><PDAT>, HPLC analysis of the monobromobimane-derivatized reaction products shows formation of a peak corresponding to PC2 from glutathione and Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, thereby demonstrating PCS enzyme activity in the fraction containing SpPCS-HA.</PDAT></PTEXT></PARA>
<PARA ID="P-00292" LVL="0"><PTEXT><PDAT>TaPCS1expression is constitutive and is enhanced by Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL></PTEXT></PARA>
<PARA ID="P-00293" LVL="0"><PTEXT><PDAT>TaPCS1 mRNA could not be detected by RNA blot analysis of wheat root mRNA. To determine whether the TaPCS1 gene is transcribed in wheat seedlings, RT-PCR analysis was performed using TaPCS1 specific primers. Fragments of the expected size were detectable for both root (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 15</PDAT></FGREF><PDAT>, top panel) and shoot samples. Expression of AtPCS1 in Arabidopsis was also analyzed by RT-PCR. The results in Arabidopsis were the same as found for TaPCS1, demonstrating that both TaPCS1 and AtPCS1 are transcribed in vivo. To determine whether exposure to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> treatment affected TaPCS1expression in wheat, wheat cDNA was used together with different amounts of competitor DNA in PCR reactions. Comparison of the band intensity indicated a 5-10 fold higher concentration of TaPCS1 message in wheat roots treated with 100 &mgr;M Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (FIG. </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT>).</PDAT></PTEXT></PARA>
<PARA ID="P-00294" LVL="0"><PTEXT><PDAT>The data disclosed herein demonstrate the isolation and functional characterization of a novel family of genes in several different organisms that mediate a dramatic increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance when expressed in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae. </PDAT></ITALIC></HIL><PDAT>Cadmium accumulation experiments, TaPCS1 induction in roots, glutathione inhibitor studies, and analysis in several yeast mutant backgrounds, together with the Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> and Cu</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sensitivity of a SpPCS disruption mutant in </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>demonstrate a central physiological role of the PCS gene family for metal tolerance. The PC deficiency of a </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>knockout strain, the PC synthesis observed in TaPCS1-expressing </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells upon Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> exposure and the phytochelatin synthase activity of purified recombinant SpPCS suggest that these genes mediate PC synthesis.</PDAT></PTEXT></PARA>
<PARA ID="P-00295" LVL="0"><PTEXT><PDAT>TaPCS1 was identified through an expression cloning strategy in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae, </PDAT></ITALIC></HIL><PDAT>by searching for clones mediating high tolerance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> in the growth medium. TaPCS1 expression enabled yeast cells to grow at more than 15-fold higher Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> concentrations than control cells. Identification of TaPCS1 using this approach was greatly enhanced by the fact that the screening was restricted to a cDNA size fraction (greater than about 1.5 kb) of a cDNA library (Schachtman and Schroeder, 1994, Nature 370:655-658), which helped-eliminate the cloning of cDNAs encoding small and abundant heavy metal-binding peptides such as metallothioneins. Selection of transformants exhibiting elevated tolerance to Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> was performed in liquid medium in order to provide extremely homogeneous screening conditions, while easily permitting the screen to be performed in parallel under different levels of selective pressure. This screening method also allowed the isolation of those cDNAs most effective in conferring Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance. The efficacy of this approach is demonstrated by the fact that, in many independent experiments, TaPCS1was the only cDNA isolated.</PDAT></PTEXT></PARA>
<PARA ID="P-00296" LVL="0"><PTEXT><PDAT>A role in metal tolerance</PDAT></PTEXT></PARA>
<PARA ID="P-00297" LVL="0"><PTEXT><PDAT>A number of findings suggest a catalytic role of the PCS gene products in metal detoxification. The observed increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulation (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 10</PDAT></FGREF><PDAT>) upon TaPCS1 expression in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>demonstrated that the tolerance phenotype is not based on the exclusion of the toxic metal, the dominant mechanism- of metal detoxification in bacteria (Silver and Phung, 1996, Annu. Rev. Microbiol. 50:753-789). On the contrary, the TaPCS1-dependent increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> accumulation is consistent with the hypothesis that TaPCS1 is involved in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sequestration as, for instance, </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>cells overexpressing the ABC type transporter hmt1 accumulate more Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> (Ortiz et al., 1992, EMBO J. 11:3491-3499). Furthermore, TaPCS1 can confer strong Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance even when expressed at low levels under non-inducing conditions (FIG. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT>C).</PDAT></PTEXT></PARA>
<PARA ID="P-00298" LVL="0"><PTEXT><PDAT>Because most toxic materials inside plant cells are sequestered in vacuoles, Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> sensitivity assays were performed using yeast vacuolar mutants. The TaPCS1-mediated increase in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance which was still observed in yeast strains that lack either a functional V-ATPase (Ho et al., 1993, J. Biol. Chem. 268:221-227) or in yeast which lack morphologically typical discernible vacuoles (Robinson et al, 1991, Mol. Cell. Biol. 11:5813-5824; </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 11</PDAT></FGREF><PDAT>) led to the conclusion that a direct role for TaPCS1 in vacuolar transport of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> ions appears unlikely, although an indirect involvement or early reaction preceding vacuolar uptake cannot be ruled out.</PDAT></PTEXT></PARA>
<PARA ID="P-00299" LVL="0"><PTEXT><PDAT>The PCS genes mediate phytochelatin synthesis</PDAT></PTEXT></PARA>
<PARA ID="P-00300" LVL="0"><PTEXT><PDAT>Synthesis of phytochelatins from glutathione upon metal exposure has been shown to be directly involved in plant metal tolerance (Zenk, 1996, Gene 179:21-30). Phytochelatin synthase was proposed to catalyze the first step in the sequestration of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> as Cd-phytochelatin complexes in vacuoles. Because a cDNA encoding a phytochelatin synthase had not been isolated and because the data disclosed herein suggested a PCS-mediated sequestration of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>, the involvement of the PCS genes in PC synthesis was examined.</PDAT></PTEXT></PARA>
<PARA ID="P-00301" LVL="0"><PTEXT><PDAT>Consistent with the aforementioned observations in plants, Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> hypersensitive mutants of </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>have been isolated which show reduced phytochelatin levels (Mutoh and Hayashi, 1988, Biochem. Biophys. Res. Commun. 151:32-39). Thus, the observed Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> hypersensitivity of the ASpPCS strain (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13B</PDAT></FGREF><PDAT>) provided further indication for the hypothesis that PCS genes directly mediate phytochelatin synthesis. Copper sensitivity is also consistent with a PC deficiency as phytochelatins form complexes with several toxic metals and with copper ions as well (Rauser, 1995, Plant Physiol. 109:1141-1149).</PDAT></PTEXT></PARA>
<PARA ID="P-00302" LVL="0"><PTEXT><PDAT>To test more directly the hypothesis that PCS genes mediate phytochelatin synthesis, the effect of BSO, a potent, specific inhibitor glutathione biosynthesis, on TaPCS1-mediated Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance was determined. BSO has been previously shown to reduce synthesis of PCs and PC-associated Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance in plant cell cultures (Steffens, 1990, Plant Mol. Biol. 41:553-575). The BSO-dependent reduction in Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance of TaPCS1 expressing </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13A</PDAT></FGREF><PDAT>) demonstrated a role for glutathione biosynthesis on TaPCS1-mediated Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> resistance. In contrast, control cells overexpressing metallothioneins showed no BSO sensitivity and less Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> resistance (FIG. </PDAT><HIL><BOLD><PDAT>13</PDAT></BOLD></HIL><PDAT>A).</PDAT></PTEXT></PARA>
<PARA ID="P-00303" LVL="0"><PTEXT><PDAT>Subsequently, HPLC analysis of monobromobimane-labeled extracts from Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-treated wildtype </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>exhibited the expected peaks for PC2 and PC3, the dominant phytochelatins of fission yeast (Kondo et al., 1985, Agric. Biol. Chem. 49:71-83; </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6B</PDAT></FGREF><PDAT>, top, peaks 1 and 2). PC2 and PC3 were undetectable in extracts of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-treated ASpPCS cells (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13B</PDAT></FGREF><PDAT>, bottom). Correspondingly, no PCS enzyme activity was detectable in protein extracts of the knock-out strain (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 14A</PDAT></FGREF><PDAT>, bottom), thereby establishing a role for SpPCS in phytochelatin synthesis. Furthermore, extracts of </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>control cells did not show formation of PC peaks in the present study (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13C</PDAT></FGREF><PDAT>, bottom). Notably, the </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>genome contains no PCS homologs (Mewes et al., 1997, Nature 387:7-65). In contrast, TaPCS1-expressing </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells formed PC2 and PC3 upon Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> exposure (</PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 13C</PDAT></FGREF><PDAT>, top). Thus, TaPCS1 expression is concluded to be sufficient for phytochelatin synthesis from glutathione in an organism whose genome does not contain a PCS homolog (Mewes et al., 1997, Nature 387:7-65). </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>has been reported to express only limited quantities of exclusively PC2 (Kneer et al., 1992, Arch. Microbiol. 157:305-310), an activity which clearly differs from that observed in TaPCS1-expressing cells, which mediates PC2 and PC3 synthesis. To demonstrate the direct catalysis of phytochelatin synthesis by the PCS proteins, a &Dgr;SpPCS strain was used as a null background for the expression and purification of a tagged version of SpPCS. Phytochelatin synthesis from glutathione was detectable in fractions eluted from a HA-antibody affinity matrix that contained no detectable protein other than the HA-tagged SpPCS and an apparent degradation product (FIG. </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>). These data demonstrate the direct catalysis of phytochelatin synthesis by the PCS proteins. On the basis of these results, the data disclosed herein demonstrate that the PCS genes encode phytochelatin synthases.</PDAT></PTEXT></PARA>
<PARA ID="P-00304" LVL="0"><PTEXT><PDAT>Phytochelatin synthase was previously reported by (Grill et al., 1 989, Proc. Natl. Acad. Sci. USA 86:6838-6842) to be a 95 kDa tetramer. The predicted molecular mass of the PCS proteins described here lies in range of 46-55 kDa. Without wishing to be bound by theory, it cannot be ruled out that the PCS genes disclosed herein encode catalytic subunits of a multimeric PC synthase.</PDAT></PTEXT></PARA>
<PARA ID="P-00305" LVL="0"><PTEXT><PDAT>Phytochelatins are involved in metal tolerance in vivo</PDAT></PTEXT></PARA>
<PARA ID="P-00306" LVL="0"><PTEXT><PDAT>The data disclosed herein concerning the metal sensitivity of the &Dgr;SpPCS strain provide molecular evidence that phytochelatins play a central role in metal detoxification in plants and </PDAT><HIL><ITALIC><PDAT>S. pombe. </PDAT></ITALIC></HIL><PDAT>Furthermore, the data disclosed herein demonstrate that lack of PC synthesis also leads to Cu hypersensitivity. This provides evidence for a more general role of phytochelatins in metal homeostasis, as was suggested earlier (Rauser, 1990, Annu. Rev. Biochem. 59:61-86) and indicated by the finding that PC-metal complexes can activate metal-depleted apoenzymes in vitro (Thumann et al., 1991, FEBS Lett. 284:66-69).</PDAT></PTEXT></PARA>
<PARA ID="P-00307" LVL="0"><PTEXT><PDAT>Consistent with the reported constitutive activity of phytochelatin synthase (Grill et al., 1989, Proc. Natl. Acad. Sci. USA 86:6838-6842) in roots and stems (Chen et al., 1997, Physiol. Plant. 101:165-172) and the suggested requirement for organisms to express metal tolerance genes constitutively (Zenk, 1996, Gene 179:21-30), TaPCS1 and AtPCS1 message were detected in roots and shoots of non-metal-stressed wheat and Arabidopsis plants, respectively. Furthermore, competitive PCR experiments using Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-treated wheat roots and TaPCS1 show metal-induced up-regulation of PCS mRNA levels (FIG. </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT>). Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>-induced increases in PCS activity have been previously reported by Chen et al. (1997, Physiol. Plant. 101:165-172) for tomato cell lines.</PDAT></PTEXT></PARA>
<PARA ID="P-00308" LVL="0"><PTEXT><PDAT>Heterologous expression of PCS genes is sufficient to enhance metal tolerance</PDAT></PTEXT></PARA>
<PARA ID="P-00309" LVL="0"><PTEXT><PDAT>In the models proposed for phytochelatin-mediated Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> complexation (Ortiz et al., 1995, J. Biol. Chem. 170:4721-4728; Rauser, 1995, Plant Physiol. 109:1141-1149), PCs function as cytosolic chelators and carriers of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> ions by forming low-molecular weight complexes which are then transported into the vacuole by transporters such as the ABC-type transporter HMT1 in </PDAT><HIL><ITALIC><PDAT>S. pombe </PDAT></ITALIC></HIL><PDAT>(Ortiz et al., 1992, EMBO J. 11:3491-3499). Inside the vacuole, more Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> and sulfide are added to the complex to produce the high-molecular weight complexes which are believed to represent the sequestered form of Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00310" LVL="0"><PTEXT><PDAT>The cloning of TaPCS1 and growth assays with </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells expressing TaPCS1, &Dgr;AtPCS1 and SpPCS demonstrated that phytochelatin synthesis alone can significantly increase cellular Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance (FIGS. </PDAT><HIL><BOLD><PDAT>8</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT>). Taken together with the evidence disclosed elsewhere herein for vacuole-independent TaPCS1-mediated Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance obtained from experiments with the &Dgr;vps18 mutant (FIG. </PDAT><HIL><BOLD><PDAT>11</PDAT></BOLD></HIL><PDAT>), this suggests that PCs represent a significant cytosolic buffer for metal ions. These data and the unexpected finding of two PCS homologs in the Caenorhabditis elegans genome raise the possibility that PC synthase overexpression could be successfully used to increase the metal tolerance of diverse organisms. Furthermore transgenic PCS expression could be useful for enhancing the removal of toxic metals by plants and other organisms for bioremediation.</PDAT></PTEXT></PARA>
<PARA ID="P-00311" LVL="0"><PTEXT><PDAT>Thus, the data disclosed herein demonstrate the isolation of a novel family of metal tolerance genes from a wide variety of organisms that encode phytochelatin synthases, as demonstrated by glutathione dependence and the PC synthesis deficiency demonstrated in a &Dgr;SpPCS strain, the phytochelatin synthesis in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>cells expressing TaPCS1and the phytochelatin synthase activity of purified recombinant SpPCS. The data disclosed herein provide molecular evidence for the model that PCs play a crucial role in metal tolerance (Grill et al., 1985, Science 230:674-676; Zenk, 1996, Gene 179:21-30; Howden et al., 1995, Plant Physiol. 107:1059-1066). The effects of TaPCS1 expression in </PDAT><HIL><ITALIC><PDAT>S. cerevisiae </PDAT></ITALIC></HIL><PDAT>on Cd</PDAT><HIL><SP><PDAT>2&plus;</PDAT></SP></HIL><PDAT> tolerance demonstrate that heterologous expression of PCS genes can dramatically enhance metal tolerance. Future research in transgenic plants and other organisms will allow testing of the potential of PCS genes for toxic metal sequestration, metal detoxification, and bioremediation.</PDAT></PTEXT></PARA>
<PARA ID="P-00312" LVL="0"><PTEXT><PDAT>The disclosures of each and every patent, patent application, and publication cited herein are hereby incorporated herein by reference in their entirety.</PDAT></PTEXT></PARA>
<PARA ID="P-00313" LVL="0"><PTEXT><PDAT>While the invention has been disclosed with reference to specific embodiments, it is apparent that other embodiments and variations of this invention may be devised by others skilled in the art without departing from the true spirit and scope of the invention. The appended claims are intended to be construed to include all such embodiments and equivalent variations.</PDAT></PTEXT></PARA>
<CWU>
<SEQLST-US ID="SEQLST-1">
<SEQ-LST-NEW>
<S100>
<S160>
<PDAT>10</PDAT>
</S160>
</S100>
<S200>
<S210>
<PDAT>1</PDAT>
</S210>
<S211>
<PDAT>1748</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Arabidopsis thaliana</PDAT>
</S213>
</S200>
<S400>
<PDAT> 1
agtaatttag gttattttcg aatccactaa cgaatcttcc acagcaaaca cttttgtgtt     60
cctctgtaat ttctcagtat atatagatac caaaacaagc agtgaaaaat ggctatggcg    120
agtttatatc ggcgatctct tccttctcct ccggccattg acttttcttc cgccgaaggc    180
aagctaatct tcaatgaagc gcttcaaaaa ggaactatgg aaggattttt caggttgatt    240
tcgtattttc agacacaatc cgaacctgcg tattgtggtt tggctagtct ctcagtggtg    300
ttgaatgctc tttctatcga tcctggacgt aaatggaaag ggccttggag gtggtttgat    360
gaatcaatgt tggattgctg cgaacctctg gaagtagtga aggaaaaagg catttcattt    420
ggaaaagttg tctgtttggc tcattgttca ggagcaaaag ttgaggcttt ccgtacaagt    480
cagagcacca ttgatgattt ccgcaaattt gtcgtcaaat gcacgagttc tgagaattgt    540
catatgatct caacatatca ccgaagtgta tttaagcaga ctgggaatgg tcacttttca    600
cctattggtg gctataatgc tgagagagat atggctttga ttcttgatgt tgctcgtttc    660
aagtatcccc ctcactgggt tcctcttaaa cttctttggg aagccatgga cagtattgat    720
cagtcaacag ggaaacgtag agggttcatg ctcatatcta gaccacacag agaacccgga    780
ttgctctata ctctgagctg caaggatgaa agctggatcg aaatagccaa gtatttgaag    840
gaagatgttc ctcgtcttgt aagttcacag catgtagatt ctgtggagaa aatcatatca    900
gttgtgttca agtcacttcc atcaaatttc aaccaattca tcagatgggt ggctgagatc    960
cgaattacag aggactcaaa ccaaaatctc agcgcagagg agaagtctag gctgaaacta   1020
aagcaattgg tgctgaagga agtgcacgaa actgaactgt tcaaacacat caataagttc   1080
ttatccacag tgggttatga agacagtctg acttatgctg ctgcaaaggc ttgttgccaa   1140
ggagctgaaa tcttatccgg aagcccatca aaagagtttt gttgtcggga aacttgcgtg   1200
aaatgcatca aaggtcctga tgactctgaa ggcacggtgg tgactggagt tgtggtgcgt   1260
gatgggaatg aacaaaaggt tgatctgtta gtgccatcga cgcaaactga gtgtgaatgt   1320
ggtcctgaag caacttatcc agcaggaaac gatgtgttca ctgcacttct attggcttta   1380
cctccacaga catggtcagg gatcaaagac caagctctta tgcatgaaat gaagcagctc   1440
atttccatgg cttccctccc aactttgctt caagaagagg tattgcatct tcgacggcaa   1500
cttcagctgc taaaacgatg ccaagagaac aaggaagagg atgatctcgc tgctcctgcc   1560
tattagttca ttgtcccaaa tcctctctct tccccatttg aatcccacgt tctctacact   1620
taattgttag aaagtctctt tattctctgt acgattcaaa ctctatttgc aatgagagat   1680
atatgtaact tgcattctat aaattgttaa tcacaataag ttaagaatcc aaaaaaaaaa   1740
aaactaaa                                                            1748
</PDAT>
</S400>
<S200>
<S210>
<PDAT>2</PDAT>
</S210>
<S211>
<PDAT>486</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Arabidopsis thaliana</PDAT>
</S213>
</S200>
<S400>
<PDAT> 2
Met Ala Met Ala Ser Leu Tyr Arg Arg Ser Leu Pro Ser Pro Pro Ala
  1               5                  10                  15
Ile Asp Phe Ser Ser Ala Glu Gly Lys Leu Ile Phe Asn Glu Ala Leu
             20                  25                  30
Gln Lys Gly Thr Met Glu Gly Phe Phe Arg Leu Ile Ser Tyr Phe Gln
         35                  40                  45
Thr Gln Ser Glu Pro Ala Tyr Cys Gly Leu Ala Ser Leu Ser Val Val
     50                  55                  60
Leu Asn Ala Leu Ser Ile Asp Pro Gly Arg Lys Trp Lys Gly Pro Trp
 65                  70                  75                  80
Arg Trp Phe Asp Glu Ser Met Leu Asp Cys Cys Glu Pro Leu Glu Val
                 85                  90                  95
Val Lys Glu Lys Gly Ile Ser Phe Gly Lys Val Val Cys Leu Ala His
            100                 105                 110
Cys Ser Gly Ala Lys Val Glu Ala Phe Arg Thr Ser Gln Ser Thr Ile
        115                 120                 125
Asp Asp Phe Arg Lys Phe Val Val Lys Cys Thr Ser Ser Glu Asn Cys
    130                 135                 140
His Met Ile Ser Thr Tyr His Arg Ser Val Phe Lys Gln Thr Gly Asn
145                 150                 155                 160
Gly His Phe Ser Pro Ile Gly Gly Tyr Asn Ala Glu Arg Asp Met Ala
                165                 170                 175
Leu Ile Leu Asp Val Ala Arg Phe Lys Tyr Pro Pro His Trp Val Pro
            180                 185                 190
Leu Lys Leu Leu Trp Glu Ala Met Asp Ser Ile Asp Gln Ser Thr Gly
        195                 200                 205
Lys Arg Arg Gly Phe Met Leu Ile Ser Arg Pro His Arg Glu Pro Gly
    210                 215                 220
Leu Leu Tyr Thr Leu Ser Cys Lys Asp Glu Ser Trp Ile Glu Ile Ala
225                 230                 235                 240
Lys Tyr Leu Lys Glu Asp Val Pro Arg Leu Val Ser Ser Gln His Val
                245                 250                 255
Asp Ser Val Glu Lys Ile Ile Ser Val Val Phe Lys Ser Leu Pro Ser
            260                 265                 270
Asn Phe Asn Gln Phe Ile Arg Trp Val Ala Glu Ile Arg Ile Thr Glu
        275                 280                 285
Asp Ser Asn Gln Asn Leu Ser Ala Glu Glu Lys Ser Arg Leu Lys Leu
    290                 295                 300
Lys Gln Leu Val Leu Lys Glu Val His Glu Thr Glu Leu Phe Lys His
305                 310                 315                 320
Ile Asn Lys Phe Leu Ser Thr Val Gly Tyr Glu Asp Ser Leu Thr Tyr
                325                 330                 335
Ala Ala Ala Lys Ala Cys Cys Gln Gly Ala Glu Ile Leu Ser Gly Ser
            340                 345                 350
Pro Ser Lys Glu Phe Cys Cys Arg Glu Thr Cys Val Lys Cys Ile Lys
        355                 360                 365
Gly Pro Asp Asp Ser Glu Gly Thr Val Val Thr Gly Val Val Val Arg
    370                 375                 380
Asp Gly Asn Glu Gln Lys Val Asp Leu Leu Val Pro Ser Thr Gln Thr
385                 390                 395                 400
Glu Cys Glu Cys Gly Pro Glu Ala Thr Tyr Pro Ala Gly Asn Asp Val
                405                 410                 415
Phe Thr Ala Leu Leu Leu Ala Leu Pro Pro Gln Thr Trp Ser Gly Ile
            420                 425                 430
Lys Asp Gln Ala Leu Met His Glu Met Lys Gln Leu Ile Ser Met Ala
        435                 440                 445
Ser Leu Pro Thr Leu Leu Gln Glu Glu Val Leu His Leu Arg Arg Gln
    450                 455                 460
Leu Gln Leu Leu Lys Arg Cys Gln Glu Asn Lys Glu Glu Asp Asp Leu
465                 470                 475                 480
Ala Ala Pro Ala Tyr Glx
                485
</PDAT>
</S400>
<S200>
<S210>
<PDAT>3</PDAT>
</S210>
<S211>
<PDAT>2561</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Arabidopsis thaliana</PDAT>
</S213>
</S200>
<S400>
<PDAT> 3
atgtctatgg cgagtttgta tcggcggtct ctttcccctc cggcgataga tttcgcttct     60
tttgaaggaa aggtgcgtta tttctcaagt gttcgatcca tggattcaat tgaaaattca    120
gggttctggg ttttaacttt ttaagtatcc ttgtgcttct ggttagagat gatcactgat    180
ttggtttttg tatgttgatt gatttggtta cttctctatc tgtatagagt ctagaaattg    240
gattttcttg ggaactgtgt aaaactcgta aaaccctaaa ccccttgctg tttttacaag    300
tttagttgtt ggtgagagat ctgagcatgc ttcatgataa atggttcacg aattattgat    360
agccaattta gtagaatggg acaagttctt ttgccctgag aatttaaatg ttgtcattgt    420
ctttgcagca aatcttcaat gaagcgcttc agaaaggcac tatggaagga tttttcgggc    480
tgatttctta ttttcagaca cagtctgagc cagctttttg tggcttagct agtctttcga    540
tggttttgaa ttctctttct attgacccgg gaagaaagtg gaaaggtata catacctcta    600
ctggagagta catttgttgg tgggtttttg aatttttttg gtttctctca gggccttgga    660
ggtggtttga tgaatcaatg ctggaatgtt gcgagccgct tgaaatagtg aaggataaag    720
gcatttcatt tggaaaagtg gtctgtttag ctcattcttc aggagcaaaa gtcgaagctt    780
tccgcacaaa tcagagcacc attgatgatt tccgcaaata tgtggtcaaa tgttcaactt    840
ctgataattg tcatatgatc tcaacatatc ataggcaagt actcaagcag gtatcatttt    900
tttggcctaa actctgtgta tattaacagt tatatggcaa ttaagtgaaa ttcattagac    960
ttaatgttat tacaaagttt gataatggtg aaactctttc atgtcttgct atgaagtccc   1020
atgctgatcg gattctaatg tctatgattg cagactggaa ctggccactt ttcacctatt   1080
ggtggttata atgctgaaag agatatggct ttgattcttg atgtcgctcg tttcaagtat   1140
cctcctcact gggttcctct taaacttctt tgggatgcca tggatagtat tgatcagtca   1200
acagggagac gtagagggta catggatctc tattcttttt cttaggcttc acttgtatga   1260
ttaaagaatg taatccgttt ctttttgcta ttctgcttta cttccaggtt catgcttata   1320
tcaagacccc acagagaacc aggattgctc tatacattag taagtccaaa gtcatggttc   1380
tattagtagt tgctgctatt acaataacat ttctttcgaa taggactgag taatgatatc   1440
ttgattatcg atttcagagt tgtaaggatg agagctggat cagcattgca aagtatttga   1500
aggaagatgt tcctcgtctt gtaagctcac aacatgttga tactattgaa agaatcttat   1560
atgttgtatt caagtcactt ccagcaaatt tcaaccaatt tatcaaatgg atggctgaga   1620
ttcgaagaac agaggatgta aatcaaaatc ttagctcaga agagaaatca aggctcaaat   1680
taaaggtatt atcttgtcca tttgcttctg aactttagtt ttccatgttt atattccatc   1740
agtttattca tcactgttct atggttcgtt ttgctgtagc aagagttact gaaacaagtg   1800
caagaaacta aactgttcaa gcatgtggat aagtttctct cctctgtgta cgaagacaat   1860
ctgccatatg ttgctgctaa ggtttattgt gacggagatg aaatcttatc gggatatgaa   1920
tcagatgaat cctgttgtaa ggaaacttgt gtcaaatgta tcaaaggtat gtttgttctt   1980
acattctggt tatctttcta agcgcttcag aaaccttggc ttgaagttag tagtgtgcaa   2040
agttctaatc aagaaatcac ttttttcttt gaatttcttg ttttacatca aggtcttggt   2100
gaggagaaag tgacagtggt agcttaccca tccgggaacg atgtgttcac tgctcttctg   2160
ttggctttac ctccacagac gtggtcaggt atcaaagacc agtcactttt gcaagaaatg   2220
aaacagctca tttccatggt tagccacccg actttgcttc aacaagaggt acataactaa   2280
gccaactctt cacttggagt ctgagttata tatcttctaa ttcttaggat aagaaacaga   2340
aatgaaactc agttatatag tctgaggatt accttctgaa gctgactctt ttttaaggct   2400
gaactccaga atccattaga tgagaaatat gtagtaaagt cagctaagtt aaatcgtttt   2460
cctttggtgg gttacaggtt ttgcatctac gacgccaact tgagatgcta aaacgatgcc   2520
aggagaataa agaagacgaa gaactctctg ctcctgccta a                       2561
</PDAT>
</S400>
<S200>
<S210>
<PDAT>4</PDAT>
</S210>
<S211>
<PDAT>452</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Arabidopsis thaliana</PDAT>
</S213>
</S200>
<S400>
<PDAT> 4
Met Ser Met Ala Ser Leu Tyr Arg Arg Ser Leu Ser Pro Pro Ala Ile
  1               5                  10                  15
Asp Phe Ala Ser Phe Glu Gly Lys Gln Ile Phe Asn Glu Ala Leu Gln
             20                  25                  30
Lys Gly Thr Met Glu Gly Phe Phe Gly Leu Ile Ser Tyr Phe Gln Thr
         35                  40                  45
Gln Ser Glu Pro Ala Phe Cys Gly Leu Ala Ser Leu Ser Met Val Leu
     50                  55                  60
Asn Ser Leu Ser Ile Asp Pro Gly Arg Lys Trp Lys Gly Pro Trp Arg
 65                  70                  75                  80
Trp Phe Asp Glu Ser Met Leu Glu Cys Cys Glu Pro Leu Glu Ile Val
                 85                  90                  95
Lys Asp Lys Gly Ile Ser Phe Gly Lys Val Val Cys Leu Ala His Ser
            100                 105                 110
Ser Gly Ala Lys Val Glu Ala Phe Arg Thr Asn Gln Ser Thr Ile Asp
        115                 120                 125
Asp Phe Arg Lys Tyr Val Val Lys Cys Ser Thr Ser Asp Asn Cys His
    130                 135                 140
Met Ile Ser Thr Tyr His Arg Gln Val Leu Lys Gln Thr Gly Thr Gly
145                 150                 155                 160
His Phe Ser Pro Ile Gly Gly Tyr Asn Ala Glu Arg Asp Met Ala Leu
                165                 170                 175
Ile Leu Asp Val Ala Arg Phe Lys Tyr Pro Pro His Trp Val Pro Leu
            180                 185                 190
Lys Leu Leu Trp Asp Ala Met Asp Ser Ile Asp Gln Ser Thr Gly Arg
        195                 200                 205
Arg Arg Gly Phe Met Leu Ile Ser Arg Pro His Arg Glu Pro Gly Leu
    210                 215                 220
Leu Tyr Thr Leu Ser Cys Lys Asp Glu Ser Trp Ile Ser Ile Ala Lys
225                 230                 235                 240
Tyr Leu Lys Glu Asp Val Pro Arg Leu Val Ser Ser Gln His Val Asp
                245                 250                 255
Thr Ile Glu Arg Ile Leu Tyr Val Val Phe Lys Ser Leu Pro Ala Asn
            260                 265                 270
Phe Asn Gln Phe Ile Lys Trp Met Ala Glu Ile Arg Arg Thr Glu Asp
        275                 280                 285
Val Asn Gln Asn Leu Ser Ser Glu Glu Lys Ser Arg Leu Lys Leu Lys
    290                 295                 300
Gln Glu Leu Leu Lys Gln Val Gln Glu Thr Lys Leu Phe Lys His Val
305                 310                 315                 320
Asp Lys Phe Leu Ser Ser Val Tyr Glu Asp Asn Leu Pro Tyr Val Ala
                325                 330                 335
Ala Lys Val Tyr Cys Asp Gly Asp Glu Ile Leu Ser Gly Tyr Glu Ser
            340                 345                 350
Asp Glu Ser Cys Cys Lys Glu Thr Cys Val Lys Cys Ile Lys Gly Leu
        355                 360                 365
Gly Glu Glu Lys Val Thr Val Val Ala Tyr Pro Ser Gly Asn Asp Val
    370                 375                 380
Phe Thr Ala Leu Leu Leu Ala Leu Pro Pro Gln Thr Trp Ser Gly Ile
385                 390                 395                 400
Lys Asp Gln Ser Leu Leu Gln Glu Met Lys Gln Leu Ile Ser Met Val
                405                 410                 415
Ser His Pro Thr Leu Leu Gln Gln Glu Val Leu His Leu Arg Arg Gln
            420                 425                 430
Leu Glu Met Leu Lys Arg Cys Gln Glu Asn Lys Glu Asp Glu Glu Leu
        435                 440                 445
Ser Ala Pro Ala
    450
</PDAT>
</S400>
<S200>
<S210>
<PDAT>5</PDAT>
</S210>
<S211>
<PDAT>2006</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Triticum aestivum</PDAT>
</S213>
</S200>
<S400>
<PDAT> 5
aatttaagca tcgaaaagcg gaagtggagg agcacaactg gcggtcgaca gcgaggcgcc     60
gacgacgact cccaggttga aatcctattg aatttcaggg acgggggaga ggaataaaaa    120
cgaggagagt cgacactcga cagacaggtg gcgagatccc ccgaagccgt ccgtactctc    180
gcagcagatc ggccggcgga agccagcagg atggaggtgg cgtcgctgta ccggcgggtg    240
ctgccgtcgc cgccggcggt ggagttcgcg tcggcggagg ggaagcggct gttcgcggag    300
gcgctgcagg gcgggaccat ggagggcttc ttcaacctca tctcctactt ccagacgcag    360
tcggagccgg ccttctgcgg cctcgcctcc ctctccgtcg tgctcaacgc gctcgccatc    420
gaccccggcc ggccgtggaa ggggccctgg cgctggttcg acgagtccat gctcgactgc    480
tgcgagcccc tccacaaggt caaggccgag ggcatcacct tcggcaaggt cgtctgcctc    540
gcgcactgcg ccggcgcccg tgtccagtcc ttccgcgccg accagaccac catccacgac    600
ttccgcgccc acctcacgcg ctgcgcctcc tcccaggact gccatctcat ctcctcctac    660
cacaggagcc ccttcaagca gactgggact ggccatttct caccgatcgg cgggtatcat    720
gccgagaaag acatggcgct catcttggat gttgcgcgct tcaaataccc tcctcattgg    780
gttccattga cgcttctctg ggatgccatg aacacgactg atgaagcaac tgggcttctc    840
agggggttca tgcttgtatc aaggcgcagt tcagctcctt cattgctcta cacagtgagt    900
tgcggccatg gaagttggaa aagcatggca aagtattgtg tggaagatgt gcccaatcta    960
ctgaaggatg agagtctaga caatgttaca acacttctgt cccgcctagt ggaatctctc   1020
ccagccaatg ctggagattt gatcaaatgt gtcattgaag ttaggagaaa agaggaaggt   1080
gaatcaagct tgagtaaaga ggagaaagaa aggctttttt tgaaggaaaa agtattacag   1140
caaatccgtg atactgatct tttcagagta gtccacgaac tgcaatatcc caaggggcta   1200
tgtggtagtt gctcgtcttc aagtgatgaa gattcgcttg ccgagattgc agccactgtg   1260
tgctgtcaag gagctgcatt cctatctggt aaccttgtat ctagagatgg gttctgctgc   1320
cgagaaacat gtatcaaatg tatagaagca aatggtgatg gactaaagac tgttatctca   1380
ggaaccgtgg tatctaaagg gaatgaacag gctgttgatt tgcttttacc aacatcctcg   1440
tcaaaaacaa gcttatgcaa ttcaaacttg aagagcaaga ttgtcaagta tccatcaagc   1500
acagatgttc taactgtcct actgctggtt ttacagccta acacatggct tggcataaaa   1560
gacgagaacg tgaaagctga atttcagagt cttgtttcaa cagacaatct tcctgatctt   1620
cttaaacagg agatactgca tctaaggcgg cagctccatt atttggctgg ttgtaaagga   1680
caggaggcat gtcaagagcc tccatcccct tagggacgct gctgcgacaa tctgctcact   1740
tggttaggag ataaggccct tggagatccc acgagcatac tatcgaggca aaaatatatg   1800
attcaataaa cagacttact tcgtgaggta ggaggacata ctaaggatca aagtaatagg   1860
attttgagag agtattggag ccaagatagc tggtaacatc ctggttaccg gtctcttttg   1920
gttcactata tatgtaaatt cttttgcgtt tatattattt tcttcgacta tgtaaaaaaa   1980
aaaaaaaaaa aaaaaaaaaa aaaaaa                                        2006
</PDAT>
</S400>
<S200>
<S210>
<PDAT>6</PDAT>
</S210>
<S211>
<PDAT>500</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Triticum aestivum</PDAT>
</S213>
</S200>
<S400>
<PDAT> 6
Met Glu Val Ala Ser Leu Tyr Arg Arg Val Leu Pro Ser Pro Pro Ala
  1               5                  10                  15
Val Glu Phe Ala Ser Ala Glu Gly Lys Arg Leu Phe Ala Glu Ala Leu
             20                  25                  30
Gln Gly Gly Thr Met Glu Gly Phe Phe Asn Leu Ile Ser Tyr Phe Gln
         35                  40                  45
Thr Gln Ser Glu Pro Ala Phe Cys Gly Leu Ala Ser Leu Ser Val Val
     50                  55                  60
Leu Asn Ala Leu Ala Ile Asp Pro Gly Arg Pro Trp Lys Gly Pro Trp
 65                  70                  75                  80
Arg Trp Phe Asp Glu Ser Met Leu Asp Cys Cys Glu Pro Leu His Lys
                 85                  90                  95
Val Lys Ala Glu Gly Ile Thr Phe Gly Lys Val Val Cys Leu Ala His
            100                 105                 110
Cys Ala Gly Ala Arg Val Gln Ser Phe Arg Ala Asp Gln Thr Thr Ile
        115                 120                 125
His Asp Phe Arg Ala His Leu Thr Arg Cys Ala Ser Ser Gln Asp Cys
    130                 135                 140
His Leu Ile Ser Ser Tyr His Arg Ser Pro Phe Lys Gln Thr Gly Thr
145                 150                 155                 160
Gly His Phe Ser Pro Ile Gly Gly Tyr His Ala Glu Lys Asp Met Ala
                165                 170                 175
Leu Ile Leu Asp Val Ala Arg Phe Lys Tyr Pro Pro His Trp Val Pro
            180                 185                 190
Leu Thr Leu Leu Trp Asp Ala Met Asn Thr Thr Asp Glu Ala Thr Gly
        195                 200                 205
Leu Leu Arg Gly Phe Met Leu Val Ser Arg Arg Ser Ser Ala Pro Ser
    210                 215                 220
Leu Leu Tyr Thr Val Ser Cys Gly His Gly Ser Trp Lys Ser Met Ala
225                 230                 235                 240
Lys Tyr Cys Val Glu Asp Val Pro Asn Leu Leu Lys Asp Glu Ser Leu
                245                 250                 255
Asp Asn Val Thr Thr Leu Leu Ser Arg Leu Val Glu Ser Leu Pro Ala
            260                 265                 270
Asn Ala Gly Asp Leu Ile Lys Cys Val Ile Glu Val Arg Arg Lys Glu
        275                 280                 285
Glu Gly Glu Ser Ser Leu Ser Lys Glu Glu Lys Glu Arg Leu Phe Leu
    290                 295                 300
Lys Glu Lys Val Leu Gln Gln Ile Arg Asp Thr Asp Leu Phe Arg Val
305                 310                 315                 320
Val His Glu Leu Gln Tyr Pro Lys Gly Leu Cys Gly Ser Cys Ser Ser
                325                 330                 335
Ser Ser Asp Glu Asp Ser Leu Ala Glu Ile Ala Ala Thr Val Cys Cys
            340                 345                 350
Gln Gly Ala Ala Phe Leu Ser Gly Asn Leu Val Ser Arg Asp Gly Phe
        355                 360                 365
Cys Cys Arg Glu Thr Cys Ile Lys Cys Ile Glu Ala Asn Gly Asp Gly
    370                 375                 380
Leu Lys Thr Val Ile Ser Gly Thr Val Val Ser Lys Gly Asn Glu Gln
385                 390                 395                 400
Ala Val Asp Leu Leu Leu Pro Thr Ser Ser Ser Lys Thr Ser Leu Cys
                405                 410                 415
Asn Ser Asn Leu Lys Ser Lys Ile Val Lys Tyr Pro Ser Ser Thr Asp
            420                 425                 430
Val Leu Thr Val Leu Leu Leu Val Leu Gln Pro Asn Thr Trp Leu Gly
        435                 440                 445
Ile Lys Asp Glu Asn Val Lys Ala Glu Phe Gln Ser Leu Val Ser Thr
    450                 455                 460
Asp Asn Leu Pro Asp Leu Leu Lys Gln Glu Ile Leu His Leu Arg Arg
465                 470                 475                 480
Gln Leu His Tyr Leu Ala Gly Cys Lys Gly Gln Glu Ala Cys Gln Glu
                485                 490                 495
Pro Pro Ser Pro
            500
</PDAT>
</S400>
<S200>
<S210>
<PDAT>7</PDAT>
</S210>
<S211>
<PDAT>1245</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Schizosaccharomyces pombe</PDAT>
</S213>
</S200>
<S400>
<PDAT> 7
atgaacattg ttaaacgagc agtcccagaa ttactgagag gaatgaccaa tgcaacacca     60
aatatcggtt tgattaaaaa caaggtagta agctttgaag ctgtcggaca actcaaaaaa    120
tctttttaca aaagacaatt gcctaaacaa tgtttagctt ttgattcatc tctcggtaaa    180
gatgtttttt tacgagcatt gcaagaggga cggatggaaa attatttttc gcttgcacag    240
cagatggtaa cccaaaacga accagctttt tgtggattgg gaactctctg catgattctt    300
aattcgctta aagttgaccc gggtagatta tggaagggat cttggcgctg gtatgatcag    360
tatatgcttg attgttgtcg atcgctaagc gatattgaaa aagatggtgt tacgctagaa    420
gagttctctt gtttagctaa ctgcaatggc cttcggacta ttacgaaatg tgtcaaagat    480
gttagctttg atgaatttcg gaaagacgta atctcttgtt ctaccattga gaataaaatt    540
atggcaattt cattttgccg gaaagtgctc ggtcaaacag gcgatggaca ttttagtcca    600
gttggaggct tcagtgaaag tgataacaag atattaatat tggacgttgc tcgatttaaa    660
tatccttgct actgggtgga tttgaagctc atgtacgaga gtatgtttcc tatcgataaa    720
gctagcggcc aacctagagg ctatgtactt ttagagccaa tgcatattcc tttaggtgtg    780
cttacagtcg gtttaaacaa gtacagctgg cgaaacgttt ccaagcatat actgcagcag    840
gcggcaacgg taaaaaacgc agacaatttg gctgaaatac ttttatccat taatcaatca    900
tcaattcctc taatccaaga acgctccaac agttcaaagt ctggtgattt cgagcatttt    960
aaagaatgta ttagaagcac aaaaacatat catttatttc tgaaacatac gaataccaat   1020
gttgaatata tcactatggc tttttgggct atattttcct tacccatgat ccaaaaagcg   1080
cttcccaaag gcgttctaga agagattcaa tctttattga aagaagttga aatttccgaa   1140
attaacactc aactaactgc gttgaaaaaa cagcttgata gtttaaccca ttgttgtaaa   1200
actgacactg ggtgttgtag ttcaagctgc tgtaaaaata cgtga                   1245
</PDAT>
</S400>
<S200>
<S210>
<PDAT>8</PDAT>
</S210>
<S211>
<PDAT>414</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Schizosaccharomyces pombe</PDAT>
</S213>
</S200>
<S400>
<PDAT> 8
Met Asn Ile Val Lys Arg Ala Val Pro Glu Leu Leu Arg Gly Met Thr
  1               5                  10                  15
Asn Ala Thr Pro Asn Ile Gly Leu Ile Lys Asn Lys Val Val Ser Phe
             20                  25                  30
Glu Ala Val Gly Gln Leu Lys Lys Ser Phe Tyr Lys Arg Gln Leu Pro
         35                  40                  45
Lys Gln Cys Leu Ala Phe Asp Ser Ser Leu Gly Lys Asp Val Phe Leu
     50                  55                  60
Arg Ala Leu Gln Glu Gly Arg Met Glu Asn Tyr Phe Ser Leu Ala Gln
 65                  70                  75                  80
Gln Met Val Thr Gln Asn Glu Pro Ala Phe Cys Gly Leu Gly Thr Leu
                 85                  90                  95
Cys Met Ile Leu Asn Ser Leu Lys Val Asp Pro Gly Arg Leu Trp Lys
            100                 105                 110
Gly Ser Trp Arg Trp Tyr Asp Gln Tyr Met Leu Asp Cys Cys Arg Ser
        115                 120                 125
Leu Ser Asp Ile Glu Lys Asp Gly Val Thr Leu Glu Glu Phe Ser Cys
    130                 135                 140
Leu Ala Asn Cys Asn Gly Leu Arg Thr Ile Thr Lys Cys Val Lys Asp
145                 150                 155                 160
Val Ser Phe Asp Glu Phe Arg Lys Asp Val Ile Ser Cys Ser Thr Ile
                165                 170                 175
Glu Asn Lys Ile Met Ala Ile Ser Phe Cys Arg Lys Val Leu Gly Gln
            180                 185                 190
Thr Gly Asp Gly His Phe Ser Pro Val Gly Gly Phe Ser Glu Ser Asp
        195                 200                 205
Asn Lys Ile Leu Ile Leu Asp Val Ala Arg Phe Lys Tyr Pro Cys Tyr
    210                 215                 220
Trp Val Asp Leu Lys Leu Met Tyr Glu Ser Met Phe Pro Ile Asp Lys
225                 230                 235                 240
Ala Ser Gly Gln Pro Arg Gly Tyr Val Leu Leu Glu Pro Met His Ile
                245                 250                 255
Pro Leu Gly Val Leu Thr Val Gly Leu Asn Lys Tyr Ser Trp Arg Asn
            260                 265                 270
Val Ser Lys His Ile Leu Gln Gln Ala Ala Thr Val Lys Asn Ala Asp
        275                 280                 285
Asn Leu Ala Glu Ile Leu Leu Ser Ile Asn Gln Ser Ser Ile Pro Leu
    290                 295                 300
Ile Gln Glu Arg Ser Asn Ser Ser Lys Ser Gly Asp Phe Glu His Phe
305                 310                 315                 320
Lys Glu Cys Ile Arg Ser Thr Lys Thr Tyr His Leu Phe Leu Lys His
                325                 330                 335
Thr Asn Thr Asn Val Glu Tyr Ile Thr Met Ala Phe Trp Ala Ile Phe
            340                 345                 350
Ser Leu Pro Met Ile Gln Lys Ala Leu Pro Lys Gly Val Leu Glu Glu
        355                 360                 365
Ile Gln Ser Leu Leu Lys Glu Val Glu Ile Ser Glu Ile Asn Thr Gln
    370                 375                 380
Leu Thr Ala Leu Lys Lys Gln Leu Asp Ser Leu Thr His Cys Cys Lys
385                 390                 395                 400
Thr Asp Thr Gly Cys Cys Ser Ser Ser Cys Cys Lys Asn Thr
                405                 410
</PDAT>
</S400>
<S200>
<S210>
<PDAT>9</PDAT>
</S210>
<S211>
<PDAT>1495</PDAT>
</S211>
<S212>
<PDAT>DNA</PDAT>
</S212>
<S213>
<PDAT>Caenorhabditis elegans</PDAT>
</S213>
</S200>
<S400>
<PDAT> 9
ctactcactc atttcattca tagtctctgc cgaaaattca tttttatatt tttccgcaag     60
atttcctatt cgatcacttc gttctgaata tcctttttcg aatggccacg ctatgagaag    120
agcagcaacc gccgaactag agaacacttc ggcaaatcgg gttcttcgta tttccgaaca    180
aatcatcttg caagcctcat tctgatcggt tgagcattct gtacacgagt ttttttgatc    240
tgcgtcgaaa gttttctgag tgcagcacat tgcgtgggga gcaaaacatt gcccgaactt    300
tcgacagcac aattggaatt cttcttcgtc gtcttctaat ggatcacata ataagaattg    360
attccacgag atcactgacg tggcaaaatc ggaatcattg atgttcacat aggctttcaa    420
tccatacatt atcagaggcc tcgttccttt ttttagttcg agctccacga gcccacgtgg    480
tagttttgtt gtaacatcaa cggagcacaa tgccttctga agagtctcca atttcaccca    540
atgaggtgga tacttgaatc ttgcaacgtc cataatcaga acttgatcag aatcctcgtg    600
ataggcggca agtggtgaaa agtgacctga tcccgtttga ccaagcacac tccgatcgta    660
gctggctacc agaacttgat catcacttcg aactgaattc acgagcgatg tccggaattt    720
tttgagaaaa tctggaaaaa aatatttgta taggacattt taaaagagga gatgtggaat    780
tacctggaga attgtcaccg tagcttactg tagattttag acgattacat tttgcaaggc    840
aggagaattg ttgtagattg attccacttc tagaaataat taattttttt ttgaacattt    900
ttaagatttt acccagatgc aaaaatttgc gattacttca gaaatttcac tgatttttca    960
tagttttttg ctagaaaaca tagaatttca acgaaacagg aaacaaaacg tcgaaaattt   1020
aatgaaattt cctaatcaat gagatttcga gattacagta aactttaaaa gttttgagac   1080
cgggtaccgt atttttggca aaaatcgcaa aatttcgtaa taatgtcatt ttacaaactt   1140
tctaatattt tccaaaggca cacaacaatc cagcatcgac tcgtgataga atctccacgg   1200
cgctttccaa actttttcag gatccacttc caacgcattc agaaccatca ctgaaaactg   1260
ctagactttg gaaaacttca aaatcaaaaa attattattt tattttacct aatgtgctca   1320
aaccacaata tgctggctca tcttgtgtcc gaaattgaga tgccaacttg aaataaatat   1380
tcgctgatcc tcgaaccaat gcctcggtga aaagtttctt gccaagctca ctggaaaact   1440
caatacacgt ctctggaagc ggcctccggt agaaattttt tgcggttacc gacat        1495
</PDAT>
</S400>
<S200>
<S210>
<PDAT>10</PDAT>
</S210>
<S211>
<PDAT>371</PDAT>
</S211>
<S212>
<PDAT>PRT</PDAT>
</S212>
<S213>
<PDAT>Caenorhabditis elegans</PDAT>
</S213>
</S200>
<S400>
<PDAT> 10
Met Ser Val Thr Ala Lys Asn Phe Tyr Arg Arg Pro Leu Pro Glu Thr
  1               5                  10                  15
Cys Ile Glu Phe Ser Ser Glu Leu Gly Lys Lys Leu Phe Thr Glu Ala
             20                  25                  30
Leu Val Arg Gly Ser Ala Asn Ile Tyr Phe Lys Leu Ala Ser Gln Phe
         35                  40                  45
Arg Thr Gln Asp Glu Pro Ala Tyr Cys Gly Leu Ser Thr Leu Val Met
     50                  55                  60
Val Leu Asn Ala Leu Glu Val Asp Pro Glu Lys Val Trp Lys Ala Pro
 65                  70                  75                  80
Trp Arg Phe Tyr His Glu Ser Met Leu Asp Cys Cys Val Pro Leu Glu
                 85                  90                  95
Asn Ile Arg Lys Ser Gly Ile Asn Leu Gln Gln Phe Ser Cys Leu Ala
            100                 105                 110
Lys Cys Asn Arg Leu Lys Ser Thr Val Ser Tyr Gly Asp Asn Ser Pro
        115                 120                 125
Asp Phe Leu Lys Lys Phe Arg Thr Ser Leu Val Asn Ser Val Arg Ser
    130                 135                 140
Asp Asp Gln Val Leu Val Ala Ser Tyr Asp Arg Ser Val Leu Gly Gln
145                 150                 155                 160
Thr Gly Ser Gly His Phe Ser Pro Leu Ala Ala Tyr His Glu Asp Ser
                165                 170                 175
Asp Gln Val Leu Ile Met Asp Val Ala Arg Phe Lys Tyr Pro Pro His
            180                 185                 190
Trp Val Lys Leu Glu Thr Leu Gln Lys Ala Leu Cys Ser Val Asp Val
        195                 200                 205
Thr Thr Lys Leu Pro Arg Gly Leu Val Glu Leu Glu Leu Lys Lys Gly
    210                 215                 220
Thr Arg Pro Leu Ile Met Tyr Gly Leu Lys Ala Tyr Val Asn Ile Asn
225                 230                 235                 240
Asp Ser Asp Phe Ala Thr Ser Val Ile Ser Trp Asn Gln Phe Leu Leu
                245                 250                 255
Cys Asp Pro Leu Glu Asp Asp Glu Glu Glu Phe Gln Leu Cys Cys Arg
            260                 265                 270
Lys Phe Gly Gln Cys Phe Ala Pro His Ala Met Cys Cys Thr Gln Lys
        275                 280                 285
Thr Phe Asp Ala Asp Gln Lys Asn Ser Cys Thr Glu Cys Ser Thr Asp
    290                 295                 300
Gln Asn Glu Ala Cys Lys Met Ile Cys Ser Glu Ile Arg Arg Thr Arg
305                 310                 315                 320
Phe Ala Glu Val Phe Ser Ser Ser Ala Val Ala Ala Leu Leu Ile Ala
                325                 330                 335
Trp Pro Phe Glu Lys Gly Tyr Ser Glu Arg Ser Asp Arg Ile Gly Asn
            340                 345                 350
Leu Ala Glu Lys Tyr Lys Asn Glu Phe Ser Ala Glu Thr Met Asn Glu
        355                 360                 365
Met Ser Glu
    370
</PDAT>
</S400>
</SEQ-LST-NEW>
</SEQLST-US>
</CWU>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>What is claimed is: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00314" LVL="0"><PTEXT><PDAT>1. An isolated nucleic acid encoding a phytochelatin synthase, wherein the synthase shares at least 35% similarity with AtPCS1 (SEQID NO:2).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00315" LVL="0"><PTEXT><PDAT>2. The isolated nucleic acid encoding a phytochelatin synthase of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said nucleic acid is selected from the group consisting of (SEQ ID NO: 1), (SEQ ID NO: 3), (SEQ ID NO: 5), (SEQ ID NO: 7), and (SEQ ID NO: 9).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00316" LVL="0"><PTEXT><PDAT>3. An isolated nucleic acid encoding a plant phytochelatin synthase, wherein the phytochelatin synthase shares at least 35% similarity with AtPCS1 (SEQID NO:2).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00317" LVL="0"><PTEXT><PDAT>4. The isolated nucleic acid of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the nucleic acid further comprises a reporter nucleic acid covalently linked thereto.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00318" LVL="0"><PTEXT><PDAT>5. The isolated nucleic acid of </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT>, said reporter nucleic acid encoding a reporter polypeptide selected from the group consisting of a FLAG octapeptide, a human influenza virus hemagglutinin epitope, a &bgr;-glucuronidase epitope, a green fluorescent protein epitope, and a luciferase epitope.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00319" LVL="0"><PTEXT><PDAT>6. A recombinant cell comprising the isolated nucleic acid of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00320" LVL="0"><PTEXT><PDAT>7. The cell of </PDAT><CLREF ID="CLM-00006"><PDAT>claim 6</PDAT></CLREF><PDAT>, wherein said cell is selected from the group consisting of a prokaryotic cell and a eukaryotic cell.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00321" LVL="0"><PTEXT><PDAT>8. A vector comprising the isolated nucleic acid of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00322" LVL="0"><PTEXT><PDAT>9. A transgenic plant stably transformed with an isolated nucleic acid encoding a phytochelatin synthase, wherein the nucleic acid comprises at least one of the group consisting of AtPCS1 (SEQID NO:1), AtPCS2 (SEQID NO:3), TaPCS1 (SEQID NO:5), SpPCS (SEQID NO:7), and CePCS (SEQID NO:9).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00323" LVL="0"><PTEXT><PDAT>10. A transgenic plant stably transformed with an isolated nucleic acid encoding a phytochelatin synthase, wherein the phytochelatin. synthase shares at least 35% similarity with AtPCS1 (SEQID NO:2).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00324" LVL="0"><PTEXT><PDAT>11. A method of generating a transgenic heavy metal resistant plant comprising introducing to the cells of the plant an isolated nucleic acid of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, encoding phytochelatin synthase, thereby generating a transgenic heavy metal resistant plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00325" LVL="0"><PTEXT><PDAT>12. A method of decreasing the level of a heavy metal in a harvestable portion of a plant, said method comprising expressing the nucleic acid of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> encoding a phytochelatin synthase in a non-harvestable portion of a plant, thereby decreasing the level of heavy metal in the harvestable portion of the plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00326" LVL="0"><PTEXT><PDAT>13. A method of removing a heavy metal from groundwater, said method comprising growing in said groundwater a transgenic plant comprising an isolated nucleic acid encoding a phytochelatin synthase, wherein said phytochelatin synthase comprises a sequence sharing at least 35% similarity with SEQID NO:2, and harvesting said plant from said groundwater, thereby removing said heavy metal from said groundwater.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00327" LVL="0"><PTEXT><PDAT>14. Cells, seeds or progeny of the stably transformed plant of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT>, each of which comprise the inserted isolated nucleic acid encoding phytochelatin synthase.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00328" LVL="0"><PTEXT><PDAT>15. Cells, seeds or progeny of the stably transformed plant of </PDAT><CLREF ID="CLM-00010"><PDAT>claim 10</PDAT></CLREF><PDAT>, each of which comprise the inserted isolated nucleic acid encoding phytochelatin synthase.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00329" LVL="0"><PTEXT><PDAT>16. A transgenic plant, stably transformed with an isolated nucleic acid encoding a phytochelatin synthase according to </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein the phytochelatin synthase shares at least 35% similarity with AtPCS1(SEQID NO:2).</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00330" LVL="0"><PTEXT><PDAT>17. A method of generating a transgenic heavy metal resistant plant comprising introducing to the cells of the plant an isolated nucleic acid of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT>, encoding phytochelatin synthase, thereby generating a transgenic heavy metal resistant plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00331" LVL="0"><PTEXT><PDAT>18. A method of decreasing the level of a heavy metal in a harvestable portion of a plant, said method comprising expressing the nucleic acid of </PDAT><CLREF ID="CLM-00002"><PDAT>claim 2</PDAT></CLREF><PDAT> encoding a phytochelatin synthase in a non-harvestable portion of a plant, thereby decreasing the level of heavy metal in the harvestable portion of the plant.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06489537-20021203-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06489537-20021203-D00002.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06489537-20021203-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06489537-20021203-D00004.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00005" ALT="embedded image" FILE="US06489537-20021203-D00005.TIF"/>
<EMI ID="EMI-D00006" ALT="embedded image" FILE="US06489537-20021203-D00006.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00007" ALT="embedded image" FILE="US06489537-20021203-D00007.TIF"/>
<EMI ID="EMI-D00008" ALT="embedded image" FILE="US06489537-20021203-D00008.TIF"/>
<EMI ID="EMI-D00009" ALT="embedded image" FILE="US06489537-20021203-D00009.TIF"/>
<EMI ID="EMI-D00010" ALT="embedded image" FILE="US06489537-20021203-D00010.TIF"/>
<EMI ID="EMI-D00011" ALT="embedded image" FILE="US06489537-20021203-D00011.TIF"/>
<EMI ID="EMI-D00012" ALT="embedded image" FILE="US06489537-20021203-D00012.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00013" ALT="embedded image" FILE="US06489537-20021203-D00013.TIF"/>
<EMI ID="EMI-D00014" ALT="embedded image" FILE="US06489537-20021203-D00014.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00015" ALT="embedded image" FILE="US06489537-20021203-D00015.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00016" ALT="embedded image" FILE="US06489537-20021203-D00016.TIF"/>
<EMI ID="EMI-D00017" ALT="embedded image" FILE="US06489537-20021203-D00017.TIF"/>
<EMI ID="EMI-D00018" ALT="embedded image" FILE="US06489537-20021203-D00018.TIF"/>
<EMI ID="EMI-D00019" ALT="embedded image" FILE="US06489537-20021203-D00019.TIF"/>
<EMI ID="EMI-D00020" ALT="embedded image" FILE="US06489537-20021203-D00020.TIF"/>
<EMI ID="EMI-D00021" ALT="embedded image" FILE="US06489537-20021203-D00021.TIF"/>
<EMI ID="EMI-D00022" ALT="embedded image" FILE="US06489537-20021203-D00022.TIF"/>
<EMI ID="EMI-D00023" ALT="embedded image" FILE="US06489537-20021203-D00023.TIF"/>
<EMI ID="EMI-D00024" ALT="embedded image" FILE="US06489537-20021203-D00024.TIF"/>
<EMI ID="EMI-D00025" ALT="embedded image" FILE="US06489537-20021203-D00025.TIF"/>
<EMI ID="EMI-D00026" ALT="embedded image" FILE="US06489537-20021203-D00026.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06489541-20021203-D00001.TIF SYSTEM "US06489541-20021203-D00001.TIF" NDATA TIF>
<!ENTITY US06489541-20021203-D00002.TIF SYSTEM "US06489541-20021203-D00002.TIF" NDATA TIF>
<!ENTITY US06489541-20021203-D00003.TIF SYSTEM "US06489541-20021203-D00003.TIF" NDATA TIF>
<!ENTITY US06489541-20021203-D00004.TIF SYSTEM "US06489541-20021203-D00004.TIF" NDATA TIF>
<!ENTITY US06489541-20021203-D00005.TIF SYSTEM "US06489541-20021203-D00005.TIF" NDATA TIF>
<!ENTITY US06489541-20021203-D00006.TIF SYSTEM "US06489541-20021203-D00006.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06489541</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021203</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>08265427</PDAT></DNUM></B210>
<B211US><PDAT>08</PDAT></B211US>
<B220><DATE><PDAT>19940624</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>C12N 1582</PDAT></B511>
<B512><PDAT>C12N 1554</PDAT></B512>
<B512><PDAT>C12N 1529</PDAT></B512>
<B512><PDAT>A01H  500</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>800290</PDAT></B521>
<B522><PDAT>800278</PDAT></B522>
<B522><PDAT>800312</PDAT></B522>
<B522><PDAT>800317</PDAT></B522>
<B522><PDAT>800320</PDAT></B522>
<B522><PDAT>8003201</PDAT></B522>
<B522><PDAT>8003202</PDAT></B522>
<B522><PDAT>8003203</PDAT></B522>
<B522><PDAT>435 691</PDAT></B522>
<B522><PDAT>435193</PDAT></B522>
<B522><PDAT>435468</PDAT></B522>
<B522><PDAT>536 236</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Genetic control of plant hormone levels and plant growth</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4801540</PDAT></DNUM>
<DATE><PDAT>19890100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Hiatt et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>4351723</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B562><NCIT><STEXT><PDAT>Lewin, R. 1987. Science 237:1570.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Reeck et al. 1987. Cell 50:667.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Napoli et al. 1990. Plant Cell 2:279-289.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Dry et al. 1992. Plant Journal 2(2):193-202.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Klein et al. 1993. Plant 190(4):498-510.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Spena et al. 1991. Mol. Gen. Genet. 227(2):205-212.* </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Szerszen et al. (1994) &ldquo;Cloning of the Genes for Metabolism of Indole-3-acetic Acid&rdquo; </PDAT><HIL><ITALIC><PDAT>Plant Physiol. </PDAT></ITALIC></HIL><PDAT>105:16 Suppl. May 1. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Szerszen et al. (1993) &ldquo;A Strategy to Regulate IAA Conjunction in Transgenic Plants&rdquo;, </PDAT><HIL><ITALIC><PDAT>Phytopathology </PDAT></ITALIC></HIL><PDAT>83:1380 No. 12. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Yang et al. (1993) &ldquo;Magnitude and Kinetics of Stem Elongation Induced by Exogenous Indole-3-Acetic Acid in Intact Light-Grown Pea Seedlings&rdquo;, </PDAT><HIL><ITALIC><PDAT>Plant Physiol. </PDAT></ITALIC></HIL><PDAT>102:717-724. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Van Onckelen et al. (1985) &ldquo;Tobacco Plants Transformed with the </PDAT><HIL><ITALIC><PDAT>Agrobacterium </PDAT></ITALIC></HIL><PDAT>T-DNA gene 1 Contain High Amounts of Indole-3-acetamide&rdquo;, </PDAT><HIL><ITALIC><PDAT>FEBS Letters </PDAT></ITALIC></HIL><PDAT>181:373-376. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Klee et al. (1987) &ldquo;The Effects of Overproduction of Two </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumerfaciens </PDAT></ITALIC></HIL><PDAT>T-DNA Auxin Biosynthetic Gene Products in Transgenic Petunia Plants&rdquo;, </PDAT><HIL><ITALIC><PDAT>Genes </PDAT></ITALIC></HIL><PDAT>&amp; </PDAT><HIL><ITALIC><PDAT>Devel. </PDAT></ITALIC></HIL><PDAT>1:86-96. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Follin et al. (1985) </PDAT><HIL><ITALIC><PDAT>Mol. Gen. Genet. </PDAT></ITALIC></HIL><PDAT>201:178-185. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Kowalczyk and Bandurski (1991) </PDAT><HIL><ITALIC><PDAT>Biochem. J. </PDAT></ITALIC></HIL><PDAT>279:509-514. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Leznicki and Bandurski (1988) &ldquo;Enzymatic Synthesis of Indole-3-Acetyl-1-&bgr;-D-Glucose I.&rdquo;, </PDAT><HIL><ITALIC><PDAT>Plant Physiol. </PDAT></ITALIC></HIL><PDAT>88:1474-1480 No. 4. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Leznicki and Bandurski (1988) &ldquo;Enzymatic Synthesis of Indole-3-Acetyl-1-&bgr;-D-Glucose II.&rdquo;, </PDAT><HIL><ITALIC><PDAT>Plant Physiol. </PDAT></ITALIC></HIL><PDAT>88:1481-1485 No. 4. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Michalczuk and Bandkurski (1982) &ldquo;Enzymic Synthesis of 1-O-indol-3-ylacetyl-&bgr;-D-glucose and Indol-3-ylacetyl-myo-inositol&rdquo;, </PDAT><HIL><ITALIC><PDAT>Biochem. J. </PDAT></ITALIC></HIL><PDAT>207: 273-281. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Rayle and Cleland (1992) &ldquo;The Acid Growth Theory of Auxin-Induced Cell Elongation is Alive and Well&rdquo;, </PDAT><HIL><ITALIC><PDAT>Plant. Physiol. </PDAT></ITALIC></HIL><PDAT>99:1271-1274. </PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
<B562><NCIT><STEXT><PDAT>Sitbon, F. (1992) &ldquo;Transgenic Plants Overproducing IAA&mdash;A Model System to Study Regulation of IAA Metabolism&rdquo;, Swedish University of Agricultural Sciences, Umea, Sweden, pp. 6-59.</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>17</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>536 232</PDAT></B582>
<B582><PDAT>536 236</PDAT></B582>
<B582><PDAT>435 691</PDAT></B582>
<B582><PDAT>435 701</PDAT></B582>
<B582><PDAT>4351723</PDAT></B582>
<B582><PDAT>435193</PDAT></B582>
<B582><PDAT>435468</PDAT></B582>
<B582><PDAT>800205</PDAT></B582>
<B582><PDAT>800DIG 40</PDAT></B582>
<B582><PDAT>800 26</PDAT></B582>
<B583US><PDAT>800 55- 58</PDAT></B583US>
<B582><PDAT>800290</PDAT></B582>
<B582><PDAT>800278</PDAT></B582>
<B582><PDAT>800312</PDAT></B582>
<B582><PDAT>800317</PDAT></B582>
<B582><PDAT>800320</PDAT></B582>
<B582><PDAT>8003201</PDAT></B582>
<B582><PDAT>8003202</PDAT></B582>
<B582><PDAT>8003203</PDAT></B582>
</B580>
<B590><B595><PDAT>6</PDAT></B595><B596><PDAT>7</PDAT></B596></B590>
</B500>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Robert S.</PDAT></FNM><SNM><STEXT><PDAT>Bandurski</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>East Lansing</PDAT></CITY>
<STATE><PDAT>MI</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Jedrzej B.</PDAT></FNM><SNM><STEXT><PDAT>Szerszen</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>late of East Lansing</PDAT></CITY>
<STATE><PDAT>MI</PDAT></STATE>
</ADR>
<DTXT><STEXT><PDAT>deceased</PDAT></STEXT></DTXT></PARTY-US>
<LEGAL-REPRESENTATIVE>
<PARTY-US><NAM><SNM><STEXT><PDAT>Jacek Szerszen</PDAT></STEXT></SNM></NAM><DTXT><STEXT><PDAT>legal representative</PDAT></STEXT></DTXT></PARTY-US>
</LEGAL-REPRESENTATIVE>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Krzysztof</PDAT></FNM><SNM><STEXT><PDAT>Szczyglowski</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>East Lansing</PDAT></CITY>
<STATE><PDAT>MI</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Michigan State University Board of Trustees</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>East Lansing</PDAT></CITY><STATE><PDAT>MI</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Greenlee Winner and Sullivan PC</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>David T.</PDAT></FNM><SNM><STEXT><PDAT>Fox</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B748US><PDAT>1638</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>Plant growth and plant growth habit can be controlled without the application of exogenous plant hormones or hormone mimetics using the nucleic acid sequences and methods provided. UDP-Glucose: Indol-3-ylacetyl-glucosyl transferase (IAGlu Transferase) amino acid sequence and nucleic acid coding sequences for this enzyme, specifically exemplified for </PDAT><HIL><ITALIC><PDAT>Zea mays</PDAT></ITALIC></HIL><PDAT>, are provided. Nucleic acid constructs directing the expression of IAGlu Transferase and the expression of antisense RNA specific therefor allows the control of growth habit and plant size in transgenic plants containing such nucleic acid constructs.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<GOVINT>
<BTEXT>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This invention was made, at least in part, with funding from the National Science Foundation (Grant No. IBN 92-07743). Accordingly, the United States Government may have certain rights in this invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>FIELD OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention relates to the control of plant hormone levels and of plant growth at the molecular genetic level. It particularly relates to nucleotide sequences encoding UDP-glucose:indol-3-ylacetyl-glucosyl transferase, and the use of these sequences and/or subsequences thereof to regulate plant growth.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>Plant growth is affected by a variety of physical and chemical factors. Physical factors include available light, day length, moisture and temperature. Chemical factors include minerals, nitrates, hormones and cofactors.</PDAT></PTEXT></PARA>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>One of the most common plant growth hormones is indole-3-acetic acid (IAA). IAA is often referred to as &ldquo;auxin.&rdquo; IAA has been demonstrated to be directly responsible for increase in growth in plants in vivo and in vitro. Those characteristics influenced by IAA include cell elongation, internodal distance (height), leaf surface area and crop yield.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Most plant tissues contain about 10</PDAT><HIL><SP><PDAT>&minus;8 </PDAT></SP></HIL><PDAT>M free IAA. There appears to be two basic pathways for the synthesis of IAA in plants, one via tryptophan and one probably through indole. These same tissues contain about 20 times that amount of IAA in the form of ester or amide conjugates; most commonly the IAA is covalently bound to a sugar moiety. This 20:1 ratio of conjugated to free IAA is generally observed even in tissues which are known to be limited in growth rate by the amount of free IAA.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>The first step in the biosynthesis of conjugates of IAA in </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>is catalyzed by UDP-glucose:indol-3-ylacetyl-glucosyl transferase (EC 2.4.1.121; also called IAA-Glucose Synthetase, IAGlu Synthetase, IAGlu Transferase). This enzyme has been purified, and its characteristics have been described (Kowalczyk and Bandurski (1991) </PDAT><HIL><ITALIC><PDAT>Biochem. J</PDAT></ITALIC></HIL><PDAT>. 279:509-514; Leznicki and Bandurski (1988) </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 88:1481-1485 and 88:1474-1480). The substrates for IAGlu Transferase are UDP-glucose and IAA, and the reaction product is 1-0-&bgr;-D-indol-3ylacetyl-glucose. IAA-glucose can be hydrolyzed by one of two hydrolases, depending on the isomeric form. These hydrolases effectively impart reversibility to the synthetase reaction.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>IAGlu is an acyl alkyl acetal, and its energetically unfavorable synthesis is followed by an energetically favorable transacylation of IAA from IAGlu to myo-inositol to yield indol-3-ylacetyl-myo-inositol (Michalczuk and Bandurski (1982) </PDAT><HIL><ITALIC><PDAT>Biochem. J</PDAT></ITALIC></HIL><PDAT>. 207: 273-281). The enzyme indol-3-ylacetylglucose-myo-inositol indol-3-ylacetyltransferase (IAInos synthetase) catalyzes this reaction (Reaction D, FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>). IAInos is believed to be a transport form of IAA, and IAInos is the substrate for the synthesis of IAInos-glycosides. Thermodynamically, IAInos synthetase is believed to be the enzyme which shifts the equilibrium from free IAA to conjugated forms of IAA. Conjugates appear to serve functions other than growth promotion such as IAA transport (Nowacki and Bandurski (1980) </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 65:422), protection of IAA against peroxidative attack (Cohen and Bandurski (1978) </PDAT><HIL><ITALIC><PDAT>Planta </PDAT></ITALIC></HIL><PDAT>139:203), storage of IAA in seeds (Bandurski et al. (1991) in </PDAT><HIL><ITALIC><PDAT>Plant Growth Substances</PDAT></ITALIC></HIL><PDAT>, C. M. Karssen (ed.), Kluwer Academic Publishing, Amsterdam, pp. 1-12) and hormonal homeostasis (Bandurski et al. (1988) in </PDAT><HIL><ITALIC><PDAT>Plant Growth Substances</PDAT></ITALIC></HIL><PDAT>, Pharis and Rood (eds.), Springer-Verlag, Berlin, pp. 341-352).</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>There have been attempts to improve crop yield by increasing the level of IAA in plants both by application of exogenous IAA and by increasing the synthesis of endogenous IAA. Yang et al. (1993) </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 102:717-724 report that exogenously applied IAA, via cotton wicking in contact with apical stem parts, stimulated stem elongation, particularly in dwarf plants. Application of exogenous IAA is not practical because the effect is limited in time and such application at the agricultural level would be prohibitively labor-intensive and expensive.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>Attempts to increase the endogenous synthesis of IAA have involved the genetic engineering of plants to contain bacterial genes for the biosynthesis of IAA. There have been several reports that expression of the </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens </PDAT></ITALIC></HIL><PDAT>IAA biosynthetic pathway genes did not result in increased plant growth (Follin et al. (1985) </PDAT><HIL><ITALIC><PDAT>Mol. Gen. Genet</PDAT></ITALIC></HIL><PDAT>. 201:178-185; van Onckelen et al. (1985) </PDAT><HIL><ITALIC><PDAT>FEBS Letters </PDAT></ITALIC></HIL><PDAT>181:373-376). Generally transgenic plants expressing higher levels of IAA via bacterial enzymes showed phenotypic abnormalities (Klee et al. (1987) </PDAT><HIL><ITALIC><PDAT>Genes Devel</PDAT></ITALIC></HIL><PDAT>. 1:86-96; Schmulling et al. (1988) </PDAT><HIL><ITALIC><PDAT>EMBO J</PDAT></ITALIC></HIL><PDAT>. 7:2621-2629). Such transgenic plants exhibited higher than normal levels of both IAA conjugates and of free IAA, particularly when the bacterial iaaM and/or iaaH genes were linked to powerful heterologous promoters (Sitbon, F. (1992) </PDAT><HIL><ITALIC><PDAT>Transgenic Plants Overproducing IAA&mdash;A Model System to Study Regulation of IAA Metabolism</PDAT></ITALIC></HIL><PDAT>, Swedish University of Agricultural Sciences, Umea, Sweden).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>It is an object of this invention to provide the nucleotide sequences encoding IAGlu Transferase and non-naturally occurring DNA molecules containing these sequences. An exemplary IAGlu Transferase coding sequence is that of </PDAT><HIL><ITALIC><PDAT>Zea mays</PDAT></ITALIC></HIL><PDAT>; as specifically exemplified herein, this sequence is presented in SEQ ID NO: 1 from nucleotide 57 to nucleotide 1472. Equivalents of the exemplified nucleotide sequence are those nucleotide sequences which encode a polypeptide with the specifically exemplified amino acid sequence given in SEQ ID NO: 2 and those nucleotide sequences which encode a polypeptide with equivalent enzymatic activity and which nucleotide sequences have substantial sequence identity (at least about 70%) to the exemplified sequence, i.e., can hybridize with the exemplified sequences under conditions of moderate or greater stringency as understood in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>It is a further object of this invention to provide for transcriptional expression of sequences complementary to the IAGlu Transferase coding sequences to reduce IAGlu Transferase gene expression in transgenic plants in order to down-regulate synthesis of the IAGlu Transferase in those plants, thus allowing for control of the proportions of free and bound IAA, thereby allowing for control of the growth habit of said plants. Conversely, transgenic plants which overexpress IAGlu Transferase are also taught herein. An iaglu coding sequence linked to either a regulated or a constitutive promoter can be introduced into plant tissue, and a transgenic plant regenerated, whereby control of the growth habit results from the relative overproduction of IAGlu Transferase in said plant. Overproduction of IAGlu synthetase results in loss of apical dominance, and a more prostrate plant than the wild-type parent plant.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE DRAWINGS</PDAT></STEXT></H>
<PARA ID="P-00013" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> illustrates metabolic reactions affecting the concentration of indole-3-acetic acid in </PDAT><HIL><ITALIC><PDAT>Zea mays</PDAT></ITALIC></HIL><PDAT>. Reaction A, carried out by IAGlu Transferase, is the synthesis of 1-0-IAA-Glucose (IAGlu) from IAA and UDP-glucose. Reaction B is the enzymatic hydrolysis of 1-0-IAGlu; the equilibrium is toward free IAA. Reaction C is the enzyme-catalyzed hydrolysis of 4-0-IAGlu and 6-0-IAGlu, which are produced by isomeration of 1-0-IAGlu. Reaction D is the enzyme-catalyzed transacylation of IAA from 1-0-IAGlu to myo-inositol to form the ester (IAInos), thus shifting the equilibrium towards esterified IAA. Reaction E is the oxidation of IAA to oxindole-3-acetic acid (OxIAA). Reactions F and G represent the glycolysation of IAInos, which further shifts the equilibrium towards IAA esters. Reaction H is the benzene ring hydroxylation of OxIAA to form 7-hydroxy-oxindole-3-acetic acid (7-OH-OxIAA). Reaction J is the glucosylation of 7-OH-OxIAA at the 7-hydroxyl; this reaction may target the molecule for inclusion into a vacuole and further catabolism. Under certain conditions young maize seedlings do not synthesize IAA de novo; the synthesis of IAA is not included in this metabolic scheme.</PDAT></PTEXT></PARA>
<PARA ID="P-00014" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is the hydropathy plot of the deduced amino acid sequence (see also SEQ ID NO: 2) of the maize iaglu gene product. Negative values indicate hydrophobic residues and positive values indicate hydrophilic regions of the protein.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is an autoradiograph from a Southern hybridization experiment using &lsqb;</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb;-labeled cDNA encoding IAGlu synthetase from maize as probe. Lanes 1, 2 and 3 contain </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>total DNA digested with EcoRI, HindIII and BamHI, respectively, hybridized under conditions of high stringency to the maize iaglu cDNA probe. Lane 4 contains </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana </PDAT></ITALIC></HIL><PDAT>DNA, digested with EcoRI and hybridized under conditions of moderate stringency to the maize iaglu cDNA probe. The positions of molecular size standards are shown at right.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>FIGS. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>A-</PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>B: </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4A</PDAT></FGREF><PDAT> illustrates the CaMV 35S promoter region of pBI121 and insertion of the iaglu cDNA in the sense orientation with respect to the 35S promoter. The numbers represent restriction fragment sizes (bp) within the iaglu cDNA portion. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 4B</PDAT></FGREF><PDAT> illustrates pBI121 into which the iaglu cDNA has been cloned downstream of the CaMV 35S promoter in the antisense direction with respect to the direction of transcription directed by the promoter. See also Example 7.</PDAT></PTEXT></PARA>
<PARA ID="P-00017" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> illustrates pBI121 into which a 505 bp EcoRV-SacI fragment comprising the 3&prime; region of the iaqlu cDNA coding sequence has been cloned in the antisense direction. See also Example 7.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT> illustrates the restriction map of a portion of pBI121 with the kanamycin resistance gene, CaMV 35S promoter, polylinker and &bgr;-glucuronidase gene.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>U.S. Pat. No. 5,190,931 (M. Inouye, issued Mar. 2, 1993) refers to methods for down-regulating target gene expression via expression of antisense molecules having nucleotide sequences complementary to portions of the target gene. Hybrid formation, between the antisense molecule and the target gene mRNA results in inhibition of translation of the target gene&apos;s mRNA into a functional gene product. U.S. Pat. No. 5,190,931, which is incorporated by reference herein, further teaches that the antisense of RNA specifically blocks the expression of complementary sequences, that the inhibition expression occurs very rapidly, the amount of target mRNA is reduced, and the more antisense RNA is made, the greater the inhibition of target gene product expression.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>U.S. Pat. No. 4,801,540 (Hiatt et al., issued Jan. 31, 1989) refers to the tomato polygalacturonase coding sequence and antisense sequences derived therefrom useful for regulating the levels of polygalacturonase, particularly in the fruits of transgenic plants expressing those antisense sequences.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>In all plants studied, indole-3-acetic acid (IAA) functions as a growth regulator. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> illustrates the reactions involving IAA and its conjugates in plants. Generally, there is a 20:1 ratio of conjugate-bound IAA to free IAA, and it has been suggested that it is the free IAA concentration which is limiting to plant growth. The IAA-conjugates do not appear to have the physiological effects attributed to IAA, i.e., the pool of IAA-conjugates appear to be ineffective at stimulating plant growth (Cohen and Bandurski (1982) </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 33:403). The first reaction in producing IAA conjugates is catalyzed by IAGlu Transferase. Thus, the ability to control, i.e., limit, the expression of IAGlu Transferase allows the control of free IAA levels in a plant by shifting the equilibrium in favor of free IAA, thereby effecting faster plant growth rates and greater crop yields.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>The following definitions of terms used herein are provided for added clarity to the skilled artisan reader.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>IAGlu Transferase means UDP-glucose:indol-3-ylacetyl-glucosyl transferase (EC 2.4.1.121; also called IAA-Glucose Synthetase, IAGlu Synthetase, IAGlu Transferase). It catalyzes the reaction between UDP-glucose and indol-3-ylacetic acid to yield 1-0-&bgr;-D-indol-3-ylacetyl-glucose. Within the scope of the present invention are truncated forms and variants of IAGlu Transferase which retain the enzymatic activity of the naturally occurring enzyme. The gene and cDNA encoding this enzyme are termed iaglu.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>A non-naturally occurring DNA molecule is one which does not occur in nature; i.e., it is produced either by natural processes using methods known to the art, but is directed by man to produce a desired result or it has been artificially produced from parts derived from heterologous sources, which parts may be naturally occurring or chemically synthesized molecules or portions thereof, and wherein those parts have been joined by ligation or other means known to the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00025" LVL="0"><PTEXT><PDAT>A transgenic plant is one which has been genetically modified to contain and express heterologous DNA. As specifically exemplified herein, a transgenic plant is genetically modified to contain and express an iaglu coding sequence operably linked to transcriptional control sequences by which it is not normally regulated or to contain and express an iaglu DNA sequence or portion thereof oriented opposite in direction to the coding sequence with the transcriptional control sequences directing the synthesis of an RNA complementary to all or a portion of the iaglu mRNA. As used herein, a transgenic plant also refers to progeny of the initial transgenic plant which progeny carry and are capable of expressing the heterologous iaglu coding sequence or iaglu antisense construct. Seeds containing transgenic embryo are encompassed within this definition.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><PDAT>An antisense nucleic acid molecule is one which is complementary in sequence, according to the well-known rules for nucleotide base-pairing, and capable of binding or hybridizing to a target nucleic acid molecule, either over a portion or over its whole length. In order to effectively inhibit the expression of a target MRNA sequence (in the present case, the mRNA encoding IAGlu synthetase), the antisense molecule is at least about 10 nucleotides in length, more generally at least about 15 nucleotides, and up to and including, the entire coding sequence and/or the entire cDNA sequence of SEQ ID NO: 1. When the antisense molecule is RNA, then it is termed an antisense RNA. One cellular iaglu target for the antisense nucleic acid, e.g., antisense RNA, can be the iaglu mRNA so that translation of the iaglu mRNA is inhibition. Additionally, inhibition of IAGlu Transferase can be via DNA:DNA:RNA triplex formation, which inhibits transcriptional expression of iaglu mRNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><PDAT>When enhanced production of IAGlu Transferase is desired, the IAGlu Transferase coding sequence is operably linked in the sense orientation to a suitable promoter, in the same orientation as the promoter, so that a sense (i.e., functional for translational expression) mRNA is produced. A transcription termination signal functional in a plant cell can be placed downstream of the coding sequence, and a selectable marker which can be expressed in a plant, can be covalently linked to the IAGlu Transferase expression unit so that after this DNA molecule is introduced into a plant cell or tissue, its presence can be selected and plant cells or tissue not so transformed will be killed or prevented from growing.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><PDAT>Where inhibition of IAGlu Transferase expression is desired in a plant, then either a portion or all of the IAGlu Transferase coding sequence or cDNA sequence can be operably linked to a promoter functional in plant cells, but with the orientation of the IAGlu Transferase coding sequence opposite to that of the promoter (i.e., in the antisense orientation) so that the transcribed RNA made is complementary in sequence to the MRNA encoding IAGlu Transferase. In addition, there may be a transcriptional termination signal downstream of the nucleotides directing synthesis of the antisense RNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><PDAT>The present inventors have isolated a cDNA sequence encoding IAGlu Transferase from </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>(maize). This sequence is given in SEQ ID NO: 1, and the deduced amino acid sequence encoded by the open reading frame of 1413 nucleotides is given in SEQ ID NO: 1. The open reading frame extends from an ATG beginning at nucleotide 57 through the stop codon ending at nucleotide 1472 in SEQ ID NO: 1. The open reading frame was rich in G and C nucleotides (36.7% G and 33.0% C), and therefore, it was found to be useful to incorporate deaza-GTP in the sequencing reactions to reduce band compression. The calculated molecular weight (MW) of the encoded protein is 49.71 kDa and the estimated pI is 5.69. These values are in good agreement with the MW and pI values obtained previously by electrophoresis of purified IAGlu synthetase: 51.0 kDa (Kowalczyk and Bandurski (1991) supra), and 5.5 (Leznicki et al. (1988) </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 88:1474), respectively. Hydropathy analysis was carried out using the MacVector computer program, release 3.5 (International Biotechnologies, Inc., New Haven, Conn.) and a window size of 7; it was based on the Kyte-Doolittle method (Kyte and Doolittle (1982) </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 157:105). This analysis (see </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>) revealed the presence of four major hydrophilic regions (amino acid residues 1 to 279, 293 to 299, 399 to 406, and 435 to 444 of SEQ ID NO: 2) of the encoded protein. Further computer analyses of the deduced amino acid sequence revealed a potential glycosylation site (N-X-S/T) at amino acid 363 (in SEQ ID NO: 2) and three potential protein kinase C phosphorylation sites (S/T-X-R/K) have been identified at amino acid residues 37, 453, and 469 (in SEQ ID NO: 2).</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><PDAT>The catalytic activity of the protein synthesized by </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>cells containing the cDNA insert from clone &num;3, cloned into the EcoRI site of pBluescript KS</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT>, was examined as described in Example 5 herein. Bacteria containing pBluescript KS</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> without an insert and bacteria containing a shorter antibody-positive cDNA (clone &num;2, 1050 bp) were used as negative controls. Both controls were totally inactive in synthesizing labeled IAGlu from labeled IAA and UDP-glucose. Extracts from cells expressing the cDNA from clone &num;3 synthesized </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>-labeled IAGlu yielding (M)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>&equals;343.143 and (M&plus;Na)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>&equals;366.126 when incubated with </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>-labeled IAA and UDP-Glucose, as determined by Fast Atom Bombardment mass spectrometry. These are the masses calculated for </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>C</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>19</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>7</PDAT></SB></HIL><PDAT>N and </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>C</PDAT><HIL><SB><PDAT>10</PDAT></SB></HIL><PDAT>H</PDAT><HIL><SB><PDAT>19</PDAT></SB></HIL><PDAT>O</PDAT><HIL><SB><PDAT>7</PDAT></SB></HIL><PDAT>NNa and this analysis proves the identity of the heavy atom labeled IAGlu. Authentic unlabeled IAGlu yielded (M)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> of 337.118 and (M&plus;Na)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> of 360.113. The activity of the cloned iaglu gene product in </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>suggests that if in plants the potential glycosylation sites are glycosylated, such glycosylation is not required for enzymatic activity, as bacterial hosts are not believed to effect glycosylation of eukaryotic gene products.</PDAT></PTEXT></PARA>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>A preparation of maize IAGlu synthetase, purified as described by Kowalczyk and Bandurski (1991) supra, was further purified by chromatography on a C</PDAT><HIL><SB><PDAT>18 </PDAT></SB></HIL><PDAT>1 mm&times;250 mm HPLC column using 0.1% trifluoroacetic acid (TFA) as solvent and a gradient of 90% (v/v) acetonitrile-water containing 0.85% TFA. Some protein degradation occurred, but the single major peak was collected for N-terminal sequencing. The amino acid sequence obtained from the N-terminus of the protein was MAPXVLVVPFPGQGXMNP (SEQ ID NO: 3), where &ldquo;X&rdquo; is an amino acid not conclusively identified. This corresponds exactly with the N terminal amino acid sequence deduced from the nucleotide sequence of the isolated clone (see SEQ ID NO: 1 and 2). The two amino acids not identified in the N-terminal sequencing experiment were shown to be histidine residues by nucleotide sequence analysis.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>A computer search for alignment of amino acid residues of the iaglu coding sequence with known amino acid sequences showed localized regions with significant sequence identity with other known UDP-Glucose- and UDP-Glucuronic-transferase proteins (Table 1). Alignment of portions of the predicted amino acid sequence of the iaglu gene from </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>with (Table 1A) human HlugP4 gene product (human liver phenol/bilirubin UDP-glucuronosyltranferase) shows a 68% sequence similarity (44% identity) over a stretch of 56 residues; with a </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>bzl gene product (Bz-McC allele) (UDP-glucose:flavenol 3-0-glucosyltransferase) 59% similarity (49% identity) over 131 residues; and Table 1B with the </PDAT><HIL><ITALIC><PDAT>Oryctolagus cuniculus </PDAT></ITALIC></HIL><PDAT>UGT2B13 gene product (rabbit liver p-nitrophenol UDP-glucuronyltransferase) 48% similarity (59% identity) over 52 residues; and with the </PDAT><HIL><ITALIC><PDAT>Rattus norvegicus rlug</PDAT></ITALIC></HIL><PDAT>23 gene product (rat liver androsterone UDP-glucuronyl transferase) 55% similarity (44% identity) over 58 residues.</PDAT></PTEXT></PARA>
<CWU>
<TABLE-US ID="TABLE-US-00001">
<TABLE-CALS>
<table frame="none" colsep="0" rowsep="0" pgwide="1" tabstyle="monospace">
<tgroup align="left" colsep="0" rowsep="0" cols="1">
<colspec colname="1" colwidth="357pt" align="center"/>
<thead>
<row>
<entry namest="1" nameend="1" rowsep="1"><PTEXT><PDAT>TABLE 1</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
<row>
<entry><PTEXT><PDAT>Alignment of Portions of the Maize IAGlu Transferase</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>Amino Acid Sequence with UDP-glycosylating Enzymes</PDAT><HIL><SP><PDAT>a</PDAT></SP></HIL></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="1" align="center" rowsep="1"></entry>
</row>
</thead>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT></PDAT></PTEXT></entry>
</row>
</tbody>
</tgroup>
<tgroup align="left" colsep="0" rowsep="0" cols="3">
<colspec colname="1" colwidth="35pt" align="left"/>
<colspec colname="2" colwidth="14pt" align="left"/>
<colspec colname="3" colwidth="308pt" align="left"/>
<tbody valign="top">
<row>
<entry><PTEXT><PDAT>A</PDAT></PTEXT></entry>
<entry></entry>
<entry></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>HlugP4</PDAT><HIL><SP><PDAT>b</PDAT></SP></HIL></PTEXT></entry>
<entry></entry>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;349 ILV</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;::&verbar;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>IAGlu</PDAT><HIL><SP><PDAT>c</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>268</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>CTKWLDTKPDRSVAYVSFGSLASLGNAQKEELARGLLAAGKPFLWVVRASDEHQVPRYLLAEATATGAAMVV</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>&verbar;&emsp;&emsp;&verbar;&verbar;&emsp;&emsp;:&verbar;&emsp;&verbar;&emsp;&verbar;&verbar;&verbar;&verbar;&verbar;&verbar;&verbar;::&verbar;&emsp;&emsp;&emsp;&emsp;&emsp;:&emsp;&emsp;&verbar;&verbar;&verbar;&emsp;&verbar;&verbar;&emsp;&emsp;:&verbar;&emsp;&verbar;&verbar;&verbar;&verbar;&emsp;:&verbar;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;:&verbar;&emsp;&emsp;&emsp;&verbar;&emsp;&emsp;&verbar;&emsp;&emsp;&verbar;&verbar;:&emsp;:&verbar;&verbar;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>bz1</PDAT><HIL><SP><PDAT>d</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>103</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>CLAWLGRQPARGVAYVSFGTVACPRPDELRELAAGLEDSGAPFLWSLREDSWPHLPPGFLDRAAGTGSGLVV</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>HlugP4</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>352</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>KWLPQNDLLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRME</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>&emsp;&verbar;&emsp;&verbar;&verbar;&emsp;&verbar;:&verbar;&emsp;&verbar;&verbar;&emsp;&emsp;&emsp;&emsp;&verbar;:&verbar;&verbar;&emsp;&verbar;&emsp;:&emsp;&emsp;&emsp;&verbar;::&emsp;&emsp;&verbar;&verbar;&verbar;&verbar;&verbar;&emsp;&verbar;&emsp;&verbar;:&emsp;&verbar;&verbar;&emsp;&emsp;&verbar;&verbar;:&emsp;:&verbar;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>IAGlu</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>340</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>PWCPQLDVLAHPAVGCFVTHCGWNSTLEALSFGVPMVAMALWTDQPTNARNVELAWGAG</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>&verbar;&verbar;&emsp;&verbar;&verbar;:&emsp;&verbar;&verbar;&emsp;&verbar;&verbar;:&verbar;&verbar;&emsp;&verbar;&verbar;&verbar;&verbar;&emsp;&verbar;&verbar;&emsp;&verbar;&emsp;&verbar;&verbar;&emsp;&verbar;&verbar;&emsp;&verbar;&verbar;&verbar;&verbar;&emsp;&emsp;&emsp;&emsp;&emsp;:&emsp;&verbar;&verbar;&emsp;&emsp;&verbar;&verbar;&verbar;:&verbar;&emsp;&emsp;&emsp;&verbar;&verbar;&emsp;&verbar;</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>bz1</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>175</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>PWAPQVAVLRHPSVGAFVTHAGWASVLEGLSSGVPMACRPFFGDQRMNARSVAHVWGFG</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>B</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT> </PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>UGT2B13</PDAT><HIL><SP><PDAT>e</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>329</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;WIPQNDLLGHPKTRAFITHGGTNGLYEAIYHGVPMVGIPLFGDQPDNIARVK</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&verbar;&emsp;&verbar;&verbar;&emsp;&verbar;:&verbar;&emsp;&verbar;&verbar;&emsp;&emsp;&emsp;&emsp;&verbar;:&verbar;&verbar;&emsp;&verbar;&emsp;&verbar;&emsp;&emsp;&emsp;&verbar;&verbar;:&emsp;&emsp;&verbar;&verbar;&verbar;&verbar;&verbar;&emsp;:&emsp;&verbar;:&emsp;&verbar;&verbar;&verbar;&emsp;&verbar;:::&verbar;:</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>IAGlu</PDAT><HIL><SP><PDAT>f</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>330</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>ATATGAAMVVPWCPQLDVLAHPAVGCFVTHCGWNSTLEALSFGVPMVAMALWTDQPTNARNVE</PDAT></PTEXT></entry>
</row>
<row>
<entry></entry>
<entry></entry>
<entry><PTEXT><PDAT>&verbar;&verbar;&emsp;&emsp;&emsp;&emsp;&emsp;&emsp;&verbar;&emsp;&emsp;&verbar;&emsp;&verbar;&verbar;&emsp;&verbar;:&verbar;&emsp;&verbar;&verbar;&emsp;&emsp;&emsp;&emsp;&verbar;&verbar;&verbar;&verbar;&emsp;&verbar;&emsp;&verbar;&emsp;&emsp;&emsp;&verbar;&verbar;:&emsp;&emsp;&verbar;:&verbar;&verbar;:&emsp;:&emsp;&verbar;:&emsp;&verbar;&verbar;&verbar;&emsp;&verbar;</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>jjj</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>I</PDAT></PTEXT></entry>
</row>
<row>
<entry><PTEXT><PDAT>rlug23</PDAT><HIL><SP><PDAT>g</PDAT></SP></HIL></PTEXT></entry>
<entry><PTEXT><PDAT>316</PDAT></PTEXT></entry>
<entry><PTEXT><PDAT>ATLGPITRVYKWLPQNDILGHPKTKAFVTHGGANGLYEAIYHGIPMIGIPLFGDQPDN</PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="center" rowsep="1"></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00001"><PTEXT><HIL><SP><PDAT>a</PDAT></SP></HIL><PDAT>Bars indicate identical amino acids; dots indicate amino acids with similar properties. </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00002"><PTEXT><HIL><SP><PDAT>b</PDAT></SP></HIL><PDAT>Human (HlugP4) (human liver phenol&emsp;bilirubin UDP-glucuronosyltranferase) amino acid sequence for residues 349-404 (SEQ ID NO: 4) (Wooster et al. (1991) Biochem. J. 278:465). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00003"><PTEXT><HIL><SP><PDAT>c</PDAT></SP></HIL><PDAT>Maize IAGlu Transferase amino acid sequence for residues 268-398 (SEQ ID NO: 5). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00004"><PTEXT><HIL><SP><PDAT>d</PDAT></SP></HIL><PDAT>Maize BZL (McC allele) (UDP-glucose:flavenol 3-O-glucosyltransferase) amino acid sequence for residues 103-233 (SEQ ID NO: 6) (Furtek et al. (1988) Plant Molec.Biol. 11:473). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00005"><PTEXT><HIL><SP><PDAT>e</PDAT></SP></HIL><HIL><ULINE><PDAT>Oryctolaqus&emsp;cuniculus</PDAT></ULINE></HIL><PDAT>(UGT2B13) (rabbit liver p-nitropheno1 UDP-glucuronyltransferase) amino acid sequence for residues 329-380 (SEQ ID NO:</PDAT></PTEXT></FOO></PTEXT></entry>
<entry><PTEXT><PDAT>7) (Tukey et al. (1993) J.Biochem 268:15260). </PDAT></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00006"><PTEXT><HIL><SP><PDAT>f</PDAT></SP></HIL><PDAT>Maize IAGlu Transferase (IAGlu) amino acid sequence for residues 330-392 (SEQ ID NO: 8). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
<row>
<entry namest="1" nameend="3" align="left"><PTEXT><FOO ID="FOO-00007"><PTEXT><HIL><SP><PDAT>g</PDAT></SP></HIL><HIL><ULINE><PDAT>Rattus&emsp;norveqicus&emsp;rlug</PDAT></ULINE></HIL><PDAT>23 gene product amino acid sequence (rat liver androsterone UDP-glucuronyl transferase) for residues 316-373 (SEQ ID NO: 9) (Jackson and Burchell (1986) Nucl. Acids Res. 14:779). </PDAT></PTEXT></FOO></PTEXT></entry>
</row>
</tbody>
</tgroup>
</table>
</TABLE-CALS>
</TABLE-US>
</CWU>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>Organization of the iaglu gene in the </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>genome was studied using radiolabeled iaglu cDNA sequence (SEQ ID NO: 1; 1731 bp) as a probe in Southern hybridizations (FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>). Under high stringency conditions, a single EcoRI or HindIII fragment and two BamHI fragments hybridized indicating that IAGlu Transferase is probably encoded by a single or low copy number gene in the maize genome. There does not, however, appear to be a BamHI site in the iaglu cDNA.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>In addition, genomic DNA (as EcoRI digests) from a variety of plant species including </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana; Nicotiana tabacum</PDAT></ITALIC></HIL><PDAT>, tobacco; </PDAT><HIL><ITALIC><PDAT>Beta vulgaris</PDAT></ITALIC></HIL><PDAT>, sugar beet; </PDAT><HIL><ITALIC><PDAT>Lycopersicon esculentum</PDAT></ITALIC></HIL><PDAT>, tomato; </PDAT><HIL><ITALIC><PDAT>Glycine max</PDAT></ITALIC></HIL><PDAT>, soybean; </PDAT><HIL><ITALIC><PDAT>Brassica oleracea </PDAT></ITALIC></HIL><PDAT>var. botrytis, cauliflower; </PDAT><HIL><ITALIC><PDAT>Sorghum bicolor</PDAT></ITALIC></HIL><PDAT>, sorghum; </PDAT><HIL><ITALIC><PDAT>Triticum vulgare</PDAT></ITALIC></HIL><PDAT>, wheat; the legume </PDAT><HIL><ITALIC><PDAT>Lotus japonicus</PDAT></ITALIC></HIL><PDAT>; and </PDAT><HIL><ITALIC><PDAT>Lemna gibba</PDAT></ITALIC></HIL><PDAT>, duckweed were analyzed for significant nucleotide sequence homology to maize iaglu cDNA sequences. Genomic DNA from the bryophyte Marchantia, the fern </PDAT><HIL><ITALIC><PDAT>Osmunda claytoniana</PDAT></ITALIC></HIL><PDAT>; the moss </PDAT><HIL><ITALIC><PDAT>Selaginella kraussiana</PDAT></ITALIC></HIL><PDAT>, the pteridophyte Psilotum (liverwort) and Equisetum (horsetail) were also analyzed. In all cases, under hybridization conditions of moderate stringency, multiple hybridizing bands (major and several minor) were observed. Without wishing to be bound by any particular theory, the inventors postulate that this reflects hybridization of the </PDAT><HIL><ITALIC><PDAT>Z. mays </PDAT></ITALIC></HIL><PDAT>iaglu cDNA probe to the equivalent iaglu genes of these plants species, as well as to other genes encoding UDP-glucose or UDP-glucuronic acid binding proteins. An example of Southern hybridization analysis for </PDAT><HIL><ITALIC><PDAT>Z. mays </PDAT></ITALIC></HIL><PDAT>and </PDAT><HIL><ITALIC><PDAT>A. thaliana </PDAT></ITALIC></HIL><PDAT>is shown in FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>. Three hybridizing bands were observed using moderately stringent conditions. However, under high stringency conditions only a single 3 kb hybridizing band was detected. The same single band was detected under moderately stringent conditions when the 5&prime;-region of the iaglu cDNA (nucleotides 1 through 598 of SEQ ID NO: 1, lacking the putative UDPG-binding site) was used as a probe, suggesting that this 3 kb band contains the </PDAT><HIL><ITALIC><PDAT>A. thaliana </PDAT></ITALIC></HIL><PDAT>iaglu gene.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>These experiments indicated that there is a detectable amino acid sequence identity of a specific segment of the iaglu gene with conserved domains of certain other known enzymes which use UDP-Glucose and/or UDP-Glucuronic acid as substrates. Because these enzymes catalyze the transfer of either glucose or glucuronic acid to their specific acceptors, the conserved amino acids probably represent those necessary to bind UDP. This suggests that the UDP-Glucose binding site is located within the region of amino acids 268 through 393 of the maize IAGlu Transferase (see SEQ ID NO: 2). This region corresponds to the most hydrophobic portion of the predicted amino acid sequence of the iaglu gene product as shown in FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>The hybridization results demonstrate that plant species other than </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>have IAGlu Transferase genes with significant degrees of nucleotide sequence homology; i.e., DNA:DNA hybridization under conditions of moderate to high stringency with the </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>iaglu probe allows the identification of the corresponding gene from other plant species. A discussion of hybridization conditions can be found for example, in Hames and Higgins (1985) </PDAT><HIL><ITALIC><PDAT>Nucleic Acid Hybridization</PDAT></ITALIC></HIL><PDAT>, IRL Press, Oxford, U.K. Generally sequences which have at least about 70% nucleotide sequence homology can be identified by hybridization under conditions of moderate stringency. Under such conditions, it is generally preferred that a probe of at least 100 bases be used. Most preferably, in the present case, the probe will be derived from the portion of the iaglu cDNA sequence 5&prime; of the region encoding the putative UDP-binding region. The UDP binding region of the maize IAGlu Transferase is encoded beginning at about nucleotide 858 in SEQ ID NO: 1. Preferably, a probe corresponding to the portion of the maize iaglu coding sequence 5&prime; to the UDP-binding region, which begins at about nucleotide 858 in SEQ ID NO: 1, is used so that DNA encoding other UDP-binding enzymes is not hybridized.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>Labels for hybridization probes can include, but are not limited to, radioactive groups, fluorescent groups, ligands such as biotin to which specific binding partners (which are in turn labeled) bind. It is the label which allows detection of the hybridization probe to the target nucleic acid molecule.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>It is understood that nucleic acid sequences other than that of SEQ ID NO: 1, from nucleotide 57 through nucleotide 1469, will function as coding sequences synonymous with the exemplified coding sequence. Nucleic acid sequences are synonymous if the amino acid sequences encoded by those nucleic acid sequences are the same. The degeneracy of the genetic code is well known to the art; i.e., for many amino acids, there is more than one nucleotide triplet which serves as the codon for the amino acid. It is also well known in the biological arts that certain amino acid substitutions can be made in protein sequences without affecting the function of the protein. Generally, conservative amino acid substitutions or substitutions of similar amino acids are tolerated without affecting protein function. Similar amino acids can be those that are similar in size and/or charge properties, for example, aspartate and glutamate and isoleucine and valine are both pairs of similar amino acids. Similarity between amino acid pairs has been assessed in the art in a number of ways. For example, Dayhoff et al. (1978) in </PDAT><HIL><ITALIC><PDAT>Atlas of Protein Sequence and Structure</PDAT></ITALIC></HIL><PDAT>, Volume 5, Supplement 3, Chapter 22, pp. 345-352, which is incorporated by reference herein, provides frequency tables for amino acid substitutions which can be employed as a measure of amino acid similarity. Dayhoff et al.&apos;S frequency tables are based on comparisons of amino acid sequences for proteins having the same function from a variety of evolutionarily different sources.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>IAGlu Transferase genes can be found in all plants, including but not limited to those which have been demonstrated to contain sequences of significant homology, as disclosed herein. Such iaglu sequences can be identified by nucleic acid hybridization experiments or when cloned in expression vectors, by cross reaction to maize IAGlu Transferase-specific antibody, or any other means known to the art, including the use of PCR technology carried out using oligonucleotides corresponding to portions of SEQ ID NO: 1, preferably 5&prime; of the region encoding the UDP-binding region of IAGlu Transferase. Such antibody can be prepared after immunizing an experimental animal with purified IAGlu Transferase or using a carrier protein-peptide conjugate, where the amino acid sequence of the peptide is taken from a hydrophilic portion of the maize IAGlu Transferase amino acid sequence (see </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT>, SEQ ID NO: 2).</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>Alternately, a cDNA library (in an expression vector) can be screened with IAGlu Transferase-specific antibody as described herein, or IAGlu Transferase peptide-specific antibody can be prepared using peptide sequence(s) from hydrophilic regions of the IAGlu Transferase protein (see FIG. </PDAT><HIL><BOLD><PDAT>2</PDAT></BOLD></HIL><PDAT> and SEQ ID NO: 2) and technology well known in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>An IAGlu Synthetase coding sequence (cDNA or genomic) can be operably linked to any transcriptional control sequence functional in plants as understood by the skilled artisan. Constitutive promoters include those from </PDAT><HIL><ITALIC><PDAT>A. tumefaciens </PDAT></ITALIC></HIL><PDAT>T-DNA genes such as nos, ocs and mas and plant virus genes such as the Cauliflower Mosaic Virus 35S and 19S genes. Any art-known regulatory sequences, promoter and/or promoter-associated sequences which direct gene expression in the desired infected or uninfected host or infected or uninfected host cell may be used to control transcription and translation of a nucleotide sequence encoding IAGlu Transferase. It will be understood that the goals of a skilled artisan will determine the choice of particular regulatory sequences or promoters.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>A transgenic plant can be produced by any means known to the art, including but not limited to </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens</PDAT></ITALIC></HIL><PDAT>-mediated DNA transfer, preferably with a disarmed T-DNA vector, electroporation, direct DNA transfer, and particle bombardment (see Davey et al. (1989) </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 13:275; Walden and Schell (1990) </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem</PDAT></ITALIC></HIL><PDAT>. 192:563; Joersbo and Burnstedt (1991) </PDAT><HIL><ITALIC><PDAT>Physiol. Plant</PDAT></ITALIC></HIL><PDAT>. 81:256; Potrykus (1991) </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Plant Physiol. Plant Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 42:205; Gasser and Fraly (1989) </PDAT><HIL><ITALIC><PDAT>Sci</PDAT></ITALIC></HIL><PDAT>. 244:1293; Leemans (1993) </PDAT><HIL><ITALIC><PDAT>Bio/Technol</PDAT></ITALIC></HIL><PDAT>. 11:522; Beck et al. (1993) </PDAT><HIL><ITALIC><PDAT>Bio/Technol</PDAT></ITALIC></HIL><PDAT>. 11:1524; Koziel et al. (1993) </PDAT><HIL><ITALIC><PDAT>Bio/Technol</PDAT></ITALIC></HIL><PDAT>. 11:194; Vasil et al. (1993) </PDAT><HIL><ITALIC><PDAT>Bio/Technol</PDAT></ITALIC></HIL><PDAT>. 11:1533). Techniques are well known to the art for the introduction of DNA into monocots as well as dicots, as are the techniques for culturing such plant tissues and regenerating those tissues. Monocots which have been successfully transformed and regenerated include wheat, corn, rye, rice and asparagus. For efficient regeneration of transgenic plants, it is desired that the plant tissue used in the transformation possess a high capacity to produce shoots. For example, tobacco leaf discs and aspen stem sections have good regeneration capacity (Sitbon, F. (1992) supra).</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>Techniques for introducing and selecting for the presence of heterologous DNA in plant tissue are well known. For example, </PDAT><HIL><ITALIC><PDAT>A. tumefaciens</PDAT></ITALIC></HIL><PDAT>-mediated DNA transfer into plant tissue, followed by selection and growth in vitro and subsequent regeneration of the transformed plant tissue to a plant is well known for a variety of plants.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>Other techniques for genetically engineering plant tissue to contain an expression cassette comprising a suitable promoter fused to the iaglu coding sequence and containing a transcription termination region are to be integrated into the plant cell genome by electroporation, cocultivation, microinjection, particle bombardment and other techniques known to the art. The expression cassette further contains a marker allowing selection of the expression cassette in the plant cell, e.g., genes carrying resistance to an antibiotic such as kanamycin, hygromycin, gentamicin, or bleomicin. The marker allows for selection of successfully transformed plant cells growing in the medium containing certain antibiotic because they will carry the expression cassette with resistance gene to the antibiotic.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>The IAGlu transferase coding sequence disclosed herein was operably linked to the strong constitutive 35S promoter of cauliflower mosaic virus (CaMV) to produce a 35S-iaglu chimeric construct, inserted into an Agrobacterium binary vector and transferred into tobacco tissue. Transgenic tobacco plants carrying the chimeric iaglu construct were regenerated, and their growth was characterized. The young seedlings of these plants appeared to have lost the characteristic apical dominance of wild-type tobacco plants, the stem internodes were shortened to almost zero length, and there were many leafy side shoots.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>Overexpression of the iaglu coding sequence in a transgenic plant effects the control of apical dominance and/or growth habit in that plant by decreasing the pool of free IAA and increasing the pool of IAA-conjugates. Apical dominance is inhibited when IAGlu Synthetase is over-expressed. Such transgenic plants display lower growth rate, multiple branching, and shoot growth which is oriented more horizontally than vertically.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>This approach can be used, for example, to produce multibranched and short-trunked fruit trees for use in modern orchards, where such trees allow for easy pesticide application, harvesting, and pruning. This approach for the control of multiple branching and apical dominance can also be used for ornamental plants, for example to produce novel ground covers, and hedge- or fence-forming plants. In case of the soybean (and other plants forming fruit in the crotch of a branch) multibranching leads to increased number of pods (fruits).</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>By contrast, the iaglu sequence or portions thereof, preferably those portions which are unique to iaglu can be used to generate antisense RNAs which inhibit the synthesis of IAGlu Transferase in a transgenic plant. Inhibition of IAGlu Transferase gene expression has the effect of increasing the pool of free IAA and decreasing the proportion of the total IAA pool present in bound form. Increasing the free IAA levels in a plant has the effect of increasing cell size, stem elongation and fruit development. Manipulating the expression of antisense RNA effective for the inhibition of IAGlu Transferase expression allows the skilled artisan to increase the rate of growth of entire transgenic plants or particular plant parts, if in the latter case, tissue-specific promoters are fused to the said gene (or portion thereof) oriented in the antisense configuration. This approach enables the production of large leaves in leafy crops like tobacco, lettuce, spinach, when a promoter specific for expression in leaves is used. Large pome and stone fruits can be likewise produced, because cell size in determined by IAA, with the choice of the appropriate promoter.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>In lumber trees, growth of cambium can lead to increased wood production in trees when antisense iaglu sequences are expressed via strong promoters, for example, the CaMV 35S promoter.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>Faster growth of the iaglu antisense-expressing transgenic plant, for example when a constitutive promoter such as the CaMV 35S or 19S promoter drives the expression of iaglu antisense sequences, can result in plant protection against certain plant pathogens, i.e., by the phenomenon known as &ldquo;disease escape.&rdquo; For example, fast growth of sorghum seedlings of 0-12 days of age significantly decreases the chance of infection of the seedlings&apos; roots by germinating oospores of </PDAT><HIL><ITALIC><PDAT>Peronosclerospora sorghi</PDAT></ITALIC></HIL><PDAT>, the casual agent of sorghum downy mildew, a devastating disease of sorghum.</PDAT></PTEXT></PARA>
<PARA ID="P-00051" LVL="0"><PTEXT><PDAT>Constitutive promoters which function to initiate gene expression in a wide range of plants include Ti-plasmid promoters (the octopine synthetase promoter, the nopaline synthetase promoter, the mannopine synthetase promoter), the CaMV 35S and 19S promoters (from cauliflower mosaic virus), the ORF7 promoter from open reading frame of the T-DNA, among others. These promoters and their sequences are well known to the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00052" LVL="0"><PTEXT><PDAT>Regulated promoters functional in plants include tissue-specific promoters including, but not limited to, those of the phaseolin gene (specific for developing seed), ribulose-1, 3-biphosphate carboxylase small subunit C gene, which is most abundantly expressed in leaf and stem tissues, and cab gene, which is also most abundantly expressed in leaf tissue. Kuhlemeier et al. (1987) </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 38: 221, and references cited therein, discusses various plant gene promoters and other promoters functional in plant cells.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>Elevation of free endogenous IAA levels by genetic engineering means has the advantage that the requirement for exogenous application of IAA or other auxin-simulating chemicals, such as 2,4-D(2,4-dichlorophenoxyacetic acid), is obviated. Genetic control of IAA levels, i.e., a plant via iaglu antisense expression, provides a means for killing field cover plants after they fulfilled their role of protecting the main fall-sown crops against such unfavorable environmental conditions as cold winds during lack of snow cover. A cover plant (preferably a legume plant) can contain an antisense construct with a promoter activated by the environmental conditions typical of the time when the cover plant is no longer needed, e.g., by warm temperature, lengthening photoperiod, or simply by application of a chemical which will activate cover crop promoter and will not be harmful to the main crop. The cover plants can be killed or inhibited in growth by expression of multiple copies of the iaglu antisense gene and the resultant overproduction of IAA at very high levels, which is known to be toxic to plants.</PDAT></PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>Inducible promoters of phytochrome (phy) genes include the following: light-triggered: e.g., the oat phyA3 promoter can be switched off/on by red/far red light (Bruce et al. (1989) </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>86:9692; Bruce and Quail (1990) </PDAT><HIL><ITALIC><PDAT>The Plant Cell </PDAT></ITALIC></HIL><PDAT>2:1081-1089). Promoters activated by warm temperature can be promoters of certain heat shock protein genes (Vierling, E. (1991) </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Plant Physiology Plant Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 42:579-620).</PDAT></PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>Promoters activated by low temperature include that of cold-regulated genes (cor) from </PDAT><HIL><ITALIC><PDAT>Arabidopsis thaliana</PDAT></ITALIC></HIL><PDAT>, e.g., cor15a or cor15b genes (Wilhelm and Thomashow (1993) </PDAT><HIL><ITALIC><PDAT>Plant Molecular Biology </PDAT></ITALIC></HIL><PDAT>23:1073-1077). cor15b, an apparent homologue of cor15a, is strongly responsive to cold and ABA, but not drought. Other cold-regulated gene promoters from </PDAT><HIL><ITALIC><PDAT>A. thaliana </PDAT></ITALIC></HIL><PDAT>include kin1, kin2, lti78, cor47, cor78 and rab18. (See, e.g., Horvath et al. (1993) </PDAT><HIL><ITALIC><PDAT>Plant Physiol</PDAT></ITALIC></HIL><PDAT>. 103:1047-1053).</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><PDAT>The antisense expression of iaglu sequence also allows a means to induce flowering at a controlled time in plants specifically requiring a long or a short photoperiod. Flowering response in these plants is under hormonal control, i.e., the production of ethylene, which promotes flowering (and fruit ripening), depends on the production of IAA. Increased levels of IAA by the antisense method described herein with the use of inducible promoters from homeotic genes from flowering plants can lead to higher levels of ethylene, and thus, to the induction of flowering and/or fruit ripening.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>The following examples, provided for illustrative purposes, are not intended to limit the scope of the invention. The examples use many techniques well known and accessible to those skilled in the arts of molecular biology, in the manipulation of recombinant DNA in plant tissue and in the culture and regeneration of transgenic plants. Enzymes are obtained from commercial sources and are used according to the vendors&apos; recommendations or other variations known to the art. Reagents, buffers and culture conditions are also known to the art. References providing standard molecular biological procedures include Sambrook et al. (1989) </PDAT><HIL><ITALIC><PDAT>Molecular Cloning</PDAT></ITALIC></HIL><PDAT>, second edition, Cold Spring Harbor Laboratory, Plainview, N.Y.; R. Wu (ed.) (1993) </PDAT><HIL><ITALIC><PDAT>Methods in Enzymology </PDAT></ITALIC></HIL><PDAT>218; Wu et al. (eds.) Methods in Enzymology 100, 101; Glover (ed.) (1985) </PDAT><HIL><ITALIC><PDAT>DNA Cloning</PDAT></ITALIC></HIL><PDAT>, Vols. I and II, IRL Press, Oxford, UK; and Hames and Higgins (eds.) (1985) </PDAT><HIL><ITALIC><PDAT>Nucleic Acid Hybridization</PDAT></ITALIC></HIL><PDAT>, IRL Press, Oxford, UK. References related to the manipulation and transformation of plant tissue include Kung and Arntzen (eds.) (1989) </PDAT><HIL><ITALIC><PDAT>Plant Biotechnology</PDAT></ITALIC></HIL><PDAT>, Butterworths, Stoneham, Mass.; R. A. Dixon (ed.) (1985) </PDAT><HIL><ITALIC><PDAT>Plant Cell Culture: A Practical Approach</PDAT></ITALIC></HIL><PDAT>, IRL Press, Oxford, UK; Schuler and Zielinski (1989) </PDAT><HIL><ITALIC><PDAT>Methods in Plant Molecular Biology</PDAT></ITALIC></HIL><PDAT>, Academic Press, San Diego, Calif.; Weissbach and Weissbach (eds.) (1988) </PDAT><HIL><ITALIC><PDAT>Methods for Plant Molecular Biology</PDAT></ITALIC></HIL><PDAT>, Academic Press, San Diego, Calif.; and various volumes of </PDAT><HIL><ITALIC><PDAT>Plant Molecular Biology Manual</PDAT></ITALIC></HIL><PDAT>, Kluwer Academic Publisher, Dordrecht. I. Potrykus (1991) </PDAT><HIL><ITALIC><PDAT>Ann. Rev. Plant Physiol. Plant Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 42:205; Weising et al. (1988) </PDAT><HIL><ITALIC><PDAT>Annu. Rev. Genet</PDAT></ITALIC></HIL><PDAT>. 22:421; van Wordragen et al. (1992) </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol. Rep</PDAT></ITALIC></HIL><PDAT>. 19:12; Davey et al. (1989) </PDAT><HIL><ITALIC><PDAT>Plant Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 13:273; Walden and Schell (1990) </PDAT><HIL><ITALIC><PDAT>Eur. J. Biochem</PDAT></ITALIC></HIL><PDAT>. 192:563; Joersbo and Brunstedt (1991) </PDAT><HIL><ITALIC><PDAT>Physiol. Plant</PDAT></ITALIC></HIL><PDAT>. 81:256 and references cited in those references. Abbreviations and nomenclature, where employed, are deemed standard in the field and are commonly used in professional journal such as those cited herein. All references cited in the present application are expressly incorporated by reference herein.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>EXAMPLES</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Example 1</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>IAGlu Transferase&mdash;Specific Antibodies</PDAT></STEXT></H>
<PARA ID="P-00058" LVL="0"><PTEXT><PDAT>Rabbit polyclonal antibodies specific for maize IAGlu synthetase were prepared by two subcutaneous injections of the protein purified as described by Kowalczyk and Bandurski (1991) supra.</PDAT></PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>The anti-IAGlu synthetase polyclonal antibodies showed cross reaction with </PDAT><HIL><ITALIC><PDAT>Escherichia coli </PDAT></ITALIC></HIL><PDAT>proteins during initial screening of the cDNA library, perhaps due to the use of Freund&apos;s adjuvant during immunization. The IAGlu antibodies were purified by affinity chromatography on cyanogen-bromide-activated Sepharose 4B with coupled </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>XL-1 Blue proteins as described &lsqb;Harlow and Lane (1988) Antibodies: </PDAT><HIL><ITALIC><PDAT>A Laboratory Manual </PDAT></ITALIC></HIL><PDAT>(Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.)&rsqb;. </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>XL-1 Blue has the genotype supE hsdRlac</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> F&apos; proAB lacI</PDAT><HIL><SP><PDAT>q </PDAT></SP></HIL><PDAT>lacZ&Dgr;M15 and is described in Bullock et al. (1987) </PDAT><HIL><ITALIC><PDAT>BioTechniques </PDAT></ITALIC></HIL><PDAT>5:376. It is preferable in the antibody purification step to use the same strain as is used as the host strain for the expression library.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 2</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Cloning and Identification of cDNA Encoding IAGlu Transferase</PDAT></STEXT></H>
<PARA ID="P-00060" LVL="0"><PTEXT><PDAT>A cDNA expression library, obtained from B. A. Larkins and J. E. Habben, University of Arizona, Tucson, Ariz., was prepared from poly (A)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> RNA extracted from W64A</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> corn endosperm tissue collected 18 days after pollination. The library was constructed in a Lambda ZAP II vector (Stratagene, La Jolla, Calif.) (Short et al. (1988) </PDAT><HIL><ITALIC><PDAT>Nucleic Acids Res</PDAT></ITALIC></HIL><PDAT>. 16:758) using standard techniques. After amplification, the library contained 4.2&times;10</PDAT><HIL><SP><PDAT>8 </PDAT></SP></HIL><PDAT>plaque forming units (pfu).</PDAT></PTEXT></PARA>
<PARA ID="P-00061" LVL="0"><PTEXT><PDAT>This expression library was then screened using the purified, IAGlu synthetase-specific antibody preparation described above. Eight positive clones (named &num;1 through &num;8) were identified from 1.5&times;10</PDAT><HIL><SP><PDAT>6 </PDAT></SP></HIL><PDAT>plaques propagated on </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>XL1-Blue. The &bgr;-galactosidase fusion proteins were induced by growth on medium containing isopropyl-B-D-thio-galactopyranoside. The clones positive for IAGlu Transferase-specific antibody binding were identified using reaction with alkaline phosphatase-conjugated second antibody (specific for rabbit IgG) and chromogenic insoluble alkaline phosphatase reaction product (Sambrook et al. (1989) supra).</PDAT></PTEXT></PARA>
<PARA ID="P-00062" LVL="0"><PTEXT><PDAT>The cDNA inserts from clones &num;1-8 were excised with R 408 helper phage and recircularized to generate subclones in the pBluescript SK phagemid vector (Stratagene, La Jolla, Calif.) &lsqb;Russel et al. (1986) </PDAT><HIL><ITALIC><PDAT>Gene </PDAT></ITALIC></HIL><PDAT>45:333&rsqb;. Both strands of the largest cDNA insert (clone &num;3, 1731 bp) were sequenced.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 3</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>cDNA Sequencing and Sequence Analysis</PDAT></STEXT></H>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>Sequence of nucleotides was determined by the chain-termination reactions using Sequenase, Version 2.0 (United States Biochemical Corp., Cleveland, Ohio) and synthetic oligonucleotide primers. Compression of bands was eliminated by use of 7-deaza dGTP. The strategy for sequencing the IAGlu Transferase cDNA entailed subcloning the following fragments of clone &num;3 in pK18: Eco RI-Sac I, Sac I-Sac I, Rsa I-Rsa I and Rsa I-Eco RI.</PDAT></PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>The nucleotide sequence of the cDNA insert (clone &num;3) and the deduced amino acid sequence were analyzed using the MacVector computer program, Release 3.5 (International Biotechnologies, Inc., New Haven, Conn.). Hydropathy analysis was based on the Kyte-Doolittle method (Kyte and Doolittle (1982) </PDAT><HIL><ITALIC><PDAT>J. Mol. Biol</PDAT></ITALIC></HIL><PDAT>. 157:105), and it was performed with a window size of 7 and using the same computer program. Computation of amino sequence identities was performed by the BLAST Network Service (National Center for Biotechnology Information, Bethesda, Md.).</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 4</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Southern Hybridization Experiments</PDAT></STEXT></H>
<PARA ID="P-00065" LVL="0"><PTEXT><PDAT>To address the apparent number of copies per genome of the gene encoding IAGlu Transferase, and to determine whether other plant species had significantly homologous sequences, Southern hybridization experiments were carried out. Maize DNA samples (10 &mgr;g each) were digested in parallel with EcoRI, HindIII and BamHI. </PDAT><HIL><ITALIC><PDAT>A. thaliana </PDAT></ITALIC></HIL><PDAT>genomic DNA (6 &mgr;g) was digested with EcoRI.</PDAT></PTEXT></PARA>
<PARA ID="P-00066" LVL="0"><PTEXT><PDAT>The digested genomic DNAs were separated by agarose gel electrophoresis (0.8% agarose), and then transferred to a Hybond-N</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> membrane (Amersham Corp., Arlington Heights, Ill.).</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><PDAT>cDNA insert &num;3 (SEQ ID NO: 1) was radiolabeled using deoxyadenosine 5&prime;-&lsqb;&agr;-</PDAT><HIL><SP><PDAT>32</PDAT></SP></HIL><PDAT>P&rsqb; triphosphate in a random priming reaction. Hybridization was carried out essentially as described in Sambrook et al. (1989) supra. High stringency conditions were used for maize DNA (hybridization in 2&times;SSC, at 65&deg; C.; last wash using 0.3&times;SSC, at 65&deg; C.), and moderate stringency conditions (hybridization in 4&times;SSC, at 65&deg; C.; last wash in 1&times;SSC, at 65&deg; C.) were used for the </PDAT><HIL><ITALIC><PDAT>A. thaliana </PDAT></ITALIC></HIL><PDAT>genomic DNA.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 5</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Enzymatic Activity of Recombinant IAGlu Transferase</PDAT></STEXT></H>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>The recombinant (putative) IAGlu Transferase was tested for enzymatic activity. The full length cDNA (SEQ ID NO: 1) was ligated into pBluescript SK</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> (Stratagene, La Jolla, Calif.) and transformed into </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>. Negative controls were isogenic </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>carrying the pBluescript KS</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> without an insert or the same vector carrying a shorter, antibody-positive cDNA insert of 1050 bp. Bacterial cells were grown to early logarithmic growth phase in 200 ml of LB medium containing ampicillin. After the cells were collected by centrifugation, the cell pellet was suspended in 5 ml grinding buffer (25 mM Tris-HCl (pH 7.6), 2 mM EDTA, 2 mM dithiothreitol, 0.5 mM phenylmethanesulfonyl fluoride, 2% (w/v) polyvinylpyrrolidone), and a cell extract was prepared by sonication (two 15 sec. bursts) on ice. The extract was then filtered through fine synthetic mesh (Miracloth, Calbiochem, La Jolla, Calif.) and the pH of the extract filtrate was adjusted to 7.6.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>The IAGlu Transferase assay mixture (0.5 mL final volume) 0.8 MM </PDAT><HIL><SP><PDAT>13</PDAT></SP></HIL><PDAT>C</PDAT><HIL><SB><PDAT>6</PDAT></SB></HIL><PDAT>-labeled IAA and 0.024 &mgr;Ci of 5-&lsqb;</PDAT><HIL><SP><PDAT>3</PDAT></SP></HIL><PDAT>H&rsqb;-IAA; 5 mM UDP-glucose; 0.1 mM dithiothreitol; 75 mM 4-(2-hydroxyethyl)-1-piperazine N&prime;-2-ethanesulfonic acid (HEPES) buffer, pH 7.4; 50 mM myo-inositol; and 0.1 ml of cell extract (27 &mgr;g protein). Incubation was for 4 hr at 37&deg; C. The reaction was stopped by addition of 0.5 ml of 2-propanol, and protein was removed by centrifugation. The supernatant solution was freed of anionic unesterified IAA by passage through a one ml DEAE-acetate column. The eluate of 50% (v/v) 2-propanol was collected, and the column further washed with the same solvent for a total volume of eluate plus washings of 5.0 ml, as described in Leznicki and Bandurski (1988) Plant Physiol. 88:1474.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>The radioactivity in an aliquot of the column eluate was determined by liquid scintillation counting; 44,250 dpm of IAA had been esterified, corresponding to 119 nmoles of putative IAGlu. A small background (1-5%) occurs unless the IAA is freshly purified by (LH-20 Sephadex) chromatography to remove non-ionic radiological decomposition products. The radioactive material eluted from the DEAE-acetate column was pooled and applied to a 10 ml bed volume LH-20 Sephadex column and eluted with 50% (v/v) aqueous ethanol. The material (41,467 dpm) eluting from 7 to 11.2 ml, identical to that for authentic IAGlu (Keglevic, D. (1971) </PDAT><HIL><ITALIC><PDAT>Carbohyd. Res</PDAT></ITALIC></HIL><PDAT>. 20:293) was pooled, and it corresponded to 112 nmoles of IAGlu. This is the expected 10% yield based on the equilibrium of Reaction A in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>. The pooled material was concentrated to near dryness and applied to a Silica Gel G thin layer chromatography plate and developed with ethyl acetate, methyl ethyl ketone, ethyl alcohol, and water (5:3:1:1) as previously described (Labarca et al. (1965) </PDAT><HIL><ITALIC><PDAT>Biochem. Biophys. Res. Comm </PDAT></ITALIC></HIL><PDAT>20:641). IAA migrates with an R</PDAT><HIL><SB><PDAT>f </PDAT></SB></HIL><PDAT>of 0.83, the R</PDAT><HIL><SB><PDAT>f </PDAT></SB></HIL><PDAT>for authentic IAA-glucose is 0.54. The radioactive material at R</PDAT><HIL><SB><PDAT>f </PDAT></SB></HIL><PDAT>0.54 was eluted from the silica gel with one ml of 50% v/v aqueous ethanol and contained 7050 dpm, corresponding to 19 nmoles of IAGlu. The loss of radioactivity is as expected for chromatography of an indolylic compound on Silica Gel. The eluted material was taken to near dryness and analyzed by Fast Atom Bombardment-Mass Spectrometry. Conditions used were a matrix of m-nitrobenzyl alcohol, a cesium ion gun using 2 &mgr;A ion flux and 37 kV accelerating voltage. The sample was scanned for compounds in the molecular weight range from 100 to 1200 daltons in a VG-ZAB2S spectrometer (VG Instruments, Ltd., Manchester, England). Authentic unlabeled IAGlu yielded (M)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> of 337.118 and (M&plus;Na)</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT> of 360.113.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 6</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>Transgenic Tobacco expressing Maize Iaglu Synthetase</PDAT></STEXT></H>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>Recombinant DNA methods were performed according to established methods (Sambrook et al. (1989) supra). The </PDAT><HIL><ITALIC><PDAT>Zea mays </PDAT></ITALIC></HIL><PDAT>iaglu-coding sequence (for IAGlu synthetase) as described herein was isolated from positive clone &num;3 as a BamHI-EcoRV fragment, and it was positioned in the sense orientation downstream of the CaMV 35S RNA promoter of the pBI121 binary vector cut with SstI and made blunt-ended with the Klenow fragment of DNA Polymerase I and then digested with BamHI to yield plasmid P</PDAT><HIL><SB><PDAT>35S</PDAT></SB></HIL><PDAT>-iaglu. The pBI121 vector is pBI101 into which an approximately 800 bp fragment containing the 35S CaMV promoter has been cloned. pBI121 is commercially available from Clontech (Palo Alto, Calif.). </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT> illustrates the relevant portion of pBI121. The presence of this plasmid and its derivatives is selected by growth on kanamycin. pBI101 is a &ldquo;promoter-less&rdquo; GUS cassette in the Agrobacterium binary plasmid vector pBIN19 (Bevan, M. (1984) </PDAT><HIL><ITALIC><PDAT>Nucl. Acids Res</PDAT></ITALIC></HIL><PDAT>. 12:8711). Both the P</PDAT><HIL><SB><PDAT>35S</PDAT></SB></HIL><PDAT>-iaglu construct and the control binary vector pBI121 (containing the 35S-gus fusion) were transformed in parallel samples of </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens </PDAT></ITALIC></HIL><PDAT>strain LBA4404 by electrotransformation. LBA4404 is a well known </PDAT><HIL><ITALIC><PDAT>Agrobacterium tumefaciens </PDAT></ITALIC></HIL><PDAT>strain carrying the transacting virulence functions necessary to facilitate the transfer of the T-DNA region of binary vectors to plants. The strain is resistant to streptomycin and is Thi</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>, which allows a strong selection for growth on minimal plates after triparental mating, as the </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>donor strains (typically MC1022, DH5, or HB101) are Thi</PDAT><HIL><SP><PDAT>&minus;</PDAT></SP></HIL><PDAT> (Hoekema et al. (1983) </PDAT><HIL><ITALIC><PDAT>Nature </PDAT></ITALIC></HIL><PDAT>303:179).</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>The </PDAT><HIL><ITALIC><PDAT>Nicotiana tabacum </PDAT></ITALIC></HIL><PDAT>SR-1 plants used for transformation were grown axenically on solid MS media (MS salts (Sigma Chemical Co., St. Louis, Mo.), 30 g/L sucrose, 0.56 mM myo-inositol, buffered to pH 5.7 with 2.5 mM 2-&lsqb;N-morpholino&rsqb;ethanesulfonic acid (MES), 0.8% tissue culture grade agar (Phytagar, trademark of GIBCO/BRL, Life Technologies, Inc., Gaithersburg, Md.). Leaves from these plants were transferred to solid medium A (MS salts, 30 g/L sucrose, 1.2 &mgr;M thiamine, 0.56 mM myo-inositol, 1 &mgr;M indole-3-acetic acid, 10 &mgr;M benzylaminopurine (BAP), buffered to pH 5.6 with 2.5 mM MES, 0.8% Phytagar) and infected with Agrobacterium strains containing either P</PDAT><HIL><SB><PDAT>35S</PDAT></SB></HIL><PDAT>-iaglu or the pBI121 control binary vector using syringe needles. After 3 days, the leaves were transferred to medium A containing 200 &mgr;g/ml kanamycin and 500 &mgr;g/ml carbenicillin. Kanamycin selects for the presence of recombinant DNA sequences, and carbenicillin selects against the </PDAT><HIL><ITALIC><PDAT>A. tumefaciens</PDAT></ITALIC></HIL><PDAT>. Emerging shoots were transferred to MS medium (containing 100 &mgr;g/ml kanamycin and 500 &mgr;g/ml carbenicillin) to induce rooting.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>Example 7</PDAT></STEXT></H>
<H LVL="1"><STEXT><PDAT>IAGlu Transferase Antisense Plasmids and Transgenic Plants</PDAT></STEXT></H>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>To make a plasmid to express an antisense RNA capable of inhibiting the translational expression of a natural iaglu gene in a plant, cDNA clone &num;3 is cleaved with EcoRI and the fragment ends are made blunt with the Klenow fragment of DNA polymerase. Plasmid pBI121 is digested with BamHI and SstI, and the ends are made blunt with the Klenow fragment of DNA polymerase. Then, the cDNA fragment and the linearized pBI121 are ligated, and the ligation mixture is transformed into </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>and transformants are selected by plating on kanamycin-containing agar.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>To identify recombinant plasmids in which the iaglu cDNA is inserted in the reverse (antisense) orientation with respect to the CaMV 35S promoter, plasmids are prepared from transformants, digested with EcoRV and SacI, and the resulting fragments are size fractionated by agarose gel electrophoresis, and plasmids having the desired orientation are identified (see scheme presented in FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>). The antisense orientation is characterized as having an EcoRV-SacI fragment of about 100 bp shorter than observed for the sense orientation.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>To create a plasmid from which antisense RNA is made corresponding to the 3&prime; portion of the coding sequence, cDNA clone &num;3 is digested with SacI and EcoRV and a 505 bp SacI-EcoRV fragment is inserted into pBI121 which has been digested with BamHI, blunt ended using the fill-in reaction of DNA polymerase Klenow fragment, and then digested with SstI. The fragments are then ligated. The ligation mixture is transformed into suitable </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>host cells, and transformants are selected by plating on solid nutrient medium containing kanamycin. The plasmid contents of transformants are analyzed by restriction endonuclease digestion to identify one of the desired nature. See </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> for a diagram of the relevant portion of the desired plasmid.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>Other iaglu antisense RNA-expressing plasmids can be constructed as follows: cDNA clone &num;3 is digested with Sau3A, and a fragment of about 776 bp is isolated and purified after agarose gel electrophoresis of the digested plasmid. This provides an iaglu-derived sequence corresponding to nucleotides 42 to 817 as given in SEQ ID NO:1, and this fragment includes the ribosome binding site of the iaglu transcript, so that when the antisense RNA is synthesized, there will be a sequence synthesized which will be capable of base pairing with the ribosome binding site of the iaglu mRNA. The ends of the Sau3A fragment are made blunt with the Klenow fragment of DNA polymerase. pBI121 is digested with SstI and BamHI, the ends are made blunt with the Klenow enzyme, and the linearized plasmid, called pBI121-DEL due to the deletion of the &bgr;-glucuronidase gene, is then gel purified. Then the purified iaglu fragment and the treated plasmid are ligated together, and the ligation mixture is transformed into competent </PDAT><HIL><ITALIC><PDAT>E. coli</PDAT></ITALIC></HIL><PDAT>, with selection for kanamycin resistance. Transformants are analyzed for their plasmid content and insert orientation by cutting with EcoRV and SacI and agarose gel electrophoresis, and at least one is chosen which contains the appropriate iaglu-derived fragment inserted in an antisense orientation relative to the CaMV 35S promoter; this plasmid is designated pBI121-DEL-antil. The antisense orientation of the Sau3A fragment will give an EcoRV-SacI fragment which is 338 bp longer than when the iaglu Sau3A fragment is inserted into pBI121-DEL in the sense orientation. Alternatively, the ligation mixture can be electrotransformed directly into </PDAT><HIL><ITALIC><PDAT>A. tumefaciens</PDAT></ITALIC></HIL><PDAT>, and the plasmids then characterized to verify the antisense orientation of the iaglu-derived insert relative to the 35S promoter. SacI cuts after nucleotide 598 within SEQ ID NO:1, which is contained within the 776 bp Sau3A fragment, and EcoRV cuts within the CaMV 35S promoter sequence.</PDAT></PTEXT></PARA>
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>The desired antisense plasmid is then introduced into </PDAT><HIL><ITALIC><PDAT>A. tumefaciens </PDAT></ITALIC></HIL><PDAT>LB4404 by triparental mating with </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>(pRK2013), and then is transferred into plant tissue as described herein. The transformed plant tissue is subjected to selection for the presence of the plasmid, and then transgenic plants are regenerated from the transformed plant tissue as described herein above.</PDAT></PTEXT></PARA>
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>The desired pBI121-antisense plasmid is then introduced into </PDAT><HIL><ITALIC><PDAT>A. tumefaciens </PDAT></ITALIC></HIL><PDAT>LB4404 by triparental mating with </PDAT><HIL><ITALIC><PDAT>E. coli </PDAT></ITALIC></HIL><PDAT>(pRK2013) (see e.g., Ditta et al. (1980) </PDAT><HIL><ITALIC><PDAT>Proc. Natl. Acad. Sci. USA </PDAT></ITALIC></HIL><PDAT>77:7347), and then is transferred into plant tissue as described herein. The transformed plant tissue is subjected to selection for the presence of the plasmid, and then transgenic plants are regenerated from the transformed plant tissue as described herein above.</PDAT></PTEXT></PARA>
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>While various embodiments of the present invention have been described in detail, it is apparent that modifications, extensions, adaptations and optimizations may occur to those skilled in the art. It is to be expressly understood that such modifications and adaptations and so on are within the spirit and scope of the present invention, as set forth in the following claims.</PDAT></PTEXT></PARA>
<CWU>
<SEQLST-US ID="SEQLST-1">
<SEQ-LST-OLD>
<S-1>
<S-1-III>
<PDAT>9</PDAT>
</S-1-III>
</S-1>
<S-2 SEQ-NO="1">
<S-2-I>
<S-2-I-A>
<PDAT>1731 base pairs</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>nucleic acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>double</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>cDNA to mRNA</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-IX>
<S-2-IX-A>
<PDAT>CDS</PDAT>
</S-2-IX-A>
<S-2-IX-B>
<PDAT> 57..1472
</PDAT>
</S-2-IX-B>
</S-2-IX>
<S-2-XI>
<PDAT>1
GAATTCGTCG GCCGCCACCT AACATCCATT GTTGCAAGAA GGATCAAGGA ACAACC         56
ATG GCG CCG CAT GTC CTC GTC GTG CCC TTC CCC GGT CAG GGA CAC ATG      104
Met Ala Pro His Val Leu Val Val Pro Phe Pro Gly Gln Gly His Met
  1               5                  10                  15
AAC CCC ATG GTA CAG TTC GCC AAG AGG CTG GCA TCC AAG GGC GTG GCC      152
Asn Pro Met Val Gln Phe Ala Lys Arg Leu Ala Ser Lys Gly Val Ala
             20                  25                  30
ACC ACG CTC GTC ACC ACC CGC TTC ATC CAG AGG ACT GCC GAC GTG GAC      200
Thr Thr Leu Val Thr Thr Arg Phe Ile Gln Arg Thr Ala Asp Val Asp
         35                  40                  45
GCG CAC CCA GCG ATG GTC GAG GCC ATC TCC GAC GGG CAC GAC GAG GGA      248
Ala His Pro Ala Met Val Glu Ala Ile Ser Asp Gly His Asp Glu Gly
     50                  55                  60
GGG TTC GCG TCG GCC GCG GGC GTT GCC GAG TAC CTG GAG AAG CAG GCG      296
Gly Phe Ala Ser Ala Ala Gly Val Ala Glu Tyr Leu Glu Lys Gln Ala
 65                  70                  75                  80
GCC GCC GCG TCG GCG TCG CTG GCG TCG CTC GTC GAG GCA CGC GCG TCG      344
Ala Ala Ala Ser Ala Ser Leu Ala Ser Leu Val Glu Ala Arg Ala Ser
                 85                  90                  95
TCT GCG GAC GCC TTC ACG TGC GTC GTG TAC GAC TCG TAC GAG GAC TGG      392
Ser Ala Asp Ala Phe Thr Cys Val Val Tyr Asp Ser Tyr Glu Asp Trp
            100                 105                 110
GTG CTG CCC GTG GCG CGG CGA ATG GGC CTG CCC GCC GTC CCC TTC TCC      440
Val Leu Pro Val Ala Arg Arg Met Gly Leu Pro Ala Val Pro Phe Ser
        115                 120                 125
ACG CAG TCG TGC GCC GTC AGC GCC GTG TAC TAC CAC TTC AGC CAG GGG      488
Thr Gln Ser Cys Ala Val Ser Ala Val Tyr Tyr His Phe Ser Gln Gly
    130                 135                 140
AGG CTT GCC GTG CCT CCG GGG GCG GCC GCG GAC GGC AGC GAC GGT GGT      536
Arg Leu Ala Val Pro Pro Gly Ala Ala Ala Asp Gly Ser Asp Gly Gly
145                 150                 155                 160
GCT GGT GCC GCC GCC CTG AGC GAG GCG TTC CTG GGG CTG CCG GAG ATG      584
Ala Gly Ala Ala Ala Leu Ser Glu Ala Phe Leu Gly Leu Pro Glu Met
                165                 170                 175
GAG AGG TCG GAG CTC CCG TCG TTC GTG TTC GAC CAT GGT CCG TAC CCG      632
Glu Arg Ser Glu Leu Pro Ser Phe Val Phe Asp His Gly Pro Tyr Pro
            180                 185                 190
ACC ATC GCC ATG CAA GCG ATT AAA CAG TTC GCT CAT GCG GGA AAG GAT      680
Thr Ile Ala Met Gln Ala Ile Lys Gln Phe Ala His Ala Gly Lys Asp
        195                 200                 205
GAC TGG GTG CTG TTC AAC TCG TTC GAA GAA CTG GAA ACC GAG GTT TTG      728
Asp Trp Val Leu Phe Asn Ser Phe Glu Glu Leu Glu Thr Glu Val Leu
    210                 215                 220
GCT GGC CTG ACA AAG TAC CTG AAG GCC CGA GCC ATC GGC CCA TGC GTG      776
Ala Gly Leu Thr Lys Tyr Leu Lys Ala Arg Ala Ile Gly Pro Cys Val
225                 230                 235                 240
CCG CTG CCC ACC GCT GGA AGG ACC GCC GGC GCC AAT GGC CGG ATC ACC      824
Pro Leu Pro Thr Ala Gly Arg Thr Ala Gly Ala Asn Gly Arg Ile Thr
                245                 250                 255
TAC GGG GCC AAC CTG GTG AAG CCG GAG GAT GCG TGC ACC AAG TGG CTA      872
Tyr Gly Ala Asn Leu Val Lys Pro Glu Asp Ala Cys Thr Lys Trp Leu
            260                 265                 270
GAC ACC AAG CCC GAC CGC TCC GTG GCC TAC GTC TCC TTC GGC AGC CTC      920
Asp Thr Lys Pro Asp Arg Ser Val Ala Tyr Val Ser Phe Gly Ser Leu
        275                 280                 285
GCG TCC CTG GGC AAC GCC CAG AAG GAG GAG CTC GCG CGC GGC CTC CTC      968
Ala Ser Leu Gly Asn Ala Gln Lys Glu Glu Leu Ala Arg Gly Leu Leu
    290                 295                 300
GCC GCC GGC AAG CCG TTC CTG TGG GTG GTG AGG GCC AGC GAC GAG CAC     1016
Ala Ala Gly Lys Pro Phe Leu Trp Val Val Arg Ala Ser Asp Glu His
305                 310                 315                 320
CAG GTC CCG CGC TAT CTC CTG GCC GAG GCG ACG GCG ACG GGC GCC GCG     1064
Gln Val Pro Arg Tyr Leu Leu Ala Glu Ala Thr Ala Thr Gly Ala Ala
                325                 330                 335
ATG GTC GTG CCC TGG TGC CCG CAG CTG GAC GTG CTG GCG CAC CCG GCC     1112
Met Val Val Pro Trp Cys Pro Gln Leu Asp Val Leu Ala His Pro Ala
            340                 345                 350
GTG GGC TGC TTC GTC ACC CAC TGC GGT TGG AAC TCC ACG CTG GAG GCG     1160
Val Gly Cys Phe Val Thr His Cys Gly Trp Asn Ser Thr Leu Glu Ala
        355                 360                 365
CTC AGC TTC GGC GTG CCT ATG GTG GCG ATG GCG CTG TGG ACG GAC CAG     1208
Leu Ser Phe Gly Val Pro Met Val Ala Met Ala Leu Trp Thr Asp Gln
    370                 375                 380
CCG ACC AAC GCT CGG AAC GTC GAG CTC GCC TGG GGC GCG GGC GTG CGC     1256
Pro Thr Asn Ala Arg Asn Val Glu Leu Ala Trp Gly Ala Gly Val Arg
385                 390                 395                 400
GCG CGC CGC GAT GCT GGC GCG GGC GTG TTC CTT CGC GGG GAA GTG GAG     1304
Ala Arg Arg Asp Ala Gly Ala Gly Val Phe Leu Arg Gly Glu Val Glu
                405                 410                 415
CGG TGC GTG CGC GCC GTC ATG GAC GGG GGC GAG GCG GCG TCT GCT GCA     1352
Arg Cys Val Arg Ala Val Met Asp Gly Gly Glu Ala Ala Ser Ala Ala
            420                 425                 430
CGC AAG GCG GCG GGG GAA TGG AGG GAC AGG GCT CGC GCC GCG GTG GCA     1400
Arg Lys Ala Ala Gly Glu Trp Arg Asp Arg Ala Arg Ala Ala Val Ala
        435                 440                 445
CCC GGT GGC AGC TCT GAC CGC AAC CTG GAC GAG TTC GTG CAG TTT GTG     1448
Pro Gly Gly Ser Ser Asp Arg Asn Leu Asp Glu Phe Val Gln Phe Val
    450                 455                 460
CGC GCC GGC GCC ACG GAG AAG TGAGAGGCGC TGGCTGTGAA GTGTGAAGGG        1499
Arg Ala Gly Ala Thr Glu Lys
465                 470
AGGTGATGTT GCAGGGTCCC AGATGTGACG ACGCGATGCG AAGGAGAAAC GTTTCGAAAC   1559
TGGAAGCAAA AAACGGTCGA AAGTTGGTGC CTCTACTTGG TTTGGTTTAT GCTTTGGGTC   1619
CACCAGCCAT AATAATATAC TTTGCTTGAG GATTCTACCA TAACAATTAT TCAGCCTTTT   1679
ATTTTCTACC CTATGAAAAA AGAAAGGTAT GTTGTGCCAT GCAGGGTTAA AA           1731
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="2">
<S-2-I>
<S-2-I-A>
<PDAT>471 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-XI>
<PDAT>2
Met Ala Pro His Val Leu Val Val Pro Phe Pro Gly Gln Gly His Met
  1               5                  10                  15
Asn Pro Met Val Gln Phe Ala Lys Arg Leu Ala Ser Lys Gly Val Ala
             20                  25                  30
Thr Thr Leu Val Thr Thr Arg Phe Ile Gln Arg Thr Ala Asp Val Asp
         35                  40                  45
Ala His Pro Ala Met Val Glu Ala Ile Ser Asp Gly His Asp Glu Gly
     50                  55                  60
Gly Phe Ala Ser Ala Ala Gly Val Ala Glu Tyr Leu Glu Lys Gln Ala
 65                  70                  75                  80
Ala Ala Ala Ser Ala Ser Leu Ala Ser Leu Val Glu Ala Arg Ala Ser
                 85                  90                  95
Ser Ala Asp Ala Phe Thr Cys Val Val Tyr Asp Ser Tyr Glu Asp Trp
            100                 105                 110
Val Leu Pro Val Ala Arg Arg Met Gly Leu Pro Ala Val Pro Phe Ser
        115                 120                 125
Thr Gln Ser Cys Ala Val Ser Ala Val Tyr Tyr His Phe Ser Gln Gly
    130                 135                 140
Arg Leu Ala Val Pro Pro Gly Ala Ala Ala Asp Gly Ser Asp Gly Gly
145                 150                 155                 160
Ala Gly Ala Ala Ala Leu Ser Glu Ala Phe Leu Gly Leu Pro Glu Met
                165                 170                 175
Glu Arg Ser Glu Leu Pro Ser Phe Val Phe Asp His Gly Pro Tyr Pro
            180                 185                 190
Thr Ile Ala Met Gln Ala Ile Lys Gln Phe Ala His Ala Gly Lys Asp
        195                 200                 205
Asp Trp Val Leu Phe Asn Ser Phe Glu Glu Leu Glu Thr Glu Val Leu
    210                 215                 220
Ala Gly Leu Thr Lys Tyr Leu Lys Ala Arg Ala Ile Gly Pro Cys Val
225                 230                 235                 240
Pro Leu Pro Thr Ala Gly Arg Thr Ala Gly Ala Asn Gly Arg Ile Thr
                245                 250                 255
Tyr Gly Ala Asn Leu Val Lys Pro Glu Asp Ala Cys Thr Lys Trp Leu
            260                 265                 270
Asp Thr Lys Pro Asp Arg Ser Val Ala Tyr Val Ser Phe Gly Ser Leu
        275                 280                 285
Ala Ser Leu Gly Asn Ala Gln Lys Glu Glu Leu Ala Arg Gly Leu Leu
    290                 295                 300
Ala Ala Gly Lys Pro Phe Leu Trp Val Val Arg Ala Ser Asp Glu His
305                 310                 315                 320
Gln Val Pro Arg Tyr Leu Leu Ala Glu Ala Thr Ala Thr Gly Ala Ala
                325                 330                 335
Met Val Val Pro Trp Cys Pro Gln Leu Asp Val Leu Ala His Pro Ala
            340                 345                 350
Val Gly Cys Phe Val Thr His Cys Gly Trp Asn Ser Thr Leu Glu Ala
        355                 360                 365
Leu Ser Phe Gly Val Pro Met Val Ala Met Ala Leu Trp Thr Asp Gln
    370                 375                 380
Pro Thr Asn Ala Arg Asn Val Glu Leu Ala Trp Gly Ala Gly Val Arg
385                 390                 395                 400
Ala Arg Arg Asp Ala Gly Ala Gly Val Phe Leu Arg Gly Glu Val Glu
                405                 410                 415
Arg Cys Val Arg Ala Val Met Asp Gly Gly Glu Ala Ala Ser Ala Ala
            420                 425                 430
Arg Lys Ala Ala Gly Glu Trp Arg Asp Arg Ala Arg Ala Ala Val Ala
        435                 440                 445
Pro Gly Gly Ser Ser Asp Arg Asn Leu Asp Glu Phe Val Gln Phe Val
    450                 455                 460
Arg Ala Gly Ala Thr Glu Lys
465                 470
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="3">
<S-2-I>
<S-2-I-A>
<PDAT>18 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>N-terminal</PDAT>
</S-2-V>
<S-2-IX>
<S-2-IX-A>
<PDAT>Protein</PDAT>
</S-2-IX-A>
<S-2-IX-B>
<PDAT> 4..15</PDAT>
</S-2-IX-B>
<S-2-IX-D>
<STEXT><PDAT> /note&equals; &ldquo;Xs &equals; amino acids which
               could not be identified with certainty.&rdquo;
</PDAT></STEXT>
</S-2-IX-D>
</S-2-IX>
<S-2-XI>
<PDAT>3
Met Ala Pro Xaa Val Leu Val Val Pro Phe Pro Gly Gln Gly Xaa Met
            1               5                   10
Asn Pro
    15
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="4">
<S-2-I>
<S-2-I-A>
<PDAT>56 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>internal</PDAT>
</S-2-V>
<S-2-XI>
<PDAT>4
Ile Leu Val Lys Trp Leu Pro Gln Asn Asp Leu Leu Gly His Pro Met
1               5                   10                  15
Thr Arg Ala Phe Ile Thr His Ala Gly Ser His Gly Val Tyr Glu Ser
            20                  25                  30
Ile Cys Asn Gly Val Pro Met Val Met Met Pro Leu Phe Gly Asp Gln
        35                  40                  45
Met Asp Asn Ala Lys Arg Met Glu
    50                  55
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="5">
<S-2-I>
<S-2-I-A>
<PDAT>131 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>internal</PDAT>
</S-2-V>
<S-2-XI>
<PDAT>5
Cys Thr Lys Trp Leu Asp Thr Lys Pro Asp Arg Ser Val Ala Tyr Val
1               5                   10                  15
Ser Phe Gly Ser Leu Ala Ser Leu Gly Asn Ala Gln Lys Glu Glu Leu
            20                  25                  30
Ala Arg Gly Leu Leu Ala Ala Gly Lys Pro Phe Leu Trp Val Val Arg
        35                  40                  45
Ala Ser Asp Glu His Gln Val Pro Arg Tyr Leu Leu Ala Glu Ala Thr
    50                  55                  60
Ala Thr Gly Ala Ala Met Val Val Pro Trp Cys Pro Gln Leu Asp Val
65                  70                  75                  80
Leu Ala His Pro Ala Val Gly Cys Phe Val Thr His Cys Gly Trp Asn
                85                  90                  95
Ser Thr Leu Glu Ala Leu Ser Phe Gly Val Pro Met Val Ala Met Ala
            100                 105                 110
Leu Trp Thr Asp Gln Pro Thr Asn Ala Arg Asn Val Glu Leu Ala Trp
        115                 120                 125
Gly Ala Gly
    130
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="6">
<S-2-I>
<S-2-I-A>
<PDAT>131 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>internal</PDAT>
</S-2-V>
<S-2-XI>
<PDAT>6
Cys Leu Ala Trp Leu Gly Arg Gln Pro Ala Arg Gly Val Ala Tyr Val
1               5                   10                  15
Ser Phe Gly Thr Val Ala Cys Pro Arg Pro Asp Glu Leu Arg Glu Leu
            20                  25                  30
Ala Ala Gly Leu Glu Asp Ser Gly Ala Pro Phe Leu Trp Ser Leu Arg
        35                  40                  45
Glu Asp Ser Trp Pro His Leu Pro Pro Gly Phe Leu Asp Arg Ala Ala
    50                  55                  60
Gly Thr Gly Ser Gly Leu Val Val Pro Trp Ala Pro Gln Val Ala Val
65                  70                  75                  80
Leu Arg His Pro Ser Val Gly Ala Phe Val Thr His Ala Gly Trp Ala
                85                  90                  95
Ser Val Leu Glu Gly Leu Ser Ser Gly Val Pro Met Ala Cys Arg Pro
            100                 105                 110
Phe Phe Gly Asp Gln Arg Met Asn Ala Arg Ser Val Ala His Val Trp
        115                 120                 125
Gly Phe Gly
    130
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="7">
<S-2-I>
<S-2-I-A>
<PDAT>52 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>internal</PDAT>
</S-2-V>
<S-2-XI>
<PDAT>7
Trp Ile Pro Gln Asn Asp Leu Leu Gly His Pro Lys Thr Arg Ala Phe
1               5                   10                  15
Ile Thr His Gly Gly Thr Asn Gly Leu Tyr Glu Ala Ile Tyr His Gly
            20                  25                  30
Val Pro Met Val Gly Ile Pro Leu Phe Gly Asp Gln Pro Asp Asn Ile
        35                  40                  45
Ala Arg Val Lys
    50
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="8">
<S-2-I>
<S-2-I-A>
<PDAT>63 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>internal</PDAT>
</S-2-V>
<S-2-XI>
<PDAT>8
Ala Thr Ala Thr Gly Ala Ala Met Val Val Pro Trp Cys Pro Gln Leu
1               5                   10                  15
Asp Val Leu Ala His Pro Ala Val Gly Cys Phe Val Thr His Cys Gly
            20                  25                  30
Trp Asn Ser Thr Leu Glu Ala Leu Ser Phe Gly Val Pro Met Val Ala
        35                  40                  45
Met Ala Leu Trp Thr Asp Gln Pro Thr Asn Ala Arg Asn Val Glu
    50                  55                  60
</PDAT>
</S-2-XI>
</S-2>
<S-2 SEQ-NO="9">
<S-2-I>
<S-2-I-A>
<PDAT>58 amino acids</PDAT>
</S-2-I-A>
<S-2-I-B>
<PDAT>amino acid</PDAT>
</S-2-I-B>
<S-2-I-C>
<PDAT>single</PDAT>
</S-2-I-C>
<S-2-I-D>
<PDAT>linear</PDAT>
</S-2-I-D>
</S-2-I>
<S-2-II>
<S-2-II-MT>
<PDAT>protein</PDAT>
</S-2-II-MT>
</S-2-II>
<S-2-III>
<PDAT>NO</PDAT>
</S-2-III>
<S-2-V>
<PDAT>internal</PDAT>
</S-2-V>
<S-2-XI>
<PDAT>9
Ala Thr Leu Gly Pro Ile Thr Arg Val Tyr Lys Trp Leu Pro Gln Asn
1               5                   10                  15
Asp Ile Leu Gly His Pro Lys Thr Lys Ala Phe Val Thr His Gly Gly
            20                  25                  30
Ala Asn Gly Leu Tyr Glu Ala Ile Tyr His Gly Ile Pro Met Ile Gly
        35                  40                  45
Ile Pro Leu Phe Gly Asp Gln Pro Asp Asn
    50                  55
</PDAT>
</S-2-XI>
</S-2>
</SEQ-LST-OLD>
</SEQLST-US>
</CWU>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>We claim: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>1. A method of using a DNA molecule comprising a nucleotide sequence encoding IAGlu Transferase to produce a transgenic plant, said method comprising the steps of</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a) cloning a nucleotide sequence encoding IAGlu Transferase having an amino acid sequence as given in SEQ ID NO:2 operably linked to transcriptional control sequences comprisng a promoter functional in a plant cell to produce an IAGlu Transferase expression construct; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>b) Cloning the IAGlu Transferase expression construct of step (a) into a plasmid vector adapted for use in a plant cell to produce a plant IAGlu Transferase expression vector; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>c) introducing said plant IAGlu Transferase expression vector of step (b) into plant tissue to produce transgenic plant tissue; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>d) regenerating said transgenic plant tissue to produce a transgenic plant, whereby IAGlu Transferase is expressed at greater than natural levels in at least one tissue of said transgenic plant, with at least one effect selected from a group consisting of inhibition of apical dominance, inhibition of stem elongation, inhibition of cell enlargement, and increased numbers of stems per plant as compared with a wild-type of said plant. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>2. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein said IAGlu Transferase has a coding sequence as given in SEQ ID NO: 1 from nucleotide 57 to 1469.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>3. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said promoter functional in a plant cell is the Cauliflower Mosaic Virus 35S gene promoter or the Cauliflower Mosaic Virus 19S promoter.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>4. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said transgenic plant is a dicotyledonous plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>5. The method of </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT> wherein said transgenic plant is a member of the Solanaceae.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>6. The method of </PDAT><CLREF ID="CLM-00004"><PDAT>claim 4</PDAT></CLREF><PDAT> wherein said transgenic plant is </PDAT><HIL><ITALIC><PDAT>Glycine max. </PDAT></ITALIC></HIL></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>7. The method of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT> wherein said transgenic plant is a monocotyledonous plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>8. The method of </PDAT><CLREF ID="CLM-00007"><PDAT>claim 7</PDAT></CLREF><PDAT> wherein said plant is selected from the group consisting of corn, rice, wheat and barley.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>9. A transgenic plant comprising a coding sequence encoding an indol-3-ylacetylglucosyl transferase having an amino acid sequence as given in SEQ ID NO: 2 and said coding sequence being a coding sequence not native to said plant or said coding sequence operably linked to transcriptional control sequences not naturally associated with said coding sequence, wherein said plant expresses IAGlu Transferase at greater than normal levels.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>10. The transgenic plant of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> wherein said iaglu coding sequence has at least 70% nucleotide sequence identity to an iaglu coding sequence as given in SEQ ID NO: 1 from nucleotide 57 to nucleotide 1469.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>11. The transgenic plant of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> wherein said iaglu coding sequence is as given in SEQ ID NO: 1 from nucleotide 57 to nucleotide 1469.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>12. The transgenic plant of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> wherein said plant is a dicotyledonous plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>13. The transgenic plant of </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT> wherein said plant is a member of the Solanaceae.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>14. The transgenic plant of </PDAT><CLREF ID="CLM-00012"><PDAT>claim 12</PDAT></CLREF><PDAT> wherein said plant is </PDAT><HIL><ITALIC><PDAT>Glycine max. </PDAT></ITALIC></HIL></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>15. The transgenic plant of </PDAT><CLREF ID="CLM-00009"><PDAT>claim 9</PDAT></CLREF><PDAT> wherein said plant is a monocotyledonous plant.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>16. The transgenic plant of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT> wherein said plant is selected from the group consisting of corn, rice, wheat and barley.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00096" LVL="0"><PTEXT><PDAT>17. A method of producing a transgenic plant having greater than natural levels of IAGlu Transferase, said method comprising the steps of:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>(a) introducing a nucleotide sequence encoding a UDP-glucose indol-3-ylacetylglucosyl transferase (Iaglu transferase), wherein said nucleotide sequence is a full length coding sequence and has at least 70% sequence identity with a nucleotide sequence as given in SEQ ID NO:1 from nucleotide 57 to nucleotide 1469, which is expressed in plant tissue into a plant cell to produce a transgenic plant cell; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(b) regenerating a transgenic plant from said transgenic plant cell; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>(c) growing said transgenic plant under conditions wherein said nucleotide sequence encoding laglu transferase is expressed, </PDAT></PTEXT></CLMSTEP>
<PARA ID="P-00097" LVL="7"><PTEXT><PDAT>whereby said transgenic plant contains greater than natural levels of laglu transferase.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06489541-20021203-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06489541-20021203-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06489541-20021203-D00003.TIF" TYPE="HALFTONE"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06489541-20021203-D00004.TIF"/>
<EMI ID="EMI-D00005" ALT="embedded image" FILE="US06489541-20021203-D00005.TIF"/>
<EMI ID="EMI-D00006" ALT="embedded image" FILE="US06489541-20021203-D00006.TIF"/>
</SDODR>
</PATDOC>

<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PATDOC SYSTEM "ST32-US-Grant-025xml.dtd" [
<!ENTITY US06489776-20021203-M00001.NB SYSTEM "US06489776-20021203-M00001.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00001.TIF SYSTEM "US06489776-20021203-M00001.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00002.NB SYSTEM "US06489776-20021203-M00002.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00002.TIF SYSTEM "US06489776-20021203-M00002.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00003.NB SYSTEM "US06489776-20021203-M00003.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00003.TIF SYSTEM "US06489776-20021203-M00003.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00004.NB SYSTEM "US06489776-20021203-M00004.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00004.TIF SYSTEM "US06489776-20021203-M00004.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00005.NB SYSTEM "US06489776-20021203-M00005.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00005.TIF SYSTEM "US06489776-20021203-M00005.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00006.NB SYSTEM "US06489776-20021203-M00006.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00006.TIF SYSTEM "US06489776-20021203-M00006.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00007.NB SYSTEM "US06489776-20021203-M00007.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00007.TIF SYSTEM "US06489776-20021203-M00007.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-M00008.NB SYSTEM "US06489776-20021203-M00008.NB" NDATA NB>
<!ENTITY US06489776-20021203-M00008.TIF SYSTEM "US06489776-20021203-M00008.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-D00000.TIF SYSTEM "US06489776-20021203-D00000.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-D00001.TIF SYSTEM "US06489776-20021203-D00001.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-D00002.TIF SYSTEM "US06489776-20021203-D00002.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-D00003.TIF SYSTEM "US06489776-20021203-D00003.TIF" NDATA TIF>
<!ENTITY US06489776-20021203-D00004.TIF SYSTEM "US06489776-20021203-D00004.TIF" NDATA TIF>
]>
<PATDOC DTD="2.5" STATUS="Build 20020918">
<SDOBI>
<B100>
<B110><DNUM><PDAT>06489776</PDAT></DNUM></B110>
<B130><PDAT>B1</PDAT></B130>
<B140><DATE><PDAT>20021203</PDAT></DATE></B140>
<B190><PDAT>US</PDAT></B190>
</B100>
<B200>
<B210><DNUM><PDAT>09705523</PDAT></DNUM></B210>
<B211US><PDAT>09</PDAT></B211US>
<B220><DATE><PDAT>20001102</PDAT></DATE></B220>
</B200>
<B500>
<B510>
<B511><PDAT>G01R 2912</PDAT></B511>
<B512><PDAT>G01R 2300</PDAT></B512>
<B512><PDAT>G01R 3100</PDAT></B512>
<B512><PDAT>G01R 1918</PDAT></B512>
<B512><PDAT>G01R 2726</PDAT></B512>
<B516><PDAT>7</PDAT></B516>
</B510>
<B520>
<B521><PDAT>324458</PDAT></B521>
<B522><PDAT>324 7649</PDAT></B522>
<B522><PDAT>324 96</PDAT></B522>
<B522><PDAT>324118</PDAT></B522>
<B522><PDAT>324658</PDAT></B522>
</B520>
<B540><STEXT><PDAT>Non-contact mechanical resonance method for determining the near surface carrier mobility in conductors</PDAT></STEXT></B540>
<B560>
<B561>
<PCIT>
<DOC><DNUM><PDAT>3195037</PDAT></DNUM>
<DATE><PDAT>19650700</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Van Nie</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324118</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4302721</PDAT></DNUM>
<DATE><PDAT>19811100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Urbanek et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324226</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4649336</PDAT></DNUM>
<DATE><PDAT>19870300</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Binder et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324118</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>4894607</PDAT></DNUM>
<DATE><PDAT>19900100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Kumada</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324 96</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5065103</PDAT></DNUM>
<DATE><PDAT>19911100</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Slinkman et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324458</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5442297</PDAT></DNUM>
<DATE><PDAT>19950800</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Verkuil</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324702</PDAT></PNC></PCIT><CITED-BY-OTHER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5517123</PDAT></DNUM>
<DATE><PDAT>19960500</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Zhao et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324458</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B561>
<PCIT>
<DOC><DNUM><PDAT>5959447</PDAT></DNUM>
<DATE><PDAT>19990900</PDAT></DATE>
<KIND><PDAT>A</PDAT></KIND>
</DOC>
<PARTY-US>
<NAM><SNM><STEXT><PDAT>Bridges et al.</PDAT></STEXT></SNM></NAM>
</PARTY-US>
<PNC><PDAT>324458</PDAT></PNC></PCIT><CITED-BY-EXAMINER/>
</B561>
<B562><NCIT><STEXT><PDAT>T. D. Stowe et al; &ldquo;Attonewton force detection using ultrathin silicon cantilevers;&rdquo; Appl. Phys. Lett., vol. 71, No. 2, Jul. 14, 1997.</PDAT></STEXT></NCIT><CITED-BY-OTHER/></B562>
</B560>
<B570>
<B577><PDAT>19</PDAT></B577>
<B578US><PDAT>1</PDAT></B578US>
</B570>
<B580>
<B582><PDAT>324458</PDAT></B582>
<B582><PDAT>324 96</PDAT></B582>
<B582><PDAT>324118</PDAT></B582>
<B582><PDAT>324 7649</PDAT></B582>
<B582><PDAT>324 7651</PDAT></B582>
<B582><PDAT>324658</PDAT></B582>
<B582><PDAT>324762</PDAT></B582>
<B582><PDAT>324240</PDAT></B582>
<B582><PDAT>324452</PDAT></B582>
<B582><PDAT>324702</PDAT></B582>
</B580>
<B590><B595><PDAT>4</PDAT></B595><B596><PDAT>6</PDAT></B596><B597US/>
</B590>
</B500>
<B600>
<B680US><DOC><DNUM><PDAT>60/163119</PDAT></DNUM><DATE><PDAT>19991102</PDAT></DATE><KIND><PDAT>00</PDAT></KIND></DOC></B680US>
</B600>
<B700>
<B720>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Timothy D.</PDAT></FNM><SNM><STEXT><PDAT>Stowe</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Palo Alto</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Daniel</PDAT></FNM><SNM><STEXT><PDAT>Rugar</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>Los Altos</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
<B721>
<PARTY-US>
<NAM><FNM><PDAT>Thomas W.</PDAT></FNM><SNM><STEXT><PDAT>Kenny</PDAT></STEXT></SNM></NAM>
<ADR>
<CITY><PDAT>San Carlos</PDAT></CITY>
<STATE><PDAT>CA</PDAT></STATE>
</ADR>
</PARTY-US>
</B721>
</B720>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>The Board of Trustees of the Leland Stanford Junior University</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Stanford</PDAT></CITY><STATE><PDAT>CT</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B730>
<B731>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>International Business Machines Corporation</PDAT></STEXT></ONM></NAM>
<ADR><CITY><PDAT>Armonk</PDAT></CITY><STATE><PDAT>NY</PDAT></STATE></ADR>
</PARTY-US>
</B731>
<B732US>
<PDAT>02</PDAT>
</B732US>
</B730>
<B740>
<B741>
<PARTY-US>
<NAM><ONM><STEXT><PDAT>Lumen Intellectual Property Services, Inc.</PDAT></STEXT></ONM></NAM>
</PARTY-US>
</B741>
</B740>
<B745>
<B746>
<PARTY-US>
<NAM><FNM><PDAT>N.</PDAT></FNM><SNM><STEXT><PDAT>Le</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B746>
<B747>
<PARTY-US>
<NAM><FNM><PDAT>Anjan K.</PDAT></FNM><SNM><STEXT><PDAT>Deb</PDAT></STEXT></SNM></NAM>
</PARTY-US>
</B747>
<B748US><PDAT>2858</PDAT></B748US>
</B745>
</B700>
</SDOBI>
<SDOAB>
<BTEXT>
<PARA ID="P-00001" LVL="0"><PTEXT><PDAT>An apparatus using a resonator probe for determining an electronic property of a conductor across a dielectric. The apparatus has a device for inducing lateral mechanical oscillations of the resonator probe and a voltage source for producing a voltage difference between the resonator probe and the conductor to create an electronic drag between the conductor and resonator probe, thus damping the mechanical oscillations of the probe. The electronic property, such as charge carrier mobility, surface resistance, charge carrier lifetime and the number of charge carriers is determined from the damping experienced by the probe.</PDAT></PTEXT></PARA>
</BTEXT>
</SDOAB>
<SDODE>
<RELAPP>
<BTEXT>
<H LVL="1"><STEXT><PDAT>RELATED APPLICATIONS</PDAT></STEXT></H>
<PARA ID="P-00002" LVL="0"><PTEXT><PDAT>This application claims the benefit of provisional patent application No. 60/163,119 filed Nov. 2, 1999, which is herein incorporated by reference.</PDAT></PTEXT></PARA>
</BTEXT>
</RELAPP>
<GOVINT>
<BTEXT>
<H LVL="1"><STEXT><PDAT>STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT</PDAT></STEXT></H>
<PARA ID="P-00003" LVL="0"><PTEXT><PDAT>This invention was supported in part by grant number ECS-9422255 from the National Science Foundation (NSF). The U.S. Government has certain rights in the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</GOVINT>
<BRFSUM>
<BTEXT>
<H LVL="1"><STEXT><PDAT>FIELD OF THE INVENTION</PDAT></STEXT></H>
<PARA ID="P-00004" LVL="0"><PTEXT><PDAT>This invention relates generally to nondestructive evaluation of semiconductor materials. More particularly, it relates to a non-contact method for determining the mobility properties below a dielectric/semiconductor interface.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>BACKGROUND</PDAT></STEXT></H>
<PARA ID="P-00005" LVL="0"><PTEXT><PDAT>Nondestructive evaluation and testing has achieved widespread industrial use. In the construction and automobile manufacturing industry, eddy current testing is used for the evaluation of steel welds and ultrasonic testing for the critical dimension measurement of manufactured parts. Eddy current testing measures the quality of steel welds by measuring inductive losses in the mental parts and ultrasonic testing looks at the phase of reflected sound waves to measure the critical dimensions of parts.</PDAT></PTEXT></PARA>
<PARA ID="P-00006" LVL="0"><PTEXT><PDAT>Over the past decade, the semiconductor industry has used nondestructive evaluation for a variety of measurements. As with other manufacturing sectors, critical dimensions device analysis is important for quality control of transistor devices. Critical dimensions can be found. from in-line contactless scanning electron micrographs (in-line SEM) or by tapping mode atomic force microscopy (AFM) for submicron profilometry.</PDAT></PTEXT></PARA>
<PARA ID="P-00007" LVL="0"><PTEXT><PDAT>Other areas which require nondestructive evaluation are measurements of doping profiles, integrated sheet resistance and carrier lifetimes. The most common means of measuring such semiconductor quantities is by fabricating test structures during the production run and probing them later. For example, from the current voltage characteristics of the so-called &ldquo;4-point-probe&rdquo; test structure, the integrated sheet resistance of an implanted or epitaxially grown region can be determined. Another example is the use of Hall probe test structures for the characterization of the type (i.e., a donor or acceptor) and background doping concentration. Such post-processing evaluation techniques require special test structures to be built during wafer production. Physical and electrical contact is made with the test devices on the wafer. If dopant profiling across the wafer needs to be performed, a series of spreading-resistance measurements must be made. Once pulled from the production mainline, such wafers are considered contaminated and are not placed back into the mainline for further processing. Obviously, such testing is important for quality control during integrated circuit fabrication but such contact testing is both time consuming and wasteful of wafer real estate.</PDAT></PTEXT></PARA>
<PARA ID="P-00008" LVL="0"><PTEXT><PDAT>Given the limitations of the above-mentioned testing methods, there has been a move in the semiconductor industry towards contactless, in-line, nondestructive evaluation. One of the first successful methods of this type was developed by Therma-Wave, Inc. of California. The method relies on using a laser to excite thermal waves in the test sample. Dopants, impurities and lattice imperfections in the sample affect the propagation of the thermal wave. Hence, a measurement of the thermal wave in the test sample, e.g., magnitude of the thermal wave, damping coefficients etc., give an indication of the sample properties. This method has been a very successful and has lead to the development of a variety of new in-situ contactless metrology tools.</PDAT></PTEXT></PARA>
<PARA ID="P-00009" LVL="0"><PTEXT><PDAT>Noncontact measurement of bulk wafer sheet-resistance was achieved through the use of eddy current loss measurements and is described, e.g., in U.S. Pat. No. 4,302,721 to Urbanek et al. If the wafer thickness is known, e.g., obtained from an ultrasonic test, then the sheet resistance of the wafer can be calculated without the need to make special test structures through a measurement of eddy current loss. Eddy current testers can measure the integrated sheet resistance on a bulk wafer or a highly conductive layer on top of a high resistivity substrate with a spatial resolution of 1 mm. In addition to measuring bulk sheet resistance, the eddy current method can be used for measuring bulk carrier lifetimes when combined with other measurement techniques. Unfortunately, eddy current testing can not provide specific information about the doping profile and carrier mobility separately. A resistance vs. depth profile can be generated but it does not give yield accurate measurements of carrier mobility at distances less than one Debye Length (L</PDAT><HIL><SB><PDAT>d</PDAT></SB></HIL><PDAT>) from the surface.</PDAT></PTEXT></PARA>
<PARA ID="P-00010" LVL="0"><PTEXT><PDAT>To obtain higher quality near surface metrology, standardized capacitance vs. voltage (C-V measurements) must be performed on MOS devices. This technique involves recording the capacitance of a MOS device versus the applied gate voltage. C-V measurements help to characterize both the charge state of a passivating gate oxide and the doping level of the silicon near the silicon dioxide interface. Traditionally, C-V measurements are performed on MOS test structures fabricated next to integrated circuit devices. More recently, mercury probes have been used to make a temporary metal contact of known area after the gate oxide is grown. After performing C-V measurements, the temporary mercury contact is removed from a wafer with a vacuum needle designed to retract the mercury. However, given the cross contamination concerns, the semiconductor industry usually discards these wafers after testing. More recent advances and techniques for performing C-V measurements can be found, e.g., in U.S. Pat. No. 5,065,103 to J. A. Slinkman et al. and other literature. Unfortunately, C-V test require significant surface preparation and can not be performed over active devices.</PDAT></PTEXT></PARA>
<PARA ID="P-00011" LVL="0"><PTEXT><PDAT>Surface photovoltage measurements (SPV) can also be used as a contactless method for probing semiconductor properties near the surface of a semiconductor wafer. In the SPV method the surface of the wafer being examined is illuminated with a sequence of high intensity laser pulses with a photon energy greater than the silicon bandgap. These pulses induce a change in the equilibrium carrier population in the conduction and valence band. This in turn leads to an oscillating photovoltage which can be capacitively sensed and then measured as a function of a DC voltage bias. Such surface photovoltage measurements can be used to measure carrier lifetimes, band bending and carrier concentration near the surface. Further information of the application of this method to sheet resistance measurements is found in U.S. Pat. No. 5,442,297 to Verkuil.</PDAT></PTEXT></PARA>
<PARA ID="P-00012" LVL="0"><PTEXT><PDAT>More recently, SPV measurements have been combined with a new measurement technique under the trademark Quantox, which relies on the deposition of ionized charge on the top layer of a gate oxide. The deposited charge is created using a corona method to ionize air molecules. The amount of charge that is deposited on the surface of the wafer can be inferred from a coulombmeter placed in series with the wafer chuck. By plotting the charge deposition versus the surface photovoltage, near surface doping and the trapped oxide charge density (interface trapped charge, mobile ionic charge and permanent charge densities) can be accurately determined.</PDAT></PTEXT></PARA>
<PARA ID="P-00013" LVL="0"><PTEXT><PDAT>Despite the above advances in the art, there is still a lack of effective methods for measuring a number of electronic properties of conductors in the near-surface region. Such measurements are especially important in measuring electronic properties such as carrier mobility of both majority and minority charge carriers in semiconductors very close to the surface. For example, at present there is no contactless in-situ method for the nondestructive evaluation of the near surface carrier mobility that can be used as a diagnostic tool prior to the testing of post-processed transistors. A nondestructive, contactless technique for determining the near surface carrier mobility and device characteristics related to mobility during the initial stages of fabrication would be a valuable metrology tool.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>OBJECTS AND ADVANTAGES</PDAT></STEXT></H>
<PARA ID="P-00014" LVL="0"><PTEXT><PDAT>In view of the above, it is a primary object of the invention to provide an apparatus and a method for measuring near-surface charge mobility in conductors across a dielectric. Specifically, it is an object of the invention to provide for contactless and non-destructive measurement of electronic properties of both minority and majority charge carriers in conductors. These measurements include electronic properties such as mobility, lifetime and surface resistivity in the region close to the conductor and dielectric interface.</PDAT></PTEXT></PARA>
<PARA ID="P-00015" LVL="0"><PTEXT><PDAT>It is another object of the invention to provide a nondestructive method of measuring electronic properties of various types of conductors including semiconductors and conducting polymers.</PDAT></PTEXT></PARA>
<PARA ID="P-00016" LVL="0"><PTEXT><PDAT>These and other objects and advantages will become apparent upon reading the detailed description.</PDAT></PTEXT></PARA>
<H LVL="1"><STEXT><PDAT>SUMMARY</PDAT></STEXT></H>
<PARA ID="P-00017" LVL="0"><PTEXT><PDAT>The objects and advantages of the invention are achieved by an apparatus using a resonator probe for determining an electronic property of a conductor across a dielectric. The resonator probe is positioned a certain distance from the conductor. The apparatus has a device for inducing lateral mechanical oscillations of the resonator probe and a voltage source for producing a voltage difference between the resonator probe and the conductor. The voltage difference creates an electronic drag between the conductor and resonator probe. The lateral oscillation of the resonator probe experiences a damping due to the electronic drag. A unit belonging to the apparatus determines the electronic property of the conductor from the damping of the oscillations of the resonator probe.</PDAT></PTEXT></PARA>
<PARA ID="P-00018" LVL="0"><PTEXT><PDAT>There are many possible devices for inducing mechanical oscillations of the resonator probe. For example, in one embodiment the device for inducing, the mechanical oscillations is a capacitive drive positioned near the resonator probe. Similarly, there are many units which can monitor the mechanical oscillations of the resonator probe. In one embodiment, the unit is an optical oscillation monitoring system. Furthermore, the oscillation monitoring unit conveniently includes logic or processing circuits for determining the damping and/or the Q-factor of the resonator probe. Also, in one embodiment of the invention, the apparatus is further equipped with a distance control for controlling and adjusting the distance between the resonator probe and the conductor.</PDAT></PTEXT></PARA>
<PARA ID="P-00019" LVL="0"><PTEXT><PDAT>The resonator probe in which the mechanical oscillations are induced can have various form factors. For example, the resonator probe can have one or more resonator members. In one embodiment, the resonator probe has two resonator members or arms extending parallel to each other thus forming a tuning fork. For measurements on millimeter scales, as is typically desired in industry, measurements can be performed using a piezoelectric tuning fork quartz oscillator using conventional electronic circuitry. In another embodiment, the resonator probe has only one resonator member in the form of a cantilever. Other designs can employ resonator members with more than two arms.</PDAT></PTEXT></PARA>
<PARA ID="P-00020" LVL="0"><PTEXT><PDAT>The voltage source of the apparatus is conveniently a versatile source capable of producing a positive and a negative voltage difference between the conductor and the resonator probe. This permits the user to study the electronic properties of both majority and minority charge carriers. The many properties which can be studied with the apparatus of the invention include parameters such as quantity of charge carriers, surface mobility of charge carriers, surface resistivity and charge carrier lifetime. These properties can be studied in conductors such as metal conductors, semiconductors and organic conductors. In any of these, the dielectric can be any dielectric or dielectric. layer including the naturally forming oxide layer or a layer such as passivation or protective layer purposely deposited on the conductor.</PDAT></PTEXT></PARA>
<PARA ID="P-00021" LVL="0"><PTEXT><PDAT>The method of the invention is practiced by first positioning the resonator probe above the dielectric and inducing lateral mechanical oscillations in the resonator probe. The voltage difference applied between the resonator probe and the conductor will affect the amount of electronic drag and hence the strength of the damping action. Thus, a comparison of the damping action at various voltage differences, e.g., no voltage difference and a particular voltage difference, yields information about the electronic drag and thereby about the electronic properties.</PDAT></PTEXT></PARA>
<PARA ID="P-00022" LVL="0"><PTEXT><PDAT>As mentioned above, the mechanical oscillations induced in the resonator probe can be applied by any suitable device. It should be noted, that in cases where air resistance plays a significant role in damping the oscillations the resonator probe can be operated in a vacuum.</PDAT></PTEXT></PARA>
<PARA ID="P-00023" LVL="0"><PTEXT><PDAT>The method of the invention is particularly useful for monitoring carrier mobility in the inversion layer underneath the gate-oxide prior to MOSFET fabrication. In addition to traditional silicon MOSFETs, the current method can be used to measure mobilities in conducting polymers used in organic semiconductor light emitting diodes and organic transistors.</PDAT></PTEXT></PARA>
<PARA ID="P-00024" LVL="0"><PTEXT><PDAT>The specifics of the apparatus and method of the invention as well as its applications are discussed in the detailed description in reference to the attached drawing figures.</PDAT></PTEXT></PARA>
</BTEXT>
</BRFSUM>
<DRWDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>BRIEF DESCRIPTION OF THE FIGURES</PDAT></STEXT></H>
<PARA ID="P-00025" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> is a plan sectional view illustrating an apparatus with a resonator probe having a single resonator member according to the invention.</PDAT></PTEXT></PARA>
<PARA ID="P-00026" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> is a graph illustrating the Q factor versus tip sample distance.</PDAT></PTEXT></PARA>
<PARA ID="P-00027" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 3</PDAT></FGREF><PDAT> is an image of a sample and the damping graph obtained for the sample using the apparatus of FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00028" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 4</PDAT></FGREF><PDAT> is a function of damping versus distance between resonant probe tip and sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00029" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> is a graph illustrating a relationship between surface damping, mobility and dopant density.</PDAT></PTEXT></PARA>
<PARA ID="P-00030" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 6</PDAT></FGREF><PDAT> is an isometric view illustrating another embodiment of the invention.</PDAT></PTEXT></PARA>
</BTEXT>
</DRWDESC>
<DETDESC>
<BTEXT>
<H LVL="1"><STEXT><PDAT>DETAILED DESCRIPTION</PDAT></STEXT></H>
<PARA ID="P-00031" LVL="0"><PTEXT><PDAT>The present invention provides a nondestructive, non-contact method for determining one or more electronic properties of charge carriers near an interface between a conductor and a dielectric. For example, the present method can be used to measure the charge carrier mobility near an interface between a conductor and a dielectric. The charge carriers can be majority or minority carriers such as electrons or holes.</PDAT></PTEXT></PARA>
<PARA ID="P-00032" LVL="0"><PTEXT><PDAT>An exemplary apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> for determining an electronic property of a conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> across a layer of a dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> is shown in FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>. Apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> has a resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> with a single resonator member </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. In this case the resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> is a micromechanical resonator and resonator member </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is a micromachined cantilever or microcantilever of length L and thickness t. For example, cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is an ultrathin single-crystal-silicon cantilever with L&equals;100 &mgr;m and t&equals;0.1 &mgr;m to 1.0 &mgr;m capable of measuring forces of less than 0.1 fN/Hz</PDAT><HIL><SP><PDAT>&minus;&frac12;</PDAT></SP></HIL><PDAT> at room temperature. Information on how to make such cantilevers can be found in literature such as T. Stowe, et al., </PDAT><HIL><ITALIC><PDAT>Attonewton Force Detection Using Ultrathin Silicon Cantilevers, </PDAT></ITALIC></HIL><PDAT>Applied Physics Letters, No. 71, 1997, pp. 288-90.</PDAT></PTEXT></PARA>
<PARA ID="P-00033" LVL="0"><PTEXT><PDAT>Conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> can be a metal conductor, a conductive polymer, a semiconductor, an organic conductor or any other conductor whose electronic properties are to be examined. In case conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is a metal, dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> can be the naturally forming oxide layer or any other dielectric. Of course, dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> can also be a passivating layer or a protective layer deposited on top of conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. For example, when conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is a semiconductor a protective layer of SiO</PDAT><HIL><SB><PDAT>2 </PDAT></SB></HIL><PDAT>is frequently used as dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>. In case conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is an organic material or a conductive polymer many types of dielectric materials can be used as a protective layer. A person skilled in the art will recognize that is some cases no layer of dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> will be present.</PDAT></PTEXT></PARA>
<PARA ID="P-00034" LVL="0"><PTEXT><PDAT>In addition to dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>, there is also a gap </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT> between cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. Gap </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT> is typically filled with an atmosphere, e.g., ambient air or a special gas. In some cases, gap </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT> is devoid of any gases. This is the case when the measurement of the electronic property or properties of conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is being performed in a vacuum. In any event, whether filled with a gas or under vacuum, gap </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT> also acts as a dielectric. Hence, the electrical property of conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is actually measured across two dielectrics in the present embodiment.</PDAT></PTEXT></PARA>
<PARA ID="P-00035" LVL="0"><PTEXT><PDAT>Resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> is positioned a certain distance D above conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> with the aid of a stage or distance control </PDAT><HIL><BOLD><PDAT>20</PDAT></BOLD></HIL><PDAT>. In particular, distance D is the distance between a tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> and an interface </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> between dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. A distance S is the distance between tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> and a surface </PDAT><HIL><BOLD><PDAT>24</PDAT></BOLD></HIL><PDAT> of dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>. Thus, the thickness of the first dielectric or, equivalently the size of gap </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT> is S and the thickness of the layer of dielectric </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT> is D-S.</PDAT></PTEXT></PARA>
<PARA ID="P-00036" LVL="0"><PTEXT><PDAT>In the present embodiment control </PDAT><HIL><BOLD><PDAT>20</PDAT></BOLD></HIL><PDAT> is a raising and lowering stage which moves resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> up and down along a vertical direction indicated by the z-axis. For good measurement resolution control </PDAT><HIL><BOLD><PDAT>20</PDAT></BOLD></HIL><PDAT> should preferably be capable of adjusting size S of gap </PDAT><HIL><BOLD><PDAT>15</PDAT></BOLD></HIL><PDAT> from a few tens of nanometers to several hundred nanometers.</PDAT></PTEXT></PARA>
<PARA ID="P-00037" LVL="0"><PTEXT><PDAT>Apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> has a device </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> for inducing lateral mechanical oscillations of resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT>, and specifically of its cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. In the present embodiment device </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> is a capacitive drive. Capacitive drive </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> has a voltage source </PDAT><HIL><BOLD><PDAT>28</PDAT></BOLD></HIL><PDAT> and a metal wire </PDAT><HIL><BOLD><PDAT>30</PDAT></BOLD></HIL><PDAT> on which an electrostatic charge can accumulate. The accumulation of electrostatic charge on wire </PDAT><HIL><BOLD><PDAT>28</PDAT></BOLD></HIL><PDAT> causes an opposite charge to accumulate on cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> in accordance with Coulomb&apos;s law and thus an electrostatic drive force F</PDAT><HIL><SB><PDAT>D </PDAT></SB></HIL><PDAT>is applied to cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. Other suitable methods of delivering a drive force to cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> include piezoelectric actuation and resonant thermal techniques.</PDAT></PTEXT></PARA>
<PARA ID="P-00038" LVL="0"><PTEXT><PDAT>Apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> has a unit </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> for monitoring the lateral mechanical oscillations of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> of resonant probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT>. A person skilled in the art will recognize that numerous types of methods including optical, electronic or acoustic can be employed for this purpose. In the present embodiment unit </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> is an optical oscillation monitoring system, and specifically an optical interferometer. Interferometer </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> has a fiber </PDAT><HIL><BOLD><PDAT>36</PDAT></BOLD></HIL><PDAT> for illuminating cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> with a test light </PDAT><HIL><BOLD><PDAT>40</PDAT></BOLD></HIL><PDAT> and receiving a scattered light </PDAT><HIL><BOLD><PDAT>42</PDAT></BOLD></HIL><PDAT> from cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. Interferometer </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> employs standard interferometric techniques to determine the mechanical oscillations of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> by comparing the phase of test light </PDAT><HIL><BOLD><PDAT>40</PDAT></BOLD></HIL><PDAT> with the phase of scattered light </PDAT><HIL><BOLD><PDAT>42</PDAT></BOLD></HIL><PDAT>. Interferometer </PDAT><HIL><BOLD><PDAT>34</PDAT></BOLD></HIL><PDAT> also has a logic or processing unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> for processing the information obtained from the interferometric measurements. Unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> can be a dedicated logic circuit or a computer.</PDAT></PTEXT></PARA>
<PARA ID="P-00039" LVL="0"><PTEXT><PDAT>A voltage source </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> is provided for producing a voltage difference between resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. In this embodiment voltage source </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> delivers a voltage V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>and is connected directly to conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. Resonator probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> is connected to ground. Source </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> is preferably adjustable and capable of producing positive and negative voltages V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>with respect to ground to thus set up positive and negative voltage differences (biases) ranging from &plus;V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>to &minus;V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>between probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00040" LVL="0"><PTEXT><PDAT>The application of voltage difference V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>between cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> induces a charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> of charge carriers </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT>. Depending on whether voltage difference V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>is positive or negative, charge carriers </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> are majority or minority charge carriers. The amount of electric charge q accumulated in distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> is proportional to voltage difference V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>, with the proportionality constant being a capacitance C between tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>, or q&equals;CV</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>. The depth of charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> is governed by a screening length L</PDAT><HIL><SB><PDAT>d</PDAT></SB></HIL><PDAT>, also known as the Debye length, in this case extending from interface </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> into conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. Charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> has a radius &eegr; governed by distance D between tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> and interface </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> to conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>, as well as the radius of curvature of tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> indicated in </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 1</PDAT></FGREF><PDAT> by R.</PDAT></PTEXT></PARA>
<PARA ID="P-00041" LVL="0"><PTEXT><PDAT>In accordance with the invention, an electronic property or properties of conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> are determined from the electromechanical coupling or electronic drag between cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> and charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT>. The electronic drag is experienced by charges </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> when cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is moved. Charges </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> follow the motion of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> by generating a surface current i. Surface current i of charges </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> experiences a resistance r in conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> and hence energy is lost. In particular, energy is lost by charges </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> to conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> in a process frequently referred to as Ohmic heating. The energy lost to Ohmic heating is extracted from the energy of moving cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. In other words, cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> experiences a breaking action or damping action on its movements because of Ohmic heating.</PDAT></PTEXT></PARA>
<PARA ID="P-00042" LVL="0"><PTEXT><PDAT>To measure an electronic property of conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> in the present embodiment drive force F</PDAT><HIL><SB><PDAT>D </PDAT></SB></HIL><PDAT>is applied along a lateral direction indicated by the x-axis. The application of drive force F</PDAT><HIL><SB><PDAT>D </PDAT></SB></HIL><PDAT>along this direction causes cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> to undergo lateral mechanical oscillations about its rest position. The oscillatory motion of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is indicated in dashed lines. The electronic drag between cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> dampens these lateral oscillations as charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> follows the oscillatory movement of tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> as indicated in dashed lines.</PDAT></PTEXT></PARA>
<PARA ID="P-00043" LVL="0"><PTEXT><PDAT>In order to eliminate the effect of other damping sources acting on cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> as much as possible it is convenient to set up drive </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> to drive cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> at or near one of its resonance frequencies (e.g., the fundamental or lowest resonance frequency) at a controlled amplitude. In situations where damping caused by the atmosphere has a significant effect on lateral oscillations of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> the measurement can be performed in vacuum. In fact, apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> can be encapsulated in a vacuum if damping due to external influences is to be minimized. It is also possible to encapsulate only resonant probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> in a vacuum for the same purpose.</PDAT></PTEXT></PARA>
<PARA ID="P-00044" LVL="0"><PTEXT><PDAT>The damping due to movement of charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> is proportional to the power losses inside conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. Thus, a ring down or decay of the lateral oscillations of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is proportional to the damping caused by electronic drag. The power loss P inside conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is related to surface resistance r and current i by the well-know formula P&equals;i</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>r. This means that damping due to electronic drag increases with increasing surface resistance. Hence, surface resistance can be derived from electronic drag, as explained in more detail below.</PDAT></PTEXT></PARA>
<PARA ID="P-00045" LVL="0"><PTEXT><PDAT>Determination of the damping caused by charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> can be performed in several ways. In accordance with a convenient approach, cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is set into lateral oscillatory motion at a frequency &ohgr;</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>by drive </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT>. Frequency &ohgr;</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>is preferably a resonant frequency of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. No voltage difference, V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>&equals;0, is applied by source </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> between probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. The ring down or decay of lateral oscillations is not affected by damping due to electronic drag in this situation. Instead, any other damping forces present, e.g., air resistance, will cause the oscillatory movement of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> to decay or ring down. This ring down rate at zero voltage difference can be used as a baseline measurement.</PDAT></PTEXT></PARA>
<PARA ID="P-00046" LVL="0"><PTEXT><PDAT>In a second step, voltage difference, V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>&equals;V, is applied between probe </PDAT><HIL><BOLD><PDAT>16</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> by source </PDAT><HIL><BOLD><PDAT>32</PDAT></BOLD></HIL><PDAT> while cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is set into lateral oscillatory motion at frequency &ohgr;</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>by drive </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT>. Now the ring down rate of the oscillations of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is much higher, since cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> also experiences damping caused by electronic drag. A comparison of the ring down rate at voltage difference V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>&equals;V with the baseline at zero voltage difference V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>&equals;0 is now used by processing unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> to calculate the damping action due to electronic-drag alone. In fact, unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> can just subtract the baseline from the ring down rate at V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>&equals;V to obtain the damping due to electronic drag alone.</PDAT></PTEXT></PARA>
<PARA ID="P-00047" LVL="0"><PTEXT><PDAT>Another approach to determining the damping caused by charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> can be based on continuously driving cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> to oscillate at resonant frequency &ohgr;</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>. In this case no ring down time is measured. Instead, processing unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> calculates the amount of power required by drive </PDAT><HIL><BOLD><PDAT>26</PDAT></BOLD></HIL><PDAT> to maintain cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> oscillating at constant amplitude. This power is proportional to the power dissipated due to electronic drag and other damping forces. A baseline measurement can be used by unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> to subtract the baseline and obtain the power losses due to electronic drag alone.</PDAT></PTEXT></PARA>
<PARA ID="P-00048" LVL="0"><PTEXT><PDAT>It should be noted that several values of voltage difference V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>and/or oscillation amplitudes of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> can be used with any approach to determine the damping due to electronic drag. However, it is preferable to maintain the oscillation frequency &ohgr;</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> below a value at which charge distribution </PDAT><HIL><BOLD><PDAT>46</PDAT></BOLD></HIL><PDAT> is no longer able to keep pace with the motion of tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT>. In other words, the effective RC time constant for the motion of charges </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> below tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> should be shorter than 1/&ohgr;</PDAT><HIL><SB><PDAT>o</PDAT></SB></HIL><PDAT>. When this is no longer the case, cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> with a longer length L and hence a lower resonant frequency &ohgr;</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>can be used.</PDAT></PTEXT></PARA>
<PARA ID="P-00049" LVL="0"><PTEXT><PDAT>In accordance with yet another approach, the damping produced by electronic drag is determined by measuring the quality factor also referred to as the Q factor of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. For example, the Q factor can be determined from a measurement of the ring down time at various distances D set by stage </PDAT><HIL><BOLD><PDAT>20</PDAT></BOLD></HIL><PDAT> between tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>. </PDAT><FGREF ID="DRAWINGS"><PDAT>FIG. 2</PDAT></FGREF><PDAT> shows a plot of Q factor versus distance D for the case where conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is a silicon semiconductor material without a dielectric layer </PDAT><HIL><BOLD><PDAT>14</PDAT></BOLD></HIL><PDAT>. The plot is obtained by progressively approaching cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> to conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00050" LVL="0"><PTEXT><PDAT>The total damping &ggr; experienced by cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> can be calculated by unit </PDAT><HIL><BOLD><PDAT>44</PDAT></BOLD></HIL><PDAT> from Q measurements based on the equation: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00001">
<MATHEMATICA ID="MATHEMATICA-00001" ALT="mathematica file" FILE="US06489776-20021203-M00001.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>&gamma;</mi>
          <mo>=</mo>
          <mfrac>
            <mi>k</mi>
            <mrow>
              <msub>
                <mi>&omega;</mi>
                <mi>o</mi>
              </msub>
              <mo>&it;</mo>
              <mi>Q</mi>
            </mrow>
          </mfrac>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>1</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00001" ALT="embedded image" FILE="US06489776-20021203-M00001.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00051" LVL="7"><PTEXT><PDAT>where k is the spring constant of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. Using this relationship, the surface-induced damping &ggr;</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>can be found by subtracting out the baseline or intrinsic damping of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> in accordance to: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00002">
<MATHEMATICA ID="MATHEMATICA-00002" ALT="mathematica file" FILE="US06489776-20021203-M00002.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msub>
            <mi>&gamma;</mi>
            <mi>s</mi>
          </msub>
          <mo>=</mo>
          <mrow>
            <mfrac>
              <mi>k</mi>
              <msub>
                <mi>&omega;</mi>
                <mi>o</mi>
              </msub>
            </mfrac>
            <mo>&it;</mo>
            <mrow>
              <mo>(</mo>
              <mrow>
                <mfrac>
                  <mn>1</mn>
                  <mi>Q</mi>
                </mfrac>
                <mo>-</mo>
                <mfrac>
                  <mn>1</mn>
                  <msub>
                    <mi>Q</mi>
                    <mi>o</mi>
                  </msub>
                </mfrac>
              </mrow>
              <mo>)</mo>
            </mrow>
          </mrow>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>2</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00002" ALT="embedded image" FILE="US06489776-20021203-M00002.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00052" LVL="7"><PTEXT><PDAT>where Q</PDAT><HIL><SB><PDAT>o </PDAT></SB></HIL><PDAT>is the intrinsic value of cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> Q factor obtained far away from the surface of conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00053" LVL="0"><PTEXT><PDAT>The computation of damping due to electronic drag and electronic properties derived therefrom are now explained based on a study of a sample </PDAT><HIL><BOLD><PDAT>50</PDAT></BOLD></HIL><PDAT> of p</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>/p grated silicon as shown in FIG. </PDAT><HIL><BOLD><PDAT>3</PDAT></BOLD></HIL><PDAT>. Sample </PDAT><HIL><BOLD><PDAT>50</PDAT></BOLD></HIL><PDAT> is measured by apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> and yields the damping image illustrated in FIG. </PDAT><HIL><BOLD><PDAT>4</PDAT></BOLD></HIL><PDAT>. The lightly doped, high resistivity p-region has much higher damping than the heavily doped p</PDAT><HIL><SP><PDAT>&plus;</PDAT></SP></HIL><PDAT>-region. The doping dependence of the damping behavior can be understood by examining the dynamics of the flow of charge i beneath tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT>. As tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> moves across sample </PDAT><HIL><BOLD><PDAT>50</PDAT></BOLD></HIL><PDAT>, the induced current i is proportional to &ngr;q/&eegr;, where &ngr; is the velocity of tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> and q/&eegr; is related to the linear density of induced charge along the direction of motion of tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT>. Since the induced charge is q&equals;CV</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>, as explained above, the current i obeys the following relation: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00003">
<MATHEMATICA ID="MATHEMATICA-00003" ALT="mathematica file" FILE="US06489776-20021203-M00003.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>i</mi>
        <mo>&Proportional;</mo>
        <mrow>
          <mfrac>
            <mrow>
              <mi>v</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>C</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msub>
                <mi>V</mi>
                <mi>S</mi>
              </msub>
            </mrow>
            <mi>&eta;</mi>
          </mfrac>
          <mo>.</mo>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>3</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00003" ALT="embedded image" FILE="US06489776-20021203-M00003.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00054" LVL="0"><PTEXT><PDAT>In general, the rate at which mechanical energy is removed from cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT> is &minus;&frac12;&ggr;</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><PDAT>&ngr;</PDAT><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>and is equal to the i</PDAT><HIL><SP><PDAT>2</PDAT></SP></HIL><PDAT>r power losses in sample </PDAT><HIL><BOLD><PDAT>50</PDAT></BOLD></HIL><PDAT>. Consequently, the damping due to electronic drag is given by: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00004">
<MATHEMATICA ID="MATHEMATICA-00004" ALT="mathematica file" FILE="US06489776-20021203-M00004.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&gamma;</mi>
          <mi>s</mi>
        </msub>
        <mo>&Proportional;</mo>
        <mrow>
          <msup>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <mi>C</mi>
                  <mo>&it;</mo>
                  <mstyle>
                    <mtext>&emsp;</mtext>
                  </mstyle>
                  <mo>&it;</mo>
                  <msub>
                    <mi>V</mi>
                    <mi>S</mi>
                  </msub>
                </mrow>
                <mi>&eta;</mi>
              </mfrac>
              <mo>)</mo>
            </mrow>
            <mn>2</mn>
          </msup>
          <mo>&it;</mo>
          <mrow>
            <mi>r</mi>
            <mo>.</mo>
          </mrow>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>4</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00004" ALT="embedded image" FILE="US06489776-20021203-M00004.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00055" LVL="0"><PTEXT><PDAT>A person skilled in the art will recognize that for any particular sample the proportionality constant in relation (4) will generally differ and should be determined separately. Additionally, relationship (4) holds within a certain range of distances D of tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> from sample </PDAT><HIL><BOLD><PDAT>50</PDAT></BOLD></HIL><PDAT>.</PDAT></PTEXT></PARA>
<PARA ID="P-00056" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> shows the distance and voltage dependence of the damping over a typical silicon sample. Far away from the sample surface (D&gt;100 nm), the damping has the V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>dependence in accordance with relation (4). However, close to sample surface (D&lt;50 nm) the V</PDAT><HIL><SB><PDAT>S</PDAT></SB></HIL><HIL><SP><PDAT>2 </PDAT></SP></HIL><PDAT>dependence no longer holds. A person skilled in the art will recognize that these general guidelines provided by relation (4) can be experimentally obtained for each sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00057" LVL="0"><PTEXT><PDAT>The effective resistance r can be approximated by using the well-known macroscopic relation: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00005">
<MATHEMATICA ID="MATHEMATICA-00005" ALT="mathematica file" FILE="US06489776-20021203-M00005.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <mi>r</mi>
          <mo>=</mo>
          <mfrac>
            <mi>L</mi>
            <mrow>
              <mi>&sigma;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <mi>A</mi>
            </mrow>
          </mfrac>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(5a)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00005" ALT="embedded image" FILE="US06489776-20021203-M00005.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00058" LVL="7"><PTEXT><PDAT>where L is the distance through which instantaneous current i flows and A is the cross-sectional area through which current i passes and &sgr; is the conductivity. Since current i instantaneously flows through a distance given by the width of charge distribution </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> or 2&eegr; (see FIG. </PDAT><HIL><BOLD><PDAT>1</PDAT></BOLD></HIL><PDAT>), L&prop;2&eegr; and since A&prop;2&eegr;L</PDAT><HIL><SB><PDAT>d</PDAT></SB></HIL><PDAT>, the effective resistance in equation (4) can be rewritten as: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00006">
<MATHEMATICA ID="MATHEMATICA-00006" ALT="mathematica file" FILE="US06489776-20021203-M00006.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mi>r</mi>
        <mo>=</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mrow>
              <mi>&sigma;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msub>
                <mi>L</mi>
                <mi>d</mi>
              </msub>
            </mrow>
          </mfrac>
          <mo>.</mo>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(5b)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00006" ALT="embedded image" FILE="US06489776-20021203-M00006.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00059" LVL="0"><PTEXT><PDAT>When conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> being tested is a doped sample, then both &sgr; and L</PDAT><HIL><SB><PDAT>d </PDAT></SB></HIL><PDAT>are functions of the doping concentration N when the charge carrier density is not significantly perturbed by band bending near the surface. The conductivity is then given by:</PDAT></PTEXT></PARA>
<PARA ID="P-00060" LVL="0"><PTEXT><F><PTEXT><PDAT>&sgr;&equals;</PDAT><HIL><ITALIC><PDAT>e&mgr;N,</PDAT></ITALIC></HIL><PDAT>&emsp;&emsp;(6)</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00061" LVL="7"><PTEXT><PDAT>where e is the charge of charge carriers </PDAT><HIL><BOLD><PDAT>48</PDAT></BOLD></HIL><PDAT> and &mgr; is their mobility. The Debye length, L</PDAT><HIL><SB><PDAT>d</PDAT></SB></HIL><PDAT>, is also a function of doping concentration N and is given by: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00007">
<MATHEMATICA ID="MATHEMATICA-00007" ALT="mathematica file" FILE="US06489776-20021203-M00007.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <mrow>
          <msub>
            <mi>L</mi>
            <mi>d</mi>
          </msub>
          <mo>=</mo>
          <msup>
            <mrow>
              <mo>(</mo>
              <mfrac>
                <mrow>
                  <msub>
                    <mi>&varepsilon;</mi>
                    <mi>s</mi>
                  </msub>
                  <mo>&it;</mo>
                  <msub>
                    <mi>&varepsilon;</mi>
                    <mi>o</mi>
                  </msub>
                  <mo>&it;</mo>
                  <msub>
                    <mi>&varepsilon;</mi>
                    <mi>b</mi>
                  </msub>
                  <mo>&it;</mo>
                  <mi>T</mi>
                </mrow>
                <mrow>
                  <msup>
                    <mi>e</mi>
                    <mn>2</mn>
                  </msup>
                  <mo>&it;</mo>
                  <mi>N</mi>
                </mrow>
              </mfrac>
              <mo>)</mo>
            </mrow>
            <mrow>
              <mn>1</mn>
              <mo>/</mo>
              <mn>2</mn>
            </mrow>
          </msup>
        </mrow>
        <mo>,</mo>
      </mrow>
    </mtd>
    <mtd>
      <mrow>
        <mo>(</mo>
        <mn>7</mn>
        <mo>)</mo>
      </mrow>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00007" ALT="embedded image" FILE="US06489776-20021203-M00007.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00062" LVL="7"><PTEXT><PDAT>where k</PDAT><HIL><SB><PDAT>b</PDAT></SB></HIL><PDAT>T is the thermal energy.</PDAT></PTEXT></PARA>
<PARA ID="P-00063" LVL="0"><PTEXT><PDAT>From these relations it follows that the damping due to electronic drag at a fixed voltage difference V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>and a fixed distance D between tip </PDAT><HIL><BOLD><PDAT>22</PDAT></BOLD></HIL><PDAT> and conductor </PDAT><HIL><BOLD><PDAT>12</PDAT></BOLD></HIL><PDAT> is: </PDAT>
<CWU>
<MATH-US ID="MATH-US-00008">
<MATHEMATICA ID="MATHEMATICA-00008" ALT="mathematica file" FILE="US06489776-20021203-M00008.NB"/>
<MATHML>
<math>
<mtable>
  <mtr>
    <mtd>
      <mrow>
        <msub>
          <mi>&gamma;</mi>
          <mi>s</mi>
        </msub>
        <mo>&Proportional;</mo>
        <mrow>
          <mfrac>
            <mn>1</mn>
            <mrow>
              <mi>&mu;</mi>
              <mo>&it;</mo>
              <mstyle>
                <mtext>&emsp;</mtext>
              </mstyle>
              <mo>&it;</mo>
              <msup>
                <mi>N</mi>
                <mrow>
                  <mn>1</mn>
                  <mo>/</mo>
                  <mn>2</mn>
                </mrow>
              </msup>
            </mrow>
          </mfrac>
          <mo>.</mo>
        </mrow>
      </mrow>
    </mtd>
    <mtd>
      <mstyle>
        <mtext>(8a)</mtext>
      </mstyle>
    </mtd>
  </mtr>
</mtable>
</math>
</MATHML>
<EMI ID="EMI-M00008" ALT="embedded image" FILE="US06489776-20021203-M00008.TIF"/>
</MATH-US>
</CWU>
</PTEXT></PARA>
<PARA ID="P-00064" LVL="0"><PTEXT><PDAT>This relationship can also be expressed on a log-log plot as:</PDAT></PTEXT></PARA>
<PARA ID="P-00065" LVL="0"><PTEXT><F><PTEXT><PDAT>log(&ggr;</PDAT><HIL><SB><PDAT>s</PDAT></SB></HIL><PDAT>&mgr;)&equals;&minus;&frac12;log(</PDAT><HIL><ITALIC><PDAT>N</PDAT></ITALIC></HIL><PDAT>)&plus;constant.&emsp;&emsp;(8b)</PDAT></PTEXT></F></PTEXT></PARA>
<PARA ID="P-00066" LVL="7"><PTEXT><PDAT>This relationship was confirmed by measuring damping &ggr;</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>due to electric drag with apparatus </PDAT><HIL><BOLD><PDAT>10</PDAT></BOLD></HIL><PDAT> in several uniformly doped n-type and p-type silicon wafers at a fixed distance D&equals;300 nm using cantilever </PDAT><HIL><BOLD><PDAT>18</PDAT></BOLD></HIL><PDAT>. Doping levels were independently determined using four point probe, measurements. Values for electron mobility (n-type) and hole mobility (p-type) were determined from well-known functions of the measured doping density. For additional information on these functions the reader is referred to Sze, </PDAT><HIL><ITALIC><PDAT>Physics of Semiconductor Devices, </PDAT></ITALIC></HIL><PDAT>2nd edition, 1981, Chapter 7, pp. 362-379.</PDAT></PTEXT></PARA>
<PARA ID="P-00067" LVL="0"><PTEXT><FGREF ID="DRAWINGS"><PDAT>FIG. 5</PDAT></FGREF><PDAT> is a plot of the measured relationship between damping &ggr;</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>due to electronic drag, charge carrier mobility and doping density. Clearly, the method of invention works well over the range of doping concentrations from 10</PDAT><HIL><SP><PDAT>14 </PDAT></SP></HIL><PDAT>to 10</PDAT><HIL><SP><PDAT>18 </PDAT></SP></HIL><PDAT>cm</PDAT><HIL><SP><PDAT>&minus;3</PDAT></SP></HIL><PDAT>. Thus, electronic drag has a direct correlation to the doping concentration in the sample.</PDAT></PTEXT></PARA>
<PARA ID="P-00068" LVL="0"><PTEXT><PDAT>Another embodiment of an apparatus </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> for measuring electronic parameters of charge carriers </PDAT><HIL><BOLD><PDAT>102</PDAT></BOLD></HIL><PDAT> is illustrated in FIG. </PDAT><HIL><BOLD><PDAT>6</PDAT></BOLD></HIL><PDAT>. Apparatus </PDAT><HIL><BOLD><PDAT>100</PDAT></BOLD></HIL><PDAT> has a resonator probe </PDAT><HIL><BOLD><PDAT>104</PDAT></BOLD></HIL><PDAT> with two resonant members </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> in the form of parallel arms of length L and thickness t. In fact, members </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> form a tuning fork </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT>. For measurements on millimeter scales, as is typically desired in industry, tuning fork </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is a piezoelectric tuning fork quartz oscillator with conventional electronic circuitry.</PDAT></PTEXT></PARA>
<PARA ID="P-00069" LVL="0"><PTEXT><PDAT>Conductive traces or metal lines </PDAT><HIL><BOLD><PDAT>112</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>114</PDAT></BOLD></HIL><PDAT> provided in members </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> which are made of non-conductive quartz lead to conducting plates or capacitive plates </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> respectively. Plates </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> terminate tips </PDAT><HIL><BOLD><PDAT>120</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>122</PDAT></BOLD></HIL><PDAT> of members </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> and are substantially flat. Because of their geometry, plates </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> provide for a large capacitance between them and conductor </PDAT><HIL><BOLD><PDAT>124</PDAT></BOLD></HIL><PDAT> positioned a distance D below them than the capacitance obtained in the previous embodiment using a cantilever with a rounded tip.</PDAT></PTEXT></PARA>
<PARA ID="P-00070" LVL="0"><PTEXT><PDAT>Tuning fork </PDAT><HIL><BOLD><PDAT>110</PDAT></BOLD></HIL><PDAT> is supported by a tuning fork support </PDAT><HIL><BOLD><PDAT>126</PDAT></BOLD></HIL><PDAT>. A voltage source </PDAT><HIL><BOLD><PDAT>128</PDAT></BOLD></HIL><PDAT> is provided to supply the voltage for establishing a voltage difference between conductor </PDAT><HIL><BOLD><PDAT>124</PDAT></BOLD></HIL><PDAT> and plates </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT> and </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT>. Conductor </PDAT><HIL><BOLD><PDAT>124</PDAT></BOLD></HIL><PDAT> is connected to ground.</PDAT></PTEXT></PARA>
<PARA ID="P-00071" LVL="0"><PTEXT><PDAT>In this embodiment conductor </PDAT><HIL><BOLD><PDAT>124</PDAT></BOLD></HIL><PDAT> is not covered with a dielectric. Gaps </PDAT><HIL><BOLD><PDAT>126</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>128</PDAT></BOLD></HIL><PDAT> between plates </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> are the only dielectric across which the measurement is performed.</PDAT></PTEXT></PARA>
<PARA ID="P-00072" LVL="0"><PTEXT><PDAT>During measurement electric drag is produced by charge distributions </PDAT><HIL><BOLD><PDAT>130</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>132</PDAT></BOLD></HIL><PDAT> induced under plates </PDAT><HIL><BOLD><PDAT>116</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>118</PDAT></BOLD></HIL><PDAT> when voltage difference V</PDAT><HIL><SB><PDAT>S </PDAT></SB></HIL><PDAT>is established between the plates and conductor </PDAT><HIL><BOLD><PDAT>124</PDAT></BOLD></HIL><PDAT>. Lateral oscillations along the x-axis of resonant members </PDAT><HIL><BOLD><PDAT>106</PDAT></BOLD></HIL><PDAT>, </PDAT><HIL><BOLD><PDAT>108</PDAT></BOLD></HIL><PDAT> are damped by the electronic drag, in accordance to the principles described above.</PDAT></PTEXT></PARA>
<PARA ID="P-00073" LVL="0"><PTEXT><PDAT>It should be noted that the method of invention can be used in conjunction with other methods, e.g., the C-V method to further improve the ability to determine electronic properties of the charge carriers near the surface of conductors.</PDAT></PTEXT></PARA>
<PARA ID="P-00074" LVL="0"><PTEXT><PDAT>The method of the invention is particularly useful for monitoring carrier mobility in the inversion layer underneath the gate-oxide prior to MOSFET fabrication. In addition to traditional silicon MOSFETs, the current method can be used to measure mobilities in conducting polymers used in organic semiconductor light emitting diodes and organic transistors.</PDAT></PTEXT></PARA>
<PARA ID="P-00075" LVL="0"><PTEXT><PDAT>The method and apparatus of invention are not limited to the above-described embodiment. For example, other designs can employ resonator members with more than two arms. The resonant member can be made in the form of a doubly supported ribbon or bridge. The manner of making such structures and their mechanics are known in the art.</PDAT></PTEXT></PARA>
<PARA ID="P-00076" LVL="0"><PTEXT><PDAT>The design of the apparatus can include micromachined resonators and can be made of materials with a high Q factor. Such materials include quartz, single-crystal silicon, polysilicon, GaAs and other materials. The design could also include integrated excitation and position sensing rather than separate drive and oscillation monitoring units. For example, piezoelectric devices can be used for piezoelectric excitation of mechanical oscillations and piezoresistive sensing. Therefore, the scope of the invention should be determined according to the appended claims and their legal equivalents.</PDAT></PTEXT></PARA>
</BTEXT>
</DETDESC>
</SDODE>
<SDOCL>
<H LVL="1"><STEXT><PDAT>We claim: </PDAT></STEXT></H>
<CL>
<CLM ID="CLM-00001">
<PARA ID="P-00077" LVL="0"><PTEXT><PDAT>1. An apparatus for determining an electronic property of a conductor across a dielectric, said apparatus comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a) a resonator probe for positioning a predetermined distance from said conductor; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>b) a means for inducing lateral mechanical oscillations in said resonator probe; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>c) a voltage source for producing a voltage difference between said resonator probe and said conductor to create an electronic drag between said conductor and said resonator probe, thereby causing a damping of said lateral mechanical oscillations; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>d) a means for determining said electronic property from said damping. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00002">
<PARA ID="P-00078" LVL="0"><PTEXT><PDAT>2. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said means for inducing said lateral mechanical oscillations comprises a capacitive drive or integrated piezoelectric devices.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00003">
<PARA ID="P-00079" LVL="0"><PTEXT><PDAT>3. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said means for determining said electronic property from said damping comprises an oscillation monitoring mechanism.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00004">
<PARA ID="P-00080" LVL="0"><PTEXT><PDAT>4. The apparatus of </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said oscillation monitoring mechanism comprises an optical oscillation monitoring system.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00005">
<PARA ID="P-00081" LVL="0"><PTEXT><PDAT>5. The apparatus of </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said oscillation monitoring mechanism comprises a processing circuit for determining said damping.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00006">
<PARA ID="P-00082" LVL="0"><PTEXT><PDAT>6. The apparatus of </PDAT><CLREF ID="CLM-00003"><PDAT>claim 3</PDAT></CLREF><PDAT>, wherein said oscillation monitoring mechanism comprises a processing circuit for determining the Q-factor of said resonator probe.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00007">
<PARA ID="P-00083" LVL="0"><PTEXT><PDAT>7. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, further comprising a distance control for controlling said predetermined distance between said resonator probe and said conductor.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00008">
<PARA ID="P-00084" LVL="0"><PTEXT><PDAT>8. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said resonator probe comprises at least one resonator member.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00009">
<PARA ID="P-00085" LVL="0"><PTEXT><PDAT>9. The apparatus of </PDAT><CLREF ID="CLM-00008"><PDAT>claim 8</PDAT></CLREF><PDAT>, wherein said resonator probe comprises two parallel resonator members forming a tuning fork.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00010">
<PARA ID="P-00086" LVL="0"><PTEXT><PDAT>10. The apparatus of </PDAT><CLREF ID="CLM-00008"><PDAT>claim 8</PDAT></CLREF><PDAT>, wherein said resonator probe comprises one resonator member in the form of a cantilever.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00011">
<PARA ID="P-00087" LVL="0"><PTEXT><PDAT>11. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said voltage source is a source for producing a positive voltage difference and a negative voltage difference.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00012">
<PARA ID="P-00088" LVL="0"><PTEXT><PDAT>12. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said electronic property is selected from the group consisting of quantity of charge carriers, surface mobility of charge carriers, surface resistivity and charge carrier lifetime.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00013">
<PARA ID="P-00089" LVL="0"><PTEXT><PDAT>13. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said conductor is selected from the group consisting of metal conductors, semiconductors, conducting polymers and organic conductors.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00014">
<PARA ID="P-00090" LVL="0"><PTEXT><PDAT>14. The apparatus of </PDAT><CLREF ID="CLM-00001"><PDAT>claim 1</PDAT></CLREF><PDAT>, wherein said dielectric is selected from the group consisting of air, oxides, passivation layers, protective layers.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00015">
<PARA ID="P-00091" LVL="0"><PTEXT><PDAT>15. A method for determining an electronic property of a conductor across a dielectric, said method comprising:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a) positioning a resonator probe a predetermined distance away from said conductor; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>b) inducing lateral mechanical oscillations in said resonator probe; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>c) producing a voltage difference between said resonator probe and said conductor such that an electronic drag is created between said conductor and said resonator probe, thereby causing a damping of said lateral mechanical oscillations; and </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>d) determining said electronic property from said damping. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00016">
<PARA ID="P-00092" LVL="0"><PTEXT><PDAT>16. The method of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, wherein said step of determining said electronic property comprises:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a) monitoring the damping action of said electronic drag; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>b) calculating said electronic property from said damping action. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00017">
<PARA ID="P-00093" LVL="0"><PTEXT><PDAT>17. The method of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, wherein said step of determining said electronic property comprises:</PDAT></PTEXT></PARA>
<CLMSTEP LVL="2"><PTEXT><PDAT>a) monitoring the Q-factor of said resonator probe; </PDAT></PTEXT></CLMSTEP>
<CLMSTEP LVL="2"><PTEXT><PDAT>b) calculating said electronic property from said Q-factor. </PDAT></PTEXT></CLMSTEP>
</CLM>
<CLM ID="CLM-00018">
<PARA ID="P-00094" LVL="0"><PTEXT><PDAT>18. The method of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, wherein said resonator probe is operated in a vacuum.</PDAT></PTEXT></PARA>
</CLM>
<CLM ID="CLM-00019">
<PARA ID="P-00095" LVL="0"><PTEXT><PDAT>19. The method of </PDAT><CLREF ID="CLM-00015"><PDAT>claim 15</PDAT></CLREF><PDAT>, wherein said resonator probe is encapsulated in a vacuum.</PDAT></PTEXT></PARA>
</CLM>
</CL>
</SDOCL>
<SDODR ID="DRAWINGS">
<EMI ID="EMI-D00000" ALT="embedded image" FILE="US06489776-20021203-D00000.TIF"/>
<EMI ID="EMI-D00001" ALT="embedded image" FILE="US06489776-20021203-D00001.TIF"/>
<EMI ID="EMI-D00002" ALT="embedded image" FILE="US06489776-20021203-D00002.TIF"/>
<EMI ID="EMI-D00003" ALT="embedded image" FILE="US06489776-20021203-D00003.TIF"/>
<EMI ID="EMI-D00004" ALT="embedded image" FILE="US06489776-20021203-D00004.TIF"/>
</SDODR>
</PATDOC>

